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Abstract 
Background 
Metastatic spinal cord compression (MSCC) can result in paralysis and is an 
oncology emergency.  Prognosis is poor if not treated early.  There are an 
estimated 1200-2500 new cases of MSCC per year in Scotland.  At 2013 there 
are limited studies which have explored the issues experienced by patients, 
carers and/or family members and healthcare professionals in the management 
of MSCC. 
Aim 
The aim of this study was to explore the perceptions and experiences of 
patients, carers and/or family members and healthcare professionals in the 
management of metastatic spinal cord compression. 
Research Design and Methods 
A case study design approach involving two phases was used.  Phase One 
involved three focus groups with healthcare professionals (n=25) and one-to-
one interviews with healthcare professionals (n=7).  Phase Two involved 
interviews with patients (n=8), carers (n=6) and healthcare professionals 
(n=42).  Patients and carers were interviewed twice over a period of six months.  
Braun and Clarke’s (2006) thematic inductive-data approach was used for data 
analysis. 
Findings 
Phase One identified an overarching theme of ‘negotiating the care pathway’ 
with four main themes: what can we do for patients with MSCC; what do we 
need to ‘trade-off’ to meet the needs of patients; how can guidelines help 
anyway; and how can we deliver optimum care in the midst of uncertainty?  The 
majority of healthcare professionals viewed the existing National Institute for 
Clinical Excellence (NICE) guidelines (2008) as inadequate and lacking in a 
strong evidence base.  Healthcare professionals acknowledged the importance 
of meeting the patient’s preferred needs and goals given the nature of this 
condition and the short life expectancy of many patients with MSCC.  Phase 
Two identified three main themes: facing uncertainty in MSCC; finding a 
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balance in MSCC and support beyond the treatment of MSCC.  A focus on 
acute management is often at odds with the palliative nature of the patient’s 
condition and this contributes to the complexity for patients, carers and 
healthcare professionals.  The findings demonstrate the intricacies of 
uncertainty which affect all the key stakeholders when MSCC presents.  There 
is a constant movement between uncertainty (of the future) and enduring 
inconsistencies (of information, treatment and advice for the future), which 
results in a struggle to find a balance.   
Conclusions 
Caring for patients with metastatic spinal cord compression is challenging with 
uncertainties surrounding the diagnosis of MSCC, spinal instability, treatment 
and support beyond the treatment of MSCC.  A theory of collaborative decision 
making based on the findings in this thesis is proposed to help reduce 
uncertainty and enable key stakeholders to make decisions in their journey with 
MSCC.   
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Glossary of terms 
 
AHP:  Allied Health Professionals: a health professional such as a 
physiotherapist (PT) or occupational therapist (OT) allied to 
medicine 
CT:   Computed Tomography 
DH:   Department of Health 
EOL:   End of Life  
EORTEC: The European Organisation for Research and Treatment of 
Cancer 
GP:  General Practitioner  
HCP:  Healthcare professionals  
IRAS:   Integrated Research Application System 
MDT:  Multidisciplinary Team  
MRI:  Magnetic Resonance Imaging 
MSCC:  Metastatic spinal cord compression (MSCC) – metastatic is a 
general term used to describe the spread of a cancer from some 
other location in the body.    
NHS:   National Health Service 
NICE:  National Institute of Clinical Governance 
PSA:  Prostate-Specific Antigen 
QOL:   Quality of Life 
QUORUM: Quality of reports of meta-analyses of randomised controlled trials 
RT:  Radiotherapy 
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Chapter 1: Introduction and background to the 
study 
1.1 Introduction 
This thesis is an exploration of the perceptions and experiences of patients, 
carers and/or family members and healthcare professionals in the management 
of metastatic spinal cord compression (MSCC).  The chapter starts with an 
account of my professional and personal interest in MSCC.  This is followed by 
a mapping of the local and national developments and changes in relation to the 
management of MSCC.  Within these changes, I focus on the rationale for a 
scoping exercise in two Scottish regions and how this current study fits in.  A 
brief summary of the pathology, diagnosis of, and treatment for MSCC are 
presented to provide the background to the study.  Finally, an outline of the 
chapters of the thesis is given. 
 
1.2 A professional and personal interest in MSCC 
In qualitative research, I feel it appropriate to write in the first person in order to 
explain the particular orientation I bring to this study (Webb 1992; Gilgun 2005).  
I acknowledge that I came to this study as a nurse having worked mainly in 
acute settings over the years.  However, during my last seven years experience 
working in an acute urology ward setting, I have personally struggled with how 
to care for patients with metastatic spinal cord compression.  In particular, I 
became interested in this condition because my previous discussions with 
colleagues revealed that a diagnosis of ‘spinal cord compression’ frightens 
people alarmingly.  However, once patients were diagnosed with metastatic 
spinal cord compression in a urology setting, they were normally transferred 
very quickly to the cancer centre for radiotherapy.  I could only think from my 
own perspective, how frightening all of this must be to them.  My colleagues and 
I have discussed patients with this condition and have often questioned whether 
we have met their true needs. 
 
My interest in research was formed over a number of years being involved in 
the development of a care pathway in transurethral resection of prostate 
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(TURP) and subsequently, in my Masters degree, I chose to evaluate two 
models of care in the management of acute urinary retention related to enlarged 
prostate.  The opportunity to enhance my understanding of metastatic spinal 
cord compression was timely when I was offered a studentship at Edinburgh 
Napier University, Scotland.  I acknowledge that the study was also driven by 
personal interest, as a family member had been diagnosed with cancer. 
 
1.3 Metastatic spinal cord compression: context of local and 
national developments 
In order to contextualise MSCC, it is necessary to provide firstly a definition and 
then outline the chronology of the Scottish and United Kingdom developments 
and changes that have taken place in relation to the management of MSCC.  
More specifically, I highlight where my study fits within these changes and 
provide the rationale for this study (Figure1). 
 
Often cancer can spread to the other areas of the body such as lungs, liver and 
bones.  Bone metastases to the spinal column are common and can compress 
the spinal cord and its surrounding structures (Aaron 1994; Bohm and Huber 
2002; Coleman 2006).  This necessitates immediate intervention to prevent 
permanent loss of neurological function.  Progression of MSCC in the spine can 
have a devastating impact on the patients and their families.  Metastatic spinal 
cord compression can be defined as:  
  
“…compression of the dural sac and its contents (spinal cord and/or 
cauda equina) by an extradural tumour mass.  The minimum radiological 
evidence is indentation of the theca at the level of clinical features.  
Clinical features include any or all of the following: pain (local or 
radicular), weakness, sensory disturbance and/or evidence of sphincter 
dysfunction.”  (Loblaw and Laperriere 1998:1613) 
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Figure 1: Chronology of the local and national developments of MSCC 
My Study 
  
 
  
* 
   
  
                                                                                       
   
                                                                                                            
  
 
          
Time line 
 
 
 
In the local context, a large prospective audit was conducted from January 1998 
to April 1999, to examine the management of patients with MSCC in Scotland 
by the Clinical Resource and Audit Group (CRAG) in three Scottish cancer 
centres; Aberdeen, Edinburgh and Glasgow.  The findings highlighted a lack of 
a referral process or clinical guidelines, causing delays in referral, diagnosis and 
treatment (Levack et al. 2001; 2002).  In addition there was a lack of early 
identification of signs and symptoms of MSCC in both acute and primary care 
services and a lack of awareness on the appropriate method of investigation to 
detect MSCC (Levack et al. 2001; 2002).   
                                                          
1 CRAG Audit (Levack et al.(2001); ² NOSCAN (North of Scotland Cancer Network); ³ WoSCAN 
(West of Scotland Cancer Network); 
4 
SCAN (South East Cancer Network) and 
5
 NICE 2008 
(National Institute of Clinical Excellence)  
1 
CRAG Audit (3 Scottish Cancer 
Centres – Aberdeen, Edinburgh & 
Glasgow) (Levack et al.2001) 
identified a need for guidelines  
3 
WoSCAN 
implemented 
‘regional guidelines’ 
Feb 2007 
1998/99           2003            2007            2008            2009            2013           
2
 NOSCAN implemented 
the ‘rapid hotline referral
system’ 2003 
5
 NICE guidelines on the 
management of MSCC 
implemented in Nov 2008 
4
 SCAN implemented 
the ‘local referral 
pathway’ Mar 2009 
Scoping exercise (Sep-Dec2007) 
West Scotland (with guidelines) 
East Scotland (no guidelines) 
Phase One  
(Jul 2009-Aug 2009) 
Phase Two  
(Sep 2009-Mar 2010) 
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Following the findings of Levack et al. (2001; 2002), the North of Scotland 
redesigned and implemented their service with a ‘rapid referral hotline system’ 
in 2003, where general practitioners, community nurses and hospital doctors 
refer patients suspected of MSCC to a designated senior clinician to discuss 
and arrange urgent MRI to improve the process of early diagnosis and 
treatment (Allan et al. 2009). 
 
In the West of Scotland, an audit was carried out to examine any improvements 
following the CRAG recommendations in relation to symptom recognition, multi-
professional care and rehabilitation of patients with MSCC (McLinton and 
Hutchison 2006).  The retrospective data on patients admitted with MSCC, 
highlights poor pain assessment, poor ambulatory status and lack of a clear 
course of action to initiate mobilisation and rehabilitation.  There was also a lack 
of a referral procedure for identifying patients suspected of MSCC.  As a result, 
a regional guideline on the management of MSCC was established in February 
2007 (McLinton and Hutchison 2006; Hutchison and Armstrong 2010). 
Within the South East of Scotland, a local referral pathway was implemented in 
March 2009 (Appendix 1: Lothian MSCC Referral Pathway).  An out-patient 
service with a protected MRI time slot for potential MSCC cases was piloted.  
SCAN MSCC audit from 2009 to 2010 showed improvements in patients 
remaining mobile on admission (Whigham 2012).  An information leaflet and 
DVD was developed and distributed to GP surgeries. 
 
As a result of the CRAG audit and subsequent developments (Levack et al. 
2001; 2002), the three Scottish cancer networks have agreed on a standardised 
dataset for auditing purposes.  An interactive DVD was developed and 
distributed to GP surgeries and clinical areas.  Update reports from the 
implementation of these guidelines and referral pathways have found 
improvements in early presentation of patients with better outcomes (Hutchison 
and Garrett 2011; Whigham 2012).  However, much work still remains with 
regards to referrals, education, patient positioning and mobilisation (Hutchison 
and Garrett 2011; Whigham 2012). 
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The national guidelines for the management of MSCC published Guideline 
CG75 (National Institute for Health and Clinical Excellence (NICE) 2008), aimed 
to improve the diagnosis and care of patients at risk of or with MSCC through 
the use of good evidence and a co-ordinated approach.  The guideline 
recommends that each cancer centre commission appropriate services for 
referral and management of patients with MSCC.  They recommend a single 
point of access to a MSCC co-ordinator who would then give clinicians advice 
and co-ordinate the care pathway. 
 
The Scottish Government recognised the improvement of cancer care as a 
priority and addressed some barriers through various national policies, such as 
Better Cancer Care: Action Plan (Scottish Government 2008; 2010) and Living 
and Dying well (Scottish Government 2011).  Having examined local and 
national developments in the management of MSCC, I now explain how my 
study contributes to the support and management of people affected by MSCC. 
1.3.1 Rationale for a scoping exercise 
There is little research into patients’, carers’ and healthcare professionals’ 
perspectives in how MSCC is managed and these avenues therefore require 
further exploration.  I undertook a scoping exercise, which involved individually 
interviewing 28 stakeholders on their current practice in two Scottish regions 
(West and East Scotland) from September 2007 to December 2007.  The 
stakeholders were those directly involved in the management and care of 
patients and included Oncologists, Neurosurgeons, Radiologists, Palliative 
Medical Consultants, Orthopaedic Consultants, a Spinal Surgeon, Registrars, 
Managers, Ward Sisters, Nurses, Clinical Nurse Specialists, Physiotherapists, 
Social Workers and Radiographers. 
1.3.2 Summary of findings from the scoping exercise 
 
The scoping exercise from both regions showed similar key issues: 
 Healthcare professionals in the acute setting perceived general 
practitioners lack identification of early symptoms of MSCC; 
 Delay in referrals and treatment; 
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 Inconsistent patient management in positioning, mobilising and 
rehabilitation; 
 Lack of verbal/written documentation of spinal stability / instability; 
 Limited access to Magnetic Resonance Imaging (MRI) facilities; 
 Limited use of bracing. 
In the West of Scotland, healthcare professionals identified a continuing delay in 
referrals despite the implementation of local guidelines (WoSCAN 2007) for 
MSCC in February 2007.  Some healthcare professionals felt that this 
information should be fed back to general practitioners in the region, while 
others said it was too early to see any difference from the implementation of 
local guidelines.  Some respondents suggested that educating patients and staff 
to recognise the early signs and symptoms of spinal cord compression was 
essential.  In the East of Scotland, the patient referral pathway from the general 
practitioner to the hospital was variable. 
 
Inconsistencies in patient management were reported despite one region 
having guidelines in place.  For example, respondents commented that 
instructions on whether ‘to bed-rest’ or ‘not to bed-rest’, were inconsistent for 
patients with suspected or confirmed MSCC.  Advice about commencement of 
ambulation varied from the day of admission to five days after five fractions of 
radiotherapy.  Decision making about positioning, mobilisation and rehabilitation 
was consultant led and sometimes their decisions conflicted with nursing 
management in relation to mobilisation to avoid complications such as chest 
infections, thrombotic episodes and caring for pressure areas.  Nursing staff 
and allied professionals reported that patients on bed-rest regularly complained 
of boredom, feeling undignified during toileting, and having difficulty eating, 
watching television or reading.  Nursing staff favoured early mobilisation but 
sometimes consultants considered early mobilisation might provoke a 
worsening of neurology, due to possible spinal instability. 
 
Assessing whether the spine is stable or unstable is a grey area.  There is 
difficulty in confirming spinal instability, as there are no agreed criteria.  Images 
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can only be reported as ‘not in alignment.’  Some clinicians expressed difficulty 
in interpreting images as they had not had any training while others said that a 
plain x-ray has a place for determining spinal stability in compression of the 
cervical region, but not in the thoracic or lumbar region.  There was a general 
absence of verbal or written documentation on the presence of spinal instability 
and this resulted in uncertainty and delays in mobilisation and rehabilitation. 
Some respondents felt MRI facilities were limited, especially on weekends, 
which meant a delay in treatment.  Some felt neurosurgeons were reluctant or 
overly cautious about operating on patients with MSCC, while some 
neurosurgeons considered that the quality of life of the patients would be poor. 
 
Most medical and nursing staff had limited experience in bracing.  Bracing is 
generally prescribed for patients with infections of the spinal cord, not 
malignancies.  There are differing opinions on bracing, as some respondents 
would fit a brace if the patient was not fit for surgery, and/or in cases with 
multiple site tumours, and/or with one or two column involvement.  Generally, 
staff said patients complained of bracing aggravating pain and found bracing 
cumbersome. 
 
This scoping exercise highlighted the variations in the management of patients 
with MSCC.  The next section presents the concerns about delays in diagnosis 
and interventions for MSCC. 
 
1.4 Pathology, clinical diagnosis, prognosis and treatment for 
MSCC 
The difficulty in determining an accurate incidence of MSCC has been well 
documented (Loblaw, Laperriere and Mackillop 2003; Schiff 2003; Cole and 
Patchell 2008; Mak et al. 2011).  A key population-based study carried out in 
Canada between 1990 and 1995, suggests that at least 2.5% (n= 3458) of all 
people with cancer experienced one or more episodes of spinal cord 
compression in the 5 years preceding death (Loblaw, Laperriere and Mackillop 
2003).   Post-mortem evidence indicates MSCC has a frequency of 5%-10% of 
all cancer cases (Barron et al. 1959).  Studies have shown that metastatic 
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epidural spinal cord compression can occur by haematogenous spread to 
vertebrae; direct epidural spread or via the lymphatic system (Boyce, Yoneda 
and Guise 1999; Maccauro et al. 2011).  Direct epidural invasion, from a 
paravertebral tumour through the inter-vertebral foramina, can cause 
compression of the spinal cord (Cole and Patchell 2008).  Lymphatic spread is 
rare.  
1.4.1 Origin of primary sites and spinal tumours  
Patients, who present with MSCC, often have primary tumours of the lungs, 
breast, and prostate (Helweg-Larsen 1996; Loblaw and Laperriere 1998; Mak et 
al. 2011).  Other less common causes are renal cell carcinoma, multiple 
myeloma, non-Hodgkin’s lymphoma, colorectal cancers, sarcomas and 
unknown primary tumours (Helweg-Larsen 1996).  Spinal tumour arises from 
inside the spinal cord (intramedullary) or outside the spinal cord 
(extramedullary) (Khanna et al. 2005).  Tumours can spread to the vertebral 
column or surrounding structures.  Figure 2 shows metastases to the vertebral 
column and the spinal cord. 
 
Figure 2: Metastatic invasion of the spinal cord (Armstrong 2006) 
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The thoracic spine is the region most commonly involved with metastasis 
(70%), followed by lumbo-sacral (20%) and cervical (10%) (Kilmo and Schmidt 
2004; Escalante et al. 2006).  More than 50% of patients with spinal metastasis 
have multiple level involvements (Togawa and Lewandrowsky 2006).  Lung, 
breast and lymphomatous metastases are more common in thoracic vertebrae; 
whereas renal, prostatic and rectal metastases are relatively more commonly 
found in the lumbo-sacral region (Boyce, Yoneda and Guise 1999; Mundy 
2002). 
1.4.2 Clinical diagnosis and prognosis 
A diagnosis of metastatic spinal cord compression is an oncological emergency.  
New onset of back or neck pain along with a history of cancer, is a red flag that 
should prompt urgent investigation (Cole and Patchell 2008; Mavrogenis et al. 
2009; Harel and Angelov 2010).  However, 10-23% of patients with MSCC have 
no prior diagnosis of malignancy (Sciubba et al. 2010; Quraishi and Esler 2011; 
Eastley, Newey and Ashford 2012).  The presentation of suspected MSCC can, 
however, be variable and depends on the vertebral level and the extent of 
involvement. 
 
The most common symptom of metastatic spinal cord compression is spinal 
pain which presents as the first symptom in 83%-95% of patients, and more 
than 96% of patients at diagnosis (Helweg-Larsen and Sorenson 1994; Levack 
et al. 2001).  It usually occurs at an average of 7 weeks before other 
neurological deficits (Levack, et al. 2002; Cole and Patchell 2008).  The three 
classic pain syndromes are: local, mechanical, and radicular pain (Sciubba et 
al. 2010).  Localised pain is confined to the region/segment of the spine that is 
affected by the metastatic disease.  Mechanical pain (also known as axial back-
pain) is aggravated with movement (axial loading of the spine) and can be 
relieved by lying down or in a supine position (Sciubba et al. 2010).  Mechanical 
pain often indicates impending or established spinal instability.  Vertebral body 
collapse may result in spinal instability.  Radicular pain is caused by 
compression or invasion of the nerve roots and follows a dermatomal 
distribution (Eleraky, Papanastassiou and Vrionis 2010).  Radicular pain is often 
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described as sharp, shooting or stabbing in nature (Sciubba et al. 2010).  Pain 
may be unilateral or bilateral. 
 
Motor weakness is the second most common symptom and occurs in 35%-75% 
of patients with MSCC (Bach et al. 1990; Helweg-Larsen and Sorenson, 1994).  
About 50%-68% of patients are unable to walk at the time of diagnosis.  
Autonomic symptoms occur late in the progression of MSCC and 50%-60% of 
patients suffer from bowel or bladder symptoms (Bach et al. 1990).  This 
presents quality of life issues when there are bowel or bladder disturbances and 
a poor prognostic sign for preservation or improvement of ambulation status 
(Cole and Patchell 2008). 
 
The prognosis for patients with MSCC is poor (Levack et al. 2001).  The median 
survival in different series ranges from 3-7 months (van der Linden et al. 2005; 
Cole and Patchell 2008).  In prostate and breast cancers, the survival is 
measurable in years, however, in lung cancer, the survival is measured in 
weeks or months (Coleman 2006).  Patients who are paralysed pre-treatment or 
post-treatment, have a shorter life expectancy compared to patients who are 
ambulant.  (Levack et al. 2001; Rades, Heidenreich and Karsten 2002). 
 
Rapid access to magnetic resonance imaging (MRI) of the whole spine has had 
a significant impact on patient management in MSCC (Schiff et al. 1998; Levack 
et al. 2002; Loblaw et al. 2005, NICE 2008) and is superior to all other imaging 
modalities (Li and Poon 1988; Colletti et al. 1996; Jacobs and Perrin 2001).  
Accordingly, MRI should be performed immediately or within 24 hours for a 
definitive treatment plan.  Figure 3 illustrates a sagittal view of a single tumour 
at thoracic level 10 causing impending cord compression. 
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Figure 3: Sagittal spine MRI scan showing a single metastatic lesion at 
T10 of a 50 year old patient with a known breast cancer (permission to use 
the image was given by patient). 
 
    
NICE (2008) guidelines recommend targeted CT with three plane reconstruction 
to assess spinal instability if vertebroplasty or spinal surgeries are planned.  
Plain films are not recommended as a routine screening for suspected MSCC 
(Algra et al. 1992). 
 
The researcher and colleagues have conducted two reviews and found no 
evidence-based guidelines on how to assess the risk of spinal instability in 
malignancy of the spine (Kilbride et al. 2010; Lee et al. 2012).  Moreover, the 
definitions of spinal instability vary (Kilbride et al. 2010; Lee et al. 2012).  White 
and Panjabi (1990: 89) defined spinal instability as “the loss of the ability of the 
spine under physiologic loads to maintain its patterns of displacement so there 
is no initial or additional neurologic deficit, no major deformity, and no 
incapacitating pain”.  The difficulty in diagnosing spinal instability can lead to 
controversy in the choice of the treatment, especially the criteria for surgical 
intervention (Bilsky and Azeem 2007).  Bilsky and Azeem (2007) propose three 
factors when making assessment on spinal instability: mechanical pain, 
neurological changes and radiologic findings.  Sciubba et al. (2010) advised 
clinicians to make decisions around treatment from a practical perspective:  to 
consider patient factors, stability, and neurology.  Other authors suggest 
Tumour 
at T10 
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mechanical pain can be an indication of spinal instability (Mercadante 1997; 
Coleman 2006; Izzo et al. 2012). 
1.4.3 Treatment 
The goals of therapy are pain control, preservation of functional status and 
quality of life.  Current acceptable treatment approaches for MSCC include 
corticosteroids, radiotherapy and surgery (Loblaw and Laperriere 1998; Prasad 
and Schiff 2005; George et al. 2010). 
 
The initial step when spinal cord compression is suspected is the routine use of 
corticosteroids, if there are no contra-indications.  Corticosteroids, usually 
dexamethasone, are prescribed to reduce the oedema and cord compression 
and relieve pain.  The optimal dose of dexamethasone is uncertain (Loblaw and 
Laperriere 1998; George et al. 2010; Harel and Angelov 2010).  Two studies 
found no statistical difference between high and moderate dose 
dexamethasone treatment regimes; and recommend lower treatment dosages 
because side effers were fewer (Vecht et al.1989; Graham et al. 2006).  The 
usual dose recommended is 16 mg/d in divided doses over several days (NICE 
2008). 
 
Various scoring systems or algorithm have been developed to assist in decision 
making of surgery and/or radiotherapy (Bauer 1995; 2002; Tokuhashi et al. 
1990; Tokuhashi et al. 2005; Tomita et al. 2001; Bilsky and Azeem 2007).  
Although some studies evaluated the scoring systems, the sample size and the 
clinical assessment alone may not be adequate in predicting survival in patients 
with MSCC (Leithner, Radl and Gruber 2008; Schultheiss 2008; Gakhar et al. 
2012). 
 
Radiotherapy alone is the most common treatment modality and is often the 
initial treatment for MSCC (Regine, Tibbs and Young 2003; Rades et al. 2006; 
Gerszten, Mendel and Yamada 2009).  It may reduce the tumour mass, thereby 
improving pain and spinal cord compression.  Patients who develop 
neurological deficits slowly have a better functional outcome after radiotherapy, 
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especially in radiosensitive tumours (Rades, Heidenrech and Karstns 2002; 
Rades et al. 2006).  There are many reported studies on the different schedules 
of radiation therapy for spinal cord compression, ranging from 8-10 Gray (Gy) in 
1-2 fractions to 30 Gy in 10 fractions (Kwok, Regine and Patchell  2005; 
MacBeth, Stephens and Hoskin 2005; Maranzano et al. 2005; Rades et al. 
2005).   The optimal dose remains controversial (George et al. 2010).  Unlike 
the conventional radiotherapy, an alternative technique - stereotactic 
radiotherapy only targets the affected vertebrae (Ryu et al. 2001; 2004).  The 
optimum dose is not known but a high dose delivered in 1-3 fractions has the 
potential for good control (Hall et al. 2011).  The use of stereotactic radiotherapy 
is limited for patients with 1-3 metastases, with no more than 2 continuous 
vertebral bodies (Bhatt et al. 2012). 
 
Surgery as a first-line treatment has shown promising benefits for patients, 
however, patient selection is important.  Surgery may be indicated, particularly 
for those with spinal instability, intractable pain and rapidly progressing loss of 
neurologic functions, but the number suitable is small.  The indication for 
surgery is usually limited to patients with one or two vertebrae involvement who 
have a good performance status and expected survival of more than three 
months (Rades et al. 2006).   
 
A US-based randomised controlled multicentre trial, Patchell et al. (2005) 
reported that patients (n=50) who underwent direct de-compressive surgery in 
addition to radiotherapy (30 Gy in 10 fractions) were more likely to retain or 
maintain their ambulatory status longer than patients (n=51) who received 
radiotherapy alone (Patchell et al. 2005).  The authors reported a significantly 
higher proportion maintained ambulation in the surgery plus radiotherapy group 
84% versus 57% in the radiotherapy alone group (Patchell et al. 2005).  This 
study has been criticised due to the small sample size and the highly selected 
patients (Knisely and Strugar 2006; Kunkler 2006).  With the strict criteria in 
patient selection, used in Patchell’s et al. (2005) study, few patients would be 
suitable for surgery. 
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Johnston and Smith (2005), reported that living with a terminal illness is a 
stressful and fearful experience which leads to feelings of a lack of control and 
defencelessness, affecting both the patient and their family.   The threat of 
physical disability and carer dependency are most distressing to the patient and 
family (Pessin, Rosenfeld and Breibart 2002).  Eva and Lord (2003), suggested 
that rehabilitation plays an important part in the management of MSCC.  Spinal 
instability affects the decisions on how to care for patients in relation to 
positioning, mobilisation, rehabilitation and pain control.  Held and Peahota 
(1993) recommend the use of a brace to support the spine and promote 
mobilisation, but Galasko, Norris and Crank (2000) reported that tumour 
metastasis to the spine can cause excruciating pain and the patient will be more 
comfortable lying down.  As a result, healthcare professionals often face conflict 
in their decision making due to the lack of evidence-based literature. 
 
1.5 Chapter summary and outline of the thesis 
The context for this study shows that bone metastasis is a complication of a 
wide range of malignancies and the rate of recurrence is unpredictable.  I have 
described the significance of MSCC in the international, the full UK and the 
Scottish context.  Development of MSCC has major clinical implications and is 
an indicator of a poor prognosis.  All literature on MSCC stresses the need for 
early diagnosis and treatment to prevent or minimise disability.  However, early 
recognition of impending cord compression can be problematic (Husband 1998; 
Levack et al. 2001; Loblaw et al. 2012). 
 
MRI is the gold standard imaging modality in identifying impending spinal cord 
compression, but is infrequently accessible in a timely fashion.  Problems exist 
defining spinal instability in MSCC.  Decisions on treatment, positioning, 
mobilisation, pain relief, and rehabilitation are complex, requiring 
multidisciplinary and multi professional discussion.  Prognostic scoring systems 
to aid decision making are not consistently used and benefits are somewhat 
conflicting.  There remains debate regarding surgery plus radiation versus 
radiation alone for patients in MSCC, despite a small randomised controlled 
trial, as the expertise may not exist for some complex spine surgery on the 
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thoracic spine.  Moreover, major surgery is associated with morbidity and 
mortality and patient selection is important.  It is not clear how clinicians make 
their decisions, when faced with multiple complex issues. 
 
The scoping exercise revealed inconsistencies in the management of patients 
with MSCC which potentially led to delays in mobilisation and prolonged 
hospital stay.  Management is variable and it is not clear how the patients are 
involved in decisions about their care.  More importantly, it is not clear how the 
inconsistencies impact on patient care.  There is limited research on how 
guidelines are translated into the clinical setting, therefore, it is timely to 
illuminate the patients’ and carers’ and healthcare professionals’ experiences 
and to contribute towards the management of MSCC and towards the national 
agenda for Scotland’s Patient Experience Programme: Better Together 
(Scottish Government 2008). 
Outline of the thesis 
This thesis is structured across seven chapters; an outline of each chapter is 
given.  Chapter 2 presents a review of the current literature on the impact of 
MSCC on patients, carers and/or family members and the challenges faced by 
healthcare professionals in managing this group of patients.  The rationale for 
the research design, methods, ethical considerations and analysis are 
presented in Chapter 3.  The findings from Phase One and Two are presented 
in Chapters 4 and 5 respectively.   Chapter 6 demonstrates the synthesis from 
the findings in relation to the literature.  Chapter 7 offers the conclusion; 
suggesting recommendations for practice, policy and areas for future research 
in MSCC. 
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Chapter 2: Literature review 
2.1 Introduction 
In this chapter I provide an integrative review focussed on understanding issues 
and challenges faced by patients, carers and healthcare professionals in the 
management of metastatic spinal cord compression (MSCC) and identify the 
gaps in knowledge.  The aims were to identify and synthesise: 
 what is known about patients’ experiences when diagnosed with MSCC; 
 what is known about carers’ and/or family members’ experiences in 
supporting the patient with MSCC; 
 what is known about the healthcare professionals’ experiences in 
managing patients with MSCC. 
 
Although systematic reviews are seen by some to be transparent as they use a 
predefined, explicit methodology (Webb and Roe 2007), Harden et al. (2004) 
caution that systematic reviews may distort, misrepresent or miss crucial 
service users’ views or perspectives.  However, an integrative review includes 
more diverse forms of evidence and would allow the synthesis of experimental 
and non-experimental research to provide breadth of perspectives, and a more 
comprehensive understanding of a particular phenomenon or a healthcare 
problem (Whittemore and Knafl 2005; Gough, Thomas and Oliver 2012).  I 
therefore applied this approach to carry out a structured integrative literature 
review.   
 
The steps of this process are as follows: 
 Identify the aim of the review; 
 Identify the search strategies;  
 Identify studies according to defined inclusion and exclusion criteria; 
 Evaluate literature against defined criteria;  
 Present a synthesis and summary of findings from the literature. 
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2.2 The aim of the review 
The aim of this integrative review was to establish a clear focus for this study of 
MSCC.  The background study on MSCC suggested that little is known about 
the patients’, carers’ and healthcare professionals’ experiences in managing 
MSCC (Chapter 1).  The findings from the scoping exercise revealed that 
inconsistencies in patient management persist and that there are concerns 
regarding the variations in the care that patients with MSCC receive.  The body 
of research evidence that exists investigates the effectiveness and comparison 
of treatments for malignancies of the spinal cord from a positivist perspective.  
However, the dynamics of an illness experience and its relationship to physical 
pathology are extremely complex and relatively unexplored. 
   
2.3 Search strategies  
To enable effective critical review of existing evidence, patient experience was 
defined as the following: 
 
“A patient’s experience of the care or treatment they have received.  This 
included a patient’s wider experiences of health care service, perceptions, 
beliefs and issues about their journey of care” (DH 2007). 
 
Therefore, literature about carers’ and/or family members’ experiences were 
also included, as their support is an integral part of the patient’s experience.  
The patient’s ‘wider experiences of health care service’ (DH 2007) incorporates 
the perspectives of healthcare professionals and the multidisciplinary team in 
different health care settings involved in the management of patients with 
MSCC.  To help to identify any gaps in research knowledge, refine research 
aims and inform methods, the terms regarding experiences, decision making, 
quality of life and end of life were added to the search strategy.  Table 1 shows 
terms relating to MSCC and this was combined with patient, healthcare 
professionals and caregiver and their related terms. These were adjusted to suit 
the terminology of the database searched.   
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Table 1: Search terms used to identify studies on MSCC 
Main terms Other related terms 
Metastatic spinal cord compression Spinal cord compression, spinal cord 
neoplasms, neoplastic metastases, 
malignant spinal cord compression. 
Patient, Consumer Participation; satisfaction; attitude; 
patient-centered care; experience; 
journey; perspectives; and decision 
making, patient. 
Palliative care; terminal care. 
Quality of life; coping; psychosocial 
aspects of illness. 
Healthcare Professionals Multidisciplinary teams; decision 
making, clinical. 
Caregiver Experience; perspectives; support. 
 
The search strategy was carried out in consultation with a librarian and modified 
according to the electronic database.  The search was focused on literature 
published between 1st January 2000 and 9th August 2012 to ensure findings 
were relevant to the review aims.  Several electronic databases, paper-based 
sources and consultations were carried out as listed below: 
 
• Medline 1st January 2000 – 9th August 2012; 
• CINAHL 1st January 2000 – 9th August 2012; 
• AMED (Allied and Complementary Medicine) 1st January 2000 – 
9th August 2012; 
• PsycINFO 1st January 2000 - 9th August 2012; 
• EMBASE 1st January 2000 – 9th August 2012; 
• Cochrane Library 1st January 2000 – 9th August 2012; 
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• Reference lists from relevant studies and reviews; 
• Additional references were gained from experts in this field. 
 
Initial literature searching was carried out in Medline using the Medical Subject 
Heading (MeSH) search terms, limited by adults, year of publication and English 
Language (Appendix 2).  This strategy was adapted for use in other databases.  
Detailed search strategies applied to CINAHL, AMED, PsycINFO and EMBASE.   
As a result, comprehensive coverage of available literature was achieved.   
Although the language was restricted to English, two foreign articles with 
English language abstracts were retrieved.  Both papers not being relevant to 
the research question were excluded.  
 
2.4 The review process 
The retrieved titles and abstracts (395) from all databases - except the 
Cochrane Library - were entered into Endnote software to enable deletion of 
duplications.  The titles and abstracts (604) from the Cochrane Library were 
checked manually and screened for relevance.  Once this was established, 
efforts were made to obtain the full-text articles.   
 
Three further articles were retrieved from relevant reference lists.  Additional 
references were obtained from the research experts in this field.  Once the 
abstracts were obtained from the search, they were reviewed for relevance to 
meet the criteria for this review.  Published work has to be methodologically 
rigorous before any findings can be regarded as useful.  The types of studies 
included are listed below:   
 Meta-analysis and systematic reviews; 
 Randomised controlled trials; 
 Primary quantitative studies and qualitative studies. 
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The process of screening for the relevance of articles is illustrated in Figure 4 
Quorum Flow Chart (Moher et al.1999). 
Figure 4:QUOROM Flow Chart (Moher et al.1999) 
 
 
 
 
 
 
 
 
 
The search yielded 999 articles: Medline 64 articles, CINAHL 210, AMED 54, 
PsycINFO 10, EMBASE 57 and Cochrane Library 604; 200 of which were 
duplicates resulting in 799 titles and abstracts being screened with 88 identified 
as being potentially relevant to the research question in accordance with the 
inclusion and exclusion criteria.  The inclusion criteria were applied to the 
selection of abstracts and articles (n=88).   
 
Twenty nine articles were deemed relevant.  Papers identified by the searches 
were read and the data extracted and summarised under pre-determined 
headings: author(s); year; country of study; care setting; aim of study; type of 
study; sample; characteristics of patients or staff groups; methods; key 
                                                          
 Quality of reports of meta-analysis of randomised controlled trial (QUOROM) (adapted Moher 
et al. 1999) 
Titles and abstracts recovered 
from the electronic search 
(n=999) 
Titles and abstracts for 
consideration (n=799) 
 
Potentially appropriate studies 
relating to the research question 
(n=88) 
Finally included and analysed 
articles.  
(n= 29) 
Titles and abstracts excluded 
due to duplicates of title or 
abstracts. (n=200) 
Titles and abstracts deemed 
not related to the research 
question 
(n=711) 
Articles not relevant to the 
research question after reading 
the full text. 
(n= 59) 
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messages and level of evidence in Scottish Intercollegiate Guideline Network 
(SIGN) (2012); see Appendix 3.  The literature was scrutinised and issues and 
themes were synthesised.   
 
The 29 studies retrieved included: one Cochrane systematic review; three other 
systematic reviews; one review, one qualitative study; 21 quantitative studies 
and two audits.  A further two articles were retrieved from the reference list 
(Levack et al. 2002 and Patchell et al. 2005).  The final total of studies is 31. 
Although these studies were assessed for quality, in this review, the purpose 
was not to exclude studies based on quality but rather to allow an overall 
judgement of the status of knowledge in the field.  Three key issues or themes 
which consistently emerged from this review were identified and provided the 
framework for the following discussion and reporting of findings from the 
integrative review as follows: 
 Impact of MSCC on patients’ experience; 
 Carers’ experience in supporting the patient with MSCC; 
 Healthcare professionals’ experiences in managing patients with 
MSCC. 
 
2.5 Impact of MSCC on patients’ experience 
There were 24 studies addressing various aspects of patients’ experiences with 
MSCC which impacted on their daily lives.  The review presents the evidence 
drawn from three systematic reviews, one randomised controlled trial, 12 
prospective studies, seven retrospective studies and one qualitative study.  A 
summary of the studies addressing the impact of MSCC on patients’ experience 
can be found in Appendix 4.  The patients’ experience of MSCC are discussed 
under the following sub-headings: impact of MSCC on patients’ survival; impact 
of MSCC treatments on patients’ quality of life; information needs of patients 
about MSCC; structured rehabilitation on patients with MSCC; impact of MSCC 
on patient as a person and transition from curative treatment to palliative care. 
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2.5.1 Impact of MSCC on patients’ survival 
There is strong evidence reporting short survival times (median 59 to 120 days), 
as a major influencing factor when describing the experience of an individual 
with a diagnosis of MSCC (Cowap, Hardy and A’ Hern 2000; Conway et al. 
2007; Huang and Jatoi 2009; Guo et al. 2010).  Cowap, Hardy and A’ Hern 
(2000), reviewed the medical records of 166 patients and reported that the 
median survival from confirmation of MSCC was 82 days (range, 1-1349 days).  
Whilst in a larger study, Conway et al. (2007), in their prospective study of 319 
patients at three Scottish cancer centres reported the median survival was 59 
days from diagnosis of MSCC (95% CI 43-75).  It must be noted survival post 
diagnosis can vary depending on the primary cancer groups.   
 
In a recent US-based retrospective review of 88 patients’ medical notes, Guo et 
al. (2010) reported the median survival was 4.3 months.  As the majority of 
patients from these studies had radiotherapy and a minority had surgical 
treatment, studies looking at different treatment modalities need to be 
considered in terms of survival times.   
 
Investigating 49 patients who had radiotherapy treatment only, Aass and Fossa 
(2005), reported the overall survival from the start of radiotherapy was a median 
of 3.5 months (range, 0.3-36.0).  One limitation to their study was that it only 
included patients with hormone resistant prostate cancer who received 
radiotherapy.  Estimated survival rates are important for people with MSCC as it 
can be influential in the decisions made regarding their treatment. 
 
Some authors suggest that palliative surgery with or without radiotherapy is a 
valuable treatment for MSCC (Wai et al. 2003; Sandalcioglu et al. 2005; Falicov 
et al. 2006; Fujibayashi et al. 2010; Wu et al. 2010).  For, example, Wai et al. 
(2003) reported the time to death ranges from 1-21 months.  Whereas, Falicov 
et al. (2006) reported an overall 50% survival in their study of 85 patients was 
39.1 weeks (95% confidence interval, 30.9-60.0 weeks).   
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Tomita et al. (2001), in their study used their surgical scoring system to 
determine the treatment for 67 of their patients.  Their findings show that the 
mean survival for 28 patients who underwent wide or marginal surgical excision 
was 38.2 months; for 13 patients who underwent intra-lesional excision, mean 
survival was 21.5 months; the mean survival for 11 patients who had palliative 
surgery and stabilisation was 10.1 months and those treated with supportive 
care was 5.3 months.  These findings may indicate that the survival of patients 
depends on the position of the incision in relation to the tumour and whether 
complete removal of the tumour was possible.  In addition, survival also 
depended on whether patients went on to receive adjuvant treatment. 
 
In contrast, Wu et al. (2010), in their prospective longitudinal study, did not 
demonstrate a prolonged survival in patients after surgery compared to the 
findings of the study by Patchell et al. (2005).  Wu et al. (2010), compared 
patients who had undergone surgery plus radiotherapy to another group of 
patients who had radiotherapy alone; no statistically significant difference was 
found between the two groups in terms of survival (P = .056).  The survival rates 
at 9 months and 18 months for the surgery group was 62% and 58.9% and for 
the non-surgery group 62% and 48% respectively.  The authors reported there 
was a moderate decline in survival between 12 months and 22 months in the 
surgery group compared with that during the initial 12 months (Wu et al. 2010).  
Overall there is no conclusive evidence about the relationship between 
treatment modalities and survival rates.  
2.5.2 Impact of MSCC treatments on patients’ quality of life 
As length of survival may not be the main aim of palliative treatment, other 
studies need to be taken into account when looking at the treatment of people 
with MSCC.  For example, Falicov et al. (2006) stressed that reduction in pain 
levels, maintenance of independent function and avoidance of neurological 
compromise are the main goals of surgical intervention.  The authors conducted 
a prospective study assessing health related quality of life (HRQOL) in patients 
who underwent surgery.  Eighty five patients were given a detailed 
questionnaire at five time points: before surgery, at six weeks, three months, six 
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months and one year post surgery.  Outcome measures were: the European 
Organisation for Research and Treatment of Cancer Quality of Life 
Questionnaire (EORTC QLQ –C30) (Aaronson et al. 1993), Health Utility Index 
(HUI) (Torrance et al. 1996), European Quality of Life – 5 Dimensions (EQ-5D) 
(Dolan 1997), Visual Analogue Scale (VAS) (Jensen, Chen and Brugger 2002) 
and Eastern Cooperative Oncology Group (ECOG) (Jonsson et al. 1996) 
functional assessment.  The authors reported surgical intervention had a 
positive impact on patients in the domains of pain relief and in overall health 
and function.  One criticism of the study, Falicov et al. (2006), was the repetition 
in some of the domains, for example, pain in VAS, QLQ-C30 and HUI and the 
additional burden this presented for patients.   
 
There was no definition of health related quality of life and no justification for the 
choice of measures used.  The authors did not specify whether patients were 
prescribed analgesics and when they completed the questionnaires.  The 
authors reported widely on the aspects of pain, however, there was less 
mention about the emotional domain.  Although the authors reported no 
significant improvement in functional scale but improvement in overall health 
status, it is not clear whether these factors influenced each domain.  With 
respect to the EORTC quality of life questionnaire, it is designed for clinical 
trials and it does not identify patients’ problems or care needs in depth.   
 
Wai et al. (2003), suggest the use of a multi-dimensional assessment of quality 
of life is more appropriate in palliative care.  The authors prospectively 
evaluated a cohort of 25 patients after surgery at one, three and six months 
during follow up and by telephone using a patient-centered questionnaire 
Edmonton Symptom Assessment (ESAS) (Bruera et al. 1991) and a physician-
determined assessment of the patient’s physical disability, the Townsend 
Functional Assessment (Townsend, Rosenthal and Smalley 1994).  ESAS is 
designed to assess a patient’s quality of life with domains in pain, tiredness, 
nausea, depression, anxiety, drowsiness, appetite, sense of wellbeing and 
shortness of breath.   
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The study demonstrates the most improved domain after surgery, was in pain.  
Significant improvements were also seen in the domains of tiredness, nausea, 
anxiety, appetite and overall wellbeing.  There was no improvement in the 
domains of depression, drowsiness and shortness of breath.  The authors 
reported the Townsend Functional Assessment showed improvement in 44% 
(n=11) of patients; therefore, neurological recovery is unpredictable (Wai et al. 
2003).  It is notable here that although surgery enhanced a patient’s quality of 
life, it is not known whether those patients who were depressed, were mobile or 
did not regain their mobility or whether the patient had poor outcomes from 
surgery. 
 
Wu et al. (2010), a Chinese-based study, compared two treatment groups 
(surgery, n = 46 patients versus non-surgery group, n = 50 patients) using a 
different quality of life measure.  Patients self administered the Functional 
Assessment of Cancer Therapy-General (FACT-G) (Cella et al. 1993) quality of 
life questionnaire at baseline, one, three, six and nine months after surgery.  
The FACT-G questionnaire measures four specific life domains: physical 
wellbeing, social/family wellbeing, emotional and functional wellbeing and in 
addition pain assessment.  Sixty seven (69.8%) patients completed all the five 
time point assessments.  These include 33 patients in the surgery group and 34 
patients in the non-surgery group.  Their findings showed that patients who 
underwent surgery fared better and maintained their quality of life over the nine 
month assessment period compared to those patients from the non-surgery 
group (Wu et al. 2010). Although the authors acknowledged that surgery was 
suitable for all patients eligible for this study, the decision making of treatment 
was left to the patient and family members.  It is not known what the patients’ 
preferences were and whether the family members’ preferences influenced the 
patient’s decisions.  It is also not known whether the patients had an 
understanding of their condition and the palliative intent of treatment. 
 
Interestingly another study considered whether satisfaction with surgical 
intervention had an impact on patients’ and family members’ mental health and 
their quality of life (Fujibayashi et al. 2010).  Thirty seven out of 71 patients 
 
 
 
 
26 
 
responded.  Overall, 30 (81.1%) of the patients were satisfied or very satisfied 
with the surgical procedure.  Pain relief was achieved in 27 patients and 
patients aged below 65 years with neurological improvements correlated 
positively with increased patient satisfaction.  There is caution in the 
interpretation of these findings, as 16 patients had died by the time of 
completion of the questionnaire and responses were collated from family 
members.  Hence, patient satisfaction may not correspond to of their family 
members.   Although the response rate was slightly over 50%, there is a 
possibility that those who did not respond were not satisfied or had poor 
outcomes.   
 
Another limitation reported was the period that elapsed between the surgery 
and the completion of the questionnaire (range, 3-69 months) which may have 
depended on unreliable memories to complete the questionnaire.  Moreover, 
surgery is considered in generally fit patients with an expected survival of at 
least 3 months.  In addition, patients who had total en bloc spondylectomy were 
excluded from the study and there was no explanation for the exclusion.  It is 
not known whether patients who had major surgery had poor outcomes or 
suffered complications. 
 
The above studies showed that improvement in pain is significant after surgery. 
However, the majority of patients who were not fit for surgery suffered from pain 
which may not have been addressed.  For example, Huang and Jatoi (2009), on 
reviewing the medical records of 39 patients found 33 (85%) patients require 
pain relief.  Whereas, Conway et al. (2007), found that almost half the patients 
in their study experienced ongoing pain because the therapeutic benefits of 
radiotherapy can only be felt around 2.6 months after treatment.   
 
Not all patients regain their neurological functions after surgery (Schoeggl, 
Reedy and Matula 2002; Wai et al. 2003; Sandalcioglu et al. 2005).  Wai et al. 
(2003), stated that stabilisation of the spine addresses the problem of pain but 
not necessarily neurological recovery and in some cases total tumour removal 
may not be achieved (Schoeggl, Reedy and Matula 2002; Sandalcioglu et al. 
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2005).  Some studies have reported that complications as a result of surgery in 
MSCC can be distressing for patients (Murakami et al. 2010; Omeis et al. 
2011).  For example, Omeis et al. (2011), conducted a retrospective case 
control study of 162 cases; 65 patients developed post operative complications.  
The incidence of surgical site infections after surgery is significant (~10%) with 
risk increasing in relation to the number of co-morbidities.  Previous surgery, 
complex plastic closures, and hospital acquired infections during primary 
surgery are also complicating factors.  Murakami et al. (2010), reported a 
significantly higher frequency of respiratory complications and delirium 
occurring in the elderly patients (although the authors advocate that surgery 
should not be avoided solely because of the patient’s advanced age).    
 
Whilst the above studies looked at outcomes from surgery, Aass and Fossa 
(2005), assessed the impact of radiotherapy on 49 patients quality of life using a 
modified Barthel Activity of Daily Living Index (Barthel ADL Index) (Wade and 
Collin 1988) at the start and end of radiotherapy treatment and at follow-up to 
death.  The authors reported radiotherapy (median target dose 30 Gy (range, 9-
40)) may improve mobility, daily life function and sphincter control in patients 
with MSCC due to hormone resistant prostate cancer.   
 
However, at the end of radiotherapy treatment, patients did not report 
improvement with regards to mobility, daily function and sphincter control.  The 
authors suggest it could be because prostate cancers are slow to respond to 
radiotherapy.  Radiotherapy was started at a median of 4 days (range, 1-66 
days) and the authors highlighted that a delay in recognition of MSCC may be 
either due to patients’ and/or doctors’ delay.  What's more, the authors could not 
confirm whether a patient’s pre-treatment neurological status was an important 
parameter predicting good clinical outcome compared to other studies as the 
Barthel ADL Index may not be sensitive towards differentiating between 
paralysis and paresis.  This study indicates the problems in the use of a 
measurement tool in evaluating physical function over a period of time. 
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Levack et al. (2004), carried out a prospective study (n=180) at three major 
cancer centres in Scotland of patients shortly after diagnosis, using the 
Schedule for Evaluation of Individualised Quality of Life – Direct weighing 
(SEIQoL-Dw) (O’Boyle et al. 1993) to measure the quality of life, Hospital 
Anxiety and Depression Scale (HAD) (Ibbotson et al. 1994) for emotional 
wellbeing, Barthel Disability Index (BDI) (Mahoney and Barthel 1965) for 
activities of daily living, Karnofsky Performance Score (KPS) (Schag, Heinrich 
and Ngnaz 1984) to measure functional outcome.  The SEIQoL-Dw 
questionnaire was developed from the technique of ‘judgement analysis’ to 
measure patients’ levels of functioning; measuring from 0 (worst) to 100 (best) 
on patients quality of life.   
 
This measure allows patients to nominate the five areas of life which are most 
important to them then rate their level of functioning or satisfaction with each, 
and indicate the relative importance of each area to their total quality of life.  
The study found that what the patients perceived was their quality of life did not 
match with healthcare professionals’ judgement about the patient’s quality of 
life.  The majority of patients scored high on family life (91%).  Health and 
mobility were nominated by 44%, 39% and 35% respectively, and 
independence at 29%.  Physical disability was not significantly associated with 
quality of life as the majority of patients viewed family life as more important to 
their quality of life.   
 
In the social/family domain, Levack et al. (2004), highlight that using SEIQoL-
Dw quality of life measure can focus attention around what matters to patients.   
The authors acknowledge that although some cues were selected more 
commonly that others, no two patients nominated the same five cues (generally, 
a combination of physical and non physical issues), therefore, it was difficult to 
predict what the patient was going to say.  The findings indicate that what 
contributes to quality of life varies widely between patients.  Moreover, it is not 
clear whether the patients have a full understanding of the consequences of 
MSCC shortly after diagnosis.  In addition, the authors stated that during the 
study, the majority of patients were actively receiving treatment with 
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dexamethasone, radiotherapy and analgesia and this can give a sense of 
optimism and hope.  There may also be disparity in what the patients expect 
and the professionals’ palliative intent.  It is also notable that 81 patients were 
unable to complete the quality of life measure questionnaire; with 57 cases 
being unwell and 24 patients not giving a reason.  Therefore, those who were ill 
or did not participate were under-represented.   
 
In a follow up to the above study, Conway et al. (2007), interviewed 128 
patients one month after diagnosis with MSCC.  They reported patients rated 
their quality of life as good despite physical disability.  The authors 
acknowledged that due to limited data on quality of life at one month after 
diagnosis, the poor performance status of patients was associated with a lower 
quality of life.  However, when individual scores were analysed, not all patients 
with a low performance status had low quality of life.  This indicates the difficulty 
in capturing the information around physical disability and quality of life in 
MSCC.  Wu et al. (2010), found both groups of patients (surgery group and the 
non-surgery group) scored favourably on the social/family well being domain.  
One explanation offered was the Chinese tradition of attending to the patient’s 
needs regardless of the patient’s treatment.  Further qualitative research may 
uncover whether support from family members or the health providers 
influences the patient’s quality of life.   
 
In the domain of emotional wellbeing, Levack et al. (2004), used the HAD 
questionnaire, and reported patients experiencing disability as a result of MSCC 
were not severely depressed and few were depressed shortly after diagnosis of 
MSCC.  The authors cautioned that depression should not be confused with 
demoralisation and sadness.  A follow up of the same group of patients at one 
month found similar results where most of the patients’ moods were reported to 
be normal (Conway et al. 2007).  Low mood correlated with low quality of life 
but the authors could not account for all patients who recorded low on the 
quality of life scores.  Some patients rated their quality of life to be high and at 
the same time recorded high levels of emotional distress.  Other patients who 
scored low in the quality of life scores had low levels of emotional distress.  This 
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suggests the difficulty in capturing the emotional wellbeing of patients and the 
factors that influence the patient’s emotional state with the use of this 
questionnaire.   
 
In contrast to these findings; Wai et al. (2003), investigated the efficacy of 
surgery for MSCC patients in respect of quality of life. The ESAS scale was 
carried out pre and post-operatively to determine any differences in symptom 
control. This study reported that patients continued to have depression, 
drowsiness and shortness of breath post-operatively with no improvement.  
Similarly, Ruff et al. (2007a; 2007b) through their prospective evaluation of 
rehabilitation after radiotherapy for MSCC patients, found that 26 (86.7%) out of 
30 patients who did not participate in a structured rehabilitation programme 
suffered clinical depression necessitating anti-depressants.  Measurements in 
this study were carried out using the Beck Depression Inventory-Second Edition 
(BDI-II) (Beck, Steer and Brown1996).  
 
Findings from these four studies are disparate; this may be due to the fact that a 
variety of measurement scales are used, none of which is designed specifically 
for MSCC.  Some authors argue that health related quality of life (HRQOL) 
measurements that are commonly used are not always viewed as helpful in 
identifying individual patient’s needs as they are not specific to MSCC (Street et 
al. 2009; 2010; Mitera and Loblaw 2010).  The reviewers stated that survival, 
pain, ambulation, neurological deficit and sphincter control are indirect 
measures of health status and utility and it is misleading to consider these as 
measures of quality of life (Street et al. 2009; 2010).  These outcome measures 
are process variables; meaning a patient’s condition can change over time.  
Therefore, they cannot give an insight into a patient’s experience and the 
impact on their care.  A qualitative approach may more effectively illuminate the 
cause and experience of depression for patients with MSCC. 
 
Street et al. (2009), in their systematic review, analysed 141 studies that 
investigated patients HRQOL outcomes as a result of surgery, surgery and 
radiation, radiation only, vertebroplasty and kyphoplasty.  The reviewers found 
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the most commonly used outcome measurement tools in general cancer studies 
are: Eastern Cooperative Oncology Group (ECOG), European Organisation for 
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC 
QCQ-30) and the European quality of Life – 5 Dimensions (EUROQOL 5D), and 
the most common patient self-assessment instruments used to assess health 
status were Short Form 36 (SF-36), Sickness Impact Profile 5 (SIP 5) and the 
Activities of Daily Living (ADL).   
 
When the validity of the different HRQOL questionnaires was compared against 
the International Classification of Functioning Disability and Health (ICF) WHO 
(2013) benchmark, the reviewers indicated that none of the instruments 
specifically address the concerns and impairments of patients with metastatic 
spinal disease.  The reviewers found that the inconsistencies, variability and 
disparity of findings on health related quality of life indicated a need for a 
disease-specific outcome tool for MSCC. 
 
Subsequently, the reviewers published the same systematic review and this 
time they introduced a new patient-administered HRQOL outcome tool specific 
for metastatic disease of the spine – Spine Oncology Study Group Outcome 
Questionnaire (SOSGOQ) (Street et al. 2010).  The reviewers claim the face 
validity of the questionnaire was assumed as the tool was developed in 
consultation with patients with metastatic spinal disease and by consensus from 
an international expert working group.  This new tool consisted of 27 questions 
covering the following domains (physical function; neurological function; pain; 
mental health; social function; and post therapy) and was intended to measure 
the disease burden specific for metastatic spinal disease (Street et al. 2010).  
However, to date, there is no study validating its use.  The reviewers mentioned 
social function however, only one vague question was found which asked 
whether the patient’s condition impairs/compromises the patient’s personal 
relationships.  The patient is given a limited choice of responses (“never,” 
“rarely” and “sometimes”) and so the answer does not really address the 
interaction between the patient and their spouse and/or family members who 
are pivotal in supporting the patient.  
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In another systematic review, Mitera and Loblaw (2010), identified five studies 
that used quality of life measures (Schedule for Evaluation of Individualised 
Quality of Life –Dw (SEIQoL-Dw); Short Form 36 (SF36) (Garratt et al. 1993); 
Paediatric quality of life inventory (PedsQL) (Varni et al. 2002); and Functional 
Assessment of Cancer Therapy (FACT-G) in radiation therapy trials for patients 
with MSCC.  The reviewers found the quality of life measures used across the 
studies were inconsistent and findings cannot be compared.  They suggest the 
concept of quality of life measures must incorporate not just the physical 
aspects but also the cognitive, emotional and subjective components that are 
important to patients.  Although the reviewers did identify quality of life 
measures that meet all the criteria (FACT-G and SEIQoL-Dw), it was thought to 
be time consuming for patients to complete these questionnaire and that  they 
did not capture the distinctive disease components of patients with MSCC 
(Mitera and Loblaw 2010).  Hence, this justifies the need for further research to 
explore patients’ perspectives in MSCC. 
 
The delay in recognising MSCC affects the outcomes of treatment.  Pre-
treatment neurological status is a predictor of functional outcome and prognosis 
is acknowledged by a few authors (Cowap Hardy and A’ Hern 2000; Wai et al. 
2003; Aass and Fossa 2005; Sandalcioglu et al. 2005).  Cowap Hardy and A’ 
Hern (2000), reported that at presentation, symptoms had been present for a 
median period of 10 days (range, 0-383 days).  Limb weakness was the most 
common symptom, followed by back pain, sensory loss and sphincter 
disturbance.   
 
In contrast, a prospective study of 319 patients conducted by Levack et al. 
(2002) found pain was reported by nearly all the patients (94%) and had been 
present for approximately three months (median = 90 days; IQ range 37-205 
days) but the site of pain did not correspond to the site of compression.  
Although patients experienced leg weakness and/or sensory problems this was 
reported late and detected even later.  Therefore, MSCC is an emergency 
condition and early recognition of the signs and symptoms of MSCC could 
reduce poor outcomes.  
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2.5.3 Information needs of patients about MSCC 
Patient education about the signs and symptoms of MSCC is important to 
facilitate early referral and is linked to coping with the diagnosis (Hutchison et 
al. 2012).  These authors recently conducted a survey in a cancer centre in 
Scotland to determine patients’ and staff views on the provision of information to 
patients with a diagnosis of MSCC or potentially at high risk of developing 
MSCC.  Questionnaires to patients and staff consisted of open and closed 
questions.  Fifty six patients (50 of the 56 patients had metastases) and 50 staff 
responded.  The staff comprised of: consultants (n=29); registrars (n=7); 
radiographer (n=1); senior ward/charge nurses (n=6) and clinical nurse 
specialists (n=7).   
 
The authors reported that a large proportion of patients did not receive 
information on MSCC (n=26) (Hutchison et al. 2012).  Thirty two per cent 
received information in verbal form, seven per cent in written form and 13% a 
combination of both.  The majority of patients (82%: n=46) did not look for 
information from any other source.  Forty eight per cent of staff said they gave 
verbal information to high risk patients prophylactic about MSCC; however, 45% 
(n=13) of consultants were not sure whether patients should be given this 
information.   
 
Views on when it is the appropriate time to give information to patients varied 
from ‘on a diagnosis of bone metastases’ to ‘disease progression’ or ‘when the 
clinician perceived the patient to be at high risk of developing MSCC’.  Forty-two 
per cent (n=21) of staff felt that the appropriate time to give information on 
MSCC was to those patients in at risk groups (primary cancer of lung, breast, 
prostate cancer or bone metastases).  However, the findings are unclear around 
which group of patients were given prophylactic information.   Patients’ views 
were also sought on whether it would be helpful for them to have the 
information about the signs and symptoms of MSCC.  Forty eight patients 
agreed, three patients disagreed and five were unsure.     
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The authors highlight that those patients who felt the information on MSCC 
would not be helpful had metastases, however, there were no reasons given for 
this response (Hutchison et al. 2012).  The authors categorised the patients 
comments into ‘want to know’, ‘don’t want to know’ and ‘neutral’.  Those 
patients who commented ‘don’t want to know’ did not give any explanation.  
Most patients were reported as wanting a combination of written and verbal 
information on MSCC.  The authors noted there was a mismatch between what 
the patient wanted to know about MSCC (both when they were diagnosed with 
the condition and prophylactically) and those of the staff.  They found that staff 
were unclear whose role it was to provide information to patients and at what 
stage patients should be given the information.  The perception was it was 
‘either everyone’s problem or someone else’s problem’.   
 
The rationale for the staffs’ attitude was perhaps because patients with MSCC 
or those at high risk may be managed at a different site-specific cancer and 
care setting.  The authors noted that four per cent of staff reported giving 
patients written information about MSCC whereas 20% of patients said they 
received it, and 77% of patients wanted it.  Seventy eight per cent of staff 
reported giving verbal information on MSCC but only 45% of patients reported 
receiving any information.   
 
One of the limitations of the Hutchison et al. (2012) study was that no 
information was given why the 45% (n=13) of consultants were not sure 
whether patients should be given prophylactic information on MSCC.   The 
authors mentioned interviewing the participants, however, the findings seemed 
to be quantified.  For that reason, the above study lacked an in-depth 
exploration of the patients and staff perspectives.  The authors acknowledged 
that a limitation of this study was that the questionnaire was administered at 
different times by patients and staff and did not reflect the individual 
communication.  In addition, there are questions on whether staff had 
awareness of the signs and symptoms of MSCC themselves.  There was also a 
lack of clarity as to whose role it is to provide this information to patients or how 
and when the decision should be made to provide it.  This is further 
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compounded by a lack of clarity as to where the patients are cared for and who 
managed them.   
 
Although Hutchison et al. (2012) explored the views of healthcare professionals, 
it is noted that only the senior ward/charge nurses and clinical nurse specialists 
were involved.  However, many of these patients are cared for by other level 
nurses on the wards.  Furthermore, patients see their general practitioners in 
the community and their views were not sought.  Therefore, further research is 
needed to explore their views and how they make decisions in communicating 
this information to the patients.  
2.5.4 Structured rehabilitation for MSCC patients  
Where patients became paraplegic due to MSCC, three studies reported that 
they benefitted from a structured rehabilitation programme (Ruff et al. 2007a; 
Ruff et al. 2007b; Tan and New 2012).  For example, Ruff et al. (2007a; 2007b), 
a US-based study, compared 12 consecutive patients who received directed 
rehabilitation for two weeks with a historical control group of 30 paraplegic 
patients with ‘no rehabilitation’.  The rehabilitation programme was aimed at 
training patient and caregiver on transfers, bowel and bladder care, incentive 
spirometry, nutrition and skin care.  To provide this rehabilitation, the authors 
suggested patients and their support network should be willing to participate in 
the programme, have expected survival of six months or more and resources 
should be available to educate and train the patients and their carers.  However, 
it must be pointed out that the ‘no rehabilitation’ group received physical therapy 
three hours a week for at least two weeks.   
 
The authors reported patients who underwent the directed rehabilitation lived 
longer (26 weeks compared to 6 weeks for patients who did not receive 
rehabilitation), were able to independently transfer compared (67%), were more 
likely to go home less depressed and had higher satisfaction with life scores 
than the ‘no rehabilitation’ group.  Patients self-reported their symptoms; 
depression using the Beck Depression Inventory-Second Edition (BDI-II); 
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satisfaction with life scale (SWLS) (Diener et al. 1985); and mobility 
independence.   
 
Twenty six of the 30 patients with ‘no rehabilitation’ (86.7%) compared to one 
patient (8.3%) suffered from clinical depression two weeks after completion of 
their radiotherapy and were treated with anti-depressants.  All patients who 
participated in the rehabilitation were discharged home.  The implication of 
rehabilitation seems to foster a positive focus for patients and carers to adjust 
and cope with the changes.  However, it is not clear whether patients and their 
carers received any support at home. 
 
In a follow up study of the same sample (see Ruff et al. 2007as discussed 
above), Ruff et al. (2007b), the rehabilitation group of patients were studied until 
death.  Their findings showed patients had reduced pain levels, with fewer 
deaths from myelopathic complications.  The possible reason given was that the 
programme gave patients and carers time to adjust and cope with daily 
activities at home. It is also notable that patients who were depressed after 
radiotherapy continued to suffer from depression until death.  The authors 
acknowledged that the rehabilitation group and the ‘no rehabilitation’ group 
were not evaluated at the same time.  Moreover, there may be some 
differences in the outcome of the rehabilitation group that may be due to 
unrecognised changes in patient care.  
 
In an Australian study, Tan and New (2012) reviewed the medical records of 
108 patients between 1996 and 2008.  The authors reported a focused 
rehabilitation programme for patients who suffered spinal cord injury due to 
tumour.  Participants in this study were found to have reduced pain levels.  The 
authors conclude that the programme brought functional benefit despite longer 
stay in the specialised rehabilitation unit (median 47.5 days, range 4-237 days).  
However, the authors suggest balancing the goals of rehabilitation with the 
short life expectancy of patients.  A limitation to this study is the retrospective 
approach which includes inaccuracies and missing data in the patients’ records.  
In addition, the authors did not describe the support, length and specific details 
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of their rehabilitation programme.  It is also notable, as in the study by Ruff et al. 
(2007a and 2007b), patients who were perceived to have a prognosis of less 
than three months were not included in the study.  Therefore, this might 
disadvantage those patients who were presumed to have a shorter life 
expectancy. 
 
Huang and Jatoi (2009), retrospectively reviewed the outcomes of 39 patients 
between 1996 and 2006 who went home without support.  Patients who 
survived beyond a year were patients who had regained their mobility.  Twenty 
five patients (64%) did not gain back their mobility.  More than half (n=23; 59%) 
required bowel care and/or bladder catheterisation and 33 (85%) needed 
analgesics.  Thirteen patients (33%) went home without help.  Others were 
transferred to a hospice or home with hospice or health facility.  The authors 
acknowledged their retrospective study could not capture the emotional state of 
patients. 
 
The authors suggest patients with MSCC who did not regain ambulation appear 
to have greater needs – physical, emotional and psycho-social.  Similar findings 
were also reported by Cowap, Hardy and A’ Hern (2000).  In fact, the authors 
suggest the identification of patients performance status on admission may help 
to anticipate and plan the level of care patients required.  However, how 
patients cope or make sense of their disability in the healthcare setting or in the 
community is not known. 
2.5.5 Impact of MSCC on patient as a person    
Literature reveals a lack of information on how patients perceive their disability 
and its effect on them as a person.  Eva et al. (2009) conducted a longitudinal 
case study to ascertain patients’ constructions on their disability as a result of 
MSCC.  Semi-structured interviews were undertaken with nine patients, six 
carers and 29 professionals at intervals through the trajectory of the patients’ 
illness.  The time points were not specified.  The authors’ findings revealed that 
the patients’ orientation to disability incorporated a twin-tracking manner; 
‘acknowledging the problem’ and ‘not acknowledging the problem’.   
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The authors described that patients ‘acknowledged their problem’ by trying to 
adapt to their unfamiliar and unpredictable body and at the same time were 
concerned about dependence on others and not wanting to be a burden.  The 
patients then reassessed their daily life and reorganised their activities by taking 
practical steps to achieve their needs.  The authors also described the patients’ 
ambivalence towards getting information, with some patients fearing the worst.  
The other theme of ‘not acknowledging the problem’ indicates patients trying to 
maintain normality for fear of being labelled as disabled.  In trying to manage 
this fear, the patients try to find solutions to overcome it.  Another theme 
described by the authors was around the patients ‘managing the tension’ by 
twin-tracking between goals that are contradictory.  Over time, the patients 
adapted to their disability but voiced concerns of future deterioration.  Although 
patients regret their loss of independence, they looked to future possibilities.  
According to the authors, the patient’s orientation of ‘not acknowledging the 
problem’ is self protective and has psychological benefits.   
 
An explanation offered was the patient’s adjustment to disability which has a 
temporal dimension where one takes time through a process of reconciling 
one’s view of self and this requires support from others.  This requires 
renegotiation in relationships with others and with the environment.  However, 
patients may not live long enough to incorporate this adjustment into their sense 
of self, therefore, they try to resist the ‘disabled identity’.   Another explanation 
given for the concept of ‘adjustment to disability’ was comparable to the process 
of a person who has been bereaved.  Although the authors used Pawson and 
Tilley’s (1997) context-mechanism-outcome theory as a basis for data 
collection, the reason for the choice was not explained.  Similarly, the authors 
did not give the explanation for the choice of George and Benett’s (2004) 
approach for within-case analysis and Glaser and Strauss’s (1967) between-
case methods of data analysis.  Moreover, the responses of carers and 
healthcare professionals were not reported and it is not known whether the 
responses of healthcare professionals influenced the patient’s understanding of 
their condition.   
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This study gave an insight into patients’ views in juggling with the reality of their 
disability.  It is not known whether the patients’ twin-tracking attitude was 
influenced by the treatment they were receiving, for example, Levack et al. 
(2004) highlight that treatment may foster optimism.  There may be disparity in 
patients’ expectation and the professionals’ intent.  Further research is needed 
to explore the perspectives of the different stakeholders in decision making in 
the management of MSCC. 
2.5.6 Transition from curative treatment to palliative care 
There is a lack of literature exploring end-of-life care specific to patients with 
MSCC.  Conway et al. (2007), reported that patients (65%; n=21/33) who are 
able to mobilise unaided had a higher chance of being discharged home.  
However, 69% (n=31/45) of those who were unable to walk at diagnosis were 
institutionalised at one month.  The authors suggest healthcare professionals 
need to have a discussion about future care focussing on patients needs, for 
example, place of care.  The majority of patients were reported to have a 
Karnofsky performance of 50 and the authors suggest patients need 
considerable nursing and medical care.  Similarly, Cowap, Hardy and A’ Hern 
(2000) stressed that treatment is palliation in the majority of cases and 
suggested it is likely that patients care needs will increase over time.  However, 
it is unclear whether patients have autonomy or preferences in the choice of 
place for their end of life care.   
 
Communication about end-of-life decisions is crucial and healthcare 
professionals should use the catastrophic event of a diagnosis of MSCC to have 
this conversation and initiate palliative care (Guo et al. 2010).  Despite evidence 
showing patients median survival time of 4.3 months, Guo et al. (2010) found 
that patients were not aware of the urgency to have an advanced directive and 
Do-Not-Resuscitate (DNR) orders.  The authors reviewed 59 patient records, 26 
(46%) had a DNR note and for those who had the presence of an advanced 
directive, the median time between the date of the directive and death was 16.5 
days.  However, the authors acknowledge this was a retrospective review of 
patient medical notes and any expression of choice in having an advanced 
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directive can vary and moreover the reasons can be difficult to capture in a 
quantitative way.   
 
Due to the limited sample size, the authors were unable to identify specific 
patient groups associated with lower advanced directive and DNR instructions.  
This study was carried out in the US; there is lack of literature on end-of-life 
issues in MSCC for comparison.  Further research is required to explore the 
experiences of patients, carers and healthcare professionals in the 
communication of end-of-life issues.  
 
Summary 
In summary, the findings from this section indicate the life expectancy of 
patients with MSCC is short and varies across the different primary type 
cancers.  The pre- treatment neurological status is a strong predictor of 
functional outcome and survival.  It is highlighted that the sooner MSCC is 
detected and appropriately treated, the better the outcome.  Treatment whether 
radiotherapy or surgery, is of palliative intent.  The review suggests that not all 
patients are suitable for surgery and that the impact of surgery on patients is 
reduction in pain.  There is controversy as to whether surgery could prolong 
survival and regaining mobility after surgery or radiotherapy is unpredictable.  
The review identified in older patients there is increase in surgical complications 
positively associated with the number of co-morbidities.   
 
It is not clear how patients cope with the toxicity or side effects of 
corticosteroids, radiotherapy or recover from surgery or indeed manage the 
complications of treatment.  Younger patients are perceived as more likely to 
want active treatment to regain functional improvement which contributes to 
quality of life.  Besides, there is a lack of evidence on patient preferences or 
whether they have a say in their treatment. 
 
Many of the studies reporting on patients’ quality of life as a result of surgical, 
radiotherapy and rehabilitation interventions and have an international focus.  It 
is apparent there are a variety of outcome tools used to measure patients’ 
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health related quality of life but most of these questionnaires have limitations.  
The majority of studies looked for efficacy of interventions and generally 
reported positive outcomes as a result of treatment.  There is disparity and 
inconsistency in their approach to variable assessments which made it difficult 
to compare their findings.  Patients have their own definition of quality of life and 
it may not be what healthcare professionals or family members judge it to be. 
 
Although these health-related quality of life tools are commonly used in general 
cancers, they are not specific to MSCC.  Some measurement tools were not 
sensitive to detect the changes, for example, patients’ physical functions, daily 
activities of living and emotional status.  The review has identified that MSCC 
has a great impact on patients across all domains. However, the subjective 
aspects from patients and carers in the domains of cognitive, emotional and 
social/family are relatively unexplored.  One study reported social/family support 
has a positive impact on a patient’s quality of life; the authors suggest it could 
be from a cultural viewpoint.  
 
The literature indicated provision of information on early signs and symptoms of 
MSCC to patients is important; there is a lack of studies around this area, 
making comparison difficult.    More importantly, an in-depth exploration of 
patients understanding of their condition is needed as the review highlighted 
some patients ‘disagreed’ or were ‘unsure’ whether it would be helpful to have 
information about the signs and symptoms of MSCC.  
 
The review suggested that planned or focused rehabilitation can improve 
patients’ psycho-social wellbeing, coping mechanism and prolonged survival.  
There is patient selection bias as the authors recommend rehabilitation for 
patients who have a life expectancy of more than three months.  Given the 
paucity of evidence and the small sample size, the effectiveness of 
rehabilitation cannot be compared.  Moreover, there is a lack of studies 
exploring the patients and carers perspectives when participating in 
rehabilitation program in MSCC.   
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Patients seemed to have ambivalence between acknowledging the problem and 
not acknowledging the problem and trying to manage this tension (Eva et al 
2009).  The patient’s attitude was thought to be self protecting and to have 
psychological benefit.  However, there is limited information about what 
communications or discussions ensued between patients, carers and 
healthcare professionals during the transition from curative to palliative care.  
This illustrates the complexity of MSCC and an understanding of the dynamics 
involved needs to be pursued. 
 
There is evidence highlighting that patients went home without support, 
however, it was not clear whether those patients were mobile or did not gain 
back their mobility.  Others were transferred to a hospice or a home with 
hospice or health facility.  There is a suggestion that patients who did not regain 
mobility appeared to have greater needs; physical, emotional and 
psychological.  It was also noted that pain control should be addressed and that 
healthcare professionals need to have a discussion about the place of care.  
Moreover, there is a lack of evidence on end-of-life discussions on prognosis, 
advanced care planning and DNR orders.  Therefore, further research is 
required to explore whether the patients preferences and support needs were 
met or not.  As the carers and/or family members play an important role in 
supporting the patients with MSCC, the next section will explore the carers’ 
perspectives about MSCC. 
2.6 Carers’ experience in supporting the patient with MSCC 
There is no study dedicated solely to the carers’ perspective in MSCC.  The 
evidence for this section was also mentioned in the patients’ experiences (Sub-
section 2.5.2).  However, to discuss this aspect on carers’ experience about 
MSCC, I refer the article by Fujibayashi et al. (2010) - details in Appendix 5. 
 
Fujibayashi et al. (2010), surveyed 37 patients and their families’ satisfaction, 
three months after surgery.  The mean age of patients was 60.1 (range, 31-85 
years).  Twenty one patients were male and 16 female.  The findings showed: 
18 carers and/or family members (48.6%) were very satisfied; nine (24.3%) 
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were satisfied; seven (18.9%) were somewhat satisfied, and two (5.4%) were 
somewhat dissatisfied. 
 
However, 21 patients were alive and 16 were dead at the time of completion of 
questionnaire.  Those 16 responses were completed by family members.  The 
authors found the patients satisfaction was due to neurological improvement, 
whereas the family members were more concerned with pain control and length 
of patient survival.  The findings may not be a true reflection of the patients’ 
perspectives, given 16 family members responded on behalf of the deceased 
patients.  It is unclear whether there were other influencing factors; for example, 
support needs, rehabilitation, age of the patients and carers.  Also, those who 
did not respond may not have been satisfied. 
 
Summary 
In summary, this review has identified a gap in the literature on the lack of views 
from carers and/or family members about MSCC. However, it is noted from 
literature in advanced cancer that carers and/or family members felt devastated 
when their loved ones had recurrent or advanced cancer and it was reported 
they had unmet needs (Hagerty et al. 2004; Sharpe et al. 2005).  Carers and/or 
family members have an important role in supporting their loved ones in the 
cancer trajectory. Therefore, it is important to have an understanding of the 
carers’ role and the dynamics around supporting the patients with MSCC.  
Moreover, there is also a lack of understanding on the interactions between 
carers and healthcare professionals in the management of MSCC. 
 
                                                          
 Note: Fujibayashi et al. (2010) reported as 7(18.9%) carers were satisfied with the surgery; 
however, on close examination, the results was 8(21.6%). 
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2.7 Healthcare professionals’ experiences in managing 
patients with MSCC 
This section will look at the healthcare professionals experience in the 
management of patients with MSCC.  The evidence in this section is drawn 
from; one Cochrane systematic review, one review, two retrospective studies 
and two audits.  Two of the studies were also mentioned in sub-sections 2.5.1 
and 2.5.2 (Tomita et al. 2001; Omeis et al. 2011). 
 
There is a lack of studies exploring the healthcare professionals’ experiences in 
managing patients with MSCC.  However, this section draws upon relevant 
studies and audits to identify the current knowledge relating to healthcare 
professionals’ practice.  A summary of the studies highlighting healthcare 
professionals’ perspectives about MSCC can be found in Appendix 6. 
 
Earlier in this review (section 2.5.2), I identified numerous studies  which 
indicated the feasibility of surgery and its positive impact on some patients 
(Sandalcioglu et al. 2005; Falicov et al. 2006; Fujibayashi et al. 2010; Wu et al. 
2010).  However, the reviews indicate the pre-treatment neurological status of 
the patient should be taken into account when making decisions regarding 
surgery.  In contrast to common knowledge that paralysis is predictive of 
survival, Tomita et al. (2001), suggest that even with paraplegia, patients may 
still have a long survival period if given the right treatment.  Their rationale was 
that patients die not because of paralysis but because of disease progression.   
Tomita et al. (2001), proposed a surgical strategy based on treatment goals to 
assist the clinician in decision making.  The authors proposed a scoring system 
to determine the type of treatment based on three prognostic factors: (1) grade 
of malignancy (slow growth, 1 point; moderate growth, 2 points; rapid growth, 4 
points), (2) visceral metastases (no metastasis, 0 points; treatable, 2 points; 
untreatable, 4 points), and (3) bone metastases (solitary or isolated, 1 point; 
multiple, 2 points).  Here, the treatment goal for each patient was set according 
to the prognostic score; long-term control, middle-term local control, short-term 
control and supportive care. 
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Tomita et al. (2001), in their phase two study (between 1993 and 1996), made 
their treatment decisions for 61 of their patients based on each patient’s 
prognostic scores, the success rate of local control of the disease was achieved 
in 43 (83%) of their patients who were treated surgically.  The authors found this 
strategy was practical and reliable.  Although the authors have reported the 
accuracy and reliability of the prognostic score system, further trials are needed 
to validate its use.  However, in this study there was no mention about taking 
into consideration patients co-morbidities.   As I have previously identified in the 
review (section 2.5.2), the risk of patients developing surgical complications 
increases with the number of co-morbidities (Omeis et al. 2011). 
 
Murakami et al. (2010) reported a retrospective review of a sub-group of elderly 
patients (32 patients > 70 years) who had undergone surgical procedure (since 
1999) based on Tomita’s prognostic scoring.  In this analysis, it was noted that 
the pre-operative general conditions of the patients were assessed using the 
Eastern Cooperative Oncology group performance status and the Karnosfsky 
performance scale.  Respiratory complications and delirium occurred 
significantly more often in the elderly group.  Despite the risk of complications in 
major surgical procedures in the elderly, the authors suggest en bloc excision 
(total en bloc spondylectomy) is feasible for selected patients with few systemic 
complications and surgery should not be avoided due to a patient’s advanced 
age. 
 
However, Yamasita et al. (2008), stated that surgeons need to have a treatment 
strategy for each individual patient with MSCC.  The authors used the total 
revised Tokuhashi et al. (2005) scoring strategy to investigate 93 patients after 
surgery.  The authors found those patients with higher total revised Tokuhashi 
scores and their primary cancer type proved helpful for predicting short-term 
functional improvement.    Sixty per cent of prostate and breast cancer patients 
were free from neurologic re-deterioration at follow up.  The authors highlight 
that a greater probability of benefit exists for prostate and breast cancer patients 
who still have effective adjuvant therapy. 
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In other primary cancer types, 70% (n=37) of colon, liver, stomach, and kidney 
cancer patients did not achieve the short-term functional improvement.  The 
authors suggest it could be that the local spinal metastases were uncontrolled.  
Therefore, the authors believed the duration of improvement in physical function 
is strongly dependent on the presence or absence of major internal organ 
metastases.  The authors indicate this knowledge would help healthcare 
professionals make decisions and also help patients and carers make informed 
decisions. 
 
Likewise, Tancioni et al. (2010), suggest that no firm conclusion can be made 
regarding the superiority of one approach versus another because of the 
heterogeneity of the patient population.  In their study, 89 patients underwent 
fairly conservative treatment followed by radiotherapy.  With this approach, their 
patients achieved long-lasting remission of pain and recovery of neurological 
function of 80% and 70% respectively.  The authors believed a multi-disciplinary 
team (oncologist, radiation oncologist and neurosurgeon) is important to choose 
the appropriate treatment. Less is known about how the healthcare 
professionals make their decisions based on the available evidence especially 
when care planning and treatment decisions are of palliative intent.  
 
In an audit carried out in the UK, Pease, Harris and Finlay (2004) identified the 
issues encountered in clinical practice were centred on the difficulty in 
assessing the status of the spine.  Although MRI is an accurate modality to 
detect spinal cord compression, it cannot reliably confirm spinal instability.  The 
knowledge of spinal status is important to determine the treatment and care of 
patients and often there was confusion about when to start mobilising the 
patient.  Patients were routinely nursed flat and commenced mobilisation after 
completion of radiotherapy (between 5-7 days).  However, after the authors 
implemented their care pathway, the majority of patients began rehabilitation 
after 1-2 days.   
 
With rehabilitation starting sooner, the authors reported increased survival and 
decreased complications such as chest infections and deep vein thrombosis 
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events.  The authors recommended collars and braces to increase patient 
functional independence, comfort and a sense of control.  Although the authors 
reported anecdotally that patients had an increased quality of life, little is known 
about the patients’ experiences with regards to decision making in mobilisation.  
There is also lack of staff perspectives in how they faced the challenges in 
making decisions about each patient’s care. 
 
A similar evaluation was carried out by Warnock et al. (2008), investigating the 
staff perspectives with the use of a questionnaire and a retrospective review of 
medical and nursing documentation.  The authors reported that the majority of 
patients who were unable to walk on admission did not regain mobility and 
patients’ experienced significant physical problems as a consequence of 
developing MSCC.  There was a discrepancy on issues of mobilisation between 
the healthcare professionals’ response and the actual practice as identified from 
the documentation.  In this study, 14 (66%) consultants, 10 (71%) specialist 
registrars and 32 (30%) nurses responded. 
 
The findings showed 75% (n=18) of doctors did not recommend that patients 
should routinely be on bed-rest, versus 69% (n=22) of nurses reporting that 
patients were routinely kept on bed-rest for the duration of treatment.  However, 
documentation revealed 88% (n=44) of patients were on bed-rest for the 
duration of their treatment and the rationale for this was not clear.  Nurses 
identified that patients on bed-rest had difficulty eating/drinking, boredom, 
isolation, low mood and complications such as pressure sores, chest infections 
and deep vein thrombosis.  Twenty one per cent (n=7) of nurses felt patients’ 
psychological concerns were met most of the time, 55% (n=17) felt they were 
met sometimes, 18% (n=6) felt patient’s concerns were rarely met and six per 
cent (n=2) said they were never met.  However, findings from documentation 
identified common emotions were; low mood, anxiety and being tearful -
specifically related to loss of independence, being incontinent, and in pain.  In 
contrast, Huang and Jatoi (2009) found no patients appeared to have 
depression severe enough to refer for a psychiatric consultation or initiation of 
anti-depressants.  Nonetheless, the authors acknowledged that patients may 
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have mild depression or the extent of depression was difficult to capture in the 
patients’ medical records.  This indicates reviewing patients’ notes may not 
capture an in- depth understanding of the patient’s psychological concerns and 
their needs may not be addressed. 
 
The evaluation also highlighted the majority of patients (43 out of the n= 50 in 
the audit) were elderly (Warnock et al. 2008).  Although the authors suggest a 
need to develop a clear guideline on mobility, assessing spinal stability and 
early referral to the physiotherapists, there was no suggestion to address the 
patient’s psycho-social or support needs.  The authors acknowledge that one 
limitation to their study was the low response rate from the nursing staff, despite 
repeated reminders and suggest that the use of other methods of data 
collection may encourage participation.  This indicates the use of a qualitative 
approach may help to understand the similarities and differences in decision 
making amongst the stakeholders in the management of MSCC.  However, 
there is an emphasis on providing treatment and care based on evidence on 
how best to care for this group of patients.  Kilbride et al. (2010) reviewed 
practice and care on the issue of spinal stability, role of braces, positioning and 
mobilisation.  The reviewers found a lack of guidelines and consensus in the 
literature on how to assess spinal instability as there are other variables to be 
considered (Kilbride et al. 2010). 
 
To ensure that patients are cared for effectively Lee et al. (2012), in their 
Cochrane systematic review investigated what treatment approaches can help 
provide healthcare professionals with their decision making in MSCC.  The 
review indicates disparity in evidence regarding stabilisation, positioning and 
initiation of mobilisation.  Moreover, there is a lack of evidence in the use of 
bracing to relieve pain or vertebral collapse to support the recommendations of 
guidelines.  Furthermore, there is a lack of current research literature about the 
preferences of patients with a poor prognosis and their quality of life needs to 
be taken into consideration in care decisions. 
 
 
 
 
 
49 
 
Summary  
In summary, the literature identified studies which have proposed a scoring 
system to assist clinicians to determine a patient’s suitability for surgery or 
supportive care.  However, there is a need for more randomised controlled trials 
to validate its accuracy.  It is notable that there is controversy in the type of 
approach in surgery, and/or with radiotherapy.  The complexity in decision 
making in MSCC is around selecting appropriate patients for treatment.  
Patients with prostate and breast cancers as primary type cancers respond 
better if there are still adjuvant treatments.  Other cancers may not respond well 
and there are other factors to consider such as; local progression of cancer in 
the spine and spreading to the other major organs.  Other issues in clinical 
practice include the difficulties in identifying spinal instability, however, it is 
deemed important to assist healthcare professionals make decisions in 
treatment and care.  The review also highlights the discrepancies in instructions 
on positioning and mobilisation and the use of braces.  There is a lack of 
guidance to help healthcare professionals make decisions based on evidence.   
Therefore, further research is required to explore healthcare professionals’ 
experiences in meeting these challenges and managing patients with MSCC. 
 
Nurses perceived the majority of patients’ psychological needs were either met 
most of the time or met sometimes but some evidence suggests a quarter of 
patients’ psychological concerns were not attended to (Warnock et al. 2008).  
Documentation revealed patients suffered emotional, psychological and 
physical problems.   However, evidence also suggests documentation may not 
capture information on depression or the extent of depression.  It is not known 
how patients coped with the impact of MSCC and whether they had ongoing 
concerns. 
 
The review indicates prognostication is crucial in initiating discussion about end-
of-life care and can empower patients in decision making.  However, little is 
known about how healthcare professionals approach this issue with the 
patients, carers and/or family members. 
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2.8 Collaborative decision making in relation to the 
complexities of MSCC 
It is apparent from the integrative review there are controversies and 
uncertainties surrounding the optimal treatment and care for patients with 
MSCC.  Treatment for MSCC is normally palliative, and healthcare 
professionals need to meet and support patients and carers during this 
challenging period (Cowap, Hardy and A’ Hern 2000; Conway et al. 2007).  
Tancioni et al. (2010), suggest a multi-disciplinary team that comprises of an 
oncologist, radiation oncologist and neurosurgeon choose the appropriate 
treatment for patients.  However, healthcare professionals cannot automatically 
assume what patients value when lifespan is limited (Levack et al. 2002).  
Evidence showed that often discussions around end-of-life decisions occur late 
for people with MSCC (Guo et al. 2010).  Moreover, the inclusion of patients 
and/or carers and other healthcare professionals in the decision making was not 
discussed. 
 
In wider literature on decision making, Menard et al. (2012), conducted a 
selected literature review to identify strategies to improve the decision making 
process in oncology.  They identified a difference between uncertainty reduction 
and management of uncertainty approach in cancer care.  The uncertainty 
reduction strategies discussed involve the physician making an evaluation of 
the patient’s medical condition; giving thorough evidence based medical 
information; and management of the likely consequences of the medical 
decision.  Blanch et al. (2009) and Politi et al. (2011), found poor patient 
satisfaction about treatment decisions when giving information on uncertain 
treatment.  Additionally there appeared to be little focus on a patient’s 
psychological status, imbalanced flow of information, and lack of relationship 
building between physician and patient.  This approach results in decisional 
conflict, especially when the strategy was focused on medical uncertainty.  
Menard et al (2012), argues that uncertainty occurs at medical, psychological 
and social levels.  Therefore, they recommend uncertainty management 
approach in decision making.  
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Another strategy the ‘shared decision making approach’ was also considered to 
have limitations (Menard et al. 2012).  Shared decision making strategies 
involve patient-centred communication where the patient is encouraged to 
participate in decision making through information exchange and negotiation.  
This is drawn from an individualised assessment of the patient’s medical, 
psychological and social status.  It is thought that this shared decision making 
approach lacks the focus on patient and physician psychological characteristics 
which can potentially alter the decision making process. For example, patients 
who are anxious or distressed may not process and exchange information with 
their physician (de Haes and Bensing 2009).  Similarly, the patient’s physician 
may not be sensitive towards detecting the patient’s distress.   
 
Menard et al. (2012), also highlight that shared decision making can lack the 
focus of multi-disciplinary input.  According to Legare et al. (2010) and Stacey et 
al. (2011), shared decision making approaches predominantly use decision aids 
to assist patients with treatment decisions.  Other authors argue that decision 
aids are designed and implemented without conceptual clarity, lack 
communication processes and the behavioural components for active 
participation in decision making (McCaffery, Irwig and Bossuyt 2007; Nelson et 
al. 2007; Street 2007). 
 
Based on their review, Menard et al. (2012), recommended a collaborative 
decision making approach with a ‘three-step’ model.  This model comprises a 
collaborative evaluation interview between the physician and the patient, a 
collaborative multi-disciplinary meeting focused at supporting the medical 
decision and a collaborative decision interview for a final decision, taking 
account of the patient’s preferences and values.  This model is based on a 
literature review within oncology in general (genetics, screening of cancers and 
in some cancers where there are treatment options) and lacks supporting 
empirical work.  In another review, using a meta-narrative approach to explore 
inter-professional collaboration models in cancer management, Gagliardi, 
Dobrow and Wright (2011), reported confusion as to whether collaborative 
decision making is a process or intervention or an intermediary outcome.  It was 
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suggested that further research is needed to explore how or whether various 
conceptual models with common elements and outcomes can be blended to 
support collaborative decision making. 
 
This section shows that a lot of work on decision making in cancer is focussed 
around uncertainty management, shared decision making, team decision 
making and collaborative decision making.  Literature has demonstrated a lack 
of definitions on the concepts or that the existing definitions lack theoretical 
clarity.  In order for policy to decide on action, there is a need for stakeholders 
to agree on and define these concepts.  Therefore empirical data from this 
current study can help to clarify the theoretical concepts in collaborative 
decision making drawing on experiences of managing MSCC.   
 
2.9. Conclusion arising from the integrative literature review 
This integrative review indicates there is limited evidence to inform an 
understanding of the patients’ experience when diagnosed with MSCC and the 
type of care they need or prefer.  MSCC is a dynamic condition that is 
unpredictable and impacts on patients across all domains.  The review indicates 
controversies and uncertainty in the treatment outcomes.  However, there are 
quite a considerable number of studies investigating patient outcomes, for 
example, survival, pain, mobility and quality of life.   The challenges lie in the 
difficulty in evaluating patient outcomes.  Most of the evidence is also focused 
on delivering an intervention or outcome of an intervention for a set period of 
time, not about the influence that ongoing support might have or how patients 
are managing with end of life issues. 
 
It must be acknowledged that the data collection for this thesis was carried out 
before some of the studies were published.  However, in keeping with 
qualitative enquiry, literature searching has been an ongoing and reflexive 
process.  The findings of this review demonstrate there remains a lack of 
representation of the patients’ experience in MSCC.  Similarly, there are gaps in 
knowledge on carers’ experiences about MSCC.  Moreover, little is known on 
the role of the healthcare professionals and their experiences in managing and 
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caring for this group of patients.  The review also highlights the trajectory of 
cancer for many of these patients and little is known about where they are 
managed and who manages them. 
 
2.10 Chapter summary 
This integrative review shows that MSCC is a devastating event and can cause 
severe morbidity and compromise survival in patients.  Early recognition and 
treatment is important to preserve neurological function.  Patients who develop 
MSCC suffer from issues in several domains: information needs, physical 
function, emotional, social, and end of life.  There are various studies 
investigating treatment outcomes such as survival, pain, neurological status, 
activities of daily living, ambulation and sphincter control.  Other studies look at 
quality of life including physical functioning, emotional wellbeing, and 
social/family wellbeing.  However, all these assessment measures are complex.  
Patients with MSCC are often elderly, ill and depressed and frequently have 
more than one co-morbidity and the survey can be a burden for them to 
complete. 
 
Furthermore, it is difficult to capture the concept of quality of life as patients may 
have their own definition of what quality of life means to them and this can 
change with time.  Some of the questionnaires, for example, the EORTC are 
made to measure quality of life constructs in clinical trials but it does not identify 
patients’ problems or needs.  Therefore, the assessment tools are not specific 
to MSCC and are not sensitive to detect the changes in a patient.  Although 
Street et al. (2010), proposed a health-related quality of life questionnaire, there 
is no publication validating its use or accuracy.  In addition, little is known about 
how these findings help to inform the patient’s needs.  The subjective 
component, the patient’s experience with MSCC, is lacking.   
There seems to be disparity in the findings around emotional wellbeing.  Some 
studies show a minority of patients were depressed whilst others show patients 
suffered clinical depression and were treated with anti-depressants.  It seems 
that the patients’ psychological issues were not fully addressed or were 
neglected.  Therefore, there is gap in the literature to provide a comprehensive 
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understanding of the impact of MSCC on patients.  Qualitative approaches to 
data gathering may help to uncover and provide evidence of patients needs. 
 
Levack et al. (2004), and Wu et al. (2010), highlight that the social/family 
wellbeing domain scores favourably, indicating that family is important to a 
patient’s quality of life.  However, little is known about the patient’s interaction 
with their spouse and/or family members and the impact the family support has 
on the patient.  There was one study with minimal information about family 
members’ satisfaction after patient’s surgical procedure (Fujibayashi et al. 
2010).  The findings showed differences in the factors that influence satisfaction 
between patients and their family members.  The reasons for this were not 
explained in depth, therefore, there is a gap in knowledge about carers’ and/or 
family members’ perspectives in MSCC.  They are, after all, pivotal in 
supporting patients. 
 
Literature highlights the complexity and controversies in treatment outcomes.  
Patients’ suitability for surgery depends on their age, co-morbidities, site of 
tumour, extent of tumour and any spread to other organs.  Younger patients 
seem to want active treatment to retain functional improvements, being related 
to quality of life.  Older patients with increased co-morbidity have an increased 
risk in acquiring complications.  However, Murakami et al. (2010), suggest 
treatment should be offered despite advanced age.  Patients are faced with 
poor prognosis and are dealing with a decline in their health status.  Treatment 
is of palliative in intent and it is not clear what the patients’ expectations, 
preferences and choices are and their experiences as a result of the 
interventions.  It is noted that patients are managed in different disease-specific 
sites, but little is known about where these patients are managed and who 
manages them.  There is also a gap in the literature in the perspectives and 
experiences of healthcare professionals as to how they make these decisions 
with regards to treatment and care. 
 
There is evidence that indicates that focused and structured rehabilitation 
programmes benefit patients and their carers.  One setback was that this 
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programme was recommended for patients with a survival expectation of more 
than three months.  It is not clear what the current practice is with regards to 
rehabilitation in the UK - although one study shows only four per cent of patients 
(5 out of 166) went to a rehabilitation unit (Cowap, Hardy and A’ Hern 2000).  
Further research is required to explore the patients and carers experience of the 
impact this has on their care and support.   
 
The review highlights the need to provide patients with information on signs and 
symptoms of MSCC to encourage early referral and treatment.  There is a need 
for research to explore how patients process information when diagnosed with 
MSCC and translate it into what it means for them.  However, the signs and 
symptoms were not specified.  There is also a lack of information about whether 
staff have awareness of the signs and symptoms of MSCC.  Likewise, there is a 
lack of clarity on when, how and by whom the information about MSCC should 
be given to patients.  Issues in clinical practice are centred on spinal stability, 
patient positioning, mobilisation and bracing, however, there is lack of best 
evidence-based recommendations.  The review indicates that the evidence 
around spinal stability, positioning, mobilisation and bracing is limited.  There is 
apparent disparity in the findings on positioning and mobilisation.  This indicates 
the need to explore the healthcare professionals’ perspectives in how they 
interpret guidelines and assess patients’ needs and preferences. 
 
There is a gap in the literature on end-of-life issues.  For example, there is a 
lack of evidence demonstrating initiation of conversations or discussion on 
prognosis.  There is also a lack of information on end-of-life needs and place of 
care.  It is not known whether patients have a choice or autonomy in end-of-life 
matters. Guo et al. (2010) reported evidence from patients’ medical notes which 
demonstrated patients were not aware of the urgency to have an advanced 
directive or do-not-resuscitate orders.  This illustrates there is a lack of 
knowledge on what patients understand or perceive regarding their condition 
and treatment in MSCC.  Besides, Eva et al. (2009) identified that patients’ 
construction of their disability seemed contradictory.  The patients seemed to 
twin-track between ‘acknowledging their problem’ and on the other hand ‘not 
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acknowledging their problems’.  However, this study did not discuss end-of-life 
issues or how this can help identify patients’ needs.  Although the authors used 
the case study method, they did not report on the interaction between patients, 
carers and healthcare professionals.  Therefore, further research is required to 
explore the similarities and differences in decision making between the key 
stakeholders in the management of MSCC.  Cowap, Hardy and A’ Hern (2000), 
Conway et al. (2007), and Huang and Jatoi (2009), recommend that healthcare 
professionals should assess the patient’s prognosis and performance status at 
the time of admission to anticipate and plan palliative care and place of care.  
There were recommendations but the authors did not expand on them.  
Therefore, there is a need to explore if patients have any autonomy or choice in 
the place of care. 
 
On the whole, the review demonstrated that evidence is of an international 
focus and the issues on the impact of MSCC on patients are similar.  However, 
the majority of evidence is of a quantitative approach.  Therefore, using a 
qualitative approach can illuminate patients’, carers’ and healthcare 
professionals’ perspectives in the management of MSCC.  Recognising the 
short survival times, interventions need to focus on the individual patient’s 
preferences and choice.  Issues on end-of-life and support needs require to be 
explored.  Given the complexity of managing MSCC and the lack of current 
evidence to underpin practice, I therefore identified the research aims and 
questions for this thesis and these are presented at the beginning of Chapter 3 
(Sections 3.1.1 and 3.1.2).  In the next chapter, I then discuss the rationale for 
case study design, research methods and data analysis in order to enhance our 
understanding of MSCC.  
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Chapter 3: Research design and methods 
3.1 Introduction 
This chapter presents an account of the research design and the rationale for 
the choice of methods.  The ethical aspects of this study will be discussed.  I 
then discuss the process of recruiting participants, the data gathering and 
analysis.   I conclude by examining my position as a researcher and how I 
ensure trustworthiness of the data.   
3.1.1 Overall aims and research questions of the study 
The overall aim was to explore the patients’, carers’ and/or family members’ and 
healthcare professionals’ perspectives and experiences in the management of 
metastatic spinal cord compression (MSCC).  It is noted that for the purpose of 
this study the word carer will be used to refer to the family caregiver whether it 
be the wife, husband, daughter, son or significant other.  Four questions were 
formulated. 
3.1.2 Research questions 
The questions that this study set out to explore were:  
 What are the patients’ perspectives and experiences when diagnosed 
with MSCC? 
 How do carers and/or family members perceive support when coping 
with the patient with MSCC? 
 What are the healthcare professionals’ perspectives and experiences in 
the management of patients with MSCC? 
 What are the similarities and differences in the perspectives and 
experiences of key stakeholders? 
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3.2 Research design 
This section reflects upon some of the philosophical underpinnings with the aim 
of understanding and developing new knowledge of MSCC.  The choice for 
adopting a qualitative approach and the case study research strategy will be 
discussed. 
3.2.1 Research Paradigm 
A paradigm can be defined as ‘a basic set of beliefs that guide action’ (Guba 
1990:17).  Denzin and Lincoln (2005), explained further that beliefs can never 
be established in terms of their definitive truth.  Perspectives, on the other hand, 
are not as solidified, nor as well unified, although they may share elements with 
a paradigm.  When discussing what constitutes knowledge and reality, this has 
been classified into two paradigms, ‘positivist’ paradigm and ‘post-positivist’ or 
‘naturalist’ paradigm (Guba and Lincoln 1994; Saks and Allsop 2007). 
 
According to Bryman (2012), quantitative research can be construed as a 
research strategy that is characterised by quantification, and has incorporated 
the norms of the natural sciences model.  The quantitative paradigm embodies 
a view of social reality as external and objective and knowledge can be 
produced through rigorous deductive methods (Bryman 2012).  In contrast, the 
post-positivist paradigm, commonly referred to as qualitative research, is 
influenced by naturalism, embodies a view that knowledge is socially 
constructed and reality is emphasised in words, is constantly shifting and 
cannot be understood by precise measurement (Bryman 2012). 
 
Guba (1990) suggests a researcher has three key questions to answer when 
choosing a qualitative approach: what is the nature of reality and how is it 
studied? (Ontology); what is the relationship between the researcher and 
knowledge? (Epistemology); and how should the researcher go about finding 
out knowledge? (Methodology) and demonstrate the assumptions by identifying 
the strategies that are seen as exemplifying these assumptions. 
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My intention was to have an in-depth understanding of the patients’, carers’ and 
healthcare professionals’ experiences about MSCC; what was their experience 
and what other factors may have influenced their experience (Ontology).  
Epistemology is about how we come to know things, the relationship between 
how the researcher comes to know the world and to justify how they gain that 
knowledge (Guba 1990).  In this study, the background study, the scoping 
exercise and the integrative review informed the nature of knowledge of MSCC 
and shaped the design of this study.  The literature review highlights the need to 
explore; the patient’s views, those of the carers who support them and the 
actions or decisions made by key healthcare professionals (Epistemology).  
Therefore, it is justified to use focus groups and individual interviews with the 
participants (Methodology). 
3.2.2 Rationale for the choice of qualitative approach 
The majority of studies in the integrative review used a quantitative approach to 
investigate the treatment outcomes, health-related quality of life and satisfaction 
with life.  The strict criteria in the recruitment of participants to the studies, the 
patient’s eligibility for treatment and rehabilitation meant that quantitative 
research was seen as the appropriate approach.  A focus on patients’ 
preferences and needs was not evident.  There was one qualitative study that 
explored the MSCC patients’ interpretations of disability, however, there was no 
report about the carers or the healthcare professionals views about this 
condition (Eva et al. 2009). 
 
According to Hopkinson, Hallett and Luker (2001), and Green and Thorogood 
(2009), the benefit of qualitative approaches  is to provide an understanding of 
different perspectives and to examine how reality is constructed rather than 
assuming or presenting one reality.  Creswell (2009), provides some 
clarification that qualitative research is an inquiry process of understanding 
based on distinct and methodological inquiry which explores a social or a 
human problem.  The intention is not to present generalised findings, but rather 
to draw from the understandings of the research subjects (Saks and Allsop 
2007).  Qualitative research is also useful to influence clinical practice where 
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the topic of study relates to service provision (Barbour 2008).  Therefore, my 
role as a researcher is to build a complex, holistic picture, analyse words, 
documents and perspectives of the participants and conduct the study of the 
phenomenon MSCC in its natural setting. 
 
The guiding design for this thesis is the qualitative approach where there is no 
pre-defined theoretical perspective.  Although the patient’s perspective of 
experience is central to the study, multiple perspectives can exist within a 
phenomenon which can be dynamic, complex and influence that experience 
(Lincoln, Lynham and Guba 2011).  I considered it important to provide patients 
and carers an opportunity to report their experiences in a healthcare 
environment which can be framed by healthcare professionals’ assumptions of 
what is best for the patients (Stiggelbout and de Haes 2001). 
 
It is equally important to explore the healthcare professionals’ perspectives as 
their actions and decisions influence the patients’ and carers’ experience and is 
very much part of the phenomenon under study (Barbour 2008).  Therefore, 
using a theory or theories may constrain my findings; instead, I chose to allow 
the themes to emerge based around my research aims and questions.   
3.2.3 Choosing the research design 
The research design provides the logical sequence of steps and procedures in 
data gathering in order to gain an understanding or gain new knowledge on the 
phenomenon.   Some authors suggest that in qualitative research, there are a 
number of designs such as grounded theory, ethnography and phenomenology 
that are necessary to explore their research questions (Morse and Field 2002; 
Denzin and Lincoln 2011).  In the early stages of this study, the use of action 
research was considered (McNiff and Whitehead 2011).  However, action 
research was not deemed a suitable choice as it became clear that little is 
known about the patient’s experience of MSCC. 
 
Both grounded and phenomenological theories insist on a higher degree of 
interpretation and were not suitable as the ways patients interact with their carer 
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and healthcare professionals were not understood.  Ethnography was discarded 
as it is associated with an understanding of a culture; however, this study is 
about a phenomenon of MSCC.  Although case study approach has similarities 
to other qualitative methodologies, it remains relatively realistic and true to the 
data (Sandelowski 2000). 
 
Therefore, a case study approach was appropriate to understand the patients’ 
experience of MSCC and the problems surrounding approaches to treatment, 
how patient/family preferences are accommodated, and how the team works.  It 
is equally important to understand the unpredictability of a condition such as 
MSCC as it is life threatening for the patients (Chapters 1 and 2).  The 
researcher needs to elucidate clearly what is being done to elicit rich narratives 
from the participants about MSCC.  The research design for this study is 
illustrated in Figure 5 (phases, methods and participants). 
 
Figure 5: Diagram of the study design 
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collection for this study was planned into two phases.  It was anticipated that all 
data collection would be carried out over a period of six to eight months.  Phase 
One, took place between July and August 2009.  Phase Two data gathering 
took place from September 2009 to March 2010.  
 
3.3 Rationale for the Case Study as a research strategy 
The case study research strategy was judged to offer a beneficial approach for 
this study as it placed emphasis on the examination of a phenomenon – MSCC 
– as a current reality for patients, carers and healthcare professionals and the 
context of MSCC in its natural setting, taking into account the dynamic process 
with all its complexity.  The case study strategy can be used within the 
quantitative or qualitative paradigm or even mixed methods (Cavaye 1996). 
 
According to Yin (2009), the case study as a strategy is the intention to find out 
more about a subject, the subject of inquiry is the case which is made up of 
many parts which is investigated within context.  Stake (1995), gave a slightly 
different view.  He contends that case study is not so much a methodological 
choice but a choice to study something and that when we effect that choice we 
are in essence studying a case (Stake 1995).  Yin (2009:18) defined the case 
study as:  
“….an empirical inquiry that investigates a contemporary phenomenon 
within its real-life context, when the boundaries between phenomenon 
and the context are not clearly evident; and in which multiple sources of 
evidence are used”.    
 
Basically, a case study should be considered when: the focus of the study is to 
answer ‘how’ and ‘why’ questions; the researcher cannot manipulate the 
behaviour of those involved in the study; the intention is to cover contextual 
conditions as they are relevant to the phenomenon under study and the 
boundaries are not clear between the phenomenon and context. 
 
The case study enables the researcher to use a variety of research methods 
and multiple sources of data to explore the research questions which then give 
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a deeper understanding and holistic view of the phenomenon (Hancock and 
Algozzine 2006; Yin 2009; Swanborn 2010; Thomas 2011).  For example, 
D’Souza (2001) used a case study approach to understand the dynamics of the 
waiting list on how their radiation therapy shortage developed.  The findings 
highlighted an interplay of factors; rising cancer incidence, increasing demands 
for radiation therapy, strained patient-doctor relationship, and an incompatible 
relationship existing between moral and legal responsibility – the government 
was viewed as morally responsible but the physicians were given the 
responsibility without the authority to change the waiting list situations. 
 
Yin (2009) stressed the importance of identifying the five key elements for 
designing and implementing a qualitative case study approach.  
 Study questions; 
 Study propositions, if any; 
 Its unit(s) of analysis; 
 The logic linking of the data to the propositions; 
 The criteria for interpreting the findings (Yin 2009: 27). 
Through addressing these components, the researcher is able to establish the 
suitability of the case study approach. 
Study questions  
In the first component, Yin (2009), suggests that the form of the study questions 
should indicate the relevance of the methodological design; questions 
pertaining to ‘who’, ‘how’, ‘what’, and ‘why’ may be suited to a case study 
approach.  The research questions in this study sought to gain an insight into 
the subjective experiences of patients (in relation to ‘who’); and ‘how’ they 
experienced the phenomenon of MSCC (in relation to ‘what’).  Similarly, the 
study aimed to understand the experience of carers (‘who’), and in ‘how’ they 
perceived support when coping with their loved ones with MSCC (‘what’).  
Seeking understanding of ‘how’ the patients, carers and healthcare 
professionals (‘whom’) experience MSCC (‘what’) allowed me to explore this 
from an inclusive and 360 degree perspective.  Therefore, a qualitative case 
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study approach was best suited to answer the ‘who’, ‘what’ and ‘how’ questions 
in this study, as the event of interest is MSCC, how MSCC is managed at the 
acute stage and the patients’ and carers’ experiences will be traced over time 
(Yin 2009; Swanborn 2010). 
Study propositions 
According to Yin (2009), research questions alone do not point to what a 
researcher should study; there is a need to develop ‘theoretical propositions’ 
which reflect the importance of theoretical issues.  Yin (2009), stresses that 
‘theory proposition’ should not be associated with the formality of grand theory 
as in social science.  Theoretical proposition can be described as a statement 
developed from relevant literature or from generalisation based on empirical 
data (Nieswiadomy 2002; Wells et al. 2012).  Miles and Huberman (1994) and 
Yin (2009), suggest that the researcher draw up a pre-determined guide to what 
should be studied within the case and at the same time remain realistic in its 
scope.  To ensure the credibility of this study, I developed the topic guides, 
using questions and propositions that had emerged from the background study 
of MSCC, the findings from the scoping exercise, the literature review and 
through consultation with my supervisors (Appendices 7-12).  Therefore, 
theoretical propositions help to ensure that the research questions can be 
adequately answered.  The theoretical propositions for this study are: 
 
1. The context within which the communication and information about 
treatment and care is crucial to understanding the impact on the patient 
and/or carers to manage uncertainty about end-of-life issues. 
 
2. The communication of uncertainty is unique to individual circumstances 
(age, capacity, coping, attitude and decision making).  How healthcare 
professionals manage the issues of uncertainty depends on their 
knowledge, experience, skills, guidelines, evidence, practice context 
within the unit, role and responsibilities.  These two fundamental factors 
for healthcare professionals have a bearing on the experience and 
perceptions on the individual (patient/carer). 
 
 
 
 
65 
 
3. Decision making by healthcare professionals is influenced by the above 
factors and will vary according to the changing status of the patient’s 
condition, effectiveness of treatment, and the response of the patient.  I 
argue that the lack of on-going communications around uncertainty 
between healthcare professionals and patients/ carers is affecting their 
coping, adjusting and management of MSCC.  
 
Miles and Huberman (1994), also recommend that the direction, structure and 
boundaries of the study be supported by a conceptual framework which 
explains the unit of analysis to be studied.  
The unit of analysis 
The unit of analysis - ‘a case’ - may be an individual, process, event, entity or 
an organisation (Yin 2009).  Case study can also be done about decisions, 
programs, implementation process and organisational change.  Yin (2009:29), 
explained that ‘in each situation’ an individual person is the case being studied 
and the individual is the primary unit of analysis.  For each individual, relevant 
information was collected and several individuals (cases) included in a multiple-
case study.  In this study, a unit of analysis comprised of a patient with MSCC, 
their carer, and key healthcare professionals involved in the patient’s care.  This 
research adopted a multiple-case study; in total eight cases were explored.  
This allowed variations and complexities around managing this group of 
patients to be obtained from different perspectives in real-time (Anthony and 
Jack 2009; Yin 2009; Bryman 2012). 
 
Miles and Huberman (1994: 18), suggest that a conceptual framework serves 
several purposes for the researcher: it specifies who and what will and will not 
be studied; assumes some relationships are based on logic, empirical findings 
and/or personal experience; and provides the opportunity to gather constructs 
(for example, organisational guidelines) into intellectual ‘bin’s (to help in making 
sense).  My conceptual framework clearly identifies ‘the patient with a diagnosis 
of MSCC’ (the heart of this study) and the patient’s experience was explored 
within the immediate acute oncology setting, in relation to their carer, key 
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healthcare professionals, unit, organisation, national policies/guidelines and the 
professional disciplines associated theories/practice context.  As this study 
explored the patients’ and carers’ experience over a time period, this framework 
included the community context linked to the case.  Figure 6, below shows the 
case, the context and the data sources to inform this study. 
 
Figure 6: Conceptual Framework for MSCC 
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The logic linking the data to the propositions and the criteria for 
interpreting the findings 
In the fourth and last components, Yin (2009), suggests that researchers return 
to the propositions to ensure data analysis is within the scope of the study and 
to provide structure for the report.  According to Baxter and Jack (2008) and 
Thomas (2011), this may limit the inductive approach when exploring a 
phenomenon.  To safeguard against becoming deductive, I kept field notes and 
memos of my thoughts and decisions to help with data analysis. 
 
In this thesis, I utilised Braun and Clarke’s (2006) thematic framework for within-
case and across-case analysis to capture broad issues in MSCC (details in 
Section 3.8).  For example, Kennedy et al. (2008a; 2008b) used within-case and 
across-case analysis to evaluate a new bereavement support service for 
families where a parent was dying from cancer.  This brought out rich 
information about the delicate and dynamic family experience of a parent dying 
of cancer.  
3.3.1 Development of theory in Case Study strategy  
Case study research can be used to describe a phenomenon, develop theory or 
test theory (Darke, Shanks and Broadbent 1998; Yin 2009; Lacono, Brown and 
Holtham 2011).  Eisenhardt and Graebner (2007), state that to justify theory 
building, the researcher has to clarify why the research question is important 
and why there is no existing theory that offers a feasible answer.  In the current 
study, the scoping exercise and literature review indicate that MSCC is an 
unpredictable condition and there are complexities surrounding its 
management.  In this situation where there is a lack of evidence and theory, 
case study can be used to provide the evidence and in the process of analysis, 
a theory can develop or generate hypothesis (Cavaye 1996; Smith 2002).  The 
use of multiple cases and across-case analysis allows the synthesis of concepts 
embedded in theories; thus the varied evidence, the constructs and interactions 
between the stakeholders are more accurate and robust (Dooley 2002; 
Eisenhardt and Graebner 2007).   
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3.4 Rationale for the choice of research methods 
In this case study, I used focus groups, individual interviews, field notes and 
document review to illuminate the experiences and perceptions of the patients, 
carers and healthcare professionals around MSCC.  Fundamental to this 
exploration was a decision or set of decisions made, why they were taken, what 
factors informed these and how care decisions were implemented and the 
perceived outcomes.  I believed that these methods would give all the 
stakeholders an opportunity to voice their experiences. 
 
Ragin (1997), Marshall (1999), Denzin and Lincoln (2011), suggest that where 
research interest involves a large number of variables and a limited number of 
cases, evidence is needed from various sources, such as documents, artefacts, 
interviews and observations to enable an in-depth inquiry into a social 
phenomenon.  Methods such as in-depth, semi-structured or unstructured 
interviews and focus groups observations are some of the recommended 
methods (Rubin and Rubin 2005).    
3.4.1 Rationale for focus groups with healthcare professionals  
I considered focus groups relevant in order to gain insights into the health 
professionals interaction and their decision making process in clinical practice.  
Focus group interviews were deemed most appropriate to explore and 
understand the group dynamics as well as individual views and experiences of 
phenomena and abstract concepts about MSCC (Barbour 2008; Krueger and 
Casey 2009).  This would be useful at Phase One to provide the platform for 
comparison with the narratives of participants in Phase Two of the study.  There 
is evidence of using focus groups within the context of a quantitative study for 
refining research instruments, but there are also many studies which have used 
focus groups in the preliminary phase of qualitative study (Barbour 2009).  In 
focus groups, the interviews contain open-ended questions to allow responses 
without setting boundaries (Krueger and Casey 2009). 
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Bloor et al. (2001), stressed that focus groups are valuable only if the purpose 
of the research is to study group norms, meanings and processes.  In my study, 
I wanted to have an insight and understanding of the different health 
professionals practice (norms), issues in their oncology area (meaning of their 
social context), their working as a team and the decisions they make (their 
social processes of communication and decision making processes). 
 
My plan was to conduct three focus groups: two in the hospital setting and one 
in the community setting.  A manageable group would consist of between 6-8 
participants.  Although it is possible to still run a discussion with a smaller group 
the desire for diversity of opinions will not be elicited (Hoyle, Harris and Judd 
2002; Barbour 2008).  However, more than 10 may be difficult for participants to 
express their opinion fully (Hoyle, Harris and Judd 2002).   
3.4.2 Rationale for individual interviews with healthcare 
professionals 
I discussed having individual interviews with healthcare professionals with my 
supervisors when some of the participants were unavailable for the focus 
groups, but expressed an interest in having an individual interview.  Barbour 
(2008), argued that there are no hard-and-fast rules and suggested giving 
people a choice as some are less inclined to discuss difficult or sensitive topics 
in a focus group.  Although the group dynamics may be missing, I took into 
consideration that some of them were policy makers and could contribute their 
views and experiences.   
3.4.3 Rationale for interviews with patients, carers and healthcare 
professionals 
I made the decision to have semi-structured interviews with patients once they 
were diagnosed with MSCC (Rubin and Rubin 2005).  Dialogue with a purpose 
contributes to the understanding of realities of an event, an experience, or an 
emotion (Lincoln and Guba 1985; Yin 2009).  During this process the 
participant’s perspective of the phenomenon under investigation will emerge 
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with the researcher’s role of a facilitator.  Pre-determined interview schedules 
were used and depending on the patient’s response, prompts were used to get 
a better understanding.   
 
Similarly, carers were interviewed individually rather than in a focus group to 
avoid disruption in their routines and being mindful of the psychological 
upheaval suffered by them and their loved ones as a result of the illness. 
 
The literature review identified that patients had unmet needs, therefore, I also 
considered a longitudinal element to capture the patient’s experience during 
their transition from hospital to home or to the hospice setting to establish an 
understanding of their experience after treatment.  I also sought to capture their 
carers’ and/or family members’ views on their support to the patient during the 
transition from hospital to home or hospice.  The time frame for follow-up was 
based on the estimation of the reported evidence on prognosis.  For example, in 
lung cancer cases, the life expectancy after diagnosis of MSCC was around 4 to 
8 weeks (Loblaw, Laperriere and Mackillop 2003). 
 
As a nurse, I had relatively well developed interviewing skills but I was going to 
interview vulnerable people towards their end-of-life, I attended a workshop and 
also talked to a Macmillan nurse about interviewing cancer patients.  It was 
necessary for me to adopt reflexive subjectivity to all aspects of this research 
(Finlay and Gough 2003; Roth and Breuer 2003).   
3.4.4 Field notes  
I considered that field notes might add to the data gathering.  For in-depth focus 
groups and interviews, field notes provide useful information.  For example, 
what the researcher observes or hears immediately after the discussion or the 
dynamics of the group can contribute to ideas or issues that can be included at 
the analytical stage (Ritchie and Lewis 2006).  
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3.4.5 Document review 
In keeping with case study methods, this study included reviewing 
documentation; for example, patients’ demographic information, their diagnosis, 
treatment, observations and care plans in order to gather background 
information about the patient.  Other key documents included imaging reports 
such as Magnetic Resonance Imaging (MRI).  This approach can used to 
corroborate and augment terms, names or different aspects of the problem and 
explain the variations in the data (Sandelowski 1995; Yin 2009).  I sought 
clarification and explanation from relevant health care specialists especially 
about the treatment and MRI reports to determine the links and gaps in 
understanding the case (Hancock and Algozzine 2006).   
 
3.5 Ethical approval and permissions process 
Ethical approval was obtained from Edinburgh Napier University Research 
Ethics and Governance Committee and Lothian Research Ethics Committee 
(Appendix 13).  The purpose of the Research Ethics Committee was to review 
the research, provide advice, and ensure that the participants’ dignity, rights, 
safety and well-being were protected.  The sample size was increased from six 
to eight patients and eight carers as suggested by the Lothian Research Ethics 
Committee.  There were some changes to the patient information sheet in line 
with the National Research Ethics Service (NRES 2009) guidelines. 
 
In this study, the Lothian Research and Development Office felt that application 
to the Caldicott Guardian (NHS 2010) was not necessary as access to patient 
information was required only after they had agreed to participate in the study.  
The study was granted ethical approval by the Lothian Research and 
Development Office in April 2009 (Appendix 14). 
 
The participants were informed they could withdraw from the study at any stage 
and reassured this would not affect their care and treatment (Royal College of 
Nursing (RCN) (2011).  All the participants were informed that the interviews 
were confidential and information provided would be anonymous and kept in 
 
 
 
 
72 
 
accordance with the Data Protection Act (1998).  Data were coded and stored in 
password protected computers in secured, locked premises.  Data will be stored 
for 5 years and destroyed after that.  Only the researcher and her supervisors 
had access to the data. 
 
The risks of a breach of confidentiality were minimal as pseudonyms replaced 
the participants’ identities in the transcribed data.  Additionally, data were 
grouped and narrative quotes were kept gender neutral to protect healthcare 
professionals’ identities. 
 
In addition, I also considered the key principles of beneficence, which 
encompasses ‘the sum of the potential benefits and the importance of the 
knowledge gained outweighing any risk or harm’ (Kvale 1996: 116), as well as 
the principle of autonomy which places an emphasis on respecting the rights of 
individuals (Green & Thorogood 2009; Beauchamp and Childress 2009).  
 
3.6  Sampling 
In a qualitative study, sample size is not meant to be representative or large in 
number.  A minimum of 6-10 participants was recommended by Morse (1994) 
and Creswell (2009).  Purposive sampling aims to select information-rich cases 
for in-depth study to examine meanings, interpretations, process and theory 
(Liamputtong and Ezzy 2005: 46).  Silverman (2000), identifies that purposive 
sampling allows a researcher to choose a case because it illustrates features or 
process of the phenomenon in various abstract dimensions, for example; 
conflicts, tensions, and human relations.  It can be an illness, a treatment, type 
of care or professional decision making. 
 
In this study, purposive sampling was used to identify those patients and carers 
who were well placed to discuss the phenomenon under investigation, which 
was their experience and perceptions of MSCC.  The sample selection was 
based on the following criteria: patients diagnosed with metastatic spinal cord 
compression; were undergoing treatment; were willing to reflect on their 
experience and willing to participate. Patients were recruited once the diagnosis 
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of spinal cord compression had been confirmed and they had been seen by the 
consultant. 
 
The criteria for carer selection to this study were: supporting the patient with a 
radiological diagnosis of metastatic spinal cord compression; eighteen years of 
age and above and able to give consent.  I obtained patients’ permission to 
approach their carers once they had agreed to participate in the study.  Key 
healthcare professionals were identified once the patients were recruited to the 
study.   
 
3.7 Recruitment of participants to the study 
In this section, I discuss how I recruited healthcare professionals for the focus 
groups and individual interviews in Phase One.   Access to stakeholders was 
through the Consultant of Oncology, Head of Cancer and Palliative Services 
and Heads of Departments.  Access to nurses and allied professionals was 
through their head of department and line managers.  However, because of the 
many disciplines involved, and not being personally familiar with the 
professionals, I discussed with my supervisors options towards identifying 
access to them.  I secured the opportunity to attend the team meetings of the 
different disciplines.  I ‘tagged’ along during some of the oncology ward rounds 
in four clinical areas.  In addition, I attended ward managers meetings and 
negotiated access to staff nurses.  I approached the general practitioners during 
one of their seminars and the district nurses during their monthly meeting. 
 
The process of data collection was not without its problems and challenges.  My 
initial dilemma was during the recruitment of patients to the study.  When I 
approached the urology consultant to recruit his patients and healthcare 
professionals to this study, he felt that his team did not have the time. However, 
he asked me to send him a copy of my research proposal.  As indicated in my 
background study, lung, breast and prostate cancer patients are common 
groups at risk of developing a recurrence of cancer.  However, I received a 
negative reply which was a blow to me.  I felt as though I had already failed 
before I even started data collection.   
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On one hand I did not want to be seen to be coercing healthcare professionals 
into participating in this research, but I would be doing a disservice to the 
patients in this group, who are one of the common groups at risk of developing 
MSCC.  I therefore reflected on my approach, and thought that a review of my 
research proposal in terms of length and details may alter the decision making.  
I wrote back to the consultant citing that the small sample size meant I only 
needed one patient from his speciality, giving a short explanation why it was 
important to have representation from this group of patients and that only two to 
three healthcare professionals would require to be interviewed for about 30 to 
60 minutes considering their busy schedule.  I was elated when I got a reply 
allowing me to have not one patient but two patients from this speciality.  On 
hindsight, I should have written a more structured letter with very clear 
information of what I needed rather than an overview of the whole study from 
the start.   
3.7.1 Phase One  
This phase of the study took place from July to August 2009.  Table 2 shows 
that I approached 66 healthcare professionals, of which 25 participated in the 
focus groups and seven in the individual interviews.  I recruited healthcare 
professionals personally and followed this up with emails.  The participants 
were recruited to reflect the range of expertise within a multi-disciplinary team 
which provided useful insights.  I provided the healthcare professional with an 
information sheet about the study and a consent form (Appendices 15 and 16).    
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Table 2 : Phase One - recruitment of healthcare professionals 
 
Approached Agreed Focus 
group 
Individual 
interview 
Withdrew 
due to 
work 
Other 
reasons/No 
reply 
Oncologist 12 7 3 3 1 5 
Neurosurgeon 4 1 1 - - 3 
Neurologist 1 1 1 - - - 
Radiologist 4 3 3 - - 1 
Registrar  4 3 - - 3 1 
Staff Grade 
Doctor 
1 1 1 - - - 
Charge Nurse 4 4 3 - 1 - 
Palliative Care 
Nurse 
2 2 2 - - - 
Nurse Practitioner 1 1 1 - - - 
Project Manager 1 1 1 - - - 
Staff Nurse 5 4 2 - 2 1 
Discharge 
Planning Co-
ordinator 
1 1 1 - - - 
Education Co-
ordinator 
1 - - - - 1 
Physio 
Superintendent 
1 - - - 1 - 
Physiotherapist 2 2 2 - - - 
Occupational 
Therapist 
2 1 1 - - 1 
General 
Practitioners 
10 5 3 2 - 5 
District Nurse 5 2 - - 2 3 
Head of Cancer 
Services 
1 1 - 1 - - 
Hospice Medical 
Director 
1 1 - 1 - - 
Consultant 
Palliative 
Medicine  
1 1 - - 1 - 
Consultant Neuro 
Imaging 
1 - - - - 1 
Head of 
Radiotherapy 
1 - - - - 1 
Total 66 42 25 7 11 23 
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3.7.2 Phase Two 
The interviews with patients, their carers’ and key healthcare professionals were 
conducted from September 2009 to March 2010.  Before I recruited the 
patients, carers and key healthcare professionals to this study, I made 
appointments to see the different oncology consultants and neurosurgeons to 
seek their help in recruiting the patients.  The treating consultant would ask the 
patient whether he/she would like to participate in the study.  When the patient 
had confirmed, I arranged to have an initial discussion with the patient.   
 
At the same time I asked the patient whether their carer would like to 
participate.  I allowed the patients and carers 24-48 hours to determine if they 
wished to take part in the study and informed consent was obtained.  An 
invitation letter, information sheet and consent were given to the participants 
(Appendices 17 - 19).  The patient’s general practitioners were informed once 
the patient had consented (Appendix 20).  The patients were also informed of 
the second interview after their discharge from the hospital.   
 
In total I approached 20 patients and recruited eight patients in line with the 
ethics requirements (Table 3).  Seven patients declined due to various reasons: 
one was too breathless to talk; one was transferred to a high dependency unit; 
five gave no reasons.  Five of the patients who had initially agreed to the 
interview did not participate due to: one patient died quite suddenly due to 
gastric bleed; one patient’s condition deteriorated and was transferred to a 
hospice; two withdrew as they were transferred back to the district hospitals; 
and one patient was a poor historian due to his intellectual ability. 
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Table 3: Phase Two - recruitment of patients, carers and healthcare 
professionals  
Participant Approached Agreed Interviewed Declined Other 
reasons 
Patient 20 13 8 7 1 died 
1 condition 
deteriorated 
2 withdrew 
1 poor 
historian 
Carer 7 6 6 - 1 withdrew 
Oncologist 6 6 6 - - 
Neurosurgeon 2 2 2 - - 
Radiologist 8 5 5 - 2 did not 
reply 
1 withdrew 
Palliative Doctor 1 1 1 - - 
Registrar 7 6 6 - 1 did not 
reply 
Senior House 
Officer 
1 1 1 - - 
Charge Nurse 1 1 1 - - 
Palliative Care 
Nurse 
1 1 1 - - 
Nursing staff 8 8 8 - - 
Physiotherapist 2 2 2 - - 
Occupational 
Therapist 
2 2 2 - - 
General 
Practitioners 
8 4 4 - 2 busy 
1 busy with 
swine flu 
vaccination 
1 did not 
attend to 
patient 
District Nurse 2 1 1 1 - 
Community 
Nurse 
2 2 2 - - 
Note: 1 carer was not approached as the patient did not want his wife to worry. 
 
Carers were recruited following the agreement of the patients.  If the carers 
were not with the patient, I would arrange to see them when they visited the 
patient.  I was aware of the patient’s rights to confidentiality and would not 
approach their carer without their permission.  I approached seven carers after 
obtaining permission from the patients and only six carers participated in the 
study (see Table 3).  One of the patients did not want his wife to participate as 
he felt she was a worrier.  Another carer agreed initially but later felt that she did 
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not have a full picture of what was happening and opted out.  My approach to 
obtaining informed consent gave the participants the choice and they did not 
feel obliged to participate in the study as demonstrated by the decision of one 
carer to opt out. 
 
Key healthcare professionals involved in the management and care of the 
patients with MSCC were invited to participate in the study following the 
interviews with the patients.  For example, I invited six treating oncologists and 
two neurosurgeons to participate in the study to explore their experience in 
managing the patient.  One of the oncologists managed three patients and I 
interviewed him twice.  The participation of key healthcare professionals from 
different disciplines was important to help verify information and to understand 
their complex roles, norms, values and the cultures of the oncology wards and 
the hospital system (Morse, 1994: 67).  
 
3.8 Data gathering process 
In this section I describe how I conducted the focus group sessions and 
individual interviews with the healthcare professionals in Phase One of this 
study.  I also provide my reflection on the process.  Table 4 shows the data sets 
for both phases in this study. 
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Table 4: Data gathering phases 
Dataset Method Participants Data 
obtained 
Phase One 
Dataset 
1 
Focus group 1 
(n=9) 
 
 
Radiologist (n=2) 
Neurologist (n=1) 
Palliative Care Nurse (n=1) 
Nurse Practitioner (n=1) 
Project Manager (n=1) 
Discharge Planning Coordinator (n=1) 
Occupational Therapist (n=1) 
Physiotherapist (n=1) 
1 transcript 
 
 
Focus group 2 
(n=12) 
 
 
Radiologist (n=1) 
Oncologist (n=3) 
Neurosurgeon (n=1) 
Senior House Officer (n=1) 
Charge Nurse (n=3) 
Physiotherapist (n=1) 
Staff Nurse (n=2) 
1 transcript 
Focus group 3 
(n=4)  
General Practitioner (n=3) 
Palliative Care Nurse (n=1) 
1 transcript 
Individual 
interview  
(n=7) 
 
Oncologist (n=3) 
Head of Cancer Services (n=1) 
Hospice Medical Director (n=1) 
General Practitioners (n=2) 
7 
transcripts 
Phase Two 
Dataset 
2 
Case study  
(n=8) 
 
1st interview with  
patients (n=8) 
2nd interview with 
patients (n=6) 
 
1st interview with  
carers (n=6) 
2nd interview with  
carers (n=5) 
 
 
Patients (n=8) 
Carers (n=6) 
Oncologist (n=6) -7 transcripts 
Neurosurgeon (n=2) 
Registrar (n=6) 
Senior House Officer (n=1) 
Charge Nurse (n=1) 
Palliative Care Nurse (n=1) 
Staff Nurse (n=8) 
Physiotherapist (n=2) 
Radiologist (n=5) 
Community Nurses (n=2) –1 transcript 
District Nurse (n=1) 
General Practitioner (n=4) 
Occupational Therapists (n=2) 
Palliative Care Doctor (n=1) 
67 
transcripts 
 
Other sources of data included documents such as patient’s demographic details, 
field notes, magnetic resonance imaging reports, nursing care plans and medical 
notes. 
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3.8.1 Phase One 
Phase One involved three focus groups and seven individual interviews with 
healthcare professionals in a cancer centre and three other *health boards in 
East Scotland (Focus group 3 and two general practitioners who participated in 
the individual interviews were from other NHS Health Boards).  Phase One data 
gathering generated 10 transcripts. 
3.8.1.1 Focus groups with healthcare professionals 
Focus Groups 1 and 2 were conducted on the 27th July 2009 and the 30th July 
2009 at a neutral venue - a nearby clinical research facility in a major teaching 
hospital in South East Scotland.  Nine participants attended the Focus Group 1 
session.  In Focus Group 2, 12 participants attended.  Focus Groups 1 and 2 
comprised healthcare professionals from a multidisciplinary team in a cancer 
centre (See Table 2).  Focus Group 3 was conducted on 8th September 2009 in 
a healthcare centre in South Scotland.  Four participants attended this session: 
three general practitioners and one palliative care nurse. 
 
For Focus Group 1, my supervisor with a medical background was there as a 
co-facilitator and contributed on the medical aspects of the discussion.  My 
colleague researcher helped in taking notes and assisted in identifying the 
speakers in the seating plan for transcribing purposes.  In Focus Group 2, my 
director of study was the note-taker.  A colleague of mine helped to take notes 
for Focus Group 3.  As lunch was provided, I mingled with the participants, 
making them feel at ease before the discussion.   
The discussion started with an introduction of the participants followed by 
background information of the study.  I started the discussion with a topic guide 
(Appendix 7), using prompts to establish flexible dialogue between the 
participants.  The session was audio recorded.  The discussions lasted 
approximately an hour.  I felt that I had facilitated the discussion in an engaging 
manner. 
                                                          
*
Health Board: There are 15 National Health Services (NHS) health boards in Scotland. 
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Focus Group 2 was a much bigger group, comprising 12 participants, and with 
so many members I did seek to draw in participants who were rather quieter.  I 
was aware that a larger group with members from different disciplines may be 
intimidating (Barbour 2008).  However I felt that the members were genuinely 
interested in this area of study and I was able to capture their similarities and 
differing opinions.  Focus Group 3 was in a general practitioner surgery with 
three general practitioners and a palliative nurse participating in the discussion. 
 
Reflecting on the focus groups discussions, I felt I was able to encourage 
interactions between the members and made sure the participants had the 
opportunity to express their views.  I had provided blank paper for the 
participants to write what their thoughts were about the focus group session and 
what they thought would be best for patient care.  This allowed them to reflect 
on their participation, as a way of summarising their thoughts.  This gave each 
participant an opportunity to state what, otherwise, they might not voice in a 
group session.  
3.8.1.2 Interviews with healthcare professionals  
Seven individual interviews were carried out with healthcare professionals who 
were unable to attend the focus group sessions.  Six interviews took place in 
the participant’s office and one interview was via Skype. 
 
I used the same topic guide as in the focus groups (Appendix 7).  The 
interviews were conducted in a fairly relaxed conversational way, allowing the 
participants to discuss issues that they were concerned about which they may 
not have brought up in a focus group discussion.   
3.8.2 Phase Two 
The data gathering in the Phase Two generated 67 transcripts (Table 4 in 
Section 3.8).   
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3.8.2.1 Interviews with patients 
The first interview was carried out after the patient had received their five 
fractions of radiotherapy as it was anticipated that the patient might have some 
response towards the treatment by this point.  The patients I recruited were 
from four oncology wards and one neurosurgery ward in a cancer centre.  Six 
patients were interviewed on oncology wards, one in a neurosurgical ward and 
another in one of the private rooms in the radiotherapy unit where the patient 
attended his radiotherapy treatment as an out-patient. 
 
In order to develop rapport with my participants and to gain their trust, I 
explained why I was carrying out the research, and my background 
(Morse1994).  Each individual interview was semi-structured to ensure the 
discussion was participant-led and flexible according to the general condition of 
the patient (Appendix 8).  The interviews lasted between approximately 40-80 
minutes. 
 
I provided privacy and a relaxed atmosphere to make patients comfortable so 
that they could share their experience.  As participants were drawn from a 
vulnerable group, the interviews at times engendered feelings of sadness, 
depression, discomfort, and dissatisfaction for the participants.  I was able to 
respond sensitively on these occasions in a supportive and empathic way; by 
enquiring whether they wanted to continue or needed to contact anyone.  The 
participants fully engaged in responding to questions and provided rich 
descriptions of their experiences. 
 
Nurse/researcher role conflicts can be challenging during data collection.  I 
struggled whilst listening to patients’ anxieties, thinking all the time whether I 
should intervene.  As a nurse I was trained to help patients and yet I had to be 
impartial as a researcher. This challenged the fundamental core of my 
professional code of practice (Nursing and Midwifery Council (NMC) 2010).  For 
example, the interview with my second case study stood out prominently in my 
mind.  The patient told me that a patient next to her bed caused her anxiety as 
she talked about being paralysed and dying.  She had apparently spoken to a 
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couple of nurses about the anxiety of the patient next to her but did not say it 
was affecting her.  I asked the patient whether she wanted me to inform the 
nurse to move her to another bay, she declined saying she was alright.   
However, I later learned from the registrar that the patient had a nightmare the 
night before her discharge home.  I was very concerned and talked to my 
supervisors, not knowing whether I had done the right thing.  However, they 
reassured me that I had taken the right steps.  I later heard from the patient 
during the second interview that her nightmare was built up over the days and 
not as a result of talking to me. 
 
In total, six patients were followed up and were interviewed at various locations: 
one at the local hospital; one at the radiotherapy department; one at the 
hospice, two patients were interviewed at their own home and one was a 
telephone interview.  One patient was ill and did not take part in the second 
interview and another died in a community hospital.  All interviews were 
conducted face to face except in case study 2 as the patient lived far away in 
the countryside.  As some patients were still on treatment, I undertook the 
interviews when each patient felt able and comfortable. As a precaution, I 
always informed a colleague that I was away for an interview and contacted her 
when the interview was over. 
 
The second interview gave me the opportunity to validate the findings from the 
first interview (Appendix 9).  However, I could not validate the second interviews 
findings as seven patients had by then died.  As I got to know the patients and 
carers, they were very welcoming when I conducted the second interview with 
them.  Although I initially planned to have the second interview 4-8 weeks after 
the first interview, realistically, this was not possible as patients and carers have 
a lot going on in their life. 
3.8.2.2 Interviews with carers 
Interviews with carers were also semi-structured to allow for being participant-
led and for flexibility (Appendix 10).  Interviews lasted between 40-80 minutes.  
The location for interviews was according to the choice of the carers.  Three 
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carers preferred to be interviewed in the ward private interviewing room whilst 
two others wanted the session in their homes.  One carer could not leave his 
home as he had to tend to his farm and was willing to have the first and second 
interview via telephone. 
 
The follow up interviews allowed clarification of previous discussions and 
explored new concerns the carer might have (Appendix 11).  Two carers had 
the follow up interviews in their home and one at the local hospital.  In one case, 
I interviewed the carer after the death of her husband as she was still keen for 
the second interview.  However, she suggested I gave her time to grieve and 
arranged the interview two months later when she felt she was comfortable to 
talk. 
 
I was touched to hear the carers’ stories as they related the turmoil they went 
through in making sense of the patient’s end of life and grieving before the 
passing of their loved ones.  For example, one carer described how she got a 
memory box for each of her daughters with treasured items to remember their 
dad.  I felt sadness when she described the funeral of her husband and showed 
me his urn containing his ashes.  I felt I was able to deal with the carers when 
they became emotional and provide support and empathy.   
3.8.2.3 Interviews with key healthcare professionals 
Participants were recruited after identifying the key healthcare professionals 
involved in the patient’s care.  The healthcare professionals were recruited in 
the cancer centre when the patient was admitted in the acute stage.  The 
individual interviews with healthcare professionals were carried out following the 
interviews of patients.  I interviewed six oncologists and two neurosurgeons 
(where two patients were referred to them) in their offices.  I also interviewed six 
registrars and one senior house officer as they may be the first person to see 
the patient before the patient’s consultant.  Efforts were made to identify those 
who made decisions on the care of patients so that the data collected was 
meaningful.  Interviews with healthcare professionals were semi-structured 
(Appendix 12). 
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The interviews with eight nurses, five registrars and one senior house officer 
generally took place in a private room on the wards or the doctors’ room.  A 
registrar from a district hospital was interviewed due to a further test done for 
case study 8.  The five radiologists’ interviews took place in a nearby seminar 
room with access to a computer as I explored specific information about MRI 
scans.  Two allied professionals were interviewed in their department; the other 
two were interviewed on the ward. 
 
General practitioners were recruited via telephone calls and letters.  Eight 
general practitioners of the patients in the study were approached.  Four 
general practitioners participated in the study.  Two general practitioners were 
interviewed via Skype video, one via a telephone call and one was a face-to-
face interview. 
 
Overall, my interviews with the healthcare professionals were very encouraging.  
Some of them said that the focus group session and the interviews gave them 
an opportunity to reflect on their practice and also to hear other team members’ 
views. 
 
3.9 Data analysis 
There are different types of qualitative data analysis software available for 
managing and storing data, for example, NVivo 8.  I attended training on the 
use of NVivo at the beginning of my study.  As I had spent a lot of time 
transcribing, I had limited time to enter them in NVivo.  Moreover, NVivo only 
helps in managing and organising data but the researcher still has to analyse it.   
I took great care to organise my transcripts for easy access and for reference.  I 
initially found it cumbersome to make entries in NVivo during the workshop and 
made the decision that I would feel more comfortable with manual qualitative 
data analysis as it got me closer to the data through using colour codes via 
highlighter pens and linking the themes. 
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3.9.1 Transcribing 
In total I had accumulated 10 transcripts for Phase One and 67 for Phase Two 
(See Table 4).  All the taped interviews were transcribed verbatim (Gibbs 2007).  
All transcripts were done on Word Documents.  For confidentiality reasons, I 
assigned their professional role followed by a number for easy identification of 
the transcripts.  For the patients and carers, pseudonyms were given.  I 
transcribed all three focus groups; patients, carers and most of the healthcare 
professionals’ interviews.  Due to time constraints I sent four taped recordings 
to a professional transcription service.  I checked the transcripts against the 
taped recordings for accuracy. 
 
As there was a limited financial fund for professional transcribing services and 
time constraints, a friend helped to transcribe some of the professionals’ taped 
recordings.  In some of my own transcribing where I had difficulty making out 
the Scottish accents, I asked my friend to check the words against the 
recording.   
3.9.2 Justification for data analysis framework 
I chose to use thematic analysis because it is a method  aimed at transparency 
and allows for the identification, analysis and reporting of patterns of the 
experiences, meanings and realities of patients, carers and healthcare 
professionals in the management of MSCC.  Thematic analysis translates 
qualitative information into themes and sub-themes which appeal to a broad 
audience (Miles and Huberman 1994; Boyatzis (1998).  It is not strongly 
attached to any pre-existing theoretical framework and can be used to achieve 
different aims within them.  The general approach in thematic analysis is 
inductive, although it can allow for the inclusion of a priori as well as emergent 
concepts (Ritchie and Spencer 1995).  Barbour (2008), and Krueger & Casey 
(2009), suggest that the choice of framework or procedure depends on the 
purpose of the study and there is no ‘right or wrong’ framework.  I initially tried 
using Strauss and Corbin’s (1998), technique, which was described as flexible.  
However, I encountered difficulties in identifying the common issues in the 
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different healthcare professionals’ perspectives due to my inexperience in 
qualitative analysis. 
 
My director of study suggested I draw up the advantages and disadvantages of 
the different analytic techniques and identify which technique would help me 
best explore my questions.  The distinction became clear that the difference 
between thematic analysis and Strauss and Corbin’s (1998), grounded theory 
approach is at the selective coding stage.   In the grounded theory method, it 
aims to develop a grounded core category at the selective coding stage and 
pulls the other categories together to form an overarching theory to explain the 
findings within the data. 
 
However, thematic analysis generates broad themes to summarise the data but 
does not necessarily aim to develop a theory to explain it (Braun and Clarke 
2006).  In thematic analysis, an in-depth analysis for a single case is done first, 
then cross-checks for the development of themes and domains linked to the 
single case (Flick 2009).  Thematic analysis also preserves the meaningful 
relationship between the participants and the distribution of perspectives on the 
topic under review (Flick 2009).  This then allows cross-analysis with other 
focus groups to show the similarities and differences of the topic under study, 
and to report the patterns within the data set.  Ritchie et al’s (1995), Framework 
Analysis, also formed my early understanding in the process of identifying 
descriptive codes, elements and categories.  However, this framework is more 
suitable for a priori-research driven coding approach.  Hence, I chose Braun & 
Clarke’s (2006), thematic analysis framework as it is suitable for an inductive-
approach to analysis and can be taken further to develop theories, models, and 
explanations which can help better understand the experiences of our 
stakeholders. 
 
Braun and Clarke’s (2006) thematic framework has been widely used.  For 
example, Crawford, Brown and Majomi (2008), used this approach to explore 
how community mental health nurses in the UK perceived their working lives; 
Bedos et.al. (2009), explored how people on social assistance perceived, 
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experienced and improved their oral health; Wong et al. (2009), examined the 
positive aspects of caring as subjectively constructed by bereaved informal 
cancer carers.   
3.9.3 Data analysis using Braun & Clarke’s (2006) thematic 
framework 
In this section I will explain the approach to data analysis of the three focus 
groups data and seven individual interviews of healthcare professionals (Phase 
One data).   According to Braun & Clarke (2006), thematic analysis provides a 
flexible tool but it can lack clear concise guidelines.  Researchers need to 
clearly report the process of their data analysis and be explicit on how they use 
the method to draw findings (Attride-Stirling, 2001; Braun and Clarke, 2006; 
Sandiford and Seymour, 2007). 
 
To ensure the clarity of the interpretation in this study I will describe the process 
of analysis using the six phases approach by Braun and Clarke (2006).  I will 
describe the approach as steps so as not to confuse with the phases of my data 
collection.  The recommended steps are listed in Table 5.  Whilst the main steps 
of my data analysis were based on Braun and Clarke (2006), I also used some 
other approaches to help me make sense of the data.  These steps are 
indicated by an asterisk (*). 
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Table 5: Phases of Thematic Analysis (Braun and Clarke, 2006) 
* My additional approach to the process 
Phases  
(described as steps) 
Description of the process 
1. Familiarising 
yourself with 
your data 
Transcribing data (if necessary), reading and re-
reading the data, noting down initial ideas 
2. Generating 
initial codes 
Coding interesting features of the data in a 
systematic fashion across the entire data set, 
collating data relevant to each code. 
*Narrative summary 
3. Searching for 
themes 
Collating codes into potential themes, gathering all 
data relevant to each potential theme. 
*Identify the conflicts, tensions and dilemmas 
4. Reviewing 
themes 
Checking if the themes work in relation to the 
coded extracts (Level 1) and the entire data set 
(Level 2), generating a thematic ‘map’ of the 
analysis. 
5. Defining and 
naming themes 
Ongoing analysis to refine the specifics of each 
theme, and the overall story the analysis tells, 
generating clear definitions, and names for each 
theme. 
6. Producing the 
report 
The final opportunity for analysis. Selection of 
vivid, compelling extract examples, final analysis of 
selected extracts, relating back of the analysis to 
the research question and literature, producing a 
scholarly report of the analysis. 
 
3.9.4 Phase One analysis  
Here I will describe the analysis of the focus groups and the individual 
interviews in Phase one, which occurred throughout the data collection as a 
continuous process, as is common in qualitative research. 
Step1) Familiarisation with the data 
Analysis is ‘the process of bringing order, structure and interpretation to the 
mass of collected data’ (Marshall and Rossman 1999:15).  My first step in the 
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analytical process was to familiarise myself with the data by listening to the 
digital recordings and transcribing the text.  For easy reference, I numbered the 
lines leaving a space on the right hand column for coding purposes. 
 
I highlighted my questions or comments in bold to distinguish between the 
participant conversation and mine for easy reading and referencing.  I identified 
the issues by highlighting text or segments of the text with coloured marker 
pens.  The aim was to understand the range of issues, variations of perceptions 
and attitudes regarding the management of patients with metastatic spinal cord 
compression.  Coding proved challenging as a novice researcher in qualitative 
data analysis, I found this task daunting and coded some of the issues as 
themes straight away thereby missing this first important stage.  Sandelowski 
(2007), recommended underlining key phrases ‘if they make some sense’.  In 
the early stages of coding, I found myself doing rigid descriptive coding which 
resulted in my focus being distracted from what the data was saying. 
Step 2) Generating initial codes    
This stage involved coding the interesting features of the data and collating data 
according to each code.  At this stage I was helped by my supervisor’s 
suggestion to code the transcript and write a narrative summary for each focus 
group and then amalgamate the dataset for all the focus groups.  Three of us, 
my supervisor (CK), a psychologist researcher (CG), and I took the transcript of 
Focus Group 1 to do the coding and a narrative summary.  Then together but 
blind to each other’s coding and narrative summary, compared and cross-
checked our findings.  There were similarities with most of our coding but 
obviously my supervisor and CG had more experience and consequently they 
were more analytical.  Cross-checking with other experts will also help to give 
credibility to the analysis of this study.  I also found Grbich (1999)’s questioning 
useful.  For example, read all the data including the researcher’s journal and in 
a critical manner pose questions such as ‘Why? How? What if? and as the 
themes emerge identify the gaps in the data.  Similarly, I have also utilised the 
process of identifying codes advocated by Ritchie et al. (1995). 
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I illustrate how I gave names to the codes which reflect the context of the 
participant’s words. I quote for example, one phrase: 
“….if patient needs further input from the therapist….” was coded as 
‘continuity of care’.   
 
Another example:  
“I think even the way doctors introduced the physio... We’ll get the physio 
to come in and see. [Laughter]  They will get you up on your feet, you 
know!  And they just expect that that’s what we are going to do ...and it’s 
not always possible.  Sometimes we do...we can’t always….” was coded 
as ‘unrealistic expectation’.   
 
To move to a higher level of abstraction I constantly asked questions about 
what is going on in the data, why is this happening, and how the issues 
compare with other issues in the data.  I used the participant occupational 
therapist’s phrase in Focus Group 1 to illustrate the abstraction from the 
meaning unit, a descriptive statement, coded and then identified as a sub-
theme and subsequently a theme:  
  
“....we um...treat patients in very acute phase and if patients need 
further input from therapist then depending on where they live, if they 
live in under the West Health Board for example there’s a rehab team 
that would pick them up and do work with them at home. If they live in 
the city, they would fall under the right remit to get rehabilitation from 
acute team in the city, so it very much depends on where the person 
lives and where there is an opportunity...”  
 
Here, a description statement is given; ‘need further input; depending on where 
they live’.  This is coded as: ‘continuity of care’.  The sub-theme and theme 
can be identified as: ‘services are different’ and ‘service-patient need gaps’ 
respectively (see Figure 7). 
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Figure 7: Coding process – Focus Group 1 (excerpt from Occupational 
Therapist) 
 
     Meaning segment                   Descriptive code                Code             Sub-theme/theme 
 
 
 
 
 
 
 
 
 
 
 
 
Step 3) Searching for initial themes 
Step 3 is the stage where the analysis should focus on the emergence of 
themes rather than the codes.  According to Braun and Clarke (2006), this is the 
stage to check if the themes work in relation to the coded extracts (level 1) and 
the entire data set (level 2); to search for some form of patterns, associations 
and explanations, this can be presented in a diagrammatic construction.  I also 
try to identify conflicts, tensions and dilemmas from both ends of the spectrum 
For example, there were views from ‘uncertainty’ to ‘certainty’; participants said 
‘do not want to take away hope from patient’ and yet said ‘be honest with 
patient’. 
 
Miles and Huberman (1994), suggest a ‘data display’ in the form of a text, 
diagram or matrix would allow the analyst to see some systematic patterns and 
inter-relationships to give a new way of arranging and thinking about the 
embedded data.  Table 6 shows my initial matrix of codes assigned to the 
theme: uncertainty – what should we do? 
“....we um...treat patients in 
very acute phase and if 
patients need further input 
from therapist then 
depending on where they 
live, if they live in West for 
example there’s a rehab 
team that would pick them 
up and do work with them 
at home.  If they live in the 
city, they would fall under 
the right remit to get 
rehabilitation from acute 
team in the city, so it very 
much depends on where 
the person lives and where 
there is an opportunity...”   
If patients need 
further input from 
therapist, it 
depends on 
where the person 
lives 
Continuity 
of care 
 
Services are 
different 
Service-patient 
need gap 
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Table 6: Matrix of theme, codes and main focus of findings 
Theme Codes Main focus of findings 
Uncertainty – 
what should we 
do? 
 Presentation of patient  
 Varied opinions 
 Consultant makes 
decisions 
 ‘play safe’ 
 Lack of knowledge on 
spinal instability 
 Communication 
problems 
 Need information to 
carry out care 
 Awareness of the impact 
of MSCC on patients 
 Delay in treatment 
 Challenging in an acute 
environment 
 Management does not 
match reality 
 
In addition to the matrix, I generated data in a thematic map for Focus Group 1 
and repeated the process for Focus Groups 2 and 3 and the 7 individual 
interviews.  An overall display of the 7 themes is shown below (Figure 8): 
uncertainty – what should we do; it is a complex condition; look for a guide; 
outcome of treatment; impact on patients; a simple plan; and continuity of care 
dilemmas.  
 
Figure 8: Focus Groups 1, 2, 3 & 7 individual interviews – preliminary 7 
themes 
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Step 4) Reviewing themes 
In step 4, some themes may need to be refined, some may not have enough 
supporting data and some may collapse into each other.  Other themes may 
have to be further broken down and separated.  At this stage, there are two 
levels of reviewing and refining the themes.  Level one is to view the level of the 
coded extracts. 
 
The extracts for each theme need to form a coherent pattern.  The second level 
involves looking at the whole dataset.  For example, in Figure 9, the theme ‘look 
for a guide’, was changed to ‘guidelines did not match reality’ because there 
were guidelines available.  Similarly, the theme ‘outcome of treatment’ was 
changed to ‘lack of evidenced base treatment’; ‘a simple plan’ was changed to 
‘a tailored plan’ and ‘continuity of care dilemmas’ to ‘transition from hospital to 
home’ (highlighted). 
 
Figure 9: Focus Groups 1, 2, 3 & 7 individual interviews – refined 7 themes 
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Step 5) Defining and naming themes 
In step 5, Braun and Clarke (2006), suggest defining and further refining the 
themes to present the findings.  This involves identifying the essence of what 
the themes are all about and how they fit together.  In refining the themes, an 
overarching theme emerged ‘negotiating the care pathway’.  Themes were then 
changed into a question format to reflect the challenges and conflicts the 
healthcare professionals experienced (Figure 10). 
 
Figure 10: Focus Groups 1, 2, 3 & 7 individual interviews – overarching 
theme and  7 themes 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11 shows the final themes: ‘MSCC is a complex condition’ was collapsed 
to ‘what can we do for patients with MSCC?; ‘lack of evidence based treatment’ 
was changed to ‘what do we need to trade-off to meet the needs of patients?.  
The other three themes were joined to ‘how can we deliver optimum care in the 
midst of uncertainty?’  
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Figure 11: Focus Groups 1, 2, 3 & 7 individual interviews – final themes 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step 6) Thematic findings 
As I began to write the story of the findings, I kept going back and forth, from 
the transcripts. The findings will be discussed in the next Chapter 4. 
 
3.9.5 Phase Two: Across-case analysis 
In Phase Two, I analysed the data using the same framework as described in 
Phase One (Braun and Clarke 2006).  I illustrate using a phrase from Case 
Study 2 (Figure 12): 
 
“I am confused and concerned and the anxiety would come from not 
knowing what’s going to come next.  You know...you don’t know what 
pathway the illness is going to take” (Patient 2, 1st interview, p1/11) 
 
The description code is; “not knowing what’s going to come next”.  This is then 
coded as: “Not knowing the future” and themed as’ facing uncertainty’. 
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Figure 12: Coding process – Case Study 2 
 
Meaning segment               Descriptive code             Code                 Theme 
 
 
 
 
 
 
 
Figure 13 shows the across-case thematic display on the theme ‘facing 
uncertainty in MSCC’ with the sub-themes: recognising and interpreting 
symptoms of the recurrence of cancer; making sense of what was happening; 
trusting healthcare professionals to make the right decisions; to ‘bed-rest’ or ‘not 
to bed-rest’; help us put the jigsaw together; when to have a conversation about 
the future?; unpredictability of losing mobility; and how long is life? 
 
Figure 13: Thematic map: Facing uncertainty in MSCC and sub-themes 
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concerned and the anxiety 
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The previous illustration is further refined by collapsing 8 sub-themes to 4 sub-
themes: ‘trying to make sense of...’; trusting healthcare professionals to make 
the right decisions; help us put the jigsaw together; and when to have a 
conversation about the future (highlighted in blue) (Figure 14).   
 
Figure 14: Thematic map: Facing uncertainty in MSCC – refining the sub-
themes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
In addition, I organised the data into case datasets and the supporting data 
sources of key healthcare professionals for easy reference when writing the 
findings (Yin 2009) (Table 7). 
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Table 7: Patients’, Carers’ profiles and ‘case-related’ data sources  
Case 
study Patients and Carers Other data sources 
Case 
Study 
1 
Betty  (Patient 1) 
 Betty (68) was diagnosed with MSCC with 
unknown primary cancer site.  She was a 
widow.  Her husband died 6 years ago. 
 Mary (48) is Betty’s daughter who has 2 
young adult daughters and 2 grand-
daughters   
Oncologist  
Registrar 
Charge Nurse 
Staff Nurse 
Physiotherapist 
Radiologist 
Community Nurses 
Case 
Study 
2 
Sandra (Patient 2) 
 Sandra (52) was found to have MSCC on 
routine follow-up scan for breast cancer  
 John (55) is Sandra’s husband 
 Sandra and John have 2 sons aged 23 and 
21 
Oncologist 
Registrar 
Staff Nurse 
Case 
Study 
3 
Jimmy (Patient 3) 
 Jimmy (74) had lung cancer and later 
developed MSCC.  He was retired 
  Jimmy did not want his wife to worry and 
requested that I did not interview her 
 Jimmy and his wife have two grown up sons 
Oncologist 
Radiologist 
Staff Nurse 
Case 
Study 
4 
Robert (Patient 4) 
 Robert (78) had recurrent MSCC  
  Jane (78) is wife of Robert 
 Robert and Jane’s two sons are married with 
children  
Oncologist 
Registrar 
Staff Nurse 
General Practitioner 
District Nurse 
Case 
Study 
5 
Richard (Patient 5) 
 Richard (61) was diagnosed with metastatic 
prostate cancer and it has spread to his 
spinal cord.  He had retired and did odd jobs 
 Linda (50) is wife to Richard.  They have 2 
grown up sons 
Oncologist 
Senior House Officer 
Staff Nurse 
Physiotherapist 
Occupational therapist 
Palliative Care Nurse 
Palliative Care doctor 
Case 
Study 
6 
Emma (Patient 6) 
 Emma (32) was diagnosed with MSCC while 
still on clinical trial chemotherapy for bowel 
cancer 
 Matthew (32) is husband to Emma 
 Emma was diagnosed with bowel cancer 
shortly after they got married.  They  have 
no children 
Oncologist 
Neurosurgeon 
Staff Nurse 
Physiotherapist 
General Practitioner 
Case 
Study 
7 
Tony (Patient 7) 
 Tony (42) was diagnosed with bowel cancer 
and later developed MSCC during clinical 
trial chemotherapy 
 Gail (42) is Tony’s wife.  She works part-
time 
 Tony and Gail have two young girls aged 5 
and 3 
Oncologist 
Neurosurgeon 
Registrar 
Staff Nurse  
Occupational Therapist 
General Practitioner 
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Case 
Study 
8 
Jock (Patient 8) 
 Jock (76) was admitted with unknown 
primary site cancer and after radiotherapy 
was investigated further and found that that 
cancer had spread from his prostate 
 Jock’s wife did not participate in the study 
citing that she was not sure what was 
happening 
Oncologist  
Registrar (District 
Hospital) 
Registrar (Cancer 
Centre) 
Staff Nurse 
General Practitioner 
 
Initially, I wrote a narrative summary for each case noting down the main issues 
for each. A narrative summary was a way to systematically study a person’s 
narrative of experience and perspectives (Bury 2001).  An overall summary was 
then written for one dataset providing a way for me to reflect and make sense of 
how the patient with MSCC negotiated his/her way through treatment regimens, 
changing physical functions and disrupted lives, and the challenges faced by 
healthcare professionals.   
 
As I was finding difficulty in analysing across cases, it was agreed I should start 
with an analysis of a single case to tease out the themes in my progress review.  
To make sense of the across case data, I drew up a matrix identifying different 
groups – patients, carers and healthcare professionals (Miles and Huberman 
1994).  Fetterman (2010), described data analysis in qualitative research as 
“…finding your way through the forest”.  I was lost in the maze and at times felt 
overwhelmed with so much data.  My supervisors asked me to stop searching 
for a pre-determined framework and said that data analysis is achieved through 
making sense of my data.  The next strategy was to write a narrative summary 
across case without looking at my raw data.  I then made a few decisions:  
1) To include the case which I had earlier intended to highlight as a 
single case;  
2) To include my previous sub-theme ‘vague signs and symptoms’ and 
change it to ‘making sense of...’ - which was initially excluded as one 
supervisor thought that was too medical, and did not capture the range of 
issues emerging from the patients and carers perspectives, and  
3) To write as a patient’s trajectory of cancer.   
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The use of narrative analysis helped to bring out the salient phenomenon 
related to the core theme and at the same time illuminate the broader social 
context of the participants (Morse and Field 2002; Thomas 2011).  On reflection 
of my interviews with patients and carers, (they would ask ‘where do you want 
me to start?’), their story seemed to have an event that triggered their 
experience.  Creswell (2009), described this as “issue-relevant meaning or 
significance of the story”.  So, it was befitting I start the story with patients 
making sense of their symptoms, as all these happened during the acute stage.  
Other subtle themes emerged during my writing of the narrative summary, for 
example, ‘trusting the healthcare professionals to make the right decisions’.  It 
became clear that not only the patients were putting their trust in the healthcare 
professionals; the healthcare professionals themselves were also trusting their 
colleagues to make the right decisions. 
 
Although the findings of ‘to bed rest’ or ‘not to bed rest’ was an issue for the 
healthcare professionals, their decisions impacted on patient care.  Another 
transformation was to amalgamate two previous sub-themes ‘preserving/losing 
mobility’ and ‘how long is life?’ to ‘when to have a conversation about the 
future?’  It became clear that based on the patient’s trajectory of cancer there 
were only three main themes: ‘facing uncertainty in MSCC’; ‘finding a balance in 
MSCC’ and ‘support beyond the treatment of MSCC’.  Table 8 is an example of 
my across-case development on the sub-theme ‘trying to make sense of...’ 
which was later refined to ‘trying to make sense of it all’.  The words or phrases 
highlighted in bold show the descriptive codes.   
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Table 8: Across-case analysis illustrating the sub-theme ‘trying to make 
sense of it all’ 
Meaning segment Codes 
“Because I was on a trial drug, I thought it was a mixture of 
everything between the chemotherapy, the trial drug.  I 
didn’t know what to expect with everything so I just thought 
I’ll wait till Monday and see what happens” (Emma, patient 
(CS6), p7/1) 
On trial drug 
 
 
Not knowing what 
to expect  
 
Wait and see 
“The fact that she had had a few falls and was, it seemed to 
me, she was losing the use of her left leg.  It was just a 
kind of worry seeing that” (Matthew (CS6), interview 1, 
p24/21)     
Falls 
‘Trying to make 
sense of...’ 
Anxious 
“...I was worried this pain I had for 2 years.  I mean the pain 
keeps carrying on, it doesn’t go away.  Yes, aha...it comes 
right through, it’s like bugs inside here [pointing to his 
chest], creeping about and you can feel all this.  Very...oh I 
was crying.  I was crying.  A 74 year old man and there were 
tears running down my eyes” (Jimmy, patient (CS3), 
Interview 1, p3/20) 
Continuous pain 
 
Make sense of 
symptoms 
 
Distress 
“I had an x-ray that told me there was something wrong 
with his lungs, but it didn’t give me a firm diagnosis.  He 
did, at that point, start to have some pain in the left side of 
his chest and – that, I think, was around the nipple area.  
But events were dictating that he had to go to hospital, more 
on the account of his breathlessness than any pain at all.  It 
was more of a localised pain, rather than a radicular one.  
Pain has never been a huge feature for him” (GP (CS8), 
p5/21) 
‘Trying to make 
sense of...’ 
Decision 
Pain 
 
Not classical pain 
Symptoms 
“...his chest x-ray was very abnormal, it looked like 
metastatic deposits but the radiologist felt he [the patient] 
may have a mixture of cardiac failure and infection.  Erm, 
but certainly spinal lesions were not expected because he 
didn’t have any symptoms at all, he didn’t have back 
pain, he didn’t have weakness in his legs, he didn’t have 
any bowel or bladder problems, erm, so yeah, that was a 
surprise and also his PSA was normal” (Registrar (CS8), 
p3/17) 
Making sense of 
signs 
 
Decision 
 
Making sense of 
presenting signs 
and symptoms 
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3.10 Position of the researcher 
When I engaged in this research, I faced quite a number of dilemmas and 
challenges.  Ballinger (2006), recommended the position of the researcher 
should be accounted for to ensure that this is consistent with the research 
methodology.   In qualitative approach, a researcher adopting a relativist 
perspective would focus on how the researcher’s presence and positioning 
might influence the research process and its outcomes.  Consequently, I 
continuously reflected and balanced between neutrality and sensitivity (Roth 
and Breuer 2003; Lincoln and Guba 1985).  In many ways, I considered that my 
background in urology helped me approach and communicate effectively with 
patients, carers and healthcare professionals as I was accustomed to working 
with people who experienced acute illness. 
    
3.11 Issues of trustworthiness 
In qualitative research, the researcher has to address issues of credibility and 
trustworthiness to ensure the research paints an accurate picture of the 
participants’ experiences of the phenomenon under study (Lincoln and Guba 
1985; Streubert and Carpenter 2011).  However, it is difficult to ensure integrity 
within qualitative research as reality is what participants perceive and events 
were captured at the moment in time within the context.  To establish credibility, 
Lincoln and Guba (1985), suggest ‘member checks’; asking the participants 
whether the researcher has captured their perspectives.  I had the opportunity 
to confirm and clarify the first interviews’ data during my second interviews.  
This was not possible for the second interviews, as seven patients had died by 
then.   A decision was made after consultation with my supervisors to present 
the main findings during one of the MSCC steering group meetings thereby 
establishing of the account rang true for those used to working with this patient 
group.  
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3.12 Chapter summary 
In this chapter I have provided a framework of the research design and the 
research process.  There is a lack of evidence on the impact of a diagnosis of 
MSCC and the views of all the stakeholders regarding its’ management.  A 
qualitative approach with case study methodology was undertaken to provide 
the accounts of all stakeholders in the management of MSCC in East Scotland. 
 
The use of case study was applicable to capture the range of data from different 
perspectives over a period of time.  The five components in designing a case 
study were discussed and applied to this study.  A conceptual framework for 
MSCC field study was drawn up to define the unit of analysis, the context and 
the sources for data collection.   Braun & Clarke’s (2006), thematic framework 
for data analysis was utilised.  Several strategies were employed to make sense 
of the across-case analysis, for example: matrix of patients, carers and 
healthcare professionals’ codes; thematic displays; a table of themes, sub-
themes and main focus of findings and a narrative summary.   
 
The use of narrative summary helped to contribute a clear understanding of the 
intricacy and multi-faceted issues faced by all stakeholders in the management 
of MSCC.  The writing up, using the patients’ trajectory of cancer has resulted in 
an in-depth description and a unique story about MSCC.   
 
Throughout the research process, an awareness of reflexivity and my position 
as a researcher was constantly discussed with my supervisors and colleagues 
to ensure credibility of the findings.  The findings from Phases One and Two will 
be discussed in Chapters 4 and 5 respectively. 
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Chapter 4: Phase One findings 
4.1 Introduction 
In this chapter, it is necessary to recap the purpose for Phase One and how this 
relates to the overall case study approach.  The current study takes the form of 
an exploratory, descriptive and explanatory case study (Gray 2004; Yin 2009).  
The inquiry can change over time (Robson 2002).  Below is the explanation on 
the phases:   
 Phase One – the focus groups and individual interviews with healthcare 
professionals provides the exploratory aspect – what is happening in the 
local context; assessing the phenomena of MSCC; what are the current 
issues facing healthcare professionals in the management of MSCC.  As 
suggested by Eisenhardt (1989) and Yin (2009), this phase was to test 
the theoretical propositions that emerge from the current study and 
compare whether they support or contradict the literature.   
 Phase Two (In Chapter 5) – an example of a single case study with 
multiple perspectives of a theme illuminates the descriptive framework 
giving a clear picture about MSCC (Yin 2009). 
 In Chapter 5, Phase Two – across-case findings from eight case studies 
provides the explanatory aspect – explaining the causal relationships 
between the stakeholders and how events unfold.  As Yin (2009), states 
this is an examination of the different explanations of the participants. 
 
In the next section, the views of the three focus groups and seven individual 
healthcare professionals are presented.  The aim of this first phase of the study 
is to explore and set the scene to the perspectives and experiences of 
healthcare professionals in their current management of patients with metastatic 
spinal cord compression.  The emergence of the overarching theme ‘negotiating 
the care pathway’ and the other four themes: what can we do for patients with 
MSCC; what do we need to ‘trade-off’ to meet the needs of patients; how can 
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guidelines help anyway; and how can we deliver optimum care in the midst of 
uncertainty? is detailed (Figure 11). 
4.2 Negotiating the care pathway 
The overarching theme ‘negotiating the care pathway’ illuminates the main 
perspectives of the healthcare professionals that the care pathway was not 
prescriptive and required complex negotiation.  Negotiating the care pathway 
was described by some of the participants as the need for guidance, criteria, or 
pathways to enable them to identify, diagnose and prescribe treatment in the 
management of patients with MSCC.  However, not all participants saw 
guidelines as being helpful with some seeking more autonomy to understand 
the patient as an individual with a short life expectancy.  This overarching theme 
permeates through the four themes.   
 
For example, the theme ‘what can we do for patients with MSCC’ is about how 
establishing the spinal status is important and why the information can help 
healthcare professionals make decisions on the care of their patients.  The 
theme ‘what do we need to ‘trade-off’ to meet the needs of patients’ highlights 
how the uncertainty about treatment outcome and prognosis results in why 
trade-off decisions are made.  The next theme ‘how can guidelines help 
anyway’ provides a basis for understanding how guidelines might influence the 
management of patients with MSCC or why they might not be helpful.  The last 
theme ‘how can we deliver optimum care in the midst of uncertainty’ describes 
healthcare professionals acknowledging how MSCC can impact on patients and 
discusses why strategies are important to support them.  Hence, the themes 
were labelled in a question format as healthcare professionals were exploring 
what challenges each discipline faced and they discussed strategies in 
overcoming those challenges.  
4.3 What can we do for patients with MSCC?  
The focus groups discussions and the individual interviews were centred on 
healthcare professionals’ interactions with MSCC patients and their carers.  
Uncertainty was experienced by some of the participants and described as 
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feeling confused or indecisive about what actions to take in caring for patients 
with MSCC.   
 
A nurse expressed her frustrations: 
“....it has been a very grey area with regards to how you nurse patients 
with spinal cord compression because nobody ever told you ‘this is how 
you care for these patients’” (Discharge Planning Co-ordinator, FG1; 
p3/12) 
For some participants, this influenced their ability to decide how they should 
position patients with MSCC and when they should start mobilising the patient.  
One of the participants explained the variations in instructions: 
“There’s different ways everybody sort of deals with patients differently, 
some people like their patients to lie flat, some people don’t mind them 
getting up to toilet, some people don’t mind them mobilising at all” 
(Charge Nurse 2, FG2; p2/1) 
The nurses were caring for the patients under the care of different medical staff, 
all with their own views, and this added to the uncertainty about what to do for 
any particular patient.  This sense of uncertainty and confusion affected how the 
participants responded to their patients.  The charge nurse added: 
“...how we go about telling them how to go about daily, you know, it’s 
getting a concrete...answer, you know, what we actually do to these 
patients when they come in certain ways” (Charge Nurse 2, FG2; p2/5) 
They identified the need for information and decision about how to carry out 
care.  They needed to be able to inform patients about their care, and this could 
be difficult.  The uncertainty of what to do would impact on patient care.  A 
member of the focus group explained and gave an example of her interaction 
with a registrar: 
Neurologist: Who makes the decision in practice on the ward, do you 
think? 
Nurse Practitioner 1: Normally, a consultant.  But then you’re waiting for the 
registrar to speak to the consultant.  The consultant, 
depending on which consultant it is, will  maybe only do a 
ward round once or twice a week, and you’re like well you 
can wait until, you know, the next morning ‘[mention name 
of doctor] have you spoken to the consultant?’ ‘No, I will find 
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out today, you know, ‘but just keep them on bed rest’” 
(Nurse Practitioner 1, FG1; p6/5). 
This account suggests the nurse needed information to make a decision about 
the care of the patient.  Meanwhile, the registrar was waiting for a decision by 
the oncologist and as a result played safe and kept the patient on bed rest.  
This indicates decision making was often characterised by playing safe and as 
a consequence patients were left immobilised.  There is a line of decision 
making and this could potentially delay the patient’s rehabilitation needs.  
However, at times consultants relied on their colleagues to establish whether 
the patient’s spine was stable to allow mobilisation.  One oncologist gave his 
views: 
“...if it was a question of spinal instability, we would expect a 
neurosurgical opinion on that, frankly, you know.  And in the meantime, 
we might keep the patient’s spine as immobile as we could while we 
were making that decision, whether movement was going to, err, cause 
further issues, yeah” (Oncologist 5, Individual interview, p8/17) 
 
This indicates that information about the patient’s spinal status is important for 
decision making about treatment and care.  The oncologist may have to depend 
on the neurosurgeon or the radiologist for guidance on whether mobilisation 
should be allowed. 
 
Although there is a notion of playing safe to avoid the consequences reported, 
some consultants would mobilise their patients immediately they start their 
radiotherapy sessions: 
“...there is no evidence base for this, but it has been our habit here that, 
um, if a patient has cord compression, you ask them just to take it easy 
and keep –until you’ve actually started their radiotherapy, you know once 
the radiotherapy’s started you’re likely to have them mobilise” 
(Oncologist 6, Individual interview, p5/20) 
This account suggests ‘enduring’ what was thought to be the appropriate 
decision in the absence of evidence.  However, the existence of guidelines did 
not necessarily help as illustrated below: 
“I think mobilisation is definitely one area we struggle with and the NICE 
guidelines...um...very much towards immobilising everybody and that’s 
clearly completely inappropriate for lots of patients who just come in with 
some neuropathic pain and the pathway (local referral pathway- see 
Appendix 1) is looking at picking up people earlier, so we are seeing 
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people with very early signs or people who are completely asymptomatic 
and to lie on their back and log rolling” (Oncologist 2, FG2; p2/33) 
Variations in the patient’s neurological status and function on admission meant 
that complete bed rest as recommended by the NICE guidelines was 
inappropriate.  There was consensus and certainty that participants needed 
information about the status of the spine, but it was acknowledged that 
assessing information about the stability of the spine was difficult.  However, 
there were communication issues: 
 “I think sometimes there’s difficulty in the communication as to whether 
somebody has a stable spine or not, you know, whether it’s unstable - 
that is not always filtered through, you know, from obviously when the 
scans are looked at and the doctor’s advised...but then it’s not always 
filtered through to nursing staff.  So, therefore the patients are invariably 
just getting left alone...umm...because and if you don’t know if it’s stable 
or not, you just keep them in bed and that obviously is not good for the 
patient.” (Nurse Practitioner1, FG1; p3/33) 
Efforts to commence rehabilitation can be delayed due to a lack of information 
or sharing of it and this has consequences on the patient’s care and quality of 
life.  Participants also suggested that patients sometimes were confused as to 
what they should be doing in regards to mobilisation and commented that they 
were allowed to get up to sit on the commode but were not allowed to do 
anything else. 
 
Examples of uncertainty about steroid therapy were also reflected as quoted: 
“Even things like steroid therapy, you know...different doctors have 
different sort of ideas of...you know...how long people should be on 
steroids or how much steroids...” (Nurse Practitioner 1, FG1; p4/19) 
The excerpt suggests variations in the treatment of MSCC with corticosteroids 
in terms of dose and duration. 
 
In summary, the descriptions provided by the participants reflected a dynamic 
state where there were periods of uncertainty and a tendency to play safe.  
There was a sense of the need for information about the spinal status in 
decision making around management and care of patients with MSCC.  Due to 
the lack of information on the spinal status, there is confusion and indecision on 
the part of nurses on how to position the patients and initiate rehabilitation.  
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There is a line of decision making between the junior doctors, registrars and 
consultant oncologists on the spinal status of patients which results in playing 
safe in the care of patients.  The participants found the NICE guidelines (2008) 
inappropriate for the care of some patients in clinical practice due to the 
variations in their presentation.  Lack of evidence and guidance makes the 
healthcare professionals decide what they think is best for patients.  For 
examples, uncertainty was also reflected in steroid therapy management.  The 
participants talked about the inconsistencies in weaning off the dose of steroids.  
However, healthcare professionals are aware of these issues; they recognise 
the needs of patients, the stage of disease and what treatment has to offer. 
 
4.4 What do we need to ‘trade off’ to meet the needs of 
patients? 
The input from the participants highlighted the complexity of caring for patients 
with MSCC and the uncertainty surrounding their clinical decision making was 
striking.  They recognised the importance of identifying spinal instability to 
inform interventions and care.  There are instances where some factors were 
‘traded off’ to take into account the patient’s shortened life expectancy. 
 
Magnetic Resonance Imaging (MRI) is the preferred diagnostic investigation for 
MSCC.  One of the participants offered this explanation as to why the findings 
may not help to determine appropriate actions.  A radiologist explained: 
“...we can comment as to how...whether different bits of this spine involved 
and therefore the likelihood  that something is affected is likely to be stable 
or lots of it is affected might be unstable but again as I said, it’s a whole 
spectrum and imaging doesn’t tell you the function of the patient, 
...so...so...we can describe what we see but we can’t make a conclusion 
from that whether the patient is definitely stable or definitely unstable and 
so...so, again it’s all ...all shades of grey” (Radiologist 3, FG2; p5/27) 
 
This indicated that MRI is a static image and cannot capture the functional 
status of patients.  This account highlights that even when the spine appears 
stable radiologically, it can still be unpredictable.  With the lack of criteria to 
determine spinal instability, another radiologist explained: 
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“...a lot of what we do is based on trauma [agreed by Radiologist 1] and 
making that decision about what is stable – there is no...um...evidence” 
(Radiologist 2, FG1, p7/21) 
 
Healthcare professionals expressed the uncertainty of their decision making 
and reported being cautious and basing their management on traumatic spines.  
This uncertainty seemed to cause anxiety, as suggested by a member of the 
group: 
“Umm, I think the problem is partly...err...everyone is frightened, you know, 
lump them together with trauma spines and think, oh well, unstable... 
nobody has told me its stable, therefore must keep them utterly immobilised 
until I get...you know some permission to move them.  But these patients 
are usually moving before they come to hospital and its rare, people, you 
know, unless you got a significant imaging finding like a ....displacement” 
(Radiologist 1, FG1; p 5/3) 
There seemed to be a notion of fear in initiating mobilisation because of the 
unpredictability of the spine status.  This resulted in playing safe in the 
management of patients with MSCC.  However, one radiologist stressed that 
one should try not to assess the spine of a patient as unstable unless certain.  
Explaining that one has to consider both the clinical and radiological perspective 
when assessing the patient and take into consideration the patient’s shortened 
life span when making decisions.  The radiologist explained further: 
“It is complex because imaging is one aspect of it and there is clinical 
assessment...err...are they getting L’hermitte’s phenomenon?  Are they 
getting problems when they mobilise, that suggest that they are getting 
some sort of neural compression; were the symptoms worst with 
movements?  Does imaging have any particular concerning features? If 
not, I don’t see why you couldn’t mobilise them gently” (Radiologist 1, 
FG1; p 6/20) 
To trade-off the difficulties in giving information and making decisions about 
spinal instability, the participants rationalised the consequences on the patient if 
they were immobilised.  For example one of the participants highlighted: 
                                                          
 L’hermitte’s phenomenon: L’ hermitte’s symptom is described as electric shock-like sensation, 
spreading down the spinal column and the lower and/or upper limbs when flexing the neck.  It 
can be brought on by extending the head or by coughing, sneezing, bending forward, laughing 
and moving the limbs (Ventafridda et al. 1991). 
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“These patients...um...may have technical definition of instability, but they 
often have...um...have a relatively short life span.  The consequences of 
immobilising are often higher than the consequences of mobilising if you 
know what I mean” (Radiologist 1, FG1, p4/34) 
 
This indicated that patients are at risk of complications such as deep vein 
thrombosis and chest infection if left immobilised.  Also it was suggested that 
patients may be aware if they were to experience symptoms of cord 
compression.  
“Most patients will know very quickly if they’re getting neural 
compression, you know, it’s not many episodes where they suddenly 
become quadriplegic out of the blue, having had...err...you know, having 
been perfectly normal up to then, most patients won’t let you move their 
neck if it’s impinging on their cord.   [...] try to avoid the assumption of 
instability for very long if not careful end up with a lot of them immobilised 
DVT’d” (Radiologist 1, FG1; p5/23) 
One of the participants stressed his decision making by highlighting that what a 
healthcare professional sees as important may not be what the patient wants.  
A neurosurgeon gave an example: 
“...even if they have cord compression, the attitude of the patients 
towards being paralysed is different depending on where the illness is. 
There are lots of other things going on in their lives: what prognosis; how 
long they are going to be living for and it may be quite different if your life 
expectancy is a matter of only a few weeks compared with, you know, 
how many years”(Neurosurgeon 1, FG2; p4/5) 
This example suggests patients perceive their disability may be influenced by 
other more pressing issues, such as, their life expectancy.  He went on further 
describing what matters to the patients: 
“Interesting, this Scottish study we did...their (patients’) concern is not 
about diagnosis but all about their family and their finances, not about 
whether they can walk again which is bizarre.  You know, from a medical 
perspective we are obsessed about whether they are stable or not 
(referring to the patient’s spine).  They are worried about their money in 
the bank; they are worried about their wives and their kids.  So, we have 
to think broadly what’s best for the patients and certainly not just from my 
perspective what operation is best for them.  It is a huge problem and 
some can go by very quickly changing day by day.” (Neurosurgeon 1, FG 
2; p17/10) 
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This account suggests that what healthcare professionals perceive as important 
may not necessarily meet the needs of the patient.  The healthcare 
professionals need to explore the patient’s preferences and priorities as their 
condition can deteriorate rapidly. 
 
The unpredictability of MSCC and the complexities surrounding information 
about spinal instability is challenging.  Lack of evidence encouraged 
suggestions for further research to obtain information about the spine.  One 
oncologist suggested: 
“I would have thought stability would be a very good basis for a 
prospective observational study of a patient’s...err...state but you 
don’t....you have to have more information about what the natural history 
of the disease was.” (Oncologist 3, FG2; p6/31) 
Another member added: 
“Well, I think what would be useful is ...would be to test a predictive 
clinical radiological tool that would give the probability and then see 
whether that comes anywhere near to what actually happens obviously 
depending on how they stabilise and such thing” (Neurosurgeon 1, FG2; 
p7/7). 
The account suggests an assessment tool may provide some information on the 
mechanics of the spine and outcomes for the patient. 
 
Furthermore, data also illuminates the uncertainties, conflicts, and dilemmas 
and the trade-off in trying to get a balance of treatment decisions not only 
related to spinal stability.  Treatment here refers to steroids, radiotherapy and 
surgery for MSCC. Healthcare professionals were aware of the lack of evidence 
on the effectiveness of treatment; on the other hand there was this notion of 
giving hope to patients by offering them some ‘trade-off’ in treatment decisions.  
A radiologist noted: 
“Radiotherapy is not going to heal their bones in a week.  Nor is it going 
to heal their bones in four or five or six weeks, probably.  So, [pause] but 
if you assume everyone is unstable then you get a lot of immobilised, 
bed-bound patients” (Radiologist 1, FG1; p7/26)   
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This quote acknowledges the limitations of radiotherapy and challenges the 
assumption that all patients with MSCC have unstable spines. 
 
An oncologist highlights his experience in terms of steroid therapy:  
“In my practice, we generally stop the steroids if they have been on it for 
a week  because the toxicity of continuing with steroids often significantly 
impairs mobility of the patient, [...]...particularly if  there’s been no 
evidence of any response to steroids, it’s difficult to know what the 
contribution of radiation is going to be” (Oncologist 3, FG2; p8/1) 
These interpretations suggest the treatment outcome with steroids and 
radiotherapy is uncertain.  Another member gave an example where treatment 
with steroids is justifiably prolonged:  
“But where there’s significant pain you might find somebody on steroids 
maintained for quite a long time because that is helpful for that as well so 
they can be on for much longer” (Charge Nurse 3, FG2; p8/10) 
On the other hand, sometimes there is a need to continue steroids for pain 
relief.  Treatment decisions are further complicated when there is recurrent 
MSCC.  An oncologist expressed his uncertainty: 
“...but as the systemic therapies have become more effective we are now 
seeing patients living now a year or more after cord compression with 
breast cancer and then returning later with secondary cancer.  This has 
caused uncertainty as to how they should be treated” (Oncologist 3, FG2; 
p9/27) 
Although there is reported effectiveness of systemic treatment in breast cancer 
and in prolonging life expectancy, there are many challenges around making 
treatment decision in MSCC.  For example, a decision for surgery depends on 
two factors.  A neurosurgeon stressed this point: 
“Um...now, it is a difficult assessment but two things we need to know are 
the functional status and the disease response to treatment.  So, the 
treatment of breast cancer for instance has changed because we want to 
know how responsive the tumour might be, you know, what oncological 
treatments might be available for deciding whether surgery is necessary 
to do and...um...so, it needs to be a decision that’s a team decision not 
just a surgical decision” (Neurosurgeon 1, FG2; p10/5) 
This excerpt suggests that the neurosurgeon needed information about the 
patient’s functional status and whether the tumour would respond to any further 
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treatment.  However, treatment decisions should be shared between oncology 
and neurosurgery practitioners.  The oncologist added that a decision also 
depends on whether it was soft tissue or bony involvement: 
“Generally, the decision depends on whether there is soft tissue or bony 
involvement to decide what is better, whether it is radiotherapy or surgery 
and where we get a neurosurgical opinion” (Oncologist 3, FG2, p10/13) 
This suggests the treatment decision depends on the extent of the tumour, 
whether it involved just the soft tissue or the vertebras.  However, to arrive at a 
definitive decision, the oncologist had to seek the opinion of the neurosurgeon.   
Another oncologist felt that the first assessment should be done by the 
neurosurgical team: 
“I think if you’ve got someone with cord compression, the first contact, 
you know, reasonably should be a neurosurgeon, but I don’t think that’s 
quite the same thing as saying, every patient should then be treated 
neuro-surgically” (Oncologist 5, Individual interview, p12/4) 
The interpretation from the account suggests that a neurosurgeon would be 
best placed to make the initial assessment; to enable a balanced decision on 
what is appropriate for the patient.  However, some medical staff felt less 
supported by their neurosurgical colleagues.  There was sometimes a delay in 
decision on definitive treatment.  The doctor commented: 
“Um...it’s not been in place a long time [meaning the referral pathway]...I 
think probably neurosurgery, it has been one of the issues...neurosurgery 
department… maybe not always been hugely helpful to us in the past, 
and because they have, you know, they are representation of the 
Steering Group there’s a much greater ‘buy in’ if you like than there was 
previously.  [...]  Neurosurgery’s been difficult to get assistance...advice 
from neurosurgery and...often difficult to actually get hold of someone 
senior.  (Oncologist 4, Individual interview, p2/33) 
The account suggests the difficulty in getting a neurosurgical opinion to assist in 
treatment decisions.  However, there is evidence of good outcomes from 
surgical intervention leading to the oncologist to question the clarity of the local 
referral pathway: 
“I mean with surgery there is actually...not sure whether it is in the 
pathway, but there is a decision making tool for when surgery is 
appropriate or not.  I’m not sure whether neurosurgeons are actually 
using it or not.  In the literature I’m sure you may have read, it’s about 10-
20 per cent of patients who surgery is appropriate, based on various 
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things underlying malignancy.  Haematology cancers, you know, by and 
large they are quite a reasonable prognosis [interrupted by phone call].  I 
don’t know but it is in...there’s a long English document – the NICE 
document ...as you know, there is a role for surgery with a better 
outcome in selecting patients for surgery” (Oncologist 4, Individual 
interview, p7/32). 
This excerpt indicates that the referral pathway may not be explicit in the 
decision making process.  Patients with haematological cancers have good 
prognosis and surgery may be appropriate for them based on evidence in the 
literature and the NICE guidelines.  However, the decision making depends on 
the neurosurgeon but whether any assessment tools are used to make surgical 
decision is not clear in the referral pathway. 
 
When surgical treatment is not appropriate, there may be issues around the 
treatment dose of radiotherapy.   Another oncologist gave an example of 
haematological cancers: 
“Well, it really depends, erm, the difficulty, I think, is that if they don’t 
have histological diagnosis, they would tend to give what would be five 
fractions, yeah.  If they have a histological diagnosis and they want to 
give radical treatment, then it could be anything up to twenty fractions” 
(Oncologist 5, Individual interview, p3/1) 
The above interpretation indicates the complexities regarding decisions around 
treatment dose; it depends on the case, type of cancer and whether histology 
result is available. 
 
In summary, there are many uncertainties surrounding treatment of MSCC, and 
with limited options to offer patients, there may be a balancing act in deciding 
what is best.  The notion of ‘trade-off’ in treatment decisions is evident from the 
healthcare professionals’ perspectives.  Oncologists expressed a need to know 
what neurosurgeons decided with regards to a patient’s suitability for surgery.  
Similarly, neurosurgeons required information from the oncologists about 
patient’s functional status and prognosis in order to make those decisions.  
These data are focussed around medical decision making with few insights to 
whether this was shared decision making with patients and the implications for 
them. 
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4.5 How can guidelines help anyway? 
Overall, participants identified the difficulties in decision making and 
acknowledged that management of MSCC guidelines exist, but there were 
mixed views about how useful these were.  A guideline refers to a formal or 
government policy or an outline on which a course of action may be based. 
 
Some participants were looking for a guide specific to patients with lumbar 
metastatic spinal cord compression: 
“...patients with, who have the lumbar sacral the whole lot just - is there a 
guideline that is more specific to people with lumbar spinal cord 
compression?  It used to be bed rest and that was it but now it’s a bit 
different” (Charge Nurse 2, FG2; p2/12) 
Some members found discrepancies in the existing NICE guidelines unhelpful.     
“I suppose we only have the pathway (referring to the local referral 
pathway), we haven’t really come up with a set protocol on what we’re 
doing and I think part of that is the concern that the NICE guidelines don’t 
quite fit with how we should align ourselves is...um...difficult” (Oncologist 
2, FG2; p3/7) 
A sense for the need for some guidelines, criteria or care pathways appeared to 
permeate through some of the data-set although there was no consensus in this 
aspect: 
“Well, we’ve got a referral pathway for patients to come in but 
that...um...neurosurgery and oncology referral pathway is something that 
is being audited at the moment, .there is no consistency here [Pause]. It 
would be handy to have, you know, more helpful to have a guideline that 
could help you guide decision making” (Project Manager, FG1; p4/14) 
Another member commented that things kept changing:  
“For so long you did one thing and a couple of years down the line, it’s 
changed and you’ve done something else, and so, you just don’t know: 
‘should we do this or should we do that?’  We still don’t know” (Discharge 
Planning Co-ordinator, FG1; p3) 
There were some aspects of care highlighted by participants where guidelines 
are needed.  Mobilisation of patients was identified as being problematic and 
the lack of a clear pathway for the patient’s journey of care proved difficult when 
discussing the responsibility for decision making.   
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Another participant raised the question: 
“...so, who makes that decision, the physio who gets the patient up or the 
nurse who gets ...and is that person responsible?  I think that is why 
everybody holds back whereas as you say, you know, if [pause] sort of 
...some kind of guidance to say well, local criteria” (Project Manager, 
FG1; p5/34) 
 
There seemed to be a lack of knowledge around who makes the decision and 
co-ordinating this between the healthcare professionals.  A nurse described the 
importance of this: 
 “And then on the ward there seems to be a lot of phone calls back and 
forth, you know, oncology are going to come and review, radiotherapy is 
going to start, you might get transfer, you know, doesn’t seem have a 
clear path for patients.  I’m not sure if it is a sort of thing whether you 
could do like a care pathway for, you know, patients with unstable cord 
compression?” (Nurse Practitioner 1, FG1; p4/6) 
The above account suggests a care pathway may prevent delays in treatment 
and give some structure to the care of patients with MSCC.  Most of the 
participants agreed that the NICE guidelines are vague and lack clarity.  The 
situation is different in clinical practice and one of the participants said that it’s 
open to individual interpretation: 
“I think it’s an evidence free zone and it’s up to individual interpretation 
and possibly NICE guidelines...um...there’s a number of areas not  
necessarily reflecting the consensus of clinical practice in NICE and 
other information where we do need to try to develop some sort of 
consensus even if not from evidence base” (Oncologist 3, FG2; p3/27). 
This comment suggests that in the absence of evidence, it would be realistic to 
reach consensus on the management of MSCC as a team.   
 
This discrepancy was also experienced by general practitioners in the 
community setting with regard to transferring patients to the hospital.  One of 
the general practitioners raised this point: 
“...the NICE guidelines have stated that patients with malignant cord 
compression should be treated as if they were...err...traumatic spinal 
fracture and completely immobilised on a body board and two man 
ambulance.  And of course they are not traumatic spinal lesions, so the 
view of ...err... [Name of health board] is that is inappropriate” (General 
Practitioner 1, FG3; p9/8). 
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A general practitioner from another health board agreed and talked about the 
Glasgow guidelines: 
“In fact, I think, in Glasgow, their spinal cord compression guidelines 
[referring to WoSCAN 2007], suggest that every case of suspected cord 
compression should be transported as a spinal injury.  Err...but, it would 
be nationally the thought that...that’s unrealistic, and that the majority of 
people with suspicion of cord compression, I mean, do not have spinal 
instability and they’re perfectly safe to be transported in the most 
comfortable position, which is usually sitting in the car rather than lying in 
the ambulance” (General Practitioner 5, p8/16). 
This account suggests that guidelines may not inform the transfer of patient 
from the community to the hospital.  However, they would be cautious if the 
patient has symptoms of severe back pain:  The general practitioner added: 
“...the only symptom would probably indicate that would be severe back 
pain that was err...made much worse on movements which might 
indicate then there might be some instability” (General Practitioner 1, 
FG3, p9/17). 
Some participants were sceptical about NICE guidelines.  A neurosurgeon 
commented:   
“...and that’s the problem, that everybody wants that didactic advice... 
‘this patient is stable.’  NICE [referring to NICE guidelines 2008] has 
come out to say ‘you’re better off saying everybody is unstable,’ but 
we’ve got a variety of conditions, very different prognoses, different 
attitudes from patients and there isn’t a golden answer, so we have to 
educate ourselves to understand that first of all...   [...]  As 
neurosurgeons, are often looked to give didactic advice about ‘is this 
patient stable?’ and that’s very difficult cause stability is a gradation from 
white to black, and most people are pretty grey in the middle.  And you 
can give various guidelines...um...but all of them will be very difficult in 
the situation.   [...] So, if people can understand that, they can begin to 
understand that relationship with the patient and explain that to the 
patient, and we won’t be continually trying to find this holy grail that the 
patient is unstable or not because that doesn’t exist in most patients.” 
(Neurosurgeon 1, FG2; p3/41) 
 
Given there are variations in the presentation of patients with MSCC and the 
unpredictability of the condition, there was a view that NICE guidelines do not 
adequately inform the management of MSCC.  In light of controversies 
surrounding the inadequacies of the national guidelines, a pragmatic approach 
was suggested: 
 
 
 
 
120 
 
“It would be very helpful if we came to a decision as to what our goal’s 
going to be for this particular condition and stop trying to find a guideline 
that you can pull out of the drawer and says that’s what’s going to 
happen...that’s what matters” (Neurosurgeon 1, FG2; p4/28). 
 
In recognising this, there is an emphasis on collaboration and agreement 
between healthcare professionals on how best to manage patients with MSCC.   
 
However, different guidelines can also be problematic: 
“Unfortunately, err...work had been done in the north, um...the west of 
Scotland went off and did their own thing and developed guidelines, and 
then the south and east came online.  Now none of the work being done 
in the other places has been wasted, but my concern would be that we 
still continue to reinvent the wheel” (Head of Cancer Services, Individual 
interview, p1/14). 
Lack of agreed guidelines can lead to inconsistent practice: 
 “I think it boils down to a bit of arrogance on the part, particularly, the 
medical staff in that they know best and everybody has an opinion and 
because there is a lack of evidence in the literature that anything [pause] 
new or different needs to be done...err...then that still leads to 
inconsistencies in pain relief, mobilisation, um, prompt referral for 
surgical opinion, is it one fraction or five fractions of radiotherapy for 
symptomatic relief...um...and everybody’s view is different but with the 
implementation of a pathway, one would hope that at least patients are 
captured at an early stage and it becomes embedded in practice” (Head 
of Cancer Services, individual interview, p4/10). 
Nevertheless, a referral pathway as a strategy could assist in early diagnosis 
and treatment of patients with MSCC. 
 
To summarise, these accounts showed that the need for guidelines was seen 
by some participants as necessary for patient care, others felt they did not meet 
the needs of the patients who may have different primary cancers; be at 
different stages of the disease; or have different prognosis and priorities 
towards the end of their lives.  There was an emphasis that healthcare 
professionals should work together as a team and that decision making should 
be a shared process. 
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4.6 How can we deliver optimum care in the midst of 
uncertainty? 
The impact of recurrent cancer on patients was described by one of the 
participants as a huge life changing event when there is loss of mobility and 
difficulties with coping.  Recognising the needs of the patients, healthcare 
professionals discussed strategies to support patients with MSCC.  A palliative 
care nurse described her concerns: 
 “Often patient and family comment on either a lack of information of 
what’s happening or conflicting information and the fear that goes along 
with, you know, [...] they may not have been particularly happy recently 
and they may already have quite a bit of functional impairment from their 
primary cancer...err...um...[Pause].  This is a huge life changing event, 
particularly if it is diagnosed late and the anger that can go along with 
finding that out...I mean...and you know, all the emotional stuff and if 
you’re lying flat on your back or you are getting conflicting information 
and all that...um...it can really help, sort of trust wise” (Palliative Care 
Nurse 1, FG1; p8/5). 
The above account suggests a diagnosis of MSCC is a devastating event.  The 
lack of information, or conflicting information, to the patients can evoke 
emotions of fear and anger.  Life expectancy depends on the primary cancer 
and when they come in with recurrent cancer, it is described as a catastrophic 
event by one oncologist: 
“I do think when patients come in and they have this catastrophic event 
and I’m not sure whether there are tools to deal well with that 
catastrophic event for patients to help them through that process phase” 
(Oncologist 3, FG2; p13/3). 
Healthcare professionals recognised that recurrence of cancer posed difficulties 
for patients and acknowledged they needed support.  In some cancers, life 
expectancy is short and giving bad news can be challenging.   
“And quite rightly many of them are very distressed by the diagnosis, and 
many of them, their carers’ are very distressed by the diagnosis, and 
often there’s not a lot of time for them to come to terms with it” 
(Oncologist 6, Individual interview, p7/17). 
Giving bad news in the acute setting can be challenging for healthcare 
professionals.  Patients and carers are likely to be distressed when faced with 
end of life issues.  An oncologist talked about patient’s psychological needs: 
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“So, I mean, their psychological needs tend to be met by the... you know, 
just the nursing staff on the ward, or us on the ward.  And if they – you 
know, they may have – we’ve got the clinical nurse specialist who will 
speak to them.  But in terms of ‘is someone depressed, or do you need 
counselling,’ often there’s no time for that because they have barely 
come to terms with their illness.  [...] So they...they would be seen by 
clinical nurse specialists, there just isn’t one – because we’re all site [site 
–meaning in the body, like lung, bowel, brain, sort of thing] um, you 
know, there’s not a cord compression nurse.  Maybe there should be” 
(Oncologist 6, Individual interview, p10/4). 
In this acute situation, psychological support varies.  The interpretation indicates 
that there was a lack of someone co-ordinating the patient’s journey and 
ensuring patients need are met.  Thus, their psychological needs may be 
overlooked.  Another concern of the participants was patients who are admitted 
with unknown cancers and having the diagnosis of MSCC at the same time. 
“I think it is very difficult if they’re presenting for the first time obviously 
they come in a number of different routes and that is one of the things we 
are trying to address through the pathway…more unified approach so 
that they get the same care.  At the minute  it’s very fragmented; who 
they are first presented to, who they are referred to … so that would be 
very different in their experience” (Oncologist 1, FG2; p11/9). 
This account highlights the different pathways patients experience on admission 
and could have an effect on them.  Another participant commented that there 
may be lack of support for patients:  
“The unknown; certainly there is a gap for support for that group of 
patients when they actually come in to hospital, and it can be quite a fast, 
through, journey for a patient who is suspected of early spinal cord 
compression: in, diagnosed, treatment, and out again.  Where do they 
get any support in the system there?  And then patients who do have 
known cancer, there’s gaps with their support...with their CNS (Clinical 
Nurse Specialist) support as well, cause...just the way the service is” 
(Project Manager, FG 1, p3/4). 
Patients with unknown cancer can also present with MSCC.  The patients 
treated in an acute setting may be discharged very quickly.  The account above 
indicates a lack of someone co-ordinating the patient’s journey and ensuring 
patients’ needs are met. 
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An Occupational Therapist added: 
“We have had a few patients that have gone to hospice because of 
difficulties...um...in psychological adjustment to their condition...um...and 
I think what...what is very difficult for the patients as well is they’re having 
the five fractions radiotherapy and that unknown entity how the function 
is going to change post radiotherapy” (Occupational Therapist 1, FG1; 
p8/27). 
 
Here the account suggests that some patients faced difficulty adjusting to their 
condition and needed psychological help and some had difficulty coping with 
the uncertainties ahead of them after treatment. 
 
In the absence of supporting evidence on the follow up care of patients, the 
majority of healthcare professionals suggested a need to deal with these 
shortcomings and provide care according to the needs of the patients through a 
clear plan and a tailored care package.   
 
A radiologist suggested a plan to start with: 
“...and I think what you need...is a ...is a plan to gently start moving.  
Most patients will know very quickly if they’re getting neural compression” 
(Radiologist 1, FG1; p5/22) 
To deal with this situation, a plan for early mobilisation was thought to be 
necessary.  A palliative care nurse added: 
“I think it is like any other sort of life changing events because it’s not 
ever one conversation you can have with people.  It’s about what does 
this mean to me and that is gradual.  So, it’s having that conversation 
reinforced” (Palliative Care Nurse 1, FG1; p9/20) 
There was a call to have an ongoing conversation and explore the patient’s 
understanding of his/her condition.  Along these lines, another member of the 
group reinforced the view: 
“...and I think as long as everyone is saying the same thing when they 
are having all these conversations.” (Physiotherapist 1, FG1; p9/27) 
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This excerpt suggests that it is important that healthcare professionals provide 
the same information to patients and in doing so mitigate the chance of giving 
conflicting information.   
 
A step-wise approach to check the patient’s understanding of their condition 
was suggested:   
 “I think as well, given that the patient is going through the Cancer Centre 
and they hope along somewhere where it’s sort of following that patient 
through how much they have actually understood and this sort of step 
approach.” (Project Manager, FG1; p9/34) 
Another participant considered: 
 “Perhaps the care pathway needs a big box on it of what patients have 
been told...so that they can then say the same thing again or change it if 
it’s a new message” (Radiologist 1, FG1, p9/30) 
Nevertheless, clarifying and checking for understanding was essential.  Having 
a conversation about prognosis with patients can be challenging – from giving 
unrealistic expectations to managing expectations.  A radiologist queried: 
“Do you think we offered unfounded expectations though?  You know, 
the evidence all points ...all the evidence said that if you got bad deficits 
before you start treatment your chance of improvement are very low” 
(Radiologist 1, FG1; p8/37) 
Another member of staff thought sometimes patients could be in denial and be 
selective in retaining information: 
“I think patients want to hear what they want to hear cause I have been 
there when doctors have been saying ‘right...now you had your five lots 
of radiotherapy we don’t really think there’s going to be awful lot of 
improvement’ and then they go away and you are left and the patient 
says ‘so, when will I be up walking again?’”(Physiotherapist 1, FG1; p9/1) 
 
Developing a coping mechanism seems to be exhibited by the patient by 
selective listening or blocking out the negative information or they may not 
understand the significance of statements about improvement and the finality of 
this. 
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However, the issue of whether patients have any information about long term or 
likely future symptoms and the problem of who breaks the bad news, highlights 
the difficulties in the conversations.  The occupational therapist commented:   
“I think part of that communication is not to deliver the expectation to the 
patients of getting...um...lots of care from lots of different people where 
they might not get it.  So, realistic expectation of care I think is quite 
important” (Occupational Therapist 1, FG1; p13/20) 
On one hand, healthcare professionals seem to offer hope but on the other, 
suggested not to deliver expectations that cannot be met.  The occupational 
therapist explained:  
“We start preparing them from the ward for where things are going to go.  
Quite often it is us that are sort of breaking the bad news about their 
functional status not improving.  But quite often that’s because you are 
forcing them to consider leaving hospital and what the implications of that 
are going to be” (Occupational Therapist 1, FG1; p14/27). 
The account indicates that patients may not have been informed about their 
future deterioration of their function and therefore unaware of its implications.  
Moreover, information about likely future symptoms depends on treatment 
outcome.  One oncologist described a dilemma: 
 “I think it’s quite a common problem that patients and carers want- to 
know what lies ahead-quite specifically - and will ask you...you know, 
what exactly is going to happen.  When we as healthcare professionals 
know that it’s very difficult to predict as there are a number of scenarios 
and is it appropriate to tell them all the different scenarios or just wait and 
see what happens.  Sometimes people want to tie you down to be very 
specific as to when exactly, how many months, or what exactly will 
happen to me, or what exactly can I expect.  I think it’s a difficult 
conversation to have.  Not always that helpful” (Oncologist 1, FG2; 
p14/13). 
It is likely patients want information about their future and this can be a difficult 
conversation to have with patients.  One participant suggested:   
“...and let patients and carers understand that sometimes things are 
uncertain and also where goals might not be, you know, set in stone...we 
will try to, you know, people will understand if they know the boundaries.” 
(Palliative Care Nurse 1, FG1; p13/32) 
This account suggests being honest with patients about the uncertainty of the 
disease and treatment. 
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Continuity of care and availability of rehabilitation services is an important issue 
and it poses some dilemmas for allied health professionals.  
“...we...um...treat patients in very acute phase and if patients need further 
input from a therapist, then depending on where they live, if they live in 
the west of the region, for example, there’s a rehab team that would pick 
them up and do work with them at home” (Occupational therapist 1, FG1; 
p1/28). 
This comment suggests that rehabilitation services are variable and inequitable.  
There is a perception that a hospice provides rehabilitation, as voiced by 
another participant: 
“But you know the reality is that hospices aren’t taking anybody for 
rehab, its palliation, you know, palliation with a short (time) span” (Nurse 
Practitioner 1, FG1; p2/19). 
There seemed to be a lack of rehabilitation services to help patients cope when 
discharged home to the community.   
“I think it’s part of the changing role of the hospice; the recognition of the 
difference in the generalist role as well specialist palliative care...but 
actually most of the rehab required is...it should be able to be provided 
for people in general with spinal cord compression, unless there are 
other sort of extremely unstable bits on top of them” (Palliative Care 
Nurse 1, FG1, p2/28). 
This excerpt implies that rehabilitation should be embedded in practice.  
Suggestions that on-going care should be looked at and be provided on a 
personalised basis, and should involve family, were the views held by some of 
the healthcare professionals.  However, the nursing staff would refer the patient 
to the physiotherapist for rehabilitation.  A charge nurse said: 
“I think you have to take each on an individual basis.  We often refer 
them on areas like yourself, you know, for the treatment [referring to the 
physiotherapist].  So, it’s generally from your service that they would go 
to rehab” (Charge Nurse 2, FG2, p12/21). 
This suggests different levels of decision making in identifying and arranging a 
patient’s rehabilitation needs.  The physiotherapist commented: 
 “...I think there’s huge impact how you are going from A to B in a new 
way when they are dealing with everything else and then this acute 
environment is very challenging….got so many different services coming 
in giving information and you can see they are completely overwhelmed 
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and the ones who have family support or younger families and you know, 
they obviously are going to cope better than maybe somebody with one 
elderly spouse but they have the issues where do they go from here” 
(Physiotherapist 2; FG2; p12). 
The above quote suggests that patients can feel overwhelmed dealing with their 
condition in an acute ward setting.  It is thought that younger patients with 
support coped better than the elderly. 
 
Another member of the focus groups said patients may not know what to expect 
until they have left the acute service: 
“I think it’s when the patient is home that suddenly they are away from 
the safety bubble of the hospital that suddenly a lot of these questions 
come out.  It’s who they then go for support in that instance. And if 
they’ve gone through the palliative services they have got that 
mechanism of support...but [pause] there are patients that don’t, they just 
get everything set up and discharged home” (Occupational Therapist, 
FG1, p9/39). 
Understanding of the implications of their condition might not be apparent to 
those affected until they go home and they might not necessary have access to 
palliative care services. 
 
Another problem in receiving rehabilitation in the community is to do with age 
cut off.  There seems to be controversy with this aspect.   
“Patients under 65 and generally, it’s the myeloma cord compressions, 
you’ve got a good chance to get them into the local rehabilitation.  [...] 
So, it’s over 65s that we struggle with more” (Occupational Therapist 1, 
FG1; p10/36) 
 
In contrast, a medical staff member felt otherwise: 
“Over 65’s will be easier because geriatrician will take on that.  Well, they 
may be less keen to take patients under 65 because they can’t be sent to 
a nursing home” (Senior House-Officer1, FG2; p12/36). 
Some participants provided the view that patients over 65 have problems 
getting rehabilitation while others think it’s the under 65’s who have this 
difficulty.  An oncologist did point out that in relation to the provision of 
rehabilitation:  
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“It’s a problem actually.  We had two patients who I’ve mentioned already 
who were paraplegic.  Both patients went to [name of local rehabilitation 
hospital] but a little bit grudgingly from the point of the view of 
rehabilitation physician...um...not sure whether it’s necessarily an ideal 
place for them.  So, both patients, they did have access to rehabilitation 
but there is nothing very specifically for this group of patients.  I don’t 
think there’s any...there’s no one in [name of city] with special interest in 
rehabilitation of spinal cord compression” (Oncologist 4, Individual 
interview, p8/31). 
 
Although rehabilitation is deemed important for patients, the rehabilitation 
services provided may not meet the needs of patients with MSCC.  A participant 
voiced a significant setback:  
“The community rehabilitation team here don’t really categorise cancer 
as a condition that is going to improve, basically.  There is the odd 
occasion if they are not busy, they will consider taking a patient on.  But 
on the whole, that’s their ruling, for example, the group of patients that 
are stroke patients are going to improve” (Occupational Therapist 1, 
FG1; p11/16). 
This comment suggests that obtaining rehabilitation support for patients with 
MSCC was challenging due to the nature of advanced cancer. 
 
Likewise, in the community setting, some of the participants reported that there 
is no domiciliary rehabilitation service available.  Patients have to travel to the 
nearest district hospital or local health centre for physiotherapy services.  A 
general practitioner commented:  
“...with the vast majority of people, they have to travel to a hospital, or if 
there is a physio department in their health centre, they would go there.” 
(General Practitioner 1, FG3; p18/8) 
This indicates variations in the availability of rehabilitation for patients with 
MSCC.  A palliative care nurse added: 
“There’s only one sort of part-time specialist palliative physio, but, you 
know, her remit is sort of within the hospital and it is very unusual for her 
to come out and do home visits.  Which means, you’re relying on 
generalist staff, I guess, in what might be a very complex situation at 
home...” (Palliative Care Nurse 2, FG3; p17/21) 
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This suggests that patients may not receive the appropriate rehabilitation 
support specific to MSCC.  
 
Matching the level of rehabilitation was further suggested by a participant: 
 “...um...and the idea of seeing whether some sort of community based 
team could be focused on this area.  [...] I think it’s an overwhelming 
experience for patients, doctors and the community staff, yet the patients 
want to get home” (Neurosurgeon 1, FG2, p17/3).  
It appears that for patients who want to go home, it poses challenges for all 
stakeholders.  A joint hospital and community based team specific to MSCC 
was proposed. Another consideration was put forward: 
 “I think to consider a pilot of as a joint hospital community based team 
that provided the resources for this group of patients, particularly one or 
two beds set aside for intensive rehabilitation where patients with cancer 
who we will know will have a better outcome, we should provide services 
to individuals who we know will benefit” (Oncologist 3, FG2; p17/25) 
However, implementing a joint hospital community based team could be 
problematic, a hospice director pointed out: 
“I don’t think it is sustainable and I don’t think you’ll get funding for it.  So, 
I think the best support for these people is by using the existing generic 
services.  [...] the existing model is primary care team, GPs, district 
nurse, community physiotherapist, occupational therapist, social 
work...um...or organised integrated with support from especially from 
palliative care if or when required.  If you try to develop a small team for 
what is a rare condition...err...you run into issues of sustainability and 
um...geography, which you can’t overcome” (Hospice Medical Director, 
Individual interview, p8/17) 
The feasibility of a community based team specific to MSCC was considered as 
not sustainable.  Moreover, it was thought that patients would be best supported 
by the existing generic primary care team.  Another participant added:   
“I don’t think we need a separate team, I think it needs to be embedded 
in the current community team” (Head of Cancer Services, Individual 
interview, p12/1) 
This comment suggested that the community team need appropriate education 
embedded in their core training to support the patient.   
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One of the members suggested early recognition pre-cord compression is 
important: 
“We know that this is a high risk group and what kind of education do we 
give that group of patients in trying to prevent...um...the devastation that 
can happen” (Project Manager, FG1, p3/1) 
Recognising and giving education to patients who are at a high risk of 
developing MSCC was suggested.  Often a patient’s diagnosis of MSCC may 
be delayed in the hospital setting:  An oncologist highlighted: 
“I think it is also educating other healthcare professionals, for people also 
sit in the hospital for a long time with symptoms and it takes a long time 
for that to be picked up” (Oncologist 1, FG2, p11/23) 
The excerpt suggests healthcare professionals out with oncology may not 
recognise signs and symptoms of MSCC.  Therefore, education can highlight 
the urgency of referring patients for early treatment.  Also to get early referral 
depended on patient presentation in the community.   
A charge nurse commented: 
“It also depends in the community, you know, how quickly the symptoms 
are picked up.  Somebody lay off their legs and some sat there for three 
weeks being completely bed bound by the time they waited until 
something’s being done.  Other people were picked up very quickly with 
just minor symptoms with back pain but presentation of getting their back 
pain done at that point in time is very difficult” (Charge Nurse 3, FG2, 
p11/16) 
This suggests the difficulty in recognising the early signs and symptoms of 
MSCC in primary care.  However, the neurosurgeon gave his view on 
identifying MSCC in the community: 
“And I think it is ok for us to sit here and criticise someone not diagnosing 
someone with spinal cord compression.  You know, you could have, say, 
‘how they missed it?’  If you were involved in the process in a helpful way 
you are more likely to get them involved even if they see one or two 
cases you could help” (Neurosurgeon 1, FG2, p17/38) 
This account suggests that instead of putting the blame on others, working 
together is more appropriate to address the issues of identifying MSCC early.  
General practitioners pointed out: 
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“Well, in the same period of time [similar to another GP’s 20 years 
career] I’ve diagnosed one and suspected possibly two which haven’t 
been confirmed on further investigation” (General Practitioner 3, FG3, 
p3/1) 
General practitioners from three different health boards reported seeing few 
patients with MSCC in their career. They talked about seeing patients with back 
pain on a daily basis.  General practitioners agreed that giving information to the 
patients before presentation was important:  
“I think the other issue is, before presentation, it’s about giving 
information so that patients will present if they get symptoms that might 
indicate that if they don’t do nothing or delay but as [refer to palliative 
care nurse 2] says it’s getting the balance between giving them enough 
information to be able to do that but not frightening them as most cases 
with cancer will not get it” (General Practitioner 1, FG3, p14/17) 
Getting the right balance can be difficult.   When asked whether it was easy for 
them to recognise the symptoms of MSCC:  
GP 1: “No! [Everyone laughs and talk at the same time].   
GP 3: Technically, it should be – it’s easy in theory what the symptoms 
are; but we don’t see it very often and it never presents classically, 
does it? [Asking other colleagues]” (General Practitioner 3, FG3, 
p5/3) 
The general practitioners accounts suggest recognising the signs and 
symptoms of MSCC can be challenging.  Another general practitioner also 
conceded: 
“One of the criteria for suspecting cord compression that we use is 
severe progressive pain, and that’s one of the ones that I personally find 
quite difficult because a lot of people with bony metastasis, for example, 
have got a lot of that pain anyway.  With metastasis, they’ve got pain, 
they’ve got tenderness and at what point do you actually say well this is 
different; this has now changed such that I have to suspect cord 
compression and need to arrange for an MRI scan?  That...that can be a 
tricky one, and that’s one where I prefer to err on the side of safety and 
phone for guidance, rather than sitting back and wait” (General 
Practitioner 5, Skype interview, p17/35) 
 
It is notable that patients with bony metastases suffer pain and differentiating 
the new pain can be difficult.  However, the patient’s safety was the main 
concern.  This account suggests that the GPs would have to trust that their 
 
 
 
 
132 
 
colleagues would make the decision.  One oncologist explained that sometimes 
identifying the symptoms of MSCC can be challenging: 
“Well, if they’ve got cord compression, they can just have straightforward 
back pain; they can have radicular pain; they can have pain when they 
cough, or pain when they strain.  They can have pain – shooting pains 
down their legs with a spinal nerve compression, so it varies.  But the 
typical radicular pain that you get with impending cord compression isn’t 
always there” (Oncologist 6, Individual interview, p/8) 
 
The general practitioners reported that their awareness on MSCC was raised 
from them receiving the local referral pathway by e-mail.   
 
In one health board, education was organised through protected time- where 
NHS 24 and the locum took over the running of the surgery and the GPs would 
attend workshops.  One general practitioner commented: 
 “So, making it easier for GPs having to decide ‘should I refer the patient 
to the orthopaedic surgeon’ or ‘should I refer to the oncologist’ or ‘should 
I refer to the urology surgeon’, or whoever, just one central point say, the 
patient may have spinal malignancy and it will then be dealt with’” 
(General Practitioner 4, Individual interview, p4/19) 
General Practitioners found decision making was easy with the referral pathway 
in each health board.   
 
With regards to education, one of the GPs said: 
“...small discussion groups I think work the best.  GPs like learning with 
their colleagues and they also like the opportunity in a small group to be 
with the specialist from the hospital to discuss the issues.  And also, it 
helps to have that personal contact because then, if you do have a 
problem, you know the person you’re phoning up, and that makes it 
easier.  The discussion groups work best when they’re sort of semi-
structured, so there may be a sort of small presentation but there’s also – 
should be plenty of time for discussion” (General Practitioner 1, FG3, 
p21/16) 
Some general practitioners talked about the follow-up of their patients and had 
regular meetings with their community nurses. 
“Cancer patients I would see on a regular basis, especially the palliative 
care set-up; we have regular meetings where we discuss every case and 
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we usually – very often the district nurses are involved and they’re the 
ones who have got the day-to-day contact with the patient” (General 
Practitioner 5, Skype interview, p18/14) 
However, there are variations on the level of funding for psychological services.  
One general practitioner commented: 
“...the availability of psychology services across [the local area] is patchy.  
And, again, one of the things NHS has been plagued with over the last 
few years is ...err...incentives, or initiatives –ring-fenced money, err, and 
so what you find is a pot of money has come in which has allowed a bit 
of the services to develop.  Err...but you never got the money to roll that 
service out to the whole health area” (General Practitioner 4, Individual 
interview, p15/13) 
This account suggests that psychological needs of the patients may be 
neglected due to funding issues. 
 
In summary, participants acknowledged that MSCC is a life changing event.  
Patients can be admitted through different pathways.  Giving bad news to 
patients and carers is challenging and psychological support is patchy and 
provision of rehabilitation is variable depending on the patient’s age, diagnosis 
and geographical area.  There are suggestions of the need to achieve 
consensus on the care of this group of patients as a team.  Healthcare 
professionals are aware about the care needs of this vulnerable group of 
patients but faced many difficulties.  Amongst them are the gaps in the support 
and continuity in their care.  Some strategies were recommended in order to 
move forward in the care of patients with MSCC.  Aspects of a tailored care 
included; a plan in commencing mobilisation, effective communication, realistic 
management of expectations and personalised care while at the same time not 
removing hope from patients.  The healthcare professionals acknowledged 
there are different groups of patients with different needs depending on their 
primary cancers and prognosis.  Although there was suggestion of a joint 
hospital community based care team specific to MSCC, it was thought this is 
not sustainable.  However, education recognising the early signs and symptoms 
of MSCC is important. 
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4.7 Chapter summary  
In conclusion, this overarching theme and four themes provide valuable insight 
into how healthcare professionals manage and care for patients with MSCC.  
MSCC is a challenging condition with uncertainties surrounding the diagnosing 
of spinal instability, treatment and management.  There was a notion of fear in 
making decisions around commencing mobilisation; so there was a tendency to 
play safe in the care of patients.  However, the healthcare professionals 
recognised the needs of the patients and the consequences of immobilisation 
and there was evidence of making trade-off decisions.  There is lack of 
guidance in terms of surgical, medical and radiological treatment but the need 
for individualised care is acknowledged.  Another concern was raised regarding 
those patients who were admitted with unknown cancers.  Rehabilitation 
services are variable and depend on the patient’s age and geographical area.  
Some participants suggested a community based team to cater specifically for 
this group of patients; however, this service is provided in the community. 
 
Education to healthcare professionals and patients on the early signs and 
symptoms of MSCC was emphasised.  General practitioners see very few 
patients in their career.  Identifying the classical signs and symptoms of MSCC 
is not easy as general practitioners see patients with back pain on a daily basis.  
However, they found the local referral pathway easy to follow.  The overall 
theme seems to revolve around negotiating for a care pathway specific to 
MSCC.  The majority of participants suggested that it was important to consider 
the patient’s perspectives, what are their priorities, and what is important to 
them and if their needs were met.  
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Chapter 5: Across-case findings 
5.1 Introduction 
This chapter presents my findings developed from Phase Two, the accounts of 
patients, carers and key healthcare professionals involved in the management 
of metastatic spinal cord compression (MSCC).  Figure 15 provides the levels of 
abstractions in Phase Two findings (details of across-case analysis in Section 
3.9.5).  Level 1 shows the three themes and nine sub-themes: facing 
uncertainty in MSCC; finding a balance in the uncertainty of MSCC; and support 
beyond the treatment of MSCC.  It became apparent from the analysis that 
stakeholders faced uncertainty (of the future) and enduring inconsistencies (of 
information, treatment and advice for the future) (Level 2 abstractions).  The 
details on the main focus of findings can be found in Table 9.   
 
Firstly, an example of a single case finding will be described to illuminate the 
multiple perspectives of a theme.  Following this the across-case findings will be 
presented with an introduction to each theme, an analysis of the finding is 
discussed which incorporates sub-themes containing the participant’s and my 
first level interpretation of the accounts. 
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Figure 15: Levels 1 and 2 abstractions of Phase Two findings 
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Theme 5.2: Facing uncertainty in MSCC 
Sub-themes: 
5.2.1 ‘Trying to make sense of it all’ 
5.2.2 Trusting healthcare professionals 
to make the right decision 
5.2.3 “Help us put the jigsaw together” 
5.2.4 When to have a conversation 
about the future? 
 
 
 
Theme 5.3: Finding a balance in 
the uncertainty of MSCC 
Sub-themes: 
5.3.1 ‘Trade-off’ 
5.3.2 “Battle plan – what is the 
next step?” 
5.3.3 Perception of the demands 
of care 
 
 
 
Theme 5.4: Support beyond the 
treatment of MSCC 
Sub-themes: 
5.4.1 “They say there is support 
out there but...” 
5.4.2 Determining the final 
moments 
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Table 9:Themes, sub-themes and main focus of findings 
 
Themes Sub-themes Main focus of findings 
 
5.2 Facing 
uncertainty 
in MSCC 
5.2.1 ‘Trying to make sense 
of it all’ 
 
 
 
 
5.2.2 Trusting healthcare 
professionals to make 
the right decision 
 
 
5.2.3 “Help us put the jigsaw 
together” 
 
5.2.4 When to have a 
conversation about the 
future? 
 Recognising and 
interpreting signs and 
symptoms at the acute 
onset of MSCC can be 
complex 
 
 Emergency decision-
making on treatment 
 To ‘bed-rest’ or ‘not to 
bed-rest’ 
 
 Timely information 
 
 
 Facing uncertainty of 
losing mobility 
 How long is life? 
5.3 Finding a 
balance in 
uncertainty 
of MSCC 
5.3.1 ‘Trade-off’ 
 
 
5.3.2 “Battle-plan – what is 
the next step?” 
 
 
5.3.3 Perception of the 
demands of care 
 Treatment options 
versus quality of life 
 
 Seeking a life line – 
hopes and treatment 
options 
 
 Reducing the demands 
of care 
5.4 Support 
beyond the 
treatment of 
MSCC 
5.4.1 “They say there is 
support out there 
but...” 
 
 
 
 
5.4.2 Determining the final 
moments 
 Changing priorities 
 Adjusting to disability 
 Variations in group 
support  
 Relationship dynamics 
 
 Monitoring of tumour 
 Difficulty living with 
cancer 
 Anticipating the final 
moments and letting go 
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5.1.1 A single case findings illustrating the multiple perspectives of 
a theme (Case Study 2)  
This single case initially illustrated the theme of ‘facing the unknown’ and was 
later refined to ‘facing uncertainty in MSCC’.  This is a descriptive account of a 
single case giving a picture of the impact of MSCC and the multiple 
perspectives in a theme.  The theme ‘facing uncertainty in MSCC’ was 
perceived by Sandra (Case Study 2) as not knowing what was going to happen 
next and what the immediate future held for her and her family. 
 
This theme permeated her husband’s perspective and posed a challenge for 
healthcare professionals when faced with the unknown.  Sandra had metastatic 
breast cancer and had accepted that her cancer could not be cured but could 
be managed.  Sandra had a fall in her garden and sought advice from her GP.  
However, it was thought the pain on her back was the result of the fall.  It was 
during her normal follow-up appointment for her breast cancer that a routine 
scan showed early signs of compression.  The sudden discovery that the 
tumour had spread to her spinal column caught her off guard.  She was quickly 
transferred to the cancer centre about 130 kilometres away from her local 
hospital to receive urgent radiotherapy.  Table 10 illuminates the multiple 
perspectives in this theme.  
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Table 10: A single case study illustrating the multiple perspectives of a 
theme –  Facing uncertainty in MSCC 
Patient “I am confused and concerned and the anxiety would come from not 
knowing what’s going to come next.  You know, you don’t know what 
pathway the illness is going to take.  You don’t understand how 
quickly it’s going to go, where it is going to go, how it’s going to be 
managed and it would...it seems that there are so many different 
variations in individuals that no one can actually give you a definite 
answer” (Sandra, 1st interview, p1/11) 
Husband “All this types of cancer, what is the average life expectancy?  But 
when you get diagnosed with cancer at the moment they can’t tell 
you because it is a sixty million dollar question.  When you get it, you 
say to your consultant ‘how long have I got?’  They will turn around 
and say we cannot tell you because your personal reaction would be 
different from somebody else. There must be somewhere down the 
line they would be able to say ‘well...’ or whatever” (John, Sandra’s 
husband, 1st interview, p21/22) 
Registrar “Um, it’s very difficult, especially with breast cancer.  We’ve got 
ladies that are eight and ten years with bone mets.  And with Sandra, 
it was a bone mets that was just very slightly starting to cause 
compression, so it’s difficult to say that things are going to be 
completely different from how it would be with ladies with bone mets.  
But then, um...if somebody’s got spinal cord compression that’s 
really quite severe, I think the prognosis is about six months...  So, 
it’s difficult...it’s very difficult to give an overall figure.  You’ve got to 
think about the patient themselves and how well they are for other 
treatments that might help.  So, yeah, it’s sort of patient-basis” 
(Registrar, p15/21) 
Patient “I got to a point where I wanted answers, but I didn’t know what my 
questions were.  You know, I didn’t actually know what I wanted to 
know” (Sandra, 1st interview, p24/30) 
Nurse “Any questions I would answer if I knew but if it’s to do with the kind 
of ins and outs of spinal cord compression, I would get the doctors to 
speak to her.  I don’t feel I have enough knowledge on the ins and 
outs.  I think medical staff should do that” (Nurse, p8/2) 
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Oncologist “She’s symptomatically better and we talked through her experience.  
I’ve known her for quite a...obviously since her relapse.  She has a 
lot of issues dealing with err...you know, the fear of the future was 
going to happen and the fact that living with metastatic disease and 
even though we have emphasised that this is low volume, good 
prognosis, prognosis is not prolonged but it’s not...ultimately the 
disease is likely to...it’s going to catch up with her” (Oncologist, 
p4/28) 
 
The across-case analysis of the interview transcripts yielded three major 
themes: facing uncertainty in MSCC; finding a balance in the uncertainty of 
MSCC; and support beyond the treatment of MSCC.  The findings are 
discussed across the 8 case studies below. 
5.2 Facing uncertainty in MSCC 
Data illuminated uncertainty as a central concept from the accounts of patients, 
carers and healthcare professionals when trying to interpret symptoms during 
the acute onset of MSCC.  The accounts in the first sub-theme showed that 
patients felt confused and distressed in trying to make sense of the changes in 
their body and the impact it was having on them as a person. 
 
Healthcare professionals described facing competing perspectives and 
encountered complexity and ambiguity in making a diagnosis whilst urgent 
treatment decisions had to be made.  Due to the threatening nature of MSCC 
and the unpredictability of paralysis, sub-theme two showed how patients and 
their carers put their trust in healthcare professionals to make the right decision 
to relieve the symptoms at the onset of MSCC.  Sometimes these decisions or a 
change of decision on the treatment and management were not explained to the 
patients. Sub-theme three demonstrated the impact of conflicting information on 
the patient’s immediate care.  Once uncertainty was resolved at the acute 
stage, other uncertainties emerged and sub-theme four described patients and 
carers anxiety and distress at the lack of information on treatment options and 
future changes to their health status.  What now follows are the accounts of 
 
 
 
 
141 
 
patients, carers and/or family members and healthcare professionals in trying to 
make sense of the signs and symptoms of MSCC.  
5.2.1 ‘Trying to make sense of it all’ 
This sub-theme illustrates that patients were trying to make sense of their 
symptoms and often did not know or understand what was happening to their 
body.  Jimmy had on-going pain from his previous thoracic surgery for lung 
cancer.  On this occasion, Jimmy recalled his distress when experiencing mixed 
symptoms of pain, tingling sensations and described feelings of “bugs creeping 
inside” his sternum area.  He expressed not remembering when he saw his GP 
but described his state of mind:   
“I really don’t know – maybe six weeks, two months.  You can’t...a lot 
was going on in my mind.  If you meet people like that [relating to 
himself]...the mind is confusing, confused you know” (Jimmy, patient 
(CS3), Interview 1, p5/25). 
This account illustrates that the symptoms experienced by the patients can be 
distressing and confusing to the patient and they may not recognise the 
significance of these.  Jimmy credited his GP for his investigations, a number of 
radiological tests and a biopsy which detected that his lung cancer had spread 
to his thoracic spine causing pain.   
 
When Sandra experienced pain in her back, she thought it was due to a fall in 
her garden.  As it coincided with her fall, her GP was not unduly worried.  On 
reflection, Sandra was trying to relate wobbly feelings in her legs to her 
hormone therapy for breast cancer: 
“But I was having dizzy spells with the Arimidex and my legs sometimes 
felt a bit [pause] wobbly.  Some days I’d feel wobbly, as though I was 
going to go down or I was going to faint, but I didn’t faint but I felt as 
though I was going to faint” (Sandra, patient (CS2), p6/9). 
 
This comment suggested Sandra was aware of changes in her body but did not 
suspect recurrence of cancer until her routine appointment with her consultant.  
In contrast to Jimmy’s and Sandra’s accounts of experiencing pain, Emma 
talked of her shock at her sudden loss of balance while doing her shopping: 
 
 
 
 
142 
 
“Just walking at the shops and was going back out to the car.  I was 
starting to get a bit lethargic...err...because I have been on 
chemotherapy.  Err, I was starting to feel a bit lethargic so I walked back 
to the car and that was when I lost my balance.  I fell but I wasn’t dizzy or 
anything.  It was just my legs just wouldn’t move” (Emma, patient (CS6), 
interview 1, p3/15). 
Emma related how she got her mobility back and drove home.  That night she 
attended her friend’s hen night but sat all night.  She had movement in her legs 
and was walking with furniture support.  Emma attributed her loss of balance to 
chemotherapy side-effects: 
“Because I was on a trial drug, I thought it was a mixture of everything 
between the chemotherapy, the trial drug.  I didn’t know what to expect 
with everything so I just thought I’ll wait till Monday and see what 
happens” (Emma, patient (CS6), p7/1). 
Emma recalled feeling numbness from her chest area to her abdomen two 
weeks prior to her fall.  Although she was worried at not having the sensation to 
go to the toilet, she was, at the same time, having small urinary accidents and 
reassured herself that there was urine coming out.  She brought up her 
concerns to her doctor during her chemotherapy session: 
“I had spoken to the doctor at my last chemotherapy err...who had done 
my medical that day.  And I had mentioned it to him and he had just said 
‘we’ll keep an eye on it’” (Emma, patient (CS 6), Interview 1, p9/1). 
This sense of a sudden loss of control over body movement and function drew 
attention to the unpredictability of MSCC which was mistaken with the side-
effects of chemotherapy.  However, Emma’s husband Matthew persuaded 
Emma to seek medical advice when she had the fall.  He summed up his 
worries:  
“Ehh...I had been at her for days...nagging her for days to come in either 
to the hospital or go to the doctors.  Erm...cause I see things happening 
to her that she’ll pay no attention to, she’s quite bullish at times and just 
gets on with things.  I tend to get angry and frustrated; it can be 
frustrating dealing with her at times, she can be that stubborn.  The fact 
that she had had a few falls and was, it seemed to me, she was losing 
the use of her left leg.  It was just a kind of worry seeing that” (Matthew 
(CS6), interview 1, p24/21). 
This comment suggested that patient’s spouse’s may be vigilant and could 
recognise the deterioration in their loved ones but patients, on the other hand, 
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may not realise the seriousness of their condition.  In these excerpts there 
seemed to be difficulty in distinguishing the trajectories of cancer and the side-
effects of chemotherapy.  
 
Emma revealed her annoyance that she was not made aware by the trial nurse 
that her cancer had spread to her bones at the time of receiving chemotherapy: 
“...but what I did discover in June (two months ago) I was meant to be 
told that I had cancer cells in my spine but I wasn’t told that.  If I had 
known that I would have been in before” (Emma, patient (CS6), Interview 
1, p14/15). 
This suggested that the patient was not aware about the progression of her 
cancer and hence did not seek treatment early.  She would have taken action if 
she had been made aware of what the changes in her body could mean.       
Patients may have existential fears, as illustrated in Richard’s case: 
“...it’s really; it’s not pain that’s what concerned me.  Cause I thought ‘is it 
the spinal cord itself - I don’t know what’s happening to it’.  ‘Am I going to 
be like that I got to go?’  When I am going to end up in the wheelchair 
cause I cannot move my back and carry on.  I was very concerned and 
distressed and agitated at that particular time, cried quite a bit” (Richard, 
patient (CS5), p13/3). 
 
Richard who had regular follow-up at his local Macmillan Centre had been 
informed by his Macmillan nurse to look out for symptoms of MSCC, however, 
he expressed not wanting to “push things further” as he had fears of the 
unknown and felt distressed.   
 
Sandra also talked of her experience on the ward with other patients in the bay 
with MSCC but who were at an advanced stage of cancer.  Sandra expressed 
her anxiety:  
“...like the lady next to me that’s got it in her spine and she is saying 
she’s dying.  I’m listening to her day in, day out, and I don’t want...  The 
thought of being like that is really anxiety for me...umm...just being 
immobile...” (Sandra, patient (CS2), Interview 1, p15/24). 
Here, the ward environment seemed to contribute to the Sandra’s anxiety when 
she encountered other patients at an advanced stage of cancer who may have 
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been paralysed and/or in the final stages of the illness.   She confided her 
uncertainty about her future:   
 “Lost at sea.  I am confused and concerned and the anxiety would come 
from not knowing what’s going to come next.  You don’t know what 
pathway the illness is going to take” (Sandra, patient (CS2), p1/11). 
Sandra’s account suggested she had ‘a snap shot’ of her future in front of her 
although she was not entirely sure what might happen which was distressing for 
her.  Her husband considered that although there were other cancer patients, 
he felt that something should have been done about this matter.  Healthcare 
professionals on the other hand were not aware of the impact of the ward 
dynamics on the patient’s experience.  The registrar explained:  
“Um, but we didn’t realise it during her stay; she didn’t mention it and the 
nurses didn’t mention it.  So, she stayed for the whole time being worried 
about – essentially, she was worried that she would end up like these 
other ladies.  But she didn’t...we didn’t pick up on that during her stay, 
which is unfortunate, because we could have maybe moved her to a 
different room or reassured her that her situation was different” 
(Registrar, CS2, p14/22). 
 
These data suggest that the ward environment can have a negative impact on 
patients or may potentially lead to poor understanding of their own condition.  
The registrar was not aware that Sandra had been moved from a two-bedded 
room to the bay to make way for a patient who became poorly.  A member of 
the nursing staff gave her reasons: 
“...sometimes we need to change like it could be we had to bring in two 
men into that room...some could be poorly and they needed to be by 
themselves.  We move patients so often here, err...so that’s why they 
move her to the 4 bedded room...various reasons” (Staff Nurse (CS2), 
p7/9).  
This suggested that staff had to prioritise the needs of the patients without 
realising the impact it had on other patients.  The patient’s ward experience led 
to worries and distress as Sandra related recurrent nightmares after her 
discharge home.   
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Robert had a similar pain in his back a year ago and was treated for MSCC.  
Robert commented on his first episode “I thought it was killed off” and was 
surprised his pain came back suddenly while travelling on the bus:  
“It started off with I was coming from my son’s house, err...in a mini bus 
and it was one of these rounds, very fast and that was when the pain 
shot right up on my back” (Robert, patient (CS4), interview 1, p2/24). 
Robert’s account suggested the symptoms may not be prominent until certain 
movements triggered off the pressure on the spinal cord.  However, Robert took 
remedial action by taking pain killers and applied a hot water bottle to ease his 
pain.  According to Robert’s consultant MSCC can recur:  
“To have cord compression the second time at the same site, again is 
unusual.  So, this is an unusual situation.  It does happen, but it’s not a 
common situation” (Oncologist (CS4), p2/6).  
 
Jane, Robert’s wife, seemed puzzled with this second episode of pain: 
“I just thought it would maybe be a one-off thing, you know.  I did not 
know it was going to...come back again, you know” (Jane, wife (CS4), 
p10/7). 
 
 
MSCC can recur and this presented challenges for patients, carers and 
healthcare professionals.  Patients and carers may not necessarily be aware of 
the possibility of recurrence and what actions to take.   
Jane explained further: 
“At first, I thought he had done something wrong, you know - at first.  But, 
as time went on, that would be about two weeks – it wasn’t severe pain, 
it wasn’t a severe pain; it was there and then, with his medication, it 
wasn’t there, you know.  But it was when it started to affect his legs that I 
had an idea then that there was something more wrong” (Jane, wife 
(CS4), p10/27).   
Jane appeared to be trying to make sense of this second episode and, as it 
occurred during the weekend, consulting her GP was not possible.  Her 
uncertainty prompted her to take action: 
“I spoke to my daughter-in-law and I explained to her.  I said ‘well, I don’t 
know what to do – whether to phone NHS24 or what to do?” (Jane, wife 
(CS4), p12/6). 
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As illustrated, carers could be the ones who make decisions whether to seek 
medical help for their spouse.  Jane explained that she was the decision maker 
as her husband was sometimes forgetful.  She was hesitant in phoning NHS 24 
due to past experience of having to “explain all over again”.  She also felt her 
husband would not necessarily receive a medical visit, and she may just be 
instructed to increase her husband’s medication. 
 
While some patients were able to voice their concerns to their doctors, some 
were not.  Betty seemed to have difficulty articulating how her symptoms 
developed.  Betty, who was diabetic, had difficulty convincing her doctors that 
something was wrong with her and had been seen by one doctor after another.  
Betty expressed her dilemma:       
“I kept saying to them ‘I’ve got a urine infection’ because I was prone to 
urine infections.  But we got a locum doctor in, they dismissed that and 
then they would give me somebody else.  And the pain started travelling 
up the body, from the bladder up and then into the ribs and this isn’t 
normal.  I know a doctor knows exactly how your body works, but nobody 
else would understand it, and if you tell her this and ‘I want to tell her this, 
and what do I tell her first?’  So you’re kind of in a quandary” (Betty, 
patient (CS1), interview 1, p2/7). 
This excerpt also indicated that symptoms of MSCC can be vague and be 
mistaken for other conditions.  In Betty’s case, she had no history of cancer and 
therefore it did not flag up any suspicion.   
 
On the other hand, sometimes general practitioners found establishing history 
from elderly patients challenging.  One general practitioner considered his 
dilemma: 
“Obviously, you don’t want to put people to a lot of trouble, sending them 
all the way to the hospital if there’s nothing there.  But having said that, at 
the back of your mind, you’re worried because you know that time is very 
important in this sort of situation, and somebody could end up paralysed 
if you don’t act quickly. [...] to a large extent you’re often operating on 
history because often the physical signs are not brilliant, you know.  
There is a degree of weakness, but we’re talking about elderly patients 
who have osteoarthritis, and it can be quite difficult to work out” (GP 
(CS4), p4/17). 
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This comment indicated physical signs of MSCC can be vague and that 
obtaining history is important but may not be easy, especially from elderly 
patients who may be confused or may have co-morbidities.   
 
At times, patients may not have realised they had a problem.  For example, it 
was Jock’s general practitioner who suspected something was wrong with him 
during his routine appointment for flu vaccination.  Jock had a good relationship 
with his general practitioner who had been monitoring his prostate cancer over 
the years.  His general practitioner noticed that Jock was unduly breathless as 
he walked through the waiting room and decided to bring him in for further 
investigations.  
“Well, from a clinical point of view, the issue at that point was really one 
hundred per cent chest.  I had an x-ray that told me there was something 
wrong with his lungs, but it didn’t give me a firm diagnosis. His breathing 
got worse and worse and worse.  He did, at that point, start to have some 
pain in the left side of his chest and – that, I think, was around the nipple 
area.  But events were dictating that he had to go to hospital, more on 
the account of his breathlessness than any pain at all.  It was more of a 
localised pain, rather than a radicular one.  Pain has never been a huge 
feature for him” (GP (CS8), p5/21). 
 
This suggested that the general practitioner was aware something was wrong 
but faced symptoms which were not classical of MSCC and the general 
practitioner may not necessarily have the experience in recognising the 
symptoms.  As Jock had a cardiac history, diagnosis proved challenging as the 
general practitioner suspected it was more likely to be a degree of heart-failure.  
This account highlighted that the general practitioner knew the patient well to be 
able to notice the physical changes in him.   
 
However, like the general practitioner, the registrar at the referring hospital also 
talked about the complexity in assessing and diagnosing Jock’s condition.  The 
registrar considers:    
“We were trying to find a couple of things.  He was obviously 
breathlessness and we wondered if he had had a pulmonary embolism, 
so that was number one.  But number two was his chest x-ray was very 
abnormal, it looked like metastatic deposits but the radiologist felt he [the 
patient] may have a mixture of cardiac failure and infection.  Erm, but 
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certainly spinal lesions were not expected because he didn’t have any 
symptoms at all, he didn’t have back pain, he didn’t have weakness in his 
legs, he didn’t have any bowel or bladder problems, erm, so yeah, that 
was a surprise and also his PSA was normal” (Registrar (CS8), p3/17). 
The above illustrates the problems in interpreting imaging studies to reach an 
accurate diagnosis.  Therefore, this indicated there was discrepancy in opinions 
between the registrar and the radiologist and arriving at a diagnosis was 
challenging from different healthcare professionals’ perspectives.  Identifying 
MSCC can be an incidental finding.   
 
There were suggestions that healthcare professionals involved in the care of 
patients with MSCC and those working in the other speciality, for example, 
surgical, urology wards and primary care general practitioners and district 
nurses should be educated in recognising the signs and symptoms of MSCC.  A 
member of medical staff considered: 
“We do need to get everyone a bit more up-to-speed and heighten the 
awareness of it (MSCC), and the MSCC pathway has done that and will 
do it.  And the education is through that; it’s through protocols, and 
through audit – as anything else” (Oncologist (CS4), p20/28).  
 
However, not all general practitioners were aware of the local MSCC referral 
pathway or the NICE guidelines: 
“I haven’t used the local referral pathway, I must admit.  All I did, 
whenever I needed to refer, was to ring up the registrar on call.  I don’t 
know whether that is the referral pathway or not, I’ve no idea whether it is 
or not.  And I’ve never seen a written referral pathway” (GP (CS4), 
p11/24). 
 
General practitioners who participated in interviews were aware of MSCC and 
felt that educating them on MSCC was not one of their learning needs.  One of 
the general practitioners stressed her views when asked whether they needed 
education on MSCC: 
“Definitely not. I mean, I think we’re all very aware of that.  We have our 
[palliative care consultant], and was very concerned about anybody that 
might be a missed metastatic deposit causing spinal compression, so, 
you know, we have been well educated on that” (GP (CS8), p16/24) 
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The general practitioner went on to describe a system of keeping track of 
cancer patients under their care and staff had regular updates about patients’ 
condition.  Here, she explained: 
General practitioner: Anybody that’s at that level of cancer, we would 
work a system called the Gold Standard.  Have you 
heard of this? 
  
Researcher:  Can you briefly explain? 
 
General Practitioner: It’s a system whereby, in our practice, what we do is 
we have a register of all the patients who have a 
diagnosis of cancer and we actually stage them.  
And on every fortnight, we will get together as a 
multi-disciplinary team and talk about the patients.  
So, we do look after our cancer patients very 
carefully (GP (CS8), p16/11).   
This implied that a mechanism was in place to monitor patients with cancer in 
the community to ensure that patients did not slip through the net.  Most general 
practitioners see very few patients with MSCC in their career.  One of the 
general practitioners emphasised this point:  
“I’ve met, what, one case in fifteen years as a GP.  If I have the need 
(like when a patient came along with a MSCC) I’ll look it up and find out 
about it, when the need arises.  [...] There’s no point in sending me flyers 
and stuff about it because they’ll go straight in the bin with the ones that 
comes in everyday for diabetes, epilepsy or chronic obstructive 
pulmonary disease; you name it, it’s here; the information...we’re just 
completely flooded with it” (GP (CS6), p8/27). 
This comment suggested general practitioners could be overwhelmed with 
competing conditions and information requirements appeared to be ‘on a need 
to know basis only’. Some healthcare professionals agreed that patients and 
their carers should be educated in recognising the warning signs of MSCC 
instead of the general practitioners: 
“I think it’s more the patients who need the education rather than the GPs 
because I think if you have patients that you know and they are at risk 
you give them the warning signs...say ‘right you need to phone us if the 
following happens’.  Because the NHS 24 does not have that level of 
support so patients end up in the wrong hospital at the wrong time.  
Erm...it’s much more difficult if you’re brand new presentation of spinal 
cord compression, never being known to the department) and that is 
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something the spinal care referral pathway is meant to be trying to 
address really” (Oncologist (CS5), p4/26). 
 
Several registrars acknowledged awareness was important to doctors but how 
education was conveyed should be done in a tailored way: 
“I think tailoring who you teach it to is important.  Erm, and kind of the 
clinical picture is important.  Just teaching people about what symptoms 
and signs might correlate with spinal cord compression actually can lead 
to a huge amount of referrals with people inappropriately being referred.  
Whereas, tailoring education and kind of emphasis on the whole clinical 
picture, err, is very important” (Registrar (CS4), p13/23). 
 
Thus, this suggested caution in giving information and the need to prevent 
undue alarm to those ‘worried well’ patients.  However, one of the general 
practitioners felt “duty-bound” to discuss with patients what to watch out for in 
relation to symptoms of MSCC once it was established that the patients had 
bony metastasis: 
“And maybe it’s hard to know at what point you say that because, you 
know, it’s a very long process this, isn’t it, you know; people start with 
prostate cancer and they go on for several years and ...with nothing much 
happening, you know, and if you tell them that too soon , you know, then 
they’ll have forgotten it by the time they need to, and it’s just really 
important either to tell them and keep telling them, or when you know that 
they’re starting to get spine pain or bone pain, to say “look, watch out for 
this.  If this happens, we don’t wait three weeks to go in and get your 
radiotherapy, we go right away, you know” (GP (CS4), p13/16). 
 
This suggested that although keeping patients aware of symptoms of MSCC 
was important, the difficulty was knowing at what stage to have this discussion 
with the patient as the trajectory of cancer can be a long process. 
 
In summary, the interpretations from these accounts showed that patients had 
varied symptoms of MSCC.  Not all patients were able to recognise and 
associate their symptoms with the recurrence of cancer and these were 
attributed to other causes or pre-existing conditions.  For some patients the 
symptoms were confusing and distressing.  They were aware something was 
wrong with their body and it evoked a sense of facing the unknown and raised 
existential fears.  Experience as an in-patient could be distressing for some as 
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the opportunity for comparison with other patients with a similar condition but at 
an advanced stage could cause misunderstanding.  Some patients appeared 
able to voice their worries to their doctors but others found difficulty in 
articulating their concerns.  However, in several cases, carers expressed 
heightened awareness that something was seriously wrong and appeared 
anxious.   
 
Healthcare professionals on the other hand, gave accounts of facing challenges 
in identifying metastatic spinal cord compression when neurological symptoms 
were not a key feature.  However, there was also a sense of uncertainty when 
MSCC can recur.  Physical signs of MSCC can be dubious and establishing 
history from an elderly population can be difficult.  Evidence also suggested 
difficulties in distinguishing natural history of cancer and of clinical trial 
treatment.  Several healthcare professionals felt general practitioners should be 
made aware of symptoms of MSCC.  This view was contentious as most 
general practitioners interviewed had an awareness of MSCC but saw very few 
patients with this condition in their career.  Education of patients and carers was 
also deemed important but the risk of causing unnecessary worry should be 
considered. 
 
The acute onset of MSCC as a complication of advanced cancer emerged as 
an uncertain problem for all participants in this study, albeit from different 
perspectives.  Amidst this uncertainty, emergency decision making on treatment 
was needed to preserve patient’s mobility status.   
 
The next sub-theme describes patients heightened awareness of MSCC, its 
threatening diagnosis and how they put their trust in healthcare professionals to 
make the right treatment decision and manage their care.     
5.2.2 Trusting healthcare professionals to make the right decisions 
This sub-theme reflected patients’ and carers’ trust in healthcare professionals 
to make the right treatment decision at the acute onset of MSCC.  To preserve 
a patient’s neurological function or treat distressing symptoms, such as pain, 
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urgent decisions by healthcare professionals to treat impending cord 
compression had to be made, sometimes without confirming where the primary 
cancer was or whether further tests were required.  Although the oncologist is 
the main decision maker, data illustrated a chain of decision making from 
different disciplines. 
 
Another issue related to this sub-theme centred around decisions on how best 
to nurse the patient during immediate care.  Although healthcare professionals 
seemed to make decisions on positioning and mobilisation, patients and carers 
were not necessarily aware of this decision.  
 
Sandra reflected on the speed of getting her CT and MRI scan and being 
transferred to the Cancer Centre for treatment:   
“I think they are trying to do things as quickly as possible, and as 
speedily as possible, to limit damage.  [...] I know that they’ve given me 
the radiotherapy – I feel reassured because the radiotherapy and the 
steroids have already started to take away the pain in my back.  So that I 
know that something’s been done.  So, it is reassuring that something’s 
been done, and been done very, very quickly” (Sandra, patient (CS2), 
p32/11). 
Here, it appeared that the patient accepted the reason for the treatment was to 
limit the damage to her spinal cord and treatment had to be quick because of 
the threatening nature of MSCC.  
 
Jimmy seemed to take on board the initial treatment decision and trusted his 
consultant to make the best decision for his subsequent treatment:  
“So, I see how well I got on in the first one [treatment] and so does the 
doctor.  So, right Jimmy we go on [repeated what the consultant told him] 
– we go on.  [...] So, same thing again only smaller doses of radiotherapy 
and then that’s it.  Then the consultant will decide what’s best for me” 
(Jimmy (CS3), p10/14). 
However, the decision arrived at by his consultant was not a straightforward one 
due to the nature of his cancer, which was a direct invasion of his spinal canal 
by a local recurrence of his primary lung cancer.  The consultant had a 
discussion with his team members to determine the dosage of radiotherapy that 
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could be tolerated by Jimmy’s spinal cord.  In this case, decision making was 
challenging as a high dose could result in paralysis.  Jimmy appeared happy 
with the decision making process despite not been fully involved as he thought 
the medical staff would make the best decision for him. 
 
Richard recognised the benefits of immediate treatment and he appeared less 
anxious.  He considered:  
“I don’t think I can get any better treatment than I’ve had, it’s been very 
quick, very prompt.  I mean it happened just so quickly but that’s better 
for me because the quicker I’m being seen, they can treat err...the cause 
and the better it is for me for the pain.  So, it’s been fine” (Richard (CS5), 
p2/28). 
Richard seemed pleased that his pain was resolved very quickly.  In contrast, 
Tony had “no choice” but to trust his oncologist and neurosurgeon’s decision as 
his mobility was compromised.  He rationalised this as follows: 
“Ehh...they couldn’t go ahead with radiotherapy until they had confirmed 
with neurology.  So, my consultant referred to the neurology department 
to review my MRI scans, to confirm if they could do anything for me, 
because it was impinging on my spinal cord; and one...ehh...my lower 
vertebrae were weak and it may break causing loss of my limbs, or 
function to my bladder or bowel” (Tony, patient (CS7), p15/26).   
Here, his oncologist appeared to be the decision maker but treatment decisions 
often involved opinions and decisions from radiologists, neurosurgeons and 
radiotherapists.  Consulting another colleague’s opinion meant trusting one’s 
colleague to make the right decision for the patient.   
One of the neurosurgeons said:    
“The difficulty is knowing what operation whether to resect all of the 
tumour during the operation or to leave it, the sort of internal scaffolding 
part of it we’ve put it in that clearly needs to be done but it is how far to 
take it that is difficult” (Neurosurgeon (CS7), p6/8) 
 
Thus it appeared there was a chain decision making process but there was 
uncertainty about the amount of tumour to be removed and the outcome of 
surgery.  However, the patient seemed unaware of this questioning undertaken 
by the healthcare professionals. 
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Tony’s wife, Gail, became emotional as we chatted in her home, as it turned out 
excision of the tumour proved difficult and only the internal fixation was done. 
“I think he [Tony] said something along the lines that...that they didn’t 
want to remove the tumour erm... that would be radiotherapy would 
err...take care of that.  And they thought radiotherapy would be the best 
thing” (Gail, wife (CS7), p12/3)   
 
This account indicated that the decision on how much tumour to remove can 
only be made during the surgery itself so even with excellent communication, 
uncertainty exists. As mentioned earlier, an important issue in the immediate 
care of patients concerned how best to nurse the patient with MSCC.  
According to the healthcare professionals, the focus here was to establish 
whether a patient’s spine was stable or unstable in order to determine the care 
for the patient.  One of the GPs reflected his experience dealing with patients 
with MSCC in the community:   
“Normally we’ll give the diagnosis to the ambulance crew and the 
ambulance crew usually know, based on that, ...um...the spinal 
instability...that they should, presumably, fix the spine in some way.  But 
it’s not something I’m familiar with but it’s good that you’re mentioning 
this now because I’ll remember that the next time [Laugh]” (GP (CS4), 
p14/14). 
Here, it seemed that the general practitioner relied on the emergency team to 
make the appropriate decision in the safe transfer of the patient to the hospital.   
 
However, on the ward setting, getting information on the patient’s spinal status 
varied.  Commonly, oncologists were not able to identify whether the patient’s 
spine was stable or not from the MRI images.  One oncologist considers: 
“I can’t but, I mean, sometimes we get, err, information on that in the 
radiology report and sometimes we don’t” (Oncologist (CS6), p4/20). 
 
This suggests that the oncologists depended on radiologists to provide them 
with the information on spinal status.  Radiologists, on the other hand, 
acknowledged they were more confident reporting spinal instability in trauma 
cases but not in malignancy.  One radiologist explained:  
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“I think we’ve got a good idea about spinal instability in the context of 
trauma because we understand the three-column theory; where, if two 
columns are affected, then the spine is unstable.  The trouble is that we 
find it very difficult to translate that into malignancy because the 
mechanism’s different.  And so, unless something has absolutely lost 
height or is displaced, then we find it very difficult to be certain about 
instability and any amount of malignant infiltration may or may not mean 
that the spine is unstable and it’s not really, in a way, something that you 
can decide with MRI.  One of the problems that we have is that we don’t 
see the amount of residual bone present because we don’t routinely CT 
these patients” (Radiologist 4, p1/8).  
This excerpt suggested there was no guide to interpreting spinal instability in 
MSCC and scan images were static and may not reflect the true status of the 
patient’s spine.  Capturing good images can sometimes be problematic.  The 
radiologist pointed out Jimmy’s case as an example: 
“If you look at the time at the beginning of the scan and the time at the 
end of the scan, we’re looking at fourteen minutes.  That’s very fast and it 
means that they’ve been...that they know the patient’s in pain, or 
otherwise agitated, and they’ve done very well to get images” 
(Radiologist 4, p10/1). 
This showed that getting a quality image of the spine can be compromised 
depending on the patient’s pain tolerance at that time.  As there were no criteria 
upon which to make decisions, information about spinal instability seemed 
vague. 
“So, um, no-one has ever shown me a convincing algorithm, if you like, 
or any mechanism by which we can accurately judge, on imaging, the 
stability of metastatic disease.  Think a lot of it goes on clinical grounds.  
And, certainly, if you’re mobilising a patient with it, you have to be quite 
careful.  If they start showing any signs of neurological compression on 
movement (and that’s a sudden change in their neurological status, or 
shooting pains, or, you know, extreme pain on movement) then, you 
know, you want to be very careful about moving them” (Radiologist 1, 
p3/20). 
 
Another oncologist talked about consulting the neurosurgeon if she suspected a 
patient had spinal instability: 
“But if I had someone that I was concerned that they were unstable, very 
symptomatic, then I would speak to neurosurgeon or physio about that 
and take it from there” (Oncologist (CS2), p4/14). 
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The above account suggested that a patient’s spinal status can be 
unpredictable and ‘pain’ seemed to be an indicator of spinal instability.  The 
interpretation above suggested that decision making on spinal instability 
involved neurosurgeons.  One of the medical staff rationalised his decision on 
mobilisation:    
“Um, my policy is that we mobilise everybody unless there’s obvious 
instability.  Um and that usually manifests itself as incident pain, and the 
pain itself, that usually stops people mobilising.  So, I put no restrictions 
at all on what people do.  I think that – I don’t think there’s any evidence 
that people are more at risk of transection if you mobilise them, and I’m 
sure they are more at risk of thrombo-embolic complications if you don’t 
mobilise them” (Oncologist, CS1, p2/19). 
Although medical staff advocated the advantages of mobilisation, others did not 
necessarily give specific instructions and believed there were protocols on the 
ward for nurses to follow.  The oncologist, however, stated that instructions 
would be given if the patient was going for surgery: 
“Ah, I’m afraid, err, I don’t see any logical reason why their risk of further 
insult to their spinal cord is diminished by finishing their radiotherapy, yet 
their radiotherapy is not going to have any immediate impact on spinal 
stability.  And so, err, I think if patients who are going for surgery, nursing 
them flat until they have surgical stabilisation, just from a common sense 
point of view, just seems the right thing to do.  [...] so for patients who are 
going for surgery, I don’t give any specific instruction” (Oncologist (CS6), 
p3/3). 
 
Others left the physiotherapists to make the assessment and decisions about 
whether to mobilise the patient or not and the intensity of exercise: 
“I see patients obviously on the ward rounds regularly, I would say ‘do 
what you can and the idea is to mobilise as soon as possible’ but largely 
it’s the physiotherapist err...assessment that determines how much 
exercise they should get...yeah” (Oncologist (CS5), p3/6). 
 
However, the physiotherapists expressed that the doctors need to be specific in 
their instructions as they may not be aware of ‘the ins and outs of the MRI’ or 
whether a patient was at risk of neurological problem: 
“Then I think it would be nice if the doctors could give us some kind of 
guidelines cause often time is the case if they came in walking then they 
continue walking but it gets a bit more vague if somebody is just 
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transferring from bed to chair but does that mean that they want us to 
see them, do they want us to, erm...to mobilise them further than that or 
should they only be bed to chair” (Physiotherapist (CS5), p1/30). 
This account showed that the physiotherapist was unable to ascertain the level 
of exercise the patients required or when there was further risk of deterioration.  
However, one of the oncologists cautioned treating MSCC as “one entity”: 
“It’s just like everything, nothing is black and white.  So, you get collapse 
of the vertebra bodies, the management would be very different, it would 
be bed-rest, you know.  If it’s unstable you worry you’ll make it worse.  If 
it’s the soft tissue mass and the patients...well mobilisation is absolutely 
fine.  And also it will be different with different disease because of the 
natural history of disease will be different and also how well you know 
that patient sometimes” (Oncologist (CS5), p5/9). 
This excerpt suggested that the management of spinal instability depended on 
whether there was involvement of the vertebra or soft tissue mass and the 
natural history of different cancers.  Individual assessment seemed to be the 
basis on which to make decisions in the management of MSCC.   
 
Similarly, a medical staff member talked about involving the surgical team to 
make decision: 
“Even though we don’t always get a direct answer from them...eh...but 
we make it a point to speak to them.  We don’t make the decision 
ourselves. I think number one is: we stick to uhh...the patient’s own sort 
of assessment how they are feeling.  If it’s uncomfortable for them to 
mobilise, then yes, obviously we wouldn’t do that, but if they are 
comfortable – without sort of significant evidence of neurological 
dysfunction – then we could use that as a guide.  Obviously, we would 
want to see the MRI and see the actual anatomy there before we decide 
on anything.  So, I think, err...most of the time we try to play it safe.  
Before we do the MRI, we asked them to sort of play it safe’ til we’ve got 
the MRI” (Registrar (CS7, p4/20). 
The interpretation suggested that information on spinal instability can be 
uncertain and the patient’s safety is at risk if allowed to mobilise.  Some of the 
nurses and allied healthcare participants identified their difficulties and anxieties 
due to different opinions given or even the absence of guidance.  One of the 
nursing staff explained the use of a care plan but pointed out that it was not 
specific to MSCC:  
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“It’s not a specific protocol and that’s what I found lacking considering 
how many people come in with it.  It’s really weird, you know, because 
there’s a protocol for everything else” (Staff Nurse (CS3), p2/20). 
 However, medical staff felt that the NICE guideline was not helpful.   
“Total immobilisation...er...and ...really very much at odds with what most 
people are doing.  [...] So really they ...it was a consensus document 
which, um...did not represent a lot of peoples’ practice, you know, and I 
was not convinced that you needed, for example, to log roll patients and 
all the other things.  So I was a bit critical of some of the NICE guidance” 
(Oncologist (CS4), p4/16).  
The account suggested that the present guideline may not be appropriate to 
clinical practice as patients may be mobile on admission. Therefore, this lack of 
guidance or protocols prompted nursing staff to ‘play safe’ in caring for their 
patients.  A member of nursing staff gave her views:  
“The way that we manage patients, is that there is a risk that they can 
perhaps do damage and they can, erm... you know, become paralysed, 
or whatever.  So, that’s kind of what I think: ‘well, if you’re on bed-rest, 
you’re not doing anything that can aggravate your situation,’ until they’ve 
had treatment and then the physiotherapists get involved once they’ve 
finished their treatment.  So, that’s kind of my rationale.  It’s the safest 
way to manage them” (S/N (CS8), p5/15). 
The unpredictability of MSCC resulted in nurses being concerned for the 
patient’s safety and there was little evidence that patients were fully informed 
about the pros and cons of mobilisation so they could contribute to decision 
making.  One of the nurses reflected her views when caring for one of her 
patients:  
“I think safety, the safety side from mobilising from getting the patient up.  
I think that was probably the most challenging you had to do.  Although 
the physios were assessing daily, they do that in the morning and 
towards the end of the day is probably when the safety is a bit more 
compromised because of tiredness” (S/N (CS6), p13/23). 
The nurses concerns reflected apprehension of things going wrong and this 
resulted in a level of indecision which contributed to mixed instructions for 
patients.   This impacted on one patient’s care and she reported her anxieties 
and confusion:  
“One’s telling you one thing, one’s telling you to do another thing: one’s 
telling me ‘you’ve to rest’, ‘you’ve not to get up and walk or you could be’ 
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...you could be like what I am now [paralysed]” (Betty, patient (CS1), 
p12/2). 
Another patient expressed that he had difficulties maintaining strict bed-rest 
before his surgery: 
“The main thing, I think, was just routine washing and going to the toilet.  
I found it very difficult to use a bedpan.  I did actually, I admit now, did 
stand up slightly and go to the toilet at the edge of my bed, because it 
was just ...on one, really difficult to do.  I started to get sore elbows, 
because you’re shuffling about in your bed with your elbows, if you want 
to move over and get a drink or move over, like maybe slide bedsores” 
(Tony, patient (CS7), p21/18). 
From the above account, it seemed paramount that patients should be on strict 
bed-rest if spinal instability was suspected. However, patients may find difficulty 
in maintaining that position for a length of time.   There were issues around 
maintaining dignity, soreness on prominent parts of the body and discomfort 
using a bedpan.  
 
A staff nurse recounted her experience when she cared for Tony:  
“No, erm...but contrary to that I never heard ‘don’t let him walk’, you 
know, ‘he’s on bed-rest’ so that wasn’t passed to us.  He was getting up 
and walking and... from my point of view I thought that’s, you know, just 
what was happening.  It wasn’t till after maybe it was the day after that I 
think the doctor came and said ‘he’s meant to be on strict bed-rest’ and 
apparently this already had been passed on but wasn’t communicated in 
our notes or our paper work.  And, the patient wasn’t compliant either, 
so, I don’t know how clear that instruction was made from the start or is it 
just non compliant” (S/N, CS7, p6/15). 
Instructions on mobilisation could easily be missed or not communicated.  
However, the patient may not be aware of the importance of strict bed-rest or 
did not participate in the decision making process.  One of the physiotherapists 
highlighted the problem of having separate documentation: 
“That raises the whole communication issues and the fact that we’re all 
working for the same patient that we should all be on the same page and 
if we were all documenting in the same medical record that we would 
have access to everybody’s information erm...from all the different teams 
which I think is ideal”(Physiotherapist (CS5), p8/8). 
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The documentation of patients care kept by different team members means that 
information may not be easily available to all the members of staff and plans for 
rehabilitation could be delayed or overlooked.  The above accounts suggested 
the issues around communication could be improved with a ‘unitary patient 
record’. 
 
To summarise, this sub-theme emphasises that given the nature of the 
condition and the sudden onset of symptoms, prompt decision making in MSCC 
is vital.   Consequently, patients had expectations and trusted that their 
consultant/healthcare professionals would make the right treatment decisions.  
Healthcare professionals on the other hand based their trust in their colleagues 
in making the right decisions for the patients under their care.  However, 
treatment decisions can be challenging and the outcomes remain uncertain.  
 
It was apparent that there were no easy answers in decisions around 
positioning and mobilisation.  Healthcare professionals’ views on guidelines 
differed, with some needing protocols and guidelines for MSCC whilst others 
took into account the patient’s priorities and their short life expectancy.  When 
discussing this issue, there was a sense that healthcare professionals had to 
consider many complex aspects when seeking a satisfactory solution to the 
problem of mobilisation.  It remains one of the challenges of caring for patients 
with MSCC. 
 
Initially, patients welcomed the urgent treatment which often was needed to give 
them relief from pain, but when the acute onset of pain had resolved, patients 
began to ask questions and had doubts about their future treatment decision 
making.  The presentation of MSCC is complex, patients often present with 
varied symptoms.  Upon presentation healthcare professionals need to discuss 
and interpret these symptoms based on history and then make complex 
decisions regarding treatment.  Patients are trying to make sense of their 
condition and healthcare professionals are trying to make sense of the 
presenting symptoms. 
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5.2.3 “Help us put the jigsaw together" 
This ‘in-vivo’ code was identified by one of the carers.  It seemed appropriate as 
it reflected the patients’ and carers’ frustrations when the initial uncertainties 
were resolved but other uncertainties emerged about the lack of information and 
sometimes not receiving timely information on diagnosis, treatment options and 
discharge plans.  Some patients and carers expressed the view that information 
could be vague or they may not understand the information given to them.  
Betty talked about the vagueness of her cancer diagnosis: 
“...they said that...umm...I did have cancer, and that they couldnae (could 
not) operate.  That they needed to take...they were actually going to do 
another scan, but that...to get a biopsy, they thought it might be in the 
pancreas.  So, after that they said they werenae (were not) doing any 
more” (Betty, patient (CS1), Interview 1, p15/26). 
Betty’s daughter, Mary, expressed her frustrations when there was any 
discrepancy on the diagnosis and she was informed initially that her mum was 
going for an emergency operation but nobody then informed her when it 
transpired the operation was not an option.  Subsequently, Betty was 
transferred to the Cancer Centre for radiotherapy.  Mary expressed not 
understanding her mum’s condition: 
 
Mary: The bone at the back of her lung, is that her rib, or is it the spine 
or...? 
 
Researcher:  Did they tell you? 
 
Mary:  No, I didnae (did not) ask.  That’s something I need to speak to 
somebody about.  This is all too vague, and we sort of...as I was 
explaining, we’re not stupid people, eh.  You need a certain 
amount of information to go and ask questions.  So, whether we’re 
getting told and saying ‘you got to go and look after her’ and 
you’ve not got a clue and you’re told...  There’s so much you need 
to know, eh; ignorance doesnae (does not) help you” (Mary, 
daughter (CS 1), Interview 1, p16/14). 
Patients and carers may not understand medical information on spinal cord 
compression and may not know what to ask or have the courage to ask 
healthcare professionals.  Then there was conflicting information about her 
mum’s discharge plans.  Mary voiced her confusion: 
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“My mum phoned me this morning telling me she has to go to the 
hospice to be assessed before coming home.  The day before, prior to 
that, she’s not getting home at all.  We didn’t know whether we’re coming 
or going...we need to talk to someone that knows.  We need somebody 
to do that so that we can then ‘put the jigsaw together and say, okay, 
here’s what we have’” (Mary, Carer (CS1), p15/22). 
Medical staff talked about juggling giving bad news and at the same time 
preparing the patient for emergency treatment: 
“For most patients it’s very difficult because they...   the classic, um, 
presentation is a Friday afternoon, in a patient who doesn’t previously 
know they’ve got cancer, who arrives paraplegic.  And so you have at the 
same time to tell them (and often not their family because their family are 
often still in the referring hospital and haven’t gone with them)...um, that 
A: they have cancer, that B: that they, er, are not walking and they may 
not walk again, and C: ‘this is the treatment we are going to try’ and that 
tends to be rushed in a way that would never be dreamt of in somebody 
who is coming for an out-patient appointment with cancer” (Oncologist 
(CS1), p7/18). 
The process of giving information on diagnosis and the planning of urgent 
treatment simultaneously can be challenging for the healthcare professionals.  
Tony gave his reaction when he was informed of his diagnosis:  
“So, it was a complete...complete shock really, because obviously, I’d 
come in for my...to find out the results of my other tumour, and found out 
there...that this is a new one which hadn’t been picked up before my 
chemotherapy, which, obviously...I wondered, because the other ones 
had been stable... [...] Second time when I found out I had a tumour, I 
was just in myself because I was just in the ward on my own.  But it was 
explained that they had to go in with the surgery” (Tony, patient (CS7), 
Interview 1, p18/14). 
This highlights that some patients’ immediate emotional needs could be 
overlooked as he/she might not have family present for support during this 
distressing time.  Similarly, Robert had no idea what the doctor meant about ‘a 
spot’ on his back: 
“I don’t know what they mean by this - this spot.  It’s just a spot in the 
spine causing trouble.  I don’t know what they mean by ‘the spot – is a 
hard spot’; where does it come from; what does the spot...what does it 
do? I don’t know” (Robert, patient (CS4), Interview 1, p5/7). 
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Or why there was a change in his treatment plan: 
“They have decided to step up and give me nine instead of five.  I don’t 
know.  I don’t know whether the spots are bad or whether they have seen 
something.  I don’t know.  I was never X-ray again” (Robert, patient 
(CS4), Interview 1, p12/13).  
 
Changes in treatment and discharge plans added to the patients and the carers 
confusion and they may not necessarily have known the reasons for the 
changed in decisions.  This sometimes meant that patients and carers were not 
fully aware of what was happening and the reasons why they were not involved 
in aspects of the decision making process.   
 
Although Sandra was pleased initially with the speed of her treatment, later in 
our conversation she confided a lack of understanding on the progression of her 
cancer:    
 “It all happened very quickly which is great but it’s difficult to get your 
head around it when it’s going at that speed.  Although you do want 
speed but you do not actually understand what it is” (Sandra, patient 
(CS2), Interview 1, p2/17).   
She added: 
I can say it’s on T10, whatever...whatever they tell me, but the actual 
cancer itself and the way it grows and what’s happening with it...umm...I 
don’t have that kind of intellect and I have to trust these people to do 
their best for me” (Sandra, patient (CS2),Interview 1, p23/15). 
Sandra gave an example of wanting in-depth information about her condition: 
“I don’t know, some people maybe don’t want it, but I quite like more a 
theoretical type of explanation as well as...not just a general, you know, 
‘you may feel dizziness,’ but actually what it’s physically doing to me.  
That...I would like to know that kind – I mean, I wanted to see my scans 
today, that’s how nosy I am.  I want to see what they look like. [...] But I 
sometimes think that should be made available to you” (Sandra, patient 
(CS2), Interview 1, p34/7).  
Sandra talked at length about her years of living with breast cancer and how her 
confidence in the health system had “chipped away” when the spread of cancer 
to her lymph nodes was not detected.  Therefore, she wanted to have details 
such as: 
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“Umm, the pathway that the disease can take.  And...what treatments; all 
the treatments that are available to me and why certain ones would be 
selected.  And I’d rather know that well in advance” (Sandra, patient 
(CS2), Interview 1, p30/6). 
 
This account indicated that the patient wanted to have detailed information to be 
able to anticipate and participate in decision making.  Although she felt 
reassured with her present consultant, she found conflicting information on the 
internet about treatment options.  She was told her tumour was inoperable but 
was not given a say: 
“I am still very mobile, I can still move about; I can feel the niggling.  I 
don’t know how long it can be controlled for; I don’t know what the other 
options are.  I have been told it’s inoperable but I have gone on to the 
internet and read in Australian and American places they can actually 
take the disc out and put a plate in, and you wonder well, why?  What’s 
available to me that I am allowed to go for and at what point would that 
kick in?” (Sandra, patient (CS2), p2/1) 
There was a sense that Sandra wanted to empower herself to participate in 
decision making and be involved in treatment plans.  She obtained information 
from the internet, which reported positive outcomes from surgery and to her this 
was at odds with the information she was being given.   
 
This suggested that patients do want follow-up information or clarification during 
the course of treatment and healthcare professionals may need to ask patients 
whether they have any concerns to discuss during their stay in the hospital.  
Sandra’s husband, however, had anxiety about her emergency admission: 
 “Err...basically speaking ‘is she coming out, what’s happening?’  They 
don’t...I mean it’s like everything else, you just get told and then you sort 
of panic and it goes to your head.  [...] You know what I 
mean...experience like that...err...I mean you could be very depressed.  
You can say it is a scary sort of feeling...” (John, husband (CS2), 
Interview 1, p10/11).   
Carers may live far from the hospital and may not have full information which 
may cause anxiety and uncertainty about the immediate future.  Patients 
attributed the lack of communication to staff working under pressure.  Some 
patients commented that information given by staff seemed rushed or 
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sometimes inadequate.  Patients expressed wanting information because they 
were uncertain of what to expect.   
 
For example, Richard talked about lots of information being available on the 
websites, and in leaflets and books that mentioned side-effects of treatment.  
There was a sense that patients were trying to relate what they had read to their 
own experience.  However, general information may not be relevant to the 
patients, as Richard pointed out he wanted information pertaining to ‘him as an 
individual’ and ‘not so much textbook’.   
 
He added:  
“...one doesn’t get time often to speak to people about what’s going on in 
your body, what the disease actually is and what it’s going to do to you 
and things like that.  So, I do think being able to speak to people 
individually with the time, for me is quite a big factor, you know, even just 
being able to speak to your doctor for an extended length of time rather 
than just, you know, the few minutes that you often get with a GP; you 
need to have extended period of time” (Richard, patient (CS5), Interview 
1, p28/18).    
Although Richard said he wanted information, he was also wary of getting too 
much information: 
“...too much information isn’t good.  Cause it starts to put things into your 
mind, I mean if I sat and read a bit of paper – erm...wheelchair.  Is that 
going to ...oh... automatically you think I’m going to end up on the 
wheelchair?” (Richard, Patient (CS 5), Interview 1, p26/14) 
 
Similarly Tony found lots of information on the internet: 
“You know, I went on the internet, finding out, phoning up, going to 
Macmillan sites, cancer research sites; there’s so much information 
there.  And I think the big thing is...ehh...you can get a lot of information 
from them, but it’s maybe not all relevant to you.  I believe they are 
consultants, they are specialists, and all that information is out there is 
for you to use.  [...]But certainly, they’ve always been open in giving me 
information and, you know, being honest” (Tony, patient (CS7), Interview 
1, p33/21). 
The above accounts showed that patients seek out information on the internet 
but identifying what was relevant to them as individuals can be difficult and can 
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potentially misinform them.  Therefore, they trusted their consultant to give them 
information that is pertinent to them.  One patient said he left this information 
giving in the hands of his consultant:  
“Only what they think is suitable for me, not what I think because I don’t 
have the intelligence” (Jimmy, patient (CS 3), 1st interview, p17, L23). 
Even though Jimmy said he left the information giving to his consultant, as the 
conversation continued he revealed that he had bought a new laptop and 
looked up information on the side effects of steroids.  This account suggested 
that patients may not know what to expect and therefore may not know what 
questions to ask.   
 
In contrast, Jock said he had received “plenty of information” but he could not 
remember and “was not really interested” but in hindsight, he commented: 
“I would’ve been listening, but taking it...only taking half of it in” (Jock, 
patient (CS8), p17/9) 
It appeared here that Jock was given information about his condition but he may 
not have understood it or been able to take in all the information at that time.  
However, his oncologist explained the unknown cause of his metastasis 
together with the need for investigations to identify the cause of progression 
which made information giving difficult.   
 
Some healthcare professionals highlighted that the referring doctor from the 
district hospitals should have given some explanation to patients as some had 
no idea why they were being transferred to the cancer centre.  In this particular 
case, Jock’s attending doctor was unable to establish whether he understood 
his condition or whether he did not want to worry his wife.  He requested his 
doctor not to inform his wife of his condition.  The registrar commented: 
 “I certainly picked up the second time that I’m not sure that he’d taken 
everything onboard, he didn’t entirely understand what was going on. He 
certainly wasn’t confused and he didn’t have a background history of 
confusion, but he certainly didn’t seem to be accepting or understanding 
of all the information, erm, regarding that. Erm, but as he didn’t want me 
to let his wife know, I, I couldn’t tell her anything” (Registrar (CS 8), 
p17/14). 
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Healthcare professionals faced an ethical dilemma when a patient wished to 
withhold information from their family.  This added to their difficulties in not 
knowing whether the patients understood their condition, were in denial or were 
exercising their right to keep their information confidential.   
 
The lack of information caused Jock’s wife anxieties as reported by his general 
practitioner during the interview: 
“What happened was his wife phoned me because she felt that perhaps 
communications hadn’t been that good.  I did get a phone call one 
afternoon asking me could I find out exactly what was happening” (GP, 
(CS 8) p7/7). 
Here, it seemed GPs could be approached and found themselves in a role as 
the patient’s or carer’s advocate in chasing for information from the hospital. 
Carers felt they did not always have the opportunity to discuss their concerns 
with the oncologist as they were usually in the presence of their spouse and did 
not want to upset their loved ones.  Carers felt they got second hand 
information from their spouse, sometimes information seemed vague or their 
spouse may not have been able to explain to them.  Their concerns were about 
how to manage when cancer progressed and balancing their own needs with 
those of their loved one.  Linda felt she knew very little:  
“Well, very little because nobody actually said anything to me.  [Husband] 
His understanding not being a medical person, he’s not really very clear 
about what I asked him” (Linda (CS5), Interview 1, p7/21). 
The above account suggested a lack of acknowledgement of the carer’s role in 
the care of patients.  Healthcare professionals seemed more focused on the 
patient’s needs and were not necessarily aware of the carer’s needs.  There 
seemed to be a lack of someone co-ordinating or being instrumental in 
identifying patient’s and carer’s needs to provide this support.  A nurse 
suggested: 
“Erm...I don’t know, it would be quite nice to know if there are people who 
could like say, you know, a link nurse or something that could come in 
provide more emotional support with the patient and explain things a bit 
more in-depth with the patients” (SN (CS7), p12/2). 
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Nurses felt they lacked the knowledge on different cancers to provide the 
information and to address this problem.   
“I think the problem is within the training, you kind of deal with something 
as you come upon it.  And if you don’t come upon it...I mean as I say I’ve 
learnt a lot more since looking after patients. [...] you know you’re getting 
flung at the task at the minute.  Err...the actual cancer side and all the 
different cancers and different things like that are kind of sitting in the 
back burner” (S/N (CS6), p3/8). 
The account suggests nurses learn and gain their skills in clinical practice.  One 
nurse talked about her conversation with the project manager working on the 
MSCC project:   
“Erm...I did say to her (the project manager) should there be training.  
She said she had offered but was told there wasn’t a need.  I was like I 
think there’s a need because especially for myself, there’s a couple of 
newly trained you just think they probably need it as well you know.  
Maybe the older ones don’t need that as they have been here a while.  
From my point of view I needed that” (S/N (CS6), p5/11).  
The nurse appears to recognise her learning needs, especially as she was new 
to the speciality.  Another nurse said that she was not confident in giving 
information to patients and their relatives and gave her reasons why: 
“We had quite a big complaint recently where a nurse had told them a 
scan was negative.  It was negative to something from memory but it 
wasn’t.  I think it was negative to spinal cord compression on that 
occasion for that patient but they did still have metastasis and it wasn’t 
negative.  So in that respect I wouldn’t tell something like you’ve got 
SCC.  I would be there but I would never be the one cause the patient 
would have questions I would not be able to answer I think as well.  And I 
think it should come from the doctors who have reviewed the scan” (S/N 
(CS2), p8/11).   
This account suggests the challenges faced by nurses in acknowledging their 
lack of understanding on MSCC.  There seemed to be a notion of fear of giving 
the wrong information.   
 
The nurses felt that the doctors are best placed to give explanation to the 
patients about their condition.  However, nurses know the importance of 
emotional support and felt providing this aspect of care can be challenging 
because of the pressure of routine work.  Some suggested that the patient’s 
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specialist nurse or a link nurse would be in the best position to attend to patients 
with MSCC.  When asked whether the patient’s primary site (tumour-specific) 
nurses would see their patients, one nurse commented:  
 “Not that I know of.  Because, some of the nurses you see them, they’re 
quite active round the wards but some of the other ones you never see at 
all.  They maybe stick more in the clinics than in the wards.  I suppose it 
depends how they divide their day up really.  But it would be good if 
there’s somebody that we could call if...if we felt that, you know, patient or 
family would benefit from a bit more information” (SN (CS7), p12/13). 
However, many specialist nurse roles are focused around primary treatment at 
diagnosis and follow-up of patients with metastatic disease may not be part of 
the remit.  If patients have palliative care needs then the palliative care nurse 
specialist may become involved but, because MSCC has acute onset, patients 
are dealt with in an acute setting so navigating the journey is complex.  A 
hospital palliative care nurse said she saw Richard when he was referred to her 
for pain management: 
“He (Richard) actually had regular contact with his local palliative care 
team.  [...] I think, probably, the referral originally came through them to 
alert us to the fact that he’d been admitted...erm...for radiotherapy.  If I 
remember, I could be wrong in that but certainly that’s the impression 
that... It’s a case of waiting until he’s actually referred to us.  So, it’s not 
necessary on admission that we would be alerted” (PCN (CS5), p1/30). 
Here it appeared that patients may not necessarily see a palliative care nurse 
unless they are referred for pain control issues.  In addition, some patients gave 
their views on what mattered to them:  
“I think for me as a patient, the greatest things would be that you have to 
see people as a holistic thing.  You know, you don’t come in the door... 
and they try, I see the doctors trying to be very human and very 
approachable, but there’s a restriction on their time.  And I do think they 
need more support to help them assist... likes of the psychologist, great 
idea but they pulled the funding” (Sandra, patient (CS2), Interview 1, 
p35/23). 
Though the patient highlighted that the psychologist helped guide her, she felt 
there was a need for back-up information: 
“So, back up with information sheets, or back it up with breast care nurse 
having the time, or an appointment with someone else who can take the 
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information the consultant...and explain what the consultant is saying to 
you” (Sandra, patient (CS2), Interview 1, p33/10). 
This account suggests there is a need to clarify and enhance understanding of 
the information given by healthcare professionals.  Patients would welcome an 
information leaflet to be read later on.  There seemed to be a need for someone 
to go through information with the patient.       
 
To summarise, when explanations were not readily available, patients felt 
frustrated as some of them did not have the courage to ask, could not formulate 
their questions, or were waiting for the healthcare professionals to provide them 
with answers.  These accounts demonstrate that healthcare professionals may 
not be aware of the need to ask patients how much information they would like 
or the need to reinforce information given at the time of diagnosis regarding 
long-term management beyond the acute onset phase.  Data also highlighted 
that patients need emotional support when receiving bad news as their family 
may not be there to provide this support.  Most of the patients wanted 
information on what was happening to their body rather than general 
information.  However, not all patients wanted the full information.  This 
indicated that information needs vary between patients and carers.   
 
Carers felt they were not involved or consulted in their loved one’s care.  Carers 
also felt they could not address their concerns in the presence of their spouse 
but would like the opportunity to have their concerns heard in order to make 
plans and to balance their needs.   
 
Patients and carers want the healthcare professionals to help ‘put the jigsaw 
together’, and that means evaluating individual needs and discussing what is 
important for the patients and their carers’.  Nurses felt they lacked sufficient 
knowledge of different cancers to provide in-depth information and suggested a 
link nurse or a specialist nurse to meet these needs.  This is discussed further 
in the next sub-theme which illuminates the complexities of deciding what 
information to give and when. 
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5.2.4 When to have a conversation about the future? 
This sub-theme demonstrated the varied opinions of patients, carers and 
healthcare professionals on when to have a discussion about the future, in 
terms of; symptoms, mobility, progression of cancer and life expectancy.  Some 
healthcare professionals felt that patients and their carers should be prepared to 
face the reality but others expressed having that conversation too early was not 
appropriate.  Some of the patients and carers accounts showed they did not 
anticipate these changes and hence such conversations caused them distress.  
Overall, this situation highlighted how healthcare professionals struggled with 
giving realistic information and planning the timing of conversations so they did 
not take hope away from patients and carers.  
 
Betty talked about losing the power in her legs and how she fell on the floor 
when trying to go to the toilet immediately after completion of her five fractions 
of radiotherapy.  Her daughter, Mary was visibly keen to know whether her mum 
would regain her mobility after her treatment or what she was capable of doing:   
“Err...the fact yes, my mum will die but right now my mum is living and 
this is her living for the family or for my mum, so really, what was to be 
decided I think is...erm...we need to speak to somebody today, just to let 
them know that erm...we really like to find out what is my mum is going to 
be finally capable of” (Mary, daughter, Interview 1, p3/18). 
This excerpt suggests a sense of not knowing what was going to happen.  Mary 
seemed to accept the fact that her mum would die but also expressed a sense 
of wanting to be prepared for the eventuality.  Healthcare professionals on the 
other hand stressed that treatment is palliative; in some cancers treatment may 
not work and the outcome remains uncertain:  
“The dose of radiation that we use is not the dose which is going to 
eradicate cancer; it’s a dose which, in people with – certainly people with 
lung cancer – usually provides at best a few weeks of palliation.  And we 
know that a significant number of cancers are not radio-responsive, so 
some people progress, I think” (Oncologist (CS1), p4/7).    
Emma talked about her lack of mobility but she was still hopeful that the 
steroids and radiotherapy would work for her: 
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“I have not felt the benefit of it but I don’t know what to expect of it.  Erm, 
I know that it’s obviously relieving the tumour but I don’t know how 
quickly the symptoms are to be relieved what have you” (Emma, patient 
(CS6), p11/7).  
 
However, some medical staff explained that the full effects of treatment may 
take time in some instances. 
“Erm...we would say six weeks to see the full effect of radiotherapy, 
although you should see some effects in the first two weeks” (Registrar 
(CS5), p12/19). 
This account indicated there was a sense of not knowing whether the treatment 
would work.   However, the physiotherapist explained that a full neurological 
assessment daily and the actual ‘getting up on the feet’ would indicate the 
capability of the patient.  The physiotherapist talked about the extent of 
deterioration in Emma:   
“Unless they do a full assessment every day, neurologically –that they 
might not really - sometimes they (the medical staff) don’t realise the 
extent of the deterioration, and I think that was what happened on that 
Thursday-Friday.  Until you actually get her (Emma) up on her feet, you 
might not realise just how much.  So, I had to keep on relaying back 
to...to the medical staff, ‘she’s deteriorated further, she’s deteriorated 
further’” (Physiotherapist (CS6), p16/22). 
Neurological assessment may not be sufficient to assess the patient’s mobility 
but the actual effort of movement would indicate the patient’s capability or 
deterioration in mobility. This suggested that getting a realistic view of the 
outcome of treatment was difficult to predict.  There were also difficulties in 
predicting when mobility would diminish. 
 
Richard reported his legs felt weak after treatment and because he experienced 
two falls on the ward, he was conscious of his walking.  Richard talked about his 
frustrations in his diminishing capabilities; for example, he had to get somebody 
to cut his grass in his garden and the maintenance man to do maintenance on 
the house.  Richard voiced his concerns for the future:   
“I still have the wheelchair at home but don’t need it.  Well, not at this 
present time, I don’t know what it will be like when I get home” (Richard, 
patient (CS5), Interview 1, p21/24).  
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This indicated the uncertainty he faced about how long he would maintain his 
capabilities.  Sandra felt that she needed to know how long she would be well 
enough to function as she taught physical education.  Sandra confided her 
anxiety: 
“I have always been independent.  So, there’s uncertainty that way 
because I don’t want to be...stop, here I don’t mean that [became 
emotional], I don’t want to be miserable and worried about money as well 
as being sick...you know.  And I enjoy my job and I don’t want to give up 
my job that way.  Umm...I feel as though I am going to lose my identity” 
(Sandra, patient, Interview 1, p15/7). 
Sandra faced the uncertainty of losing function and the significant impact that 
this would have on her physically, financially and emotionally.  Sandra was also 
worried how her two children would cope if her mobility deteriorated: 
“Well, my eldest son was ten when I had to tell him I had cancer the first 
time – because I was advised to let the boys know.  So, Denis was eight 
and Simon was ten, so they’ve lived with this through their whole 
teenage years.  And I’ve always been quite positive and been, you know, 
on the go.  But every time, something like me getting brought in here, 
you can see it in their faces, you know” (Sandra, patient (CS2), p16/11). 
This account suggested that Sandra and her family had faced uncertainty of 
cancer recurring over the years and it had impacted on the quality of their family 
life.  
 
Some healthcare professionals felt that patients should be informed of their 
future symptoms but not all agreed: 
“Well, I think it’s best discussed after they’ve had their radiotherapy and 
you see the effect of the radiotherapy.  Some people, it takes longer for 
them to get an effect, and if you start talking about all sorts of different 
things it can be quite distressing” (Registrar (CS4), p19/24). 
However, for Emma, it came as a shock and adjusting to her disability caused 
ongoing frustrations.  She talked of her determination to get her strength back: 
“I know my left leg isn’t moving as it should be but because of my 
determination I will get that moving [laughs] so, err...and with the steroids 
it does make me confident to be able to get that” (Emma, patient (CS6), 
p11/1). 
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Here, the patient wanted to be positive and not lose hope.  Medical staff 
described conversations around diagnosis and prognosis as difficult.  Some of 
the patients expressed a need to know the prognosis to allow them boundaries 
to work with and to help them make short or long term plans.  Sandra, for 
example, gave her reasons for wanting to know: 
“Basically, how long you’re going to live.  How long you’re going to be 
well enough to function?  [...]It’s like your whole life is on hold because 
they don’t give you...um...parameters to work within.  And I can 
understand they don’t want to because of the new advances in drugs and 
things, they don’t want to tell you too much.  But – as a patient it makes 
me feel... [Big sigh] I can’t focus on anything because my life’s always on 
hold.  I got to a point with depression” (Sandra, patient (CS2), p17/1). 
This account demonstrates that the patient found it hard to cope with not 
knowing what her future held and it stopped her from moving forward.   
However, Sandra’s consultant was aware that she had not been coping and the 
issue around prognosis was brought up during her follow-up appointment.  The 
oncologist reflected her conversation with Sandra: 
“We haven’t been any more specific than that because I don’t think you 
can be really apart than talk about it you know.  She’s already kind of 
exceeded the statistics and done better than the statistic would have said 
she would do at this stage.  And so I pointed that out to her and I hope 
that is reassuring to her.  So, we had had some conversations about her 
prognosis” (Oncologist, p6, L14). 
This illustrated that healthcare professionals faced difficulty in discussing issues 
around prognosis when the patient’s survival had exceeded the expected life 
span in statistical predictions.  There was the uncertainty whether she would 
continue to respond to further treatment. 
 
Sandra’s husband believed getting information on prognosis was going to help 
them make plans.  John considered: 
“I mean most people want to know whether it’s good or bad or indifferent 
and if you get told that’s the best way.  And then you can cope with it or 
make plans whatever you know what I mean.  Put it this way, say if 
somebody were to come and tell me ‘hi John, you’ve got four years to 
live’ or ‘John, you have only a year to live’.  If I have four years, I would 
do ‘x, y and z’ right, but if I have only a year to live I won’t be going to 
work tomorrow, I would be going somewhere else cause there’s 
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something in this world I want to do before I die” (John, husband (CS2), 
Interview 1, p23/17).  
The above quote illustrates John wanted to know his wife’s prognosis in a 
qualitative way rather than in statistical terms.  For John and Sandra, knowing 
the prognosis would provide some form of ‘control’ to be able to make plans.   
 
Not all patients, however, wanted to know their prognosis and this posed 
challenges for healthcare professionals in determining whether to have that 
conversation with patients and their carers’.  Richard talked about how he 
reconciled with the issue around prognosis: 
“They are not going to fix me, you know, but extend and give me quality 
of life, and that’s all, really, I can expect at the present time.  For how 
long, I don’t know.  There’s nobody who can tell me that, obviously, 
either.  It could be next week; it could be next year.  I’ve been diagnosed 
for coming up to two years or whatever it may be.  So, no, no, I don’t 
want to know, no.  So...I don’t think so, no.  I’d rather just err...pass away 
peacefully, if you know what I mean” (Richard, patient (CS5), Interview 2, 
p17/22). 
 
Here, it seemed Richard was being realistic about his condition and would 
rather not know how long he was going to live.  His wife, Linda expressed not 
wanting to be weighed down by that information too: 
“You don’t really want to know what someone’s opinion is of your life 
expectancy, you know, because I’m not very much in favour of that 
because I think that is a horrible burden to have.  I think I’d rather not 
know something like that” (Linda, wife (CS5), interview 1, p12/17). 
 
Some of the healthcare professionals felt it was not appropriate to discuss 
prognosis when patients were on active treatment or if they had other treatment 
options still available.  The oncologist made his point: 
“But I actually disagree with the idea that you have to tell everybody this 
is how many months you have until it is appropriate when you can’t do 
anymore.  Then that’s the right time to do it” (Oncologist (CS5), p4/4). 
Other healthcare professionals had to listen for cues from their patients as not 
all patients wanted to talk about end of life issues.  The oncologist reflected his 
discussion with Emma and her husband:   
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“I mean she was immensely disappointed but she accepted and didn’t 
challenge, err, the information that she was given.  And in fact she had 
very little in the way of follow-on questions.  So, err, that’s really why 
prognosis, in terms of survival, was not discussed.  Because she, 
effectively, stopped the conversation” (Oncologist (CS6), p7/17) 
The oncologist seemed to give the control to the patient as a means of opening 
a discussion on prognosis and took the cue that she did not want to have that 
discussion.   In contrast to what the oncologist perceived, both Emma and her 
husband, Matthew seemed to want to know the prognosis but at the same time 
described it as a “mixed bag”. 
“Err...time scales – err...in some ways you don’t want to know type, but I 
have to – I’m a stickler for those kinds of things; I need to... Yeah.  It’s a 
mixed bag” (Emma and Matthew (CS6), Interview 1, p30/25). 
There was a sense that the patient and carer oscillated between the desire for 
more information and avoidance of information on prognosis.  Matthew added 
his reasons for wanting information on prognosis: 
“It’s more upsetting not knowing what’s ahead.  Cause your mind starts 
to go into overdrive, and you think ‘what are they keeping from you?’ or 
‘are they not telling you everything?’  They never are [Emma: they 
always do tell.] Yeah, they do tell, but it’s your mind that starts to kind of 
go that way, so I’d rather just know everything and deal with it at that 
point” (Matthew, husband (CS6), Interview 1, p31/10). 
Matthew expressed that he needed time to think through the information given 
to him.  However, healthcare professionals sometimes may not interpret this 
cue accurately.  The consultant commented on his observation at the time of 
breaking bad news and knowing the couple over the years: 
“Err, she expressed disappointment, rather than fear.  Err, he said very 
little.  Err, which is quite normal for him.  Because I’ve met him many 
times over four years, and he tends to say very little” (Oncologist (CS6), 
p8/11). 
 
In contrast to the above accounts, Betty seemed to accept that she was going 
to die but left her fate to a higher power.  According to her consultant, Betty 
‘was extraordinarily sanguine’ about her paralysis and her imminent death: 
“...she didn’t really accept the prognosis that we were suggesting 
because, from her point of view, God was going to look after her and it – 
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whatever happened was up to Him, not up to her or us anyway, so it 
really didn’t matter” (Oncologist (CS1), p7/14). 
Patients and carers also discussed about having existential fears of progression 
of cancer.  Jimmy described his concerns: 
“The first thing I thought I had fear when I was told ‘how long I’ve got to 
live?’  That’s the first thing that comes in my mind ‘How long?’ But then I 
say before I had the cancer, I only have so long to live anyway and I 
wasn’t frightened then.  I might be frightened if I am going to die 
screaming with pain and salivating about, cannot talk and all that” 
(Jimmy, patient (CS3), Interview 1, p14/7).  
 
Jimmy and Sandra feared they could end their lives suffering in pain.  However, 
when probed further, they seemed to get this information from the internet.   
Sandra said:  
“You know...it could go to my brain; it’s this...I’m going to be in agony, the 
pain...  And all the internet says, when it is in the bones, it’s...the pain is 
horrendous.  You just imagine this torturing death that you’re going to 
suffer, and that’s just the way...you know, when you read – and I read 
[Laughs]” (Sandra, patient (CS2), Interview 1, p20/31). 
 
These interpretations indicated patients have existential fears of suffering in 
pain at their end of life.  Healthcare professionals may not be aware of this 
issue and a discussion around pain control may be reassuring to the patients.  
Similarly, carers Matthew and Linda had worries about their loved ones 
suffering in pain and breathing problems.  Linda confided her concerns: 
“Umm...I’d have liked to talk to somebody about the disease and the 
umm...progression of the disease and you know, what is...I mean I know 
everybody is a unique individual and everyone would be slightly different 
and how the disease progresses.  I would just like some general 
information and you know progression and halting that progression and 
generally what kind of things helped” (Linda, wife (CS5), Interview 1, 
p12/11).  
Carers have concerns of not knowing how to recognise and cope with 
deterioration in their loved one’s when the time was near.  Carers seemed to 
need someone to explain and provide the information to be able to anticipate 
and support their loved one’s needs. 
 
 
 
 
 
178 
 
In contrast to the above accounts, Jock did not seem worried about his 
prognosis.  He reasoned:  
“I don’t want to live till I’m over eighty (I’m seventy-six), it’s no use living 
to that age if you can’t get about and be active”  (Jock, patient (CS8), 
Interview 1, p10/18). 
Here, it seemed that the patient was more concerned with quality of life rather 
than longevity. 
 
In conclusion, patients and carers experienced uncertainty in not knowing what 
the future held and wanted answers for some of their concerns.  For example, 
patients had questions about how long they were going to remain mobile, 
issues around how long they had left and about progression of cancer.  Patients 
showed extreme fear of suffering and dying in pain and being helpless.  Carers 
also have fears of not recognising and coping with the deterioration in their 
loved ones condition.  Healthcare professionals, on the other hand, found that 
diagnosing MSCC was challenging; treatment in metastatic disease is mainly 
palliative; response to treatment is uncertain and, therefore, conversations 
around maintaining mobility and life expectancy can be difficult.  These findings 
suggested there is a chain of decision making from healthcare professionals 
and there are some areas of concerns that healthcare professionals can help to 
clarify or to provide an explanation for patients and carers.  However, they may 
not necessarily know, identify correctly or anticipate when to have a 
conversation with the patient and/or carer regarding the patient’s future.   
5.2.5 Summary 
This theme reflected patients’ and carers’ difficulties in judging the significance 
of the signs and symptoms of MSCC whilst healthcare professionals faced 
challenges in recognising and identifying the patients presenting symptoms.  
There was evidence that patients trusted the healthcare professionals in making 
the right decisions and welcomed the immediate treatment and care.  Some 
patients later questioned whether the healthcare professionals had made a 
balanced decision when the treatment they received was different from those 
they had read about via the internet.   
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Not all primary care professionals were aware of the local referral pathway or 
the NICE guidelines on MSCC and other healthcare professionals were 
sceptical about the NICE guidelines (2008) in clinical practice.  Contradictory 
instructions on mobilisation added to the patients’ distress and uncertainty.  
Other uncertainties emerged after the initial treatment and some patients and 
their carers felt information was not forthcoming.  However, patients’ and carers’ 
needs for information varied where prognosis and end of life issues are 
concerned.  Healthcare professionals’ perspectives in giving patients 
information on prognosis and future symptoms were debatable due to the 
uncertainty of the disease pathway and outcome of treatment.  There seemed 
to be uncertainty from the accounts of the patients’, carers’ and healthcare 
professionals’ perspectives but evidence also illuminated their strategies in 
balancing and managing these uncertainties which will be discussed in the next 
theme.  
5.3 Finding a balance in the uncertainty of MSCC 
In this second theme, I give examples from the accounts of patients, their carers 
and healthcare professionals to demonstrate a range of ways to find a balance 
to deal with the uncertainty of MSCC.  Sub-theme 5.3.1 shows healthcare 
professionals sought to make ‘trade-off’ decisions about treatment versus the 
quality of life of the patients.  Patients and carers appeared to feel the 
progression of cancer was beyond their control, however, sub-theme 5.3.2 
demonstrated their ‘battle plan - what is the next step’’ highlighting their 
priorities and hopes for the future.  Healthcare professionals faced challenges 
as treatment was palliative and there were difficulties anticipating the 
progression of cancer.  Sub-theme 5.3.3 reflects different perspectives of the 
demands of care.  Accounts from the patients illustrated they did not want their 
families to be burdened with their care; however, carers felt decisions of care 
made by healthcare professionals might be disparate from their needs.  The 
following sub-themes are the interpretations of patients, carers and healthcare 
professionals in finding a balance in the uncertainty of MSCC.   
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5.3.1 ‘Trade-off’ 
This sub-theme demonstrated healthcare professionals’ decision making in the 
context of impending cord compression treatment.  There was a notion of trying 
to find a balance where healthcare professionals sought to make trade-off 
decisions in treating advanced cancer versus the patient’s quality of life.  
However, treating metastatic disease was challenging as the treatment was 
palliative and medical staff found it difficult to determine the patient’s response 
to treatment.  Patients and carers, on the other hand felt dis-empowered with 
the recurrence of cancer but data showed their coping strategies in dealing with 
uncertainty of MSCC. 
 
Healthcare professionals talked about making difficult treatment decisions.  In 
the account below, the oncologist got his team involved in Jimmy’s treatment 
plans.  Jimmy was mobile and quite pain free at that time.  The team had to 
consider the dosage of radiotherapy to give Jimmy:   
“So, if you assume that the cancer has a 100% chance of causing 
paralysis in due course, then the question is; do you give a radiation 
dose that gives a one per cent risk, or a 10% risk, or a 20% risk, or a 
50% risk of causing that same problem in due course?  Er, and in the 
end he had a dose which probably runs about a five per cent risk of 
causing him radiation injury.  Erm, I suppose it might’ve been possible to 
give a higher dose with a higher risk, but in the end we didn’t go that far.  
Just compromised somewhat” (Oncologist (CS3), p12/8). 
Here, it appeared that the oncologist made a trade-off decision with the dosage 
of radiotherapy versus maintaining the physical outcome.  The focus in this 
case was on the physical condition of the patient which informed decisions 
around treatment.  The account here seemed to be shared decision making.  
However, this team discussion was confined to a specific discipline only and did 
not involve the patient or carer as part of the team.   
 
Healthcare professionals discussed making decisions based on evidence.  One 
oncologist referred to the NICE guidelines (2008): 
“There is very little comment there about non-surgical intervention.  
There was one radiotherapist on the group, but very little about 
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radiotherapy and at one stage there was virtually nothing about 
radiotherapy, it was all about surgical nursing intervention.  The other 
thing was, of course, there was no evidence base at all to make those 
recommendations on” (Oncologist (CS4), p4/10). 
This interpretation suggested that evidence on radiotherapy treatment was 
limited and therefore there is uncertainty in the outcome.  Another medical staff 
member commented on the evidence of surgery outcomes:  
“Well, there’s American randomised trials saying that surgery plus 
radiotherapy, um, is better than radiotherapy alone, in terms of how long 
people walk for, and the various outcomes.  It’s a very highly selected 
sub-group...and how many people it actually applies to is a difficult 
question.  And there are severe limitations over that in terms of, erm, 
theatre access and putting the two people together (neurosurgeon and 
thoracic surgeon), about the patient’s fitness for the procedure” 
(Oncologist (CS1), p5/1). 
Although there was some evidence on surgery, it is a complex procedure 
involving the collaboration of different disciplines and patients may not 
necessarily meet the criteria and have other co-morbidities.  However, patients 
may not have this information or understand the levels of decisions made by 
healthcare professionals.   
 
Robert compared his condition to another patient in the same bay.  He said: 
“A chap, he’s in the room...and he’s got the same as me ‘a spot’ but his 
is actually curled around the spine and they don’t know what to do with it.  
He’s going to have operation to get rid of that before he gets 
err...chemotherapy or anything.  They never told me mine is...err...but 
they are giving me...I am getting radiotherapy.  So, it must be alright, not 
having any worries about me ‘crippled man’” (Robert, patient (CS4), 
Interview 1, p9/15).   
It was not clear whether the patient understood his condition; it appeared that 
his consultant made a trade-off decision: 
“Re-treatment is always difficult.  We would have considered surgical 
intervention.  I presume it’s because...er...of the extent of the disease, 
which was...um...extensive (just looking at the MRI scan report) and the 
fact that he’s got multiple areas of bone disease, which would make 
surgery more difficult.  But, certainly, you need to consider – both the first 
time and the second time – surgical intervention.  That was 
excluded...ah...and, therefore, we re-treated him with radiotherapy” 
(Oncologist (CS4), p2/14).    
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Some oncologists made decisions based on the age and the general health of 
the patient: 
“Err, and I think for young, fit patients, there may be a role for surgery, 
err, so the role of surgery was discussed with the on call neurosurgical 
team and felt not to be appropriate” (Oncologist (CS6), p1/23). 
The oncologist was trying to make a trade-off decision based on the patient 
being young and fit and the potential that surgery could prolong life.  One 
member of medical staff expressed that most challenging thing for him was to 
inform the patient whether surgery was possible or not:   
“So, sometimes we might feel a bit inadequate in answering the patient’s 
questions about these things, but then we say that neurosurgeons are 
the best people to answer these questions.  And, in our minds, 
sometimes it is difficult because...err...the decision of whether to go 
ahead with operative treatment or not can be different, depending on the 
surgeons involved.  So, I think there’s probably...it needs a bit of 
consistency in that...in...in the decision on whether to operate or not –
because we need to tell the patient”(Registrar (CS7), p12/20).        
The accounts suggested decision-making on surgery depended on the 
neurosurgeon but this could differ between neurosurgeons and this could delay 
the treatment for the patients.  As he indicated, Tony’s operation was delayed. 
On the other, he also pointed out that the surgeons may have their own 
priorities, time factor and availability of resources such as theatre.  In addition, 
the doctor was uncertain how decisions were made for Tony and Emma: 
Registrar: Err...I’m not sure, to be honest, in the sense that...err...  
Because we had a similar patient but...who had a 
slightly...err...she had some evidence of neurological involvement 
before, and she was not offered an operation. (Registrar (CS7), 
p13/14) 
Researcher:  Are you talking about Emma?   
Registrar: Yeah.  So, the thing is she had a bit more neurology and 
she was in a similar situation as Tony: she had a mixed response 
to chemotherapy, she was on a trial...similar sort of situation.  
She’s a young patient as well.  But she had some neurology at 
presentation, so I don’t know if that was the decision...that was 
the reason why they decided not to operate on her” (Registrar 
(CS7), p13/20). 
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The above showed the decision making process can be complicated and no two 
cases are the same and the neurosurgeons criteria for surgery may differ.  
Conveying this uncertainty to patients can be awkward.  The neurosurgeon 
gave his reasons on Emma’s condition: 
“If the spine is unstable and you can put metal-ware in, you stabilise the 
spine, yes.  But in her case, we had nothing to fix the metal-ware to – 
with the multiple secondaries up and down the spine” (Neurosurgeon 
(CS6, p7/3).  
However, the neurosurgeon prioritised patient’s survival to benefit from surgery:     
“Whether or not we operate?  Yeah.  Um...basically, it comes down to 
how long does the patient have to survive?  If the oncologists say ‘well, 
they’ve got several years of life - you know, predicted life –ahead of 
them’; that’s fine, we will do large operations.  If, however, they say ‘well, 
there’s only three to six months of life, we expect,’ then it really isn’t 
appropriate that we have...undertaken massive operations.  They are not 
going to recover. They are not going to live long enough to recover or get 
any benefit from it” (Neurosurgeon (CS6), p5/1). 
 
The neurosurgeon made a ‘trade-off’ decision based on patient’s life 
expectancy and quality of life.  However, he depended on the oncologist to 
predict the patient’s life expectancy before any decision on surgery could be 
made.  Sometimes this movement of decision making between the oncologist 
and neurosurgeons could cause some confusion for the patient who may have 
been given the impression that surgery could ‘fix’ them and then it turned out 
that surgery was not possible.  The neurosurgeon explained:  
“The major problem, from my point of view, is getting them (patients and 
carers) to understand why you’ve made the decision, you know, 
whatever you’ve arrived at, trying to explain to them.  Because, they 
usually know people that have had an operation and trying to explain that 
no two are the same and there are various things you have to think 
about...  That can be very difficult for them to get hold of, especially if 
they’ve spoken to someone...um...say outwith oncology, or out with 
neurosurgery, who has already given them an idea.  Um...which we meet 
quite commonly: ‘oh, you’ll go to the neurosurgeons and they’ll fix you’” 
(Neurosurgeon (CS6), p7/13). 
This account suggested that the patient’s expectations may be raised but 
conveying the decision can be complicated when the patient was given ‘false 
hope’ and the neurosurgeon needs to balance the perceived benefits of certain 
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treatments with the realities of the trajectory of the condition.  When surgery is 
not an option, some patients would ask for more information about other 
treatment.  The neurosurgeon said: 
“Usually, if there’s no surgery: “what is the treatment?” “Will the treatment 
make them any better?”  If the answer is “no,” I have difficulty answering 
that.  I don’t know what the outcome is from radiotherapy, so I tell them 
to ask the radiotherapist that.  Um... “how long will it be before they’re 
completely unable to walk?”  Again, it’s impossible to say that.  Usually, 
they ask questions to which we don’t have answers: they want us to look 
into the future and cross bridges we don’t even see.  Um...it’s very 
difficult to answer the questions” (Neurosurgeon, CS6, p8/14). 
The exchange in conversation illustrates the difficulty the neurosurgeon faced in 
conveying the decision to the patient when surgery was not possible and the 
outcome of radiotherapy uncertain.  In addition, this account demonstrates the 
patient had to approach several people to get answers to their queries.   
 
Another neurosurgeon gave his views on his decision about Tony who had 
metastatic colon cancer: 
“What is the prognosis and how good are they at the moment, if they are 
bad to begin with and they are unlikely to walk again, well, they can but 
they are much less likely to...so that’s my view of them, that’s the two 
difficult things; one is easy to sort out, walking or not, the histology and 
the implications of it but the prognosis is the harder thing” (Neurosurgeon 
(CS7, p7/11). 
This suggested that patient’s mobility status and prognosis was an important 
guide.  However, when asked what other criteria he would consider in his 
decision making to operate on the patient; the neurosurgeon considered: 
“No, just looking at him and talking to him, what is his expectation, what 
he wants to do and all those sorts of thing, that’s what guides me most” 
(Neurosurgeon (CS7), p7/21). 
Here it appeared the neurosurgeon used a person-centred approach to his 
decision making, taking into account the patient’s wishes. 
 
Accounts from patients and carers also illuminated their strategies for coping 
with uncertainty when there were limited treatment options.  Richard talked of 
his prostate cancer which had spread to his bones and moving from one clinical 
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trial to another which failed to bring down his PSA (Prostate-Specific Antigen).  
He summed up his lack of choice treatment-wise: 
“I know it’s not curable which I think is the main thing.  I know all the 
treatment I’m getting is to give me relief and to keep cancer at bay but 
each time they do it, it’s likely that’s going to show itself in another place 
and I know they can only do so much” (Richard, patient (CS5), Interview 
1, p25/18).  
This showed the patient knew progression of cancer was beyond his control 
and there was a sense of disempowerment.  The following account revealed 
that Richard wanted quality time with his wife but found it frustrating: 
“So, I want to cram as much into what time I’ve got … is now to do as 
much as I can.   And that can be a little bit frustrating ‘cause there’s lot of 
things stand in your way like going on holidays and things like that.  Like 
booking and suddenly find you’ve got treatment, so you got to cancel 
your holidays, all stuff like that” (Richard, patient (CS5), Interview 1, 
p23/7). 
Recurrence of cancer presented challenges and brought sudden changes to the 
plans of Richard and his wife.  As identified above, Richard had to make a 
‘trade-off’ decision on receiving treatment versus spending quality time with his 
wife.  
 
In some instances, decisions could be made by the registrar or on call 
oncologist to transfer the patient to the cancer centre for treatment.  The patient 
is then referred to the cancer-specific oncologist for subsequent care.  One 
oncologist gave Jock’s case as an example: 
“But this guy had hypercalcaemia, which is a poor prognostic factor for 
malignancy. He had metastatic disease in his lungs, which is a poor 
prognostic factor...erm, and what we seemed to have succeeded in doing 
erm...was to make him spend twelve of his last 34 days in the cancer 
centre, rather than in his district hospital.  So, our attempt to prevent his 
spinal cord compression progressing had the effect of separating him 
from his family and friends for one-third of his remaining lifetime.  
Erm...whether, if we hadn’t treated him, he would’ve become paraplegic 
in the meantime, I don’t know...  [...] But I don’t think that discussion 
would have been held with him before he came up” (Oncologist (CS8), 
p2/14). 
This excerpt suggests that decisions to accept patients could be made by a 
doctor on call without exploring this with the patient.  The decision about 
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treatment may or may not have been discussed as to whether to trade-off 
treatment against quality of life considering the patient’s poor prognosis.  There 
seemed to be a chain of decision making at various levels with patients coming 
through the system from different pathways.  There is the likelihood of delayed 
diagnosis and treatment and the impact it would have on patients and their 
carers was great.   
 
One neurosurgeon commented on the local MSCC referral pathway: 
Neurosurgeon: [Pause] It’s fine.  They should come to neurosurgery first 
because the big decision is going to be: ‘can we do an operation 
to improve the patient?’  If we can’t, we know where the patient’s 
going.  Um...referral to somewhere else – to oncology, for 
example – sometimes doesn’t result in the neurosurgeons being 
involved until it’s too late” (Neurosurgeon (CS6), p9/28). 
Researcher: You mean to say...would you see the patient first, or...? 
Neurosurgeon: I don’t think it matters who sees the patient first in a good 
system, as long as the neurosurgeon gets involved in this 
decision – ‘will there be an op?’ – at the beginning.  What we 
sometimes see is the patients come to us with a...say, two 
collapsed vertebrae, but these metastases have been known 
about for six months.  You know, we may have considered 
resection six months earlier, when the neurological...the 
neurological state is much better, whereas, now if they have 
collapsed...compressed the cord, there’s no guarantee we can 
produce improvement.  We sometimes feel we should’ve got 
some patients sooner, but there’s more than one pathway.  
[Laugh]” (Neurosurgeon (CS6), p10/5).   
This account suggests that the likelihood of prolonging patient’s life expectancy 
is better if the patient was referred early before vertebrae involvement.  
Importantly, the neurosurgeon should be consulted in the decision making 
about the feasibility of surgery.  However, co-ordination was required to achieve 
this.  The neurosurgeon considers:   
“...but, certainly, a hospital based team (the same as they have the MDT 
for inter-cranial tumours) would be very useful, in that we could meet...  
well, the MDT meet once a week; we could meet once a week/once a 
fortnight (they’re not as common) and discuss the best way forward for 
patients, but er...I think that would be a good move: to have a team that 
meets – sort of, surgeons, oncologists or whatever description, and 
radiologists meet and discuss the case” (Neurosurgeon (CS6, p12/14). 
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A multidisciplinary team (MDT) for MSCC would allow an understanding of the 
decision making process and avoid delaying diagnosis and treatment.  
However, there was no mention of including the patient as part of the team and 
identifying what the patient’s preference or needs are.  
 
Data showed healthcare professionals made their decisions by taking into 
consideration the available evidence, consulting with other colleagues and the 
patient’s life expectancy.  Some healthcare professionals seemed to focus on 
the neurological condition and prognosis of the patients to plan decisions 
around treatment, whilst others involved patients in a person-centred approach 
by identifying what patients wanted.  The complexity appears to be the different 
pathway patients undertake and this can delay the diagnosis and treatment.  To 
reduce the decision making process chain, a co-ordinated MDT was seen as a 
possible solution to the management of MSCC.  However, including the patient 
as part of the MDT team would identify what the patient’s preferences and their 
needs are.  In the next sub-theme, some patients and carers give accounts of 
how they recognised they needed to move forward and described their battle 
plans in facing the uncertainty of MSCC. 
5.3.2 “Battle plan – what is the next step” 
This sub-theme “battle plan – what is the next step” was described by one of the 
carers which reflected the patients and carers accounts in trying to find a 
balance by seeking out other treatment options and quality time with their 
family.  There was a sense that patients and carers wanted to move on, 
however, some of them found difficulty doing this with the uncertainty of MSCC.  
Healthcare professionals on the other hand were often uncertain about a 
patient’s response to treatment and whether they were suitable and fit for 
further treatment.  This sub-theme describes this mismatch between the two 
requirements.    
 
For example, Emma and Matthew described wanting to know what the 
healthcare professionals had for them which they referred to as a “battle plan – 
what is the next step”.  Matthew was keen to know: 
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“I mean, once I know what’s happening, I can get a battle plan, as it 
were, eh.  [...] Eh...just how positive Emma is and how much she keeps 
fighting on.  We try to look into err...to different treatments, err...or all 
different options, diet eh and everything like that eh.  Just to keep fighting 
away; you cannot...they always say you cannot lie down eh to these 
things.  If Emma keeps fighting, I will keep fighting” (Matthew, husband 
(CS6), Interview 1, p27/12). 
The excerpt suggested the patient and carer look for other perspectives and 
described their determination to find alternative treatment.  The use of ‘battle’ 
language seemed to illustrate having control of the situation.  The occupational 
therapist thought Emma may not have been realistic but gave an explanation of 
the patient’s positive mind-set: 
“But what’s hard with this lady is that um, four years ago she had cancer 
[bowel] and she was told she only had six months to live.  And she’s still 
here.  But when we told her that ‘we don’t expect the power in your legs 
to come back’, it may be hard for her to accept that”. (Occupational 
Therapist (CS6), p12/27). 
The patient’s experience of defying the odds seemed to add uncertainty to the 
trajectory of cancer and could potentially make planning for end-of-life care 
difficult.   
 
Jane also used “battle” language to illustrate her point as her husband 
previously had an episode of MSCC: 
“We were devastated when he was diagnosed with it, you know, we just 
said ‘well, we’ll fight it together’ you know. And then, when we knew that 
it was into the bones...  my doctor at that time said ‘look, it’s very slow, 
very slow growing in the bones.  You could die of old age before that, 
you know’.  He would have the bad pain because of that in the bones, 
and then we had quite a long period in between that he was well and you 
push it to the back of your mind” (Jane, wife (CS4), Interview 1, p2/19). 
The account suggested a fighting spirit, a sense of having control of the 
situation.  There was also a sense that trajectory of cancer was a long process 
full of uncertainty of when recurrence could occur.  This illustrated patients and 
their carers coped by compartmentalising cancer in their mind. 
 
Richard, for example, knew that his treatment was palliative but there was 
uncertainty about further funding: 
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“But I’ve still got the radiotherapy to go through, I’ve got the 
chemotherapy if they get the funding and I’ve still got the strontium, so 
I’ve still got, you know, like three, not options, but three things I can get 
which is going to be of help at the end of the day so that kind of gets my 
life line” (Richard, patient (CS5), Interview 1, p25/2). 
There was a sense of this patient wanting to have the reassurance that there 
were further treatment options available.  However, his consultant was 
uncertain whether Richard would respond to his radiotherapy treatment and 
whether he was fit for further treatment.  The oncologist talked about his 
concerns:  
“Err...I mean he did well, he got his radiotherapy, he’s still walking, 
actually walked home.  And it’s just that he’s a very unfortunate man and 
his disease progressed unfortunately.  Hopefully he might be well for the 
second line treatment but he might not be” (Oncologist (CS5), p3/34). 
Although there was uncertainty on the treatment outcome, the advances in 
cancer treatment could raise the patient’s hopes and expectations and this 
added to the uncertainty of prolonged survival.  Furthermore, the availability or 
appropriateness of treatment complicated the perceptions of patients and 
carers.  For example, both Sandra and her husband, John, took a political view 
on the availability of treatment.  Sandra was uncertain of her treatment plan: 
“Um...I don’t know what kind of treatment plan they are going to offer me.  
And I don’t know how much say I’ll have in that.  And then you wonder, 
well, if it is NHS, if it is private, if I was in different county, is there 
different things that I would get?  ...what I was told was that the operation 
could be more dangerous towards me than the tumour is itself at this 
stage.  And that I suppose I can accept.  But then you think, is it money?  
Is it politics?  Is it just that that’s the way the NHS is?” (Sandra, patient 
(CS2), Interview 1, p22/8) 
This account suggested the patient questioned whether she was at a 
disadvantage in terms of treatment being offered to her.  Sandra had difficulty 
coping with this uncertainty: 
“But I just don’t know what the future holds, and this living in fear, I 
suppose, is hard to cope with most of the time [patient became 
emotional]” (Sandra, patient (CS2), Interview 1, p22/26). 
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This account reflected the anxiety Sandra experienced not knowing her future 
treatment.  John, however, identified the inequality between the resources given 
to the treatment for cancer.  
“You always got the doubt- is the drug that is being dispensed the right 
one for you?  Because I mean I recalled a few years ago, we actually 
knew somebody in the north east, his wife was diagnosed with breast 
cancer.  And at that time she was on a drug which we couldn’t get up 
here but the drug Sandra was getting at that time was a better one than 
what she first got.  At the end of the day, it’s the postcode lottery 
whether you’re staying in the right place and all the rest of it” (John, 
husband (CS2), Interview 1, p6/25). 
Here there was a doubt about the right drug being given and whether the 
treatment given might be subject to the geographical area the patient is from.  
Healthcare professionals stressed the importance of telling patients the aims of 
the treatment, however, that can be challenging:  
“Um, for the patient, they should be…should be aware of the aims of 
treatment, um… and I think it’s quite a difficult thing when patients come 
in with very poor mobility because of spinal cord compression.  It’s, em, I 
don’t know, really know how we’re meant to say to them ’this might not 
get much better’.  I don’t know how…   it’s…it’s very difficult to say that to 
a patient you’re trying to treat.  And it’s, you know, you want to leave 
them with some hope that they might get their mobility back, um… but 
that maybe brings unrealistic expectations for the patients and relatives” 
(Registrar (CS2), p9/12). 
Healthcare professionals want to be realistic yet they do not want to take hope 
away from the patient. Getting that balanced was challenging.  There seemed to 
be tensions within their experience of balancing hope and reality.   
 
Some patients seemed to try to find a balance by coping with their treatment in 
stages.  In Jimmy’s case, further treatment depended on how well he 
responded to his treatment: 
“What really is going to happen, I’ll only do that as it comes along.  I told 
you it’s the five treatments of radiotherapy.  No, it should finish but they 
are extending it so I am doing another two – just two and that’s another 
back part and they are going to check that.  Then hopefully, I have 
agreed to do the other four and a half or five weeks – that’s another 
session” (Jimmy, patient (CS3), p11/3).  
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This account showed the uncertainty in the treatment outcome and there was a 
sense of coping with the here and now.  Despite saying he was going to take it 
“a step at a time”, Tony appeared anxious on the plans after his discharge from 
the hospital: 
“But I’m sure the neurosurgeon has been in touch with oncology ward, so 
I’m imagining they will tell me, before they release me, what the next step 
is, but I don’t know, as yet” (Tony, patient (CS7), Interview 1, p32/27).     
This indicates that the discharge plan had not been discussed with the patient 
which placed undue worry on him.  When Betty was informed that there was 
nothing the doctors could do, she described her future as ‘a journey’ and how 
she was coping: 
“And, as I said, they couldn’t do anything more for me, but I said ‘we’ll 
take it from there’ I just take one day at a time and make the most of 
what I’ve got there in my family and...  I’m quite...I’m not even stressing 
myself out about it because I know that this is another part of a journey 
I’m going on” (Betty, patient (CS1), p21/13). 
There was a sense of helplessness at the same time trying to have positive 
thinking by focusing on “here and now” instead of worrying about the future.   
 
Some participants felt disempowered when there was no treatment option 
available; however, this varied and as demonstrated below, Betty seemed to 
accept her illness: 
“And I depend on Him (God) for everything.  And my faith keeps me 
strong.  And that helps me to keep my calm in the storm” (Betty, patient 
(CS1), p18/23). 
Here, Betty seemed to try to take control and find meaning in her life by turning 
to her faith for comfort.  The patient adopted a positive outlook which was seen 
as a strength that provided a sense of meaning and coping.   
 
Jock voiced his anxiety about his immediate future when he got back to his local 
hospital:   
“I don’t know what they’re going to do to me next.  And I’ll probably go to 
[name of local hospital] tomorrow or the next day. Well, as soon as they 
can get transport I think” (Jock, patient (CS8), Interview 1, p1/5).  
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Jock was also uncertain of his future living circumstances: 
Jock: Looking away ahead, the only thing that worries me is if I ever 
needed to be taken into care where...I do not want that.  That’s a 
worry.  
Researcher:  What do you mean by that?   
Jock: Well, a care home or something.  Well, you’d have to pay for it, for 
a start.  Selling your house and all this nonsense. 
This quote illustrated the patient’s worries about his future living and financial 
circumstances and implications for his family.   
 
This sub-theme illustrated the notion of finding a balance where patients were 
seeking other perspectives in the midst of MSCC.  Some patients and their 
carers looked for alternative treatment, others were uncertain about future 
funding for their treatment and some participants were accepting of their 
condition and future.  Some of the patients and carers expressed their doubts 
about the efficacy of the drugs provided, realising the potential futility of 
continuing treatments whilst others felt that the provision of treatment could be 
politically influenced.  However, there were also tensions in balancing hope and 
non-curative treatment, which added a layer of uncertainty to the pathway of 
cancer. 
 
Data illustrated some patients tried to move on by coping on a day to day basis 
whilst others seek a ‘battle plan’ to deal with the unknown.  Healthcare 
professionals wanted to give a realistic picture, however, they did not want to 
take hope away from the patients.   When there was no treatment available, 
some patients accepted their illness by turning to their faith for comfort.  Others 
were worried about the demands of care on their family.  These data 
demonstrate that all participants, lay and professional had a number of 
decisions and preferences to balance, as they dealt with the uncertainty of 
MSCC.   
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5.3.3 Perception of the demands of care 
The accounts in sub-theme 5.3.3 illustrate patients’ concerns about the lack of 
support for their carers.  Some patients were worried about imposing demands 
of care on their carers and families.  As a result some patients revealed little 
information about their condition to their families.  Carers, however felt 
healthcare professionals did not involve them enough in the care of their spouse 
or parent. 
 
Healthcare professionals thought that as the majority of elderly patients had an 
elderly partner they might be too frail themselves to care for the patient.  The 
following are examples of the different perspectives that patients, carers and 
healthcare professions took in trying to reduce the demands of care. 
 
Some patients were concerned there was no support for their carers.  Richard 
commented: 
“I think a lot...more emphasis maybe put on the people that care as in if 
it’s the daughter looking, err...someone or a wife looking after the 
husband because they at the end of the day, are the carer, not someone 
that comes in from outside to either clean the house or to do whatever 
they do, you know, it’s that individual who is attached to the person” 
(Richard, patient (CS5), p29/7). 
The above account indicates the patient thought his wife needed some support.  
Jimmy was resigned to giving as little information as possible to his wife and 
family.  He described his wife as a ‘worrier’.  He considered: 
“How the consultant is taking it, he’ll not say ‘see you in December you’ll 
not be walking’.  He’s not telling me that, because he doesn’t know.  So if 
he doesn’t know, how do I know?  So, if I don’t know, I don’t tell my 
family.  So, why give them extra worries, concerns, if it is not necessary.  
And that’s the way I am looking and that’s the way I want it.  My wife, she 
got upset and crying and the rest of it, you know” (Jimmy, patient (CS3), 
Interview1, p10/24). 
This excerpt reflected the uncertainty of the trajectory of cancer and it appeared 
that the patient was trying to protect his family from unnecessary worries.  It 
demonstrates the patient taking control of the situation and making his own 
decisions based on knowing his wife and protecting her. 
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Likewise, carers were trying to protect their loved ones.  Jane talked of her “built 
up” stress from the time John’s prostate cancer had spread to his bones.  Jane 
became emotional as she revealed her state of mind: 
“You learn to live with it.  And I keep up for his sake, you know, I’m on 
anti-depression tablets which he doesn’t know” (Jane, wife (CS4), 
Interview 1, p1/31). 
This interpretation indicated that carers faced challenges in caring for their 
loved ones over time and the illness often had an unpredictable trajectory.  
Although Jane said she could turn to her children for help, she was reluctant to 
make demands on them as they had their own families.  Jane confided that it 
was her GP who detected that she needed something to calm her nerves: 
“Ehh, I think the doctor saw that I was needing...needing just something” 
(Jane, wife (CS4), Interview 1, p20/18). 
The carer’s ongoing concern had an impact on her quality of life, however, GPs 
often develop a close relationship with patients and their families and it 
appeared that Jane’s GP was able to recognise her needs.   
 
Mary looked at caring for her mum as her ‘responsibility’ rather than a burden 
and was disappointed the healthcare professionals did not involve her in 
planning her mum’s care.  Mary stressed her point: 
“...whoever makes the decision doesnae (does not) know what sort of 
family... one shoe doesnae fit a dozen people, you know what I mean.  
Basically, it should be discussed with whoever it is that cares for you, 
whether that is going to be possible” (Mary, daughter (CS1), Interview 1, 
p17/14). 
The point the carer was making was that family support differs and here she 
wanted to be actively involved in her mother’s care. 
 
Data revealed that often the carer was unaware of what was being planned and 
felt that healthcare professionals made assumptions of their needs.  The family 
circumstances and life stage of patients and carers was instrumental in how 
they coped with MSCC and the support they needed.  However, it appeared 
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that healthcare professionals had to consider various factors in protecting the 
family.  The oncologist gave his views on the reality of circumstances: 
“The people who are paraplegic will very often go to hospice, rather than 
home.  Um, on the grounds that in, err, an elderly population needing full 
care, there is rarely a carer who can do that, because the carer is usually 
as old and not much less frailer than the patient you want to look after in 
the first place.  Um, and you always have concerns about having one 
seventy-five year-old looking after another seventy-five year-old at three 
o’clock in the morning: what happens when that goes wrong?” 
(Oncologist (CS1), p16/25). 
Here, the patient and her daughter may be oblivious to the intention of the 
healthcare professionals to protect the family.  These interpretations suggested 
that getting a balance was complex and the medical management and 
treatment was not always a priority for patients and carers, particularly once 
pain and symptom management was achieved. There existed a mismatch in 
many respects between the meaning of balance for healthcare professionals 
and patients and their carers.  This second theme has drawn on patients’, 
carers’ and healthcare professionals’ accounts to provide a picture of the 
processes of decision making and strategies in finding a balance in the 
uncertainty of MSCC.   
5.3.4 Summary 
Data illuminated trade-offs between treatment versus quality of life and how 
patients and their carers talked of ‘battle plans’.  Some patients seemed to have 
strategies to move forward whilst others had difficulty living with the progression 
of their cancer.  There was evidence of different views on the demands of care 
from all perspectives.  Some patients were concerned with the lack of support 
for their carers.  There were, however, some patients who did not want to worry 
their families.  Carers, on the other hand, felt left out of the discussion about the 
care of their loved ones.  Contrary to this, patients and carers were unaware of 
the healthcare professionals’ intentions of reducing the demands of care when 
planning what they thought was appropriate for the patients and carers needs.   
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5.4 Support beyond the treatment of MSCC 
This last theme demonstrated patients’ and carers’ transitional needs from 
hospital to home or district hospital/hospice, after the initial treatment of MSCC.  
The long-term implications became more obvious as patients, carers and 
healthcare professionals participated in a range of decisions and negotiations 
around how care should be managed.  Sub-theme 5.4.1 “They say there is 
support out there but...” showed differences emerged between groups of 
participants.  Examples were given where healthcare professionals were 
providing for what they perceived were the support needs of the patients in the 
community.  This did not necessarily match with what the patients and their 
carers wanted.  In addition patients and carers sometimes felt excluded from 
the decision making.  Furthermore, some patients faced challenges living with 
the progression of cancer and sub-theme 5.4.2 illustrated patients and carers 
inherent anxieties around ‘determining the final moments’. 
 
Healthcare professionals may not be aware of how to facilitate these changed 
priorities or the needs of the patients and their carers.  Below are the accounts 
of patients and carers as their priorities changed and how manoeuvring the 
healthcare system was challenging from all perspectives.   
5.4.1 “They say there is support out there but...” 
Given the nature of MSCC as a condition and the limited life expectancy of 
many patients, issues around going home could be contentious and different 
views could prevail.  This ‘in-vivo’ code “They say there is support out there 
but...” indicated patients and their carers had various needs at different stages 
of their cancer journey.  However, healthcare professionals provided support 
they thought matched the needs of the patients in the community.  Some 
carers, on the other hand were not consulted about what was needed.  
Furthermore, patients and carers priorities and needs changed and healthcare 
professionals were not always aware of this, so did not anticipate and facilitate 
these changed priorities. 
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For some patients, their physical capabilities meant they could not carry out 
their daily activities.  During her time on the ward Sandra was assessed and 
identified by a member of staff that she needed some equipment to help her at 
home.  However, the staff said:   
“We have another pro-forma here...that tells us kinds’ of what kind of 
house, there’s any problems.  She might have needed a bed rail to help 
her get in and out of bed.  We have a social meeting every Tuesday to 
discuss this kind of things.  But she’s probably been and gone.  And it 
has been decided no” (Staff Nurse (CS2, p4/5). 
This account suggested the patient was discharged home very quickly and this 
precluded addressing these issues.  It appears there was a lack of follow up.  
Sandra also found getting practical help was difficult: 
“They say there is support out there.  I did speak to the financial guy, 
who said there was nothing they could do for me.  I did ask about a 
disability pass because if I’m trying to carry messages or...or walking...  
but because I can walk 50 metres, I’m not entitled to a pass” (Sandra, 
patient (CS2), Interview 1, p27/19).  
Here, it appears the patient had difficulty obtaining help from social services 
agencies.  Besides facing physical challenges, some patients and their carers 
had financial worries.   
Sandra’s husband, John considers: 
“You don’t seem to get an allowance for having cancer.  No, well, the 
thing is we have a wage packet we don’t get any help, right, because we 
earn too much money.  It’s people who don’t earn money at all who 
seems to get it which I think is quite wrong because at the end of the day 
I’ve paid my tax and national insurance and I feel as if why should people 
in the lower income just get help with...you know, I mean we’ve got a 
lifestyle we still should get help” (John, husband (CS2), Interview 1, 
p19/19). 
 
In contrast, Jimmy got help with claiming his benefits: 
“I have something from the doctor I have to send away for.  
Letters...aha...benefits.  She (clinical nurse specialist) said ‘you definitely 
got to get that’.  I get it for my legs and arthritis in my back – a small one.  
She said no, she says you have to get a lot of benefits because you need 
to jump in taxis and all the rest, you need to move about and you take 
that” (Jimmy, patient (CS3), Interview 1, p15/20).  
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These accounts suggest some patients needed disability or financial support 
but they may not necessarily know how to access the appropriate social 
services.   
 
In Jimmy’s case, he felt supported by his nurse specialist in helping him with 
this information.  However, many patients were unaware of this assistance from 
the hospital social services department or the Macmillan, or Maggie’s Centre. 
 
For patients who were mobile, going home was straightforward, however, if the 
patient was paralysed, this was more challenging.  For example, Betty wanted 
to go home but her daughter, Mary, described getting her mum home had been 
“a fight and red tape the whole way”.  Mary stressed her point on both 
interviews: 
“I think what is important for medical staff erm...that are dealing with 
people with...spinal cord compression or any sort of cancer or illness that 
erm...patients have a right when they do want to go home. They have a 
right. And family have a right to make the choice whether they want to 
care for family [Patient: at home] and they shouldn’t have been dismissed 
without actually speaking to the family” (Mary, daughter (CS1), 
Interview2, p23/23). 
This account suggests the patient’s daughter wanted to participate in decision 
making in her mother’s care and was prepared to care for her.  However, the 
registrar who was assigned to see to Betty’s discharge anticipated the risk of 
Betty going home: 
“And because she lived alone, um...it would be medical negligence to 
send her back home, where she can’t cook, eat, or go to the toilet, or 
anything like that.  So, the hospice was the only viable option in her case, 
because she’s big – totally immobile.  If she lived with somebody, that 
person alone can’t take care of her needs” (Registrar (CS1), p18/9). 
This account suggests that healthcare professionals make decisions they 
perceive to be in the best interest of the patient. 
 
However, the patient and carer may not have been involved in discussions 
and/or the availability of support in the community investigated.  Mary was able, 
through her friends working in their local hospital, to arrange for her mum to be 
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transferred there instead.  Four weeks later, during my second interview with 
Betty and Mary at their local hospital, they were still waiting for her discharge 
home.  Two community nurses talked of their experiences of arranging for 
Betty’s package of care: 
“Because this lady had been risk assessed by the hospital to say she 
needed four people at all times for moving and handling.  This was a big 
problem for us.  But they also said that she needed 24 hour care.  We do 
not provide 24 hour care.  But you’ve got the legal aspect of then putting 
your staff at risk, - lift, moving and handling with people who aren’t 
properly trained (meaning the carer).  We had to get legal advice before 
she came home, you know, where we stood legally if family wanted to be 
involved” (Community Nurse 2 (CS1), p5/34). 
This interpretation suggests that although the patient’s family wanted to 
participate in the patient’s care, there were legal implications involved.  
Moreover, arranging a care package also involved approval from other 
agencies.  The community nurse continued: 
“So, you’re always waiting on people getting back to you.  So, it’s just 
getting the puzzle to fit.  [...] but this is with every discharge: you get 
limited information and it’s like a fishing trip; you have to get...you’re 
gathering information from everybody you meet until you build up a better 
picture” (Community Nurse 2 (CS1), p20/6).  
It was notable that getting resources involved a range of agencies and it was 
evident that getting coherent information and transition in care from hospital to 
home could be challenging for the community nurses.   
 
One of the community nurses talked about the assessment done by the hospital 
team: 
 “I think it was the multi-disciplinary team within the ward that said that 
was what was needed.  And if that hadn’t been documented, we could 
have then gone and done our own and decided, because the lady was 
easier to move than initially we were told.  Once she was at home, things 
were different.  You know, with the right – we didn’t put a hoist in 
because it did hurt her and because of her oedema, etcetera – but with 
the right sliding sheets, the right bed, etcetera, she was easier to move, 
and I think two could’ve probably done it” (Community Nurse1 (CS1), 
p8/12).     
These accounts highlight the prescriptive pathway followed when arranging for 
this patient’s care package and delayed the patient’s discharge home.  This 
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proved challenging for the healthcare professionals in the community as they 
needed to look beyond the task and take into account the other aspects of the 
patient’s needs, home environment and priorities for continuity of care to be 
effective.  In contrast, Emma’s going home was a different experience.  The 
occupational therapist considered:  
“The options have been discussed with her.  You know, whether its home 
or hospice or somewhere else.  Um, we discuss with her and her 
husband and they both were super keen to get her home” (Occupational 
Therapist (CS6), p12/13). 
Here, Emma had an accelerated discharge home with all help put in place.  The 
occupational therapist commented on the swift community arrangement:  
 “They’re all working really efficiently actually.  Because initially we were 
saying that maybe the end of next week, but we gave the district nurse a 
phone and she says that ‘we can maybe try and get services in by 
Tuesday’” (Occupational Therapist (CS6), p17/27). 
There seemed to be variations in getting support from different geographical 
areas.  In some regions, support was arranged and put in place at short notice, 
whereas in other areas, support services were not readily available.  
Furthermore, it was apparent that some patients were given a choice in their 
place of care whilst others did not have a say.  A senior nurse described that 
discharge planning can be challenging: 
“Erm...I guess for us, it’s...it’s really the ongoing (care).  Cause, I mean 
we’re quite an acute side of things.  And it’s the uncertainty of how long 
it’s going to take for that patient erm...to find the appropriate placement 
for them.  And for us that’s...even in the acute area, that is a problem” 
(Charge Nurse (CS1), p6/22).   
There was a sense that trajectory of cancer was a long process and considered 
a chronic condition and when an acute episode occurred this needed immediate 
attention.  However, arranging subsequent care was challenging and patients 
needs could be overlooked. 
 
Although Jimmy was still mobile, his consultant gave his reasons for referring 
Jimmy to the palliative care team.  He said: 
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“And we usually...we try for most patients, if they will accept the idea, to 
get them to make contact with Marie Curie…. Macmillan at diagnosis, if 
they are incurable.  Because it means that, when they do need 
somebody, they know where to go straight away, and they know who the 
person is, rather than otherwise” (Oncologist (CS3), p16/6) 
This account indicates the oncologist was anticipating the patient’s future needs 
and addressing the transition from hospital to the palliative care team in the 
community.   
 
In Jimmy’s case, he was happy for his consultant to make the decisions for him: 
“I think it’s the Marie Curie or something this way or another.  The other 
support to get me for here: my own doctor, the nurse who sees me – 
excellent.  Even...even my family says she helps me in every way, helps 
me in every way: ‘Jimmy take this’, ‘Jimmy do that way’, ‘that’s the way’.  
She will work out for me” (Jimmy, patient (CS3), Interview 2, p10/34). 
Here, it appears Jimmy accepted his follow-up care unequivocally.  This excerpt 
also highlights that his specialist nurse was his source of professional support 
and that there was a sense of staying connected and supported.  Some patients 
and their carers seemed to get into a routine by the time of the follow-up 
interview.  For example, Matthew laughed when we talked about using the hoist 
“I think I’m better at that than most of the nurses that come in!” He added with 
the nurses help: 
“Yep, gets her up in the morning, gets her all ready to go, and then at 
night just putting her to bed.  They were here three times a day, but we 
were finding they weren’t needed, so we just put them off.  It gives us our 
day” (Matthew, husband (CS6), Interview 2, p2/5). 
This excerpt indicates that the patient and her husband had priorities and needs 
which changed over time and they wanted privacy and quality time together. 
 
Richard was discharged home but experienced difficulty controlling his pain.  A 
week later he was admitted to the hospice for pain management.  When 
Richard’s condition deteriorated, Linda, felt the healthcare professionals at the 
hospice did not give him an opportunity to stand on his feet but treated him like 
“an invalid”: 
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 “ It’s like I’m out of control, that they...that the people who are looking 
after him now have the control and, you know, they’re, they’re kind of 
managing him in a way which I am not in a total agreement with.  Um, I 
mean I wouldn’t mind...you know, cause I understand they’ve got to 
protect their own staff, but what I would like in addition is perhaps using 
the hoist is giving him a chance to stand and to get practice in that” 
(Linda, wife (CS5), Interview 2, p23/18).     
Linda, also a nurse herself said she understood that the staff would be blamed if 
they knew about Richard being at risk and did not take notice.  However, she 
expressed that healthcare professionals may assume “the risk was high” 
although she thought it was a “probability”. 
“So, I do know all that, but at the same time I think there’s a balance 
between risk and I don’t, I don’t know quite how to put it, um, because 
like we all fly and we all go in cars and we know there’s a risk.  It’s 
not...life isn’t free from risk, and it’s that balance of trying to not take 
away unnecessarily someone’s independence without trying to maintain 
what they have” (Linda, wife (CS5), Interview 2, p25/8). 
The account above suggests that sometimes carers were willing to take risks.  
The interpretation also highlighted this sudden disruption could be challenging 
for carers to cope and they wanted some control in managing their daily routine.  
It also appeared that the carer may not have been involved in discussions about 
the patient’s deterioration or about the use of the hoist.  Linda added: 
“I’d imagined we’d use a wheelchair of course but I didn’t realise we’d be 
using a hoist or we’d be waiting on people coming to do that and all that 
kind of thing and, you know, having people come four times a day.  I 
mean your life’s not really your life anymore” (Linda, wife (CS5), 
Interview 2, p29/19). 
This account demonstrates that the level of support and the nature of the 
interventions required came as shock to the carer.  Although Linda was grateful 
for the care and attention, she felt that healthcare professionals were “a bit 
prescriptive” and did not understand why using the hoist could not co-exist with 
giving her husband some opportunities to stand.  Moreover, there was a sense 
of apprehension of losing their control and privacy with the frequent care that 
was planned.  In addition, carers expressed that they faced a dilemma when 
discussing their concerns with the patient’s consultant.  Linda considers: 
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“I think because he’s under the hospice then the doctor [consultant’s 
name] obviously isn’t going to interfere with that, so all we’re gonna do is 
go back and see, um, the consultant at the end of the month I think” 
(Linda, wife (CS5), Interview 2, p4/11). 
This account suggests that patients and carers have to deal with different care 
providers and getting their concerns across was not easy.  The lack of 
opportunity to discuss their concerns resulted in continued anxiety and 
uncertainty in the carers.  In some instances, patients reported there were 
issues around communication between the hospital and their GPs.  Sandra 
commented that her GP was not in “the loop” and was “not up to speed” with 
her recent admission to the hospital: 
“And two weeks after I was out [of hospital] my doctor still well...two 
weeks after the consultant had prescribed me this drug, two weeks 
after that she still hadn’t had the letter telling her what drug I was on.  I 
had to spelled it out to her and take the packet with me to show her 
what it was so that she could get the prescription ordered” (Sandra, 
patient (CS2), Interview 2, p45/18).    
Continuity of care could be a problem when communication was delayed.  This 
may result in treatment delays, increased stress and a loss of confidence in the 
health service.  Some GPs felt communication with the hospital was adequate; 
however, one of them felt that a personal call could clarify patient’s subsequent 
needs.  One GP said: 
“...they were absolutely insistent: oh, the hospital says that the nurse has 
to do this, you know.  And so, our district sister was going in every day 
for two weeks to check blood sugar that there was nothing wrong with, 
you know.  [...] it might have been better if someone had phoned up and 
spoken to one of the doctors in the practice – because that was kind of 
complex – and explain what was happening, rather than just send this 
home with a message to the patient which was very clear but probably 
unnecessary – I mean, there was really no need for that man to check 
his blood sugar twice a day, there really wasn’t” (GP (CS4), p6/32). 
This excerpt suggests the hospital was prescribing ‘hospital type care’ instead 
of discussing with the patient’s GP.  As the GP knew his patient was diabetic, 
his wife would not have the problem of monitoring her husband’s blood sugar.  
This also suggested that resources could have been better placed in other 
areas.  Similar communication issues were also encountered between 
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hospitals.  The registrar at the Cancer Centre commented about receiving Jock 
from the district hospital:    
“Um, in Jock’s case, when he was transferred up, um, he had very little 
information sent with him about his, um, his background and certainly he 
had a transfer letter but he had had previous follow-up for his prostate 
cancer and none of those letters were copied, um, and sent up to us, we 
had to organise that after he was admitted” (Registrar (CS8), p16, 18). 
This showed the need to gather information from different aspects of the 
patient’s medical history.  The registrar at the district hospital had difficulty 
making out Jock’s discharge information and commented Jock needed further 
investigation and explained why it was delayed:   
“Erm, I had spoken to them on the phone before I went on holiday to 
basically say ‘yes’ to his transfer coming back, and they had mentioned a 
possibility of a biopsy erm, and they said they would put it in the letter 
which they sort of did, but it was, as I say it was difficult to read.  [...] 
there was a delay because the staff who received him back couldn’t read 
the letter clearly, erm, and there were concerns about trying to get him 
home, trying to get care arranged and equipment arranged for home, and 
it kind of got overlooked.  So, I came back from holiday and arranged the 
biopsy fairly quickly” (Registrar (CS8), p27/19).  
These accounts suggest a chain of communication at different levels between 
hospitals, general practitioners and the different support agencies. This 
increased the possibility of patient’s needs and their continuity of care being 
overlooked or falling through the net.  The discharge letters can vary from 
structured discharge forms to a fax letter with minimal information. 
 
Jock had further investigation after his transfer back to his district hospital.  
Although Jock had a history of meningioma and prostate tumour, his PSA was 
low enough to be suspicious.  His skin lesion biopsy confirmed the primary site 
of spread.  According to the registrar, Jock was very anxious to go home by that 
time and they had to rush to get his investigation done:  
“His final diagnosis was a little bit odd.  I’ve got it here. [Shuffling of 
papers] Erm, metastatic small cell neuroendocrine carcinoma, erm... the 
pathologist has reported that the most likely site being prostate.  Erm, so 
it’s just a slightly atypical type of prostate carcinoma.  It was a little 
metastatic deposit that was in his skin, so they did it with ultrasound 
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guidance...because you couldn’t actually really feel it” (Registrar (CS8), 
p19/2). 
Patients may continue to have further investigations after radiotherapy to 
determine the primary site of spread.  This could cause anxiety and uncertainty 
for the patient and his family.  However, not all medical staff felt the need to do 
further investigation if the patient had a short life expectancy especially in lung 
cancers.  Betty was an unknown primary case and after several investigations; 
it was futile to continue once her mobility deteriorated.  
 
Accounts from patients and carers also illuminated the disruption and in some 
instances difficulty in coping with side-effects from steroids and radiotherapy 
once they were home.  Richard, however, was admitted to the hospice a week 
later for his pain management.  His palliative doctor was not sure whether 
Richard’s change in mobility was due to the sudden drop in the steroid dose 
and restarted him on steroids, which improved initially.  However, when 
planning his discharge, the difficulty was getting the steroids dose right: 
“The steroids made the leg oedema worse, which made his mobility 
poorer, but when we dropped the steroids, then his mobility got worse 
again, so it was just there were lots of factors going on with him and so 
it...it took a long time to get things set up to get him home” (Palliative 
Care Doctor (CS5), p4/26). 
The situation for Sandra seemed to have affected her greatly.  She described 
not being aware of the effects of treatment and that extreme fatigue had led to 
difficulties performing her daily tasks.  Sandra expressed her frustrations: 
“Erm...I would wake up and I was absolutely soaked in sweat from head 
to toe.  I come out in a rash on my back but the doctor said sometime 
coming down from the steroids, you know, when you’ve been on a high 
dose of steroids and as you come down you can go through quite a few 
different experiences.  I just don’t think I took in or understood just how 
[Pause] badly they can affect you or they seemed to affect me.  
Erm...and I don’t think I realised...I didn’t think with only 5 doses of 
radiotherapy I would feel as tired as I do” (Sandra, patient (Case Study 
2), Interview 2, p6/12). 
Sandra was used to leading a busy life in which she was in control, however, 
her extreme fatigue and her rash had resulted in several visits to her GPs.  
Sandra talked about being depressed: 
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“I felt quite bad and what is the point of going on and looking back now, I 
felt as though I could end it now and it was the steroids that were doing it 
and I felt really down.  I also felt really drunk all the time when I came 
home as though I had about 6 bottles of wine” (Sandra, patient (Case 
Study 2), Interview 2, p9/1). 
Patients also talked about difficulty coping with their pain.  During our second 
interview, Jimmy talked about his continued pain despite receiving radiotherapy 
treatment and that adjusting to a comfortable level, with morphine was difficult.  
He talked about his frustrations during meal times:   
“Aye...sitting is sore.  I sit there I get sore but...what I do is I stand 
up...no, I’ll do that for a while and then another thing  is...I stand up 
[illustrating by standing up] and I have been walking straight and that 
eases it off.  Even I eat standing up.  I eat standing up and then I can 
enjoy my food” (Jimmy, patient (CS3), Interview 2, p5/23). 
By coincidence, after our second interview, I saw Jimmy on the ward.  He 
related that he had been admitted twice, once to the hospice and then to the 
cancer centre because he had overdosed with his pain killers.  He, however, 
was mobile but sometimes needed the aid of a walking stick. 
 
Whilst some patients had difficulty coping with the side-effects of treatment and 
pain, some patients expressed difficulties in adjusting to their disability.  For 
example, Emma’s mobility rapidly deteriorated but it was when she was home 
the reality sank in: 
“I think it was just the realisation that I was in the chair and I had lost the 
use of my legs and...erm... I was having to depend on everybody and I 
think that’s basically what it was” (Emma, patient (CS6), Interview 2, 
p14/19). 
Although Emma said she was coping fine and consoled herself that she could at 
least move around in her wheelchair, she found it frustrating and said she had 
“lost her confidence”:  
“I don’t know.  Just going out and people seeing me in the wheelchair, 
and that’s just never been me, so...so, it’s that...it’s just something that I 
need to get used to” (Emma, patient (CS6), Interview 2, p11/8). 
This excerpt suggests Emma was apprehensive about the stigmatisation of her 
disability, resulting in a loss of self-esteem.  She realised she had to adjust to 
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her changed circumstances.  However, she was not keen about attending 
support groups activities: 
“I just don’t want to go along to that kind of thing and it be constant talk 
about cancer and what have you.  It’s not that I’m trying to bury my head; 
it’s just I don’t feel I need it at this moment in time” (Emma, patient (CS6), 
Interview 2, p16/2). 
 
In contrast, Robert and Richard had previously been attending the Macmillan 
Centres for managing their pain before this episode of MSCC.  They were 
enthusiastic about the support they received from their local centres.  Richard 
could not fault the support he received thus far: 
“...it’s a terrific place to go to get different views, to see people who are in 
a similar...who got cancer in the prostate what have you, so it’s a good 
place to go to.  It’s kind of relaxed...” (Richard, patient (CS5), Interview 1, 
p16/9).  
Here, it appears the Macmillan Centre seems to have provided emotional 
support and symptom control.  Richard’s wife, Linda, on the other hand, felt that 
she had to deal with it herself:  
“...I find it is of limited benefit because at the end of the day what can 
anybody say to me, you know.  It’s something that you have to work 
through in your own head.  And of course, again I pray about it and then 
you have to just ...it’s accepting it and then also thinking well at least he’s 
not dead” (Linda, wife (CS5), Interview 2, p37/6). 
Although patients and their carers had varied views about support groups, most 
of them talked of good support from their spouses, families and friends. 
“My mum’s in every day, my dad’s in every second day, if not every 
day” (Emma, patient (CS6), Interview 2, p16/14). 
Some carers turned to spirituality for comfort.  Others preferred a personal 
contact or a phone call from a healthcare professional.  Sandra felt her previous 
sessions with a psychologist had helped her:   
“You get lots and lots of support at the beginning or when you got 
problems and you spoke to the doctor.  And I had the psychologist to talk 
to, she has moved away now.  Erm...I got no one...and you know, my 
husband, I feel guilty because I feel as I talk something to do with me 
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every day and it must wear him down” (Sandra, patient (CS2), Interview 
2, p14/24). 
However, her sessions with the psychologist were discontinued as her 
consultant felt that she no longer needed that service.  Sandra talked about 
experiencing extreme fatigue and her reaction to her bone-strengthening 
medication.  All these compounded on her rollercoaster of emotions:  
“I have good days where I feel quite positive.  Today I don’t feel bad.  
There are other days where I feel really, really low, really down.  And I 
can’t pick myself up for anything...and on those days...I love...there was 
somebody I could speak to when I needed them.  It’s not frequent and 
not regular basis” (Sandra, patient (CS2), Interview 2, p17/12). 
Sandra described her experience as an “isolated feeling of dealing with it on 
your own”.  Sandra considers: 
“Erm, I just think you don’t have a district nurse coming in anymore just 
to check on you although I don’t have anything physical but nobody will 
phone you up and say ‘how are you doing today?’; ‘how are you 
keeping?’ you know.  For three months you’re on your own and then you 
got a five minutes slot, 10 minutes slot to get out all your worries, any 
symptoms, get that sorted and out the door you go and you’re another 
three months on your own.  So, for the majority of time I feel I deal with 
this cancer by myself” (Sandra, patient (CS2), Interview 2, p41/27). 
Sandra felt a sense of being abandoned and ‘journeying alone’ in her cancer 
journey.  Although she said her husband was supportive, she felt he was not 
able to handle the emotional aspect and may not understand what she was 
going through.  John too, had his worries and was uncertain how his teenage 
sons were coping: 
“That I can’t honestly say because I think it affected them in different 
ways.  Erm, one is at uni obviously affected because he was not 
concentrating right obviously.  My other son, well, he’s [signs] he’s trying 
to block it out.  He’s trying to ignore it.  So, I say he is dealing in his own 
way” (John, husband (CS2), p15/12). 
Carers sometimes did not reveal their worries or concerns to their loved ones 
and this may be interpreted as not emotionally engaged.  Patients sometimes 
may not have family support or live in a remote area and this can have an 
emotional impact on them.  According to Sandra, her mum and sister were not 
supportive and her nearest neighbour lives far away.  Healthcare professionals 
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may need to explore patients support networks and consider alternative 
support. 
 
Similarly Tony found difficulty dealing with his emotions: 
“I suppose I keep a lot of things inside myself.  I have my own particular 
moments, but, as I said, I find it difficult to talk to family members about 
things – how...exactly how I’m feeling – sometimes, 
because...eh...because it gets...it just gets too emotional, and I..and then 
I don’t get the support that I need at that time.  Not through any of that 
person’s fault; it’s just because it’s too strong an emotional contact for 
talking like that, because it breaks down to...  But if you talk to someone 
that is not emotional, then they can stay fixed on what you’re trying to 
say” (Tony, patient (CS7), Interview 1, p28/13). 
The above accounts suggest patients felt lonely and talking to someone as and 
when needed would have been beneficial.  It also suggests that patients talking 
to family members may be difficult as they too were emotionally involved.  
Therefore, this suggests not all patients turn to their family for emotional 
support.  Healthcare professionals may need to recognise that individuals cope 
differently and may not necessarily ask for help. 
 
Illness and the recurrence of cancer had a profound effect on all the family and 
home is where many of the challenges were faced and needed to be met.  
However, healthcare professionals may not be aware of patients’ needs as not 
all patients were able to articulate their worries and as in Sandra’s case, did not 
want to bother the healthcare professionals. 
 
Some carers expressed frustration in their attempts to resume normal family 
life.  Gail and Tony had two young girls age three and five.  Gail kept Tony’s 
Zimmer frame out of sight:  Gail gave the reasons for her action: 
“And he’s got a Zimmer frame which I didn’t like him using it at all.  
Erm...we put it in the garden...erm...I didn’t like it in the house.  I think it’s 
an old person’s ...I just didn’t like seeing him using it” (Gail, wife (CS7), 
Interview 1, p23/8). 
This account suggests that the carer had difficulty adjusting to her husband’s 
changed needs and it affected their family dynamics.  There was sadness in 
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Tony’s voice when he confided about his difficulties participating in his 
children’s care due to his condition.  He acknowledged the increased demands 
on his wife, looking after him and their children: 
“It’s hard for me because I feel as though I’m not doing my bit, I’m not 
doing my share, I’m not helping out and I’m not...eh...well...held my 
children as much.  This is frustrating and a bit err...hard, a bit hard for 
me, you know what I mean” (Tony, patient (CS7), Interview 2, p26/5). 
These interpretations suggest that for patients and carers, the development of 
MSCC and their attempts to move forward is difficult and impacted on family 
dynamics. 
 
Matthew confided about his living circumstances: 
“Eh, I think I adjusted quicker and easier than I thought I would with the 
change.  It’s obviously a – I don’t think its ideal having Emma down here 
[referring to the living room].  It’s ideal for the situation, but not ideal for 
me; I want her back upstairs, eh...” (Matthew, husband (CS6), Interview 
2, p9/11).   
Here, it indicates that physical changes to home and living space had an impact 
on getting back to normality for the patient and carer.  In addition relationships 
could be affected with the role change.  Patients and their carers reported the 
shifting of roles from wife or husband to carer.  Gail took over responsibility for 
dealing with her family’s practical needs; for example, driving her children to 
school, attending to Tony’s hospital appointments and at the same time working  
part-time. 
 
Linda talked about having to reduce her working hours which meant less 
income, however, she had been poorly lately: 
“I’m not sleeping very well at the moment because of that and 
worrying about Richard and, you know, all these things, so I don’t feel 
brilliant at the moment” (Linda, wife (CS5), Interview 2, p41/6). 
This account suggests that she had to cut down on her working hours to look 
after her husband and this had affected her health and perhaps their financial 
security. 
The main issue from these interpretations is that for patients and carers, after 
the initial treatment was over, the impact and the long term implication of what 
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was happening became more obvious.  Some of the professionals’ decision 
making was grounded in the acute phase of the patient’s condition and the 
transitional needs from hospital to home were not always identified and met.  
For patients who remained mobile, their support varied depending on their life 
expectancy.  However, if the patient was paraplegic, the rapidity of organising 
support services appeared to vary depending on their geographical areas.  
Some patients had a choice in their place of care, while for others decisions 
were made for them.  Moreover, there appeared to be a chain of communication 
from different agencies and the patient’s needs could be overlooked.  Some of 
the patients were unaware of the impact of coming off steroids and the side-
effects after completion of radiotherapy.   
 
Patients talked about experiencing extreme fatigue, some had difficulty 
managing their pain and in some cases felt depressed and found difficulty in 
coping with their daily activities.  They were uncertain of their health status and 
their capacity to continue working.  When the patient’s physical capabilities 
deteriorated, support in terms of equipment and financial aid could be 
challenging for patients and their carers to access.  
 
Healthcare professionals may not be aware of their changed priorities and the 
support they provided may not necessarily meet the needs of the patients and 
their carers’.  Patients and carers views towards support groups were mixed.  
Some patients were offered psychological help while others were not.  Some 
patients expressed difficulty turning to their family for emotional support as the 
carers and family members themselves were emotionally involved.  However, 
they expressed that support can be in the form of a telephone call from a 
healthcare professional.   
 
Some patients and carers expressed frustration in their attempts to return back 
to their normal family life.  The next sub-theme illustrates that patients continued 
to face uncertainty as their physical functions deteriorated and this raised fears 
around dying.  Carers found themselves struggling with uncertainty and trying to 
determine the patient’s final moments.   
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5.4.2 Determining the final moments 
This last sub-theme indicates that the patients’ and carers’ cancer journeys 
were still fraught with uncertainty and that there were movements between 
waiting for continued treatment and palliation of symptoms and death.  Others 
expressed the fear and anxiety of not knowing how to determine the final 
moments.   
 
Tony had radiotherapy following surgery but in interview 2, he talked about his 
concerns regarding continued treatment: 
“Eh...now my concern is...I suppose my big concern, because I have this 
problem, I’ve stopped the chemo now my initial tumours the longer the 
time extends out that these might get bigger.  So, that’s my concern, my 
worry at the moment and so that’s why I wanted everything really to go 
quickly so that they can go back on course for my original treatment” 
(Tony, patient (CS7), Interview 2, p11/22). 
On a similar note, patients also talked about waiting for MRI scans to be taken 
on their spinal cord.  Richard was admitted to the hospice after experiencing 
falls and had pain issues.  Richard expressed his continued worry during my 
second interview with him: 
“I mean, I don’t know whether they can do the chemo, I don’t know 
whether they can do the strontium; and I don’t know whether...um...the 
radiotherapy’s working.  I don’t know.  I mean, I really don’t know.  And I 
don’t know how they actually tell without going to get MRI scans, or 
whatever it may be.  This is what I’m hoping to discuss on Monday with 
the doctor” (Richard, patient (CS5), Interview 2, p11/5). 
The above accounts show the patient’s constant oscillation between palliative 
and curative treatment demonstrating the link to the uncertainty of the illness 
pathway.  In my field notes, I recorded my conversation with one radiologist: 
Researcher: “Do you do scans to check whether the tumour has 
shrunk?” 
Radiologist: “Not necessarily, unless they are going to treat the patients” 
(Field notes R1). 
However, patients did not have the information that scans may not be routinely 
done unless there was further treatment planned.  The ‘waiting for a scan’ 
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caused some patients to have continued worry.  Moreover, over the years of 
follow-up, patients had expectations of surveillance scans, and when this did 
not happen, they experienced continued uncertainty. 
 
Patients also raised the issue of the follow-up being too long apart, notably as 
they assumed the urgency in getting treatment at the acute stage also meant 
they would be followed up closely.  Sandra highlighted the need to monitor her 
tumour which would provide her with peace of mind: 
“I think it would put my mind at rest if I did get a scan and they said the 
tumour has shrunk” (Sandra, patient (Case Study 2), Interview 2, 
p33/26). 
The above accounts suggest patients need to be reassured in knowing that 
there were no problems detected and this seemed important to assist them to 
cope with their cancer.  In interview 2, Sandra said she had several episodes of 
nightmares after her discharge from the hospital.  She described her 
indeterminate state as “waiting for the inevitable”:  Sandra added: 
“But it was scary, it was all about being immobile, being tied to 
something, not being able to do things for myself get about and 
...umm...that I was going to die” (Sandra, patient (CS2), Interview 2, 
p1/16). 
The accounts demonstrated an oscillation between wanting treatment and 
monitoring against the understanding this could be terminal.  For example, the 
palliative doctor talked about Richard’s reaction after his appointment with his 
oncologist: 
“So, when Richard came back from that appointment, he was feeling 
very optimistic.  I think just the fact that [name of consultant] had given 
him an appointment after Christmas had made him feel ‘oh, gosh!  so, I’ll 
make it past Christmas then!” (Palliative Care Doctor (CS5), p17/9). 
This evidence suggests that patients perceived follow-up appointments as an 
indicator to their life expectancy.  Emma’s GP talked about how she tried to 
determine Emma’s understanding of her terminal stage:  
“I said to her, you know, ‘have you any questions?’  and I said things like 
‘sometimes people are worried about what happens at the end,’ and I 
said ‘is that something you want to ask me any questions about?’ and 
 
 
 
 
214 
 
she said ‘no,’ and she said ‘I might do nearer the time,’ and I said ‘yeah, 
that’s fine; I’ll just keep dropping hints and you can let me know if you 
want anything.’” (GP (CS6), p4/23). 
Emma expressed her fear when confronted: 
“I’m scared.  She asked me...erm...about my issues about dying and 
what have you, and how I’m always sort of cheery and what have you.  
But I am...scared of dying...erm...and that’s what I was saying to her.  
And she was asking if I wanted to be resuscitated, and...erm...I said 
‘yes’” (Emma, patient (CS6), Interview 2, p20/13). 
This indicates that a discussion around end-of-life issues was a sensitive area 
but the GP had to explore the patient’s wishes in her final moments.  Emma’s 
GP encouraged Emma to contact her priest: 
“She was a member of the...Catholic Church and I encouraged her to get 
in contact with her priest, but I don’t think she ever did.  I think she 
thought she would live longer and I don’t think she wanted to cause any 
trouble to anybody.  That was very ‘Emma’.  [...] I would have liked 
Emma to have sought support from her priest and that would have, 
um...been a comfort to me; not on a spiritual level, but I would have felt 
that I had...that all those areas had been covered” (GP (CS6), p6/19). 
This suggests that the GP tried to provide what she viewed as holistic care, 
however, not all patients were ready or wanted spiritual care.  Carers on the 
other hand expressed their ongoing anxiety about end-of-life issues.  Matthew 
expressed his worries about his uncertainty on how to establish Emma’s final 
moments: 
“Well, things like pain.  If it starts to come back, with any tumour growing, 
if they’re putting any pressure, like on the bone or things like that again.  
The tumours in her lymph nodes are near her air pipe – wind pipe, 
whether it starts putting pressure on that causing breathing problem.  It’s 
all ‘what ifs,’ really.  You try not to dwell on it too much, but it’s those type 
of fears and it’s those kind of symptoms that may present, that type of 
thing” (Matthew, carer (CS6), Interview 2, p11/9). 
Here, the carer’s uncertainty was in respect of trying to establish and anticipate 
what signs and symptoms to look out for to determine their loved one’s final 
moments.  Linda also talked about facing and “not fighting the inevitable” when 
Richard became poorly.  She talked about making an appointment to discuss 
this issue with Richard’s consultant: 
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“I think I’ll do that and then Richard is not there, you see and the last 
thing I want for Richard to have is a horrible prognosis, you know, cause 
that’s discouraging... and I think he’s better just not having all the details 
and I...yeah.  Whereas, um, it would be better if I had them so I can be 
realistic, cause the last thing I want to be is in denial that this is 
happening and, you know, and fighting against the inevitable instead of 
you know, just accepting all the help I can get and just going with it, if you 
see what I mean” (Linda, wife (CS5), Interview 2, p19/18). 
Here, the carer thought she should shield her husband from the worst news.  It 
was notable that the carer’s needs for information on prognosis changed when 
the patient’s condition deteriorated.  This account suggests that the carer felt 
helpless; however, she had to accept and prioritise what was important at this 
final moment.  Linda was not keen to know her husband’s prognosis during the 
acute stage of MSCC; however, the above account showed her needs were 
more pressing at the terminal stage.  This may also indicate she wanted control 
in anticipating grieving.   
 
Richard, however, talked about his emotions: 
“Well, you’re emotional all the time.  I mean, I think most people would go 
through maybe a day/a couple of days without feeling particularly 
emotional, and then it suddenly hits you again that, you know, it might 
not be long, and you get a bit tearful and that.  And it just comes and 
goes, you know.  It might be in the middle of the night, it might be you’re 
sitting getting your dinner and you feel a bit of flush of tears and what 
have you, because you know you’re not seeing your grand-bairns (grand 
children), or whatever it may be.  But again, what do you do, you know?  
You just have to accept the fact that’s going to be there; there’s nothing 
much you can do about that” (Richard, patient (CS5), Interview 2, 
p18/25). 
It appears the patient had difficulty coping emotionally and experienced fears of 
dying and was also worried on issues beyond death.  These fears can occur at 
anytime, as Richard said he could be crying at mealtimes.  There was a sense 
of helplessness and the patient talked about accepting the roller coaster 
emotions.  Richard turned to his chaplain for spiritual comfort: 
“...there’s a better place to go to, not to be frightened, that Linda’s going 
to be looked after, my family will be...so, I’m quite comfortable with that.  
Quite comfortable” (Richard, patient (CS5), p20/17). 
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There was a sense that both the patient and his wife knew what was going to 
happen and appeared to be protecting each other.  Richard confided that his 
mainstay was to go home and be with his family.  Sadly, Richard died before 
Christmas at the hospice. 
 
Betty’s daughter gave the researcher a lift to the train station.  On the way she 
expressed not knowing when her mum’s final moments were.  She talked about 
her uncertainty during the journey to the train station: 
“You know, they have removed her catheter because it kept getting 
blocked.  She was passing large clots of blood, I am not sure whether 
this is her coming to the end” (Field note C2). 
Carers face difficulty when seeing their loved ones slipping away: 
“Tony not being here...hmm...hmm...thinking that yeah...I think about it 
every day.  I don’t tell him that but yeah I think about it every day of him 
not being here” (Gail, wife (CS7), Interview 1, p17/14).  
Here, it appears the carer was grieving and was anticipating life without her 
husband.  Tony was readmitted to the hospital for jaundice but his condition 
deteriorated rapidly; his consultant encouraged him to spend his last Christmas 
at home with his family.  Sadly Tony died before the researcher had the second 
interview with Gail.  However, Gail was keen to continue with the second 
interview and agreed to meet two months later to allow her to grieve.  During 
the second interview Gail said it was hard to accept the bad news but felt 
supported by his consultant: 
“She did ask me if I had any questions, and at that point I thought ‘no I 
won’t ask her how long,’ and then, luckily, she phoned me a couple of 
days later and I did ask her”(Gail, wife (CS7), Interview 2, p13/27). 
This implies the carer wanted to determine her husband’s final moments, 
however, she did not want to cause her husband emotional distress.  A 
telephone call from Tony’s consultant showed support and gave Gail an 
opportunity to voice her concerns and ask questions.  This information gave the 
carer some anticipation that death was near.  Gail talked about her decision and 
her conversation to her husband: 
“He didn’t know how long, but I got that from [name of oncologist], but 
then I couldn’t keep that from Tony because we...we always shared 
things; we never kept anything from each other.  So I went up, once the 
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girls were in their bed that night, and I did tell him that ‘I can’t keep it from 
you: [name of oncologist] said you’ve got about two to three weeks,’ and 
he said ‘well, I kind of like knew that’” (Gail, wife (CS7), Interview 2, 
p6/22). 
The goal is then shifted from ‘cure’ to providing her husband with comfort and 
an opportunity to say goodbye.   
“Well, you know, we kind of like cried and just did the...the normal 
emotional things, eh.  And, erm...you know, he just wanted to make sure 
that the girls and me were well looked after.  His mum and dad came 
down for a weekend, before Christmas – and he sat with his mum for a 
good four/five hours and they sat and chatted and his mum found a lot 
from Tony what he wanted, you know, about the future and things like 
that” (Gail, wife (CS7), Interview 2, p14/5). 
Defining the final moments allowed patient and parents an opportunity to 
express the patient’s last wishes and to say goodbye.  The final moment also 
allowed patient’s spouse to express her wishes.  Gail brought up their 
conversation about Tony’s ashes:   
“Well, he was...he said to...erm...unbeknownst to me at the time (and I 
felt ...I did say to him that I felt quite hurt about it, but we sorted it out) 
that he was...his ashes he was going to give to his mum and dad, so they 
could...emm...once the mum and dad had died, Tony’s ashes would be 
spread with them” (Gail, wife (CS7), p47/26). 
Tony’s parents were anxious about Gail coping on her own.  Gail, however, 
made the decision to have her husband die at home knowing that it was what 
he would have wanted.  Gail felt supported by his GP’s constant visits to ensure 
she got the help she wanted.   
 
Although Gail thought she could cope with her husband’s care, she was 
emotionally not prepared to cope with Tony’s requiring constant personal care.  
Gail related that Tony was still very much concerned about his dignity till the 
very end of his dying days.  She continued: 
“And he said ‘I don’t want you remembering me like this’.  Which was 
pretty horrendous, because he’d lost a lot of weight; his...his bottom was 
just like flesh hanging, and you know that wasn’t Tony” (Gail, wife (CS7), 
Interview 2, p3/16). 
Maintaining a husband and wife relationship was difficult as the wife’s role 
changed to a carer and witnessing a dying patient can be distressing.  Gail, 
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although she was happy with the help of the district nurses, felt there were 
some who were insensitive when having a conversation about her husband in 
front of their young children: 
“...that nurse came down and she was talking about things that I thought 
hold on, my five year-old daughter’s here, do you know?  I can’t 
remember what it was.  When she left, I just went into floods of tears 
because I thought she was un- I just thought you were the last person, 
district nurse-wise, to handle my husband, and I wasn’t happy with that, 
because I didn’t like her...her attitude. It was kind of like matter of 
fact...em” (Gail, wife (CS7), Interview 2, p4/23). 
The above account suggests the carer was already distressed dealing with her 
husband’s final moments and was also trying to shield her children from the 
crisis.  However, the attending nurse in that situation may not have been tactful 
in managing the issues where young children were concerned. 
 
This section reflects patients and carers accounts of their experience when the 
end was near.  Some patients were still oscillating between curative treatment 
and palliative symptom control.  Some patients look to their appointments with 
their consultants as an indicator of their life expectancy and reassurance.  
Carers on the other hand, were concerned about not knowing how to determine 
the final moments of their loved ones. 
 
Medical staff faced the challenge of when to broach the issues of patients dying 
and how to provide holistic care that included spirituality.  Some patients and 
their carers turned to spirituality for emotional support, others to their family 
members and their doctors.  It was also noted that patients wanted to die at 
home but they were worried that their spouse could not cope.  The 
interpretations also illustrate that patients’ and carers’ needs change at different 
stages of the cancer trajectory.  It was also unclear how children were 
supported in facing the uncertainty when of one of their parents was dying of 
MSCC.  Patients were concerned and wanted to have the comfort of knowing 
their spouses were taken care of.  However, carers talked about anticipating the 
inevitable and they were grieving in anticipation of the death of their loved ones. 
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5.4.3 Summary 
This theme showed that patients’ and their carers’ in their journeys beyond the 
treatment of MSCC experienced changed priorities, continued uncertainty and 
un-met needs.  There was a lack of follow-up in terms of practical aids and 
securing help from disability and social services proved difficult for some 
patients.  However, those patients who were guided felt supported.  Some 
patients and carers talked about anticipating a loss of income whilst others did 
not seem to have financial worries.   
 
Patients were not aware of the side-effects of steroids and radiotherapy and 
experienced extreme fatigue, depression and skin rashes.  Others continued to 
have problems with their pain control.  Some patients had the choice of going 
home whilst others had decisions made for them which meant they ended up in 
somewhere which would not have been their choice.  Patients, carers and 
healthcare professionals in the community found decisions on support care 
made by the hospital staff were prescriptive and dealing with different agencies 
was challenging.  Patients found communicating with different health providers 
difficult and this affected their continuity of care. 
Patients who were mobile talked of the uncertainty of their future and expressed 
difficulty in living with cancer.  However, those who were paralysed came to 
terms with their disability, but found frustration in adjusting.  Most patients 
experienced good emotional support from their spouse and family but some had 
difficulty expressing their emotions to their spouses or family.  There were 
variations on patients’ and carers’ views on group support; with some finding 
conversation around cancer, depressing.  The unpredictability of MSCC led to 
changed relationship and family dynamics, as patients and carers struggled to 
find a balance. 
 
The boundaries between curative and palliative intent were blurred as patients 
oscillated between continuing treatment, palliation of symptoms and death.  
Patients gauged their life expectancy on their appointment with their consultant.  
When patients’ mobility deteriorated, carers were unprepared for the level of 
support and found it distressing and felt out of control.  Both patients and carers 
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found defining the final moments challenging.  Discussing end of life issues was 
sensitive and patients expressed a fear of dying.  There was a sense of patients 
and carers protecting each other from receiving bad news.  Patients wanted to 
die at home but felt their spouses or family might not cope.  Carers were 
grieving, but wanted to be in control and expressed a desire for some indication 
to help them anticipate the final moments and giving them the opportunity to say 
goodbye. 
 
5.5 Chapter Summary 
This chapter with the themes and sub-themes provides the accounts of 
patients’, carers’ and healthcare professionals’ experiences at different stages 
of the patient’s journey with MSCC.  The patients’ and their carers’ narratives 
illustrated the difficulties in trying to make sense of the symptoms of MSCC.   
Patients experienced emotions such as anxiety, distress, confusion, uncertainty 
which raised existential fears.  Healthcare professionals, on the other hand,   
experienced difficulty recognising and identifying the patient’s presenting 
symptoms.  It is evident that patients’ and their carers’ information needs in 
recognising the symptoms of MSCC have not been addressed.  Although it was 
debatable whether GPs needed education in MSCC, it was apparent that the 
signs and symptoms of MSCC were not readily differentiated by healthcare 
professionals in all settings. 
 
The patient’s risk of losing mobility influenced the need for urgent treatment.  
This suggests the scope for decision making was limited and patients put their 
trust in healthcare professionals to make the best decisions for them.  However, 
some patients later had doubts whether they had made a balanced decision 
based on the treatment options that were available. 
 
The apparent lack of timely information on diagnosis, treatment decisions and 
how the progression of cancer was going to affect the patients, contributed to 
patients’ and their carers’ uncertainty of their immediate and long term future.  
The acute ward setting with patients at different stages of their cancer trajectory 
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could potentially cause misunderstanding and anxiety.  Although patients and 
carers looked up the internet for information, this appeared to cause distress for 
some.  These interpretations suggested that patients’ and carers’ concerns and 
their need for information were not readily met.  There were variations in the 
need for information on prognosis and future symptoms of MSCC, however, 
patients and their carers wanted some indication of their immediate future to 
make short and long term plans. 
 
The accounts from patients, carers and healthcare professionals described the 
trade-off decisions in balancing the treatment versus quality of life.  Evidence 
suggests patients wanted to participate in decision making; however, they may 
not be aware of the levels of decision making involving different disciplines.  It 
was notable that the patients, carers and healthcare professionals showed 
strategies to find a balance in the face of ambiguity and uncertainty.  Some 
patients and carers talked about dealing with the present and spending quality 
time with their families, some had difficulty living with cancer, and others talked 
about alternative treatment.  However, patients and carers were trying to reduce 
the demands on each other and might not be aware of the plans healthcare 
professionals had for them. 
 
Patients and their carers gave accounts of challenges in the transition from the 
acute setting to their home or to another healthcare setting.  Evidence suggests 
that some patients and carers may not be involved in the decision making 
process and therefore, some of the support provided a mismatch to what they 
anticipated.  Moreover, patients and their carers priorities changed and 
therefore some of their needs were unmet.  Patients and carers faced 
uncertainty defining the final moments and looked for reassurance from their 
follow-up appointment with their consultant.  The three themes illustrate that 
patients, their carers and healthcare professionals faced uncertainty which is 
multifaceted at different levels in MSCC.  There is alternation in the interface 
between curative and palliative care in the patient’s trajectory of the cancer 
journey.  Several key issues from these findings will be discussed in Chapter 6.   
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Chapter 6: Discussion 
6.1 Introduction 
In Chapter 6, I outline how I have addressed my research questions and explain 
how they were exemplified in this study.  I then present my synthesis using 
three key themes identified from both phases of this study in relation to relevant 
literature and policies, focusing on the new knowledge that has been generated 
from this study.  The three key themes are: uncertainty in MSCC; finding a 
balance in MSCC; and support beyond the treatment of MSCC (Figure 16). 
From these themes important concepts emerged which contributed to the 
theory of collaborative decision making in MSCC.  The assumptions of this 
proposed theory are illustrated in Figure 17.  Further explanation on the 
development of this theory is found in Appendix 21.   
 
In addition, the strengths and limitations of this study will be discussed.  I 
conclude with my reflections on the research process, what I have gained from 
undertaking this study and how this is going help me in the future.  
6.2 Answering the research questions 
This study set out to explore four research questions prior to data gathering.  
Having discussed the findings, I will summarise that I have addressed the 
research questions. 
What are the patients’ perspectives and experience when diagnosed 
with MSCC? 
The patients’ experience of MSCC was confusion, distress, uncertainty, anxiety 
and not knowing what was happening to their body.  They expressed fear of 
becoming paralysed, fear of dying in pain and suffering, and a sense of 
helplessness.  Patients felt lonely and abandoned even though they had good 
family support, therefore, their emotional needs were often not met.  They 
continued to endure uncertainty, inconsistencies and struggled to find a 
balance. 
How do carers and/or family members perceive support when coping 
with the patient with MSCC? 
 
 
 
 
223 
 
Carers’ experiences were of being left in the dark and not being involved and 
consulted by healthcare professionals in providing support to the patient, 
although they had been providing the bulk of the care and support prior to the 
hospital admission of the patient.  They felt distress, a sense of helplessness 
and not knowing how to cope with the transition towards end of life.   
What are the healthcare professionals’ perspectives and experiences in 
the management of patients with MSCC? 
Healthcare professionals’ experiences were of uncertainty around treatment 
outcomes and the unpredictability of the patient’s functional outcome and 
prognosis.  They felt a sense of helplessness when treatment was no longer 
curative. 
What are the similarities and differences in the perspectives and 
experiences of key stakeholders?  
The case studies have revealed that patients, carers and healthcare 
professionals all make decisions.  The current study indicates that all 
stakeholders were looking for a structure to guide them in decision making 
although their goals varied.  Most patients wanted to take control of their 
situation and lives. However, sometimes decisions made, or a change of plans 
were not explained to them which affected their ability to make decisions about 
their job, their finances, spending time with their family, and to prioritise what 
was important to them. There were examples of patients who put their trust in 
and handed over responsibility to health care professionals to determine their 
care and management of MSCC. This emphasises the challenges for health 
care professionals in determining what an individual patient and/or carer may 
want.  
 
The carers’ experience was that decisions made were often prescriptive and 
they were not consulted, despite their role in supporting the patient.  They also 
had to make decisions about their job, how to recognise deterioration in the 
patient, and recognise they themselves were going through a period of 
transition and were grieving in anticipation of their pending loss.  Although they 
 
 
 
 
224 
 
appreciated support, this requires negotiation and respect for their privacy and 
allowing them to spend quality time as a family.  
 
The healthcare professionals’ experiences illuminate the many variations which 
could exist in the management and care of patients with MSCC.  Guidelines on 
mobilisation were not appropriate in clinical practice, and there was a feeling of 
apprehension and a notion of fear in mobilising a patient when the spinal status 
was not known.  Therefore, healthcare professionals tended to play safe’ at all 
levels and tended to discourage mobilisation in most cases.  This is further 
compounded by the outcome uncertainty of treatment.  Decision making 
involved other disciplines and some of the healthcare professionals felt less 
supported.  As a result of a lack of evidence, the healthcare professionals 
endured the inconsistencies and prescribed care they thought would be in the 
best interest of the patients.  Healthcare professionals felt that rehabilitation 
would benefit patients, however, there was limited access to services specific to 
patients with MSCC.  The support for patients on discharge was perceived by 
healthcare professionals in primary care as too prescriptive as patient needs 
may not be intense and moreover those needs changed overtime. 
 
My synthesis of the findings and the wider literature has resulted in the 
development of a theory on collaborative decision making.  Figure15 illustrates 
my level 1 and level 2 abstraction of concepts in the patient’s journey in MSCC 
which was explained in three stages.  The acute onset, at the left hand corner, 
relates to uncertainty in MSCC; the intermediate care relates to finding a 
balance in MSCC and finally the transition care, at the right hand corner, is 
about support beyond the initial treatment of MSCC.   Each stage is 
represented in a box identifying the factors that influenced or impacted upon the 
patient’s, carer’s and healthcare professionals’ experiences in MSCC.  Having 
discussed all three stages, there was a sense of consistent themes which 
culminate in another, higher level of abstraction (level 2 of abstraction), where 
all stakeholders experienced constant movement between uncertainty and 
enduring inconsistencies, resulting in struggling to find a balance in MSCC.  
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Figure 16: Levels 1 and 2 abstraction of Phases One and Two findings 
 
    Level 1:           Acute onset     Intermediate care                             Transition of care 
            
      
   Patient              Patient                                 Patient      
         
          
          
          
   Carer                   Carer                     Carer 
         
       
     
   HCPs              HCPs                     HCPs 
 
 
 
                Uncertainty 
    Level 2                   
         Enduring inconsistencies 
 
             
6.3 Uncertainty in MSCC 
New/vague symptoms, confusion, 
distress, uncertainty, anxiety and 
existential fears.  Not knowing when 
to seek help. 
_____________________________ 
Sensing something is wrong, 
anxiety, uncertainty. Not knowing 
who to turn to. 
_____________________________ 
Make sense of presenting signs and 
symptoms, urgent decision making, 
fear of making decisions on 
mobilisation, playing safe, 
uncertainty of treatment outcomes. 
 
 
 
6.4 Finding a balance in MSCC                   
Need to take control of life, linked to 
information to inform decisions about 
future care and treatment, job, 
finances and family.  Trusting the 
healthcare professionals to make the 
right decisions. 
_____________________________ 
Less involved in care and support by
HCPs – do not know what is 
happening so feel excluded. 
_____________________________ 
Seek opinions, guidelines 
inappropriate in clinical practice,
make trade-off decisions, and endure 
inconsistencies 
6.5 Support beyond the treatment of 
MSCC 
Variations in support, felt abandoned, fear of 
dying in pain and suffering, fear of losing 
control, continue to endure uncertainty.   
______________________________ 
Challenges in supporting the patient, 
negotiate support, not knowing when to 
recognise the final moments, continue to 
endure uncertainty.  
________________________________ 
Variations in the availability and referral to 
other agencies.  Uncertainty of future 
deterioration. 
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6.3 Uncertainty in MSCC 
One of the main findings from this study was that MSCC is a complex condition 
plagued by uncertainty within the trajectory of the illness.  As the onset of 
MSCC is often sudden, unexpected and severe, patients are normally admitted 
to and treated in the acute setting.  A focus on acute management is often at 
odds with the palliative nature of the condition and this contributes to the 
complexity for patients, carers and healthcare professionals.  The findings from 
this study demonstrate the intricacies of uncertainty which affect all the key 
stakeholders when MSCC presents.  
 
Awareness of the signs and symptoms of MSCC was seen as integral in 
initiating action in getting medical help (Sections 4.6 and 5.2.1).  This supports 
guidelines and previous studies (NICE 2008; Levack et al. 2001; Mitera and 
Loblaw 2010; Hutchison et al. 2012).  However, evidence from the current study 
demonstrated that only one patient of the eight who participated was informed 
by his Macmillan nurse about the signs and symptoms of MSCC.  One patient 
had recurrent MSCC but he thought he was cured the first time (Section 5.2.1).  
Often patients and carers’ were unable to make sense of their symptoms.  The 
patients gave accounts of new and vague symptoms from severe back pain, 
shooting pain, pain in the sternum, feelings described as ‘bugs’ creeping, 
numbness from chest to abdomen, urinary retention and sudden loss of mobility 
(Section 5.2.1).  The patients’ and carers’ accounts displayed a level of 
confusion leading to distress, fears and uncertainty for both patients and carers.  
This proved challenging for patients as they sometimes found it difficult to 
verbalise their concerns.  This reinforces the suggestions made through the 
study by Levack et al. (2002), to listen to the patient’s symptoms.   
 
Although all eight patients in the current study were mobile on admission, two 
patient’s mobility deteriorated rapidly after treatment.  The unpredictable nature 
of MSCC indicates the limitations in the use of health-related quality of life 
assessments to assess the patient’s quality of life (Section 2.5.2).  Some 
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patients attributed their symptoms to concomitant chemotherapy and hormone 
therapy (Section 5.2.1).   
 
One of the patients felt let down when she was not informed that her cancer had 
spread to her lungs and bones, whilst another said he did not understand why 
there was recurrence when he was still undergoing treatment.  Both patients 
indicated they would have sought treatment early if they had information about 
early signs and symptoms of MSCC.  This issue was reflected in a recent study 
by Hutchison et al. (2012), who found that the majority of patients want 
prophylactic information about MSCC.  Wilkins and Woodgate (2012), also 
reported cancer survivors want healthcare professionals to provide information 
about a second cancer risk in order for them to make decisions about how to 
take care of that risk.   
 
Mitera and Loblaw (2010), reported that 69% (n=27) of patients delayed 
seeking medical attention for their symptoms despite 95% of patients (n=38 out 
of 40 patients) previously having been informed by their physician about the 
suspicion of MSCC.  However, the common reasons given were patients in their 
study did not associate their symptoms with MSCC.  As mentioned above, one 
patient in the current study had an awareness of the signs and symptoms of 
MSCC (Section 5.2.1).  However, the patient confessed he had fear of the 
unknown, experienced existential fears, confusion and distress, and only sought 
medical attention when his pain worsened.  Eadie and MacAskill (2008), offered 
an explanation that people who fear cancer can respond irrationally to 
symptoms and consequently delay treatment, especially men.  Although this 
study was about cancer screening, this can be taken on board for MSCC as 
patients need to have an understanding of what might indicate MSCC in order 
to differentiate from “normal” changes.  So although patients may have the 
information about possible signs of MSCC they may not act on this.  To 
overcome this, Manson and O’Neill (2007), suggest that giving information 
alone is not enough, but strengthening the level of understanding is required in 
order to empower patients. 
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Mitera and Loblaw (2010), found that patients with only one neurological 
symptom, such as back pain, had an interval median delay of 19 days 
compared to those who had more than one symptom (a median delay of 14 
days).  During this interval, 50% of patients deteriorated neurologically; a critical 
time window for treatment to reduce the likelihood of irreversible neurological 
damage (Husband 1998; Mitera and Loblaw 2010).  Audits have reported that 
some patient’s symptoms had been present for more than four weeks before 
treatment (Levack et al. 2001; Sui, Fleming and Kehoe 2012; Whigham 2012).    
 
NICE guidelines (2008), and Hutchison et al. (2012), do not recommend giving 
the information about signs and symptoms of MSCC to carers.  Findings from 
this study suggest that carers and the patient’s significant others do have an 
influential role in persuading and making the decision to seek medical help on 
behalf of their spouse or parents (Section 5.2.1).  For example, one carer (Case 
Study 4) recalled her husband had back pain for 2 weeks and the pain got 
worse while on a bumpy bus ride but it was only when the patient’s legs felt 
weak, that she suspected something was wrong.  This concurs with other 
studies on advanced cancers, where carers were able to ‘sense the changes’ in 
their spouse/family members and get help (Mellon, Northouse and Freeman-
Gibb 2006; Penrod et al, 2012).   
 
The benefits of family involvement have been highlighted by Gilbar (2012).  The 
current study also revealed that although the carers sensed something was 
wrong, they did not know who to turn to or what actions to take.  Carers were 
hesitant as to whether to get help during weekend from NHS 24 or the hospital 
(Section 5.2.1).  In cases where MSCC was an incidental finding, sometimes 
the delay occurred when patients were seen by locum doctors who did not 
necessarily know the patients or were not aware of the signs and symptoms of 
MSCC.  The findings of this study reveal potential for gaps in the care pathway 
and guidelines, and patients and carers should be advised to contact the 
oncology centre directly.   
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Hutchison et al. (2012), found disparity in healthcare professionals’ views in 
initiating awareness in patients at high risk of developing MSCC.   Within the 
findings of this study, there were suggestions that general practitioners, district 
nurses and medical staff out with oncology should be educated in recognising 
signs and symptoms of MSCC, while others said patients and carers should be 
made aware of MSCC (Section 4.6 and 5.2.1).  There remain uncertainties 
about who is responsible and when the right time is to give this information.   
 
In this study, general practitioners expressed that where there is evidence of 
metastatic disease, giving patients information before presentation was 
important.  However, getting the balance right and not frightening patients was 
challenging (Section 4.6 and 5.2.1).  Some general practitioners talked of the 
follow up of their patients and had regular meetings with their community 
nurses.  One general practitioner explained they already had a mechanism in 
place called ‘the Gold Standards Framework (GSF 2004)’ and held regular 
meetings with staff to discuss their cancer patients (Section 5.2.1).   
 
The Gold Standards Framework (2004), is a model that ensures good practice 
is available to all people nearing their life’s end, irrespective of their diagnosis.  
Through this framework, better co ordination and collaboration between 
healthcare professionals can provide care in consultation with the patient and 
family.  However, several studies have evaluated the implementation of GSF 
and reported variations in the process in inter-professional communications, 
and the impact on patients and carers is not known (Munday et al. 2007; 
Thomas and Noble 2007; Walshe et al. 2008; Dale et al. 2009; Shaw et al. 
2010).  An important point in the current study is that patients were often being 
followed up by their tumour-specific doctors during their cancer treatment and 
their contact with their general practitioner could be minimal (Section 5.4.1).  
Thus general practitioners might not be actively involved in the patient’s follow-
up.  This finding has not been reported in the literature.  Therefore, to make any 
difference, giving information about signs and symptoms of MSCC should be 
embedded within a patient’s tumour-specific doctor’s consultation with 
reminders by the patient’s general practitioners.  
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Contrary to perceptions that general practitioners need education on the signs 
and symptoms of MSCC, in this study, general practitioners indicate they are 
already aware of signs and symptoms (Section 4.6 and 5.2.1).  They reported 
seeing very few patients with MSCC in their career.  They also expressed that 
assessing and establishing the symptoms of impending MSCC was challenging 
in reality, especially in elderly patients who may be confused or have co-
morbidities, such as osteoarthritis.   
 
Although some of the general practitioners acknowledged they were not aware 
of the local referral pathway and the NICE guidelines (2008), they felt their need 
for information was ‘on a need to know basis only’.  Some other general 
practitioners and medical staff felt that tailored education with an emphasis on 
the ‘whole clinical picture’ was important.  Some general practitioners indicated 
that education sessions in the format of discussion groups with colleagues from 
the hospital would be helpful (Section 4.6).  Therefore, the findings in this study 
underline the important role of tailored education in supporting healthcare 
professionals.  
 
This thesis identified that it is not easy to detect impending or cord compression 
in metastatic disease.  A Cochrane review highlighted that very few studies 
were carried out in primary care to identify what “red flags” could be potentially 
helpful (Henschke et al. 2011).  The general practitioners in the current study 
mentioned that identifying signs and symptoms of MSCC as straightforward in 
theory, but challenging in reality.  One significant symptom they would look out 
for was severe progressive pain in patients with a history of cancer (Sections 
4.6 and 5.2.1).  However, most patients with metastasis have pain and 
identifying when the pain had changed in nature was challenging to detect.  In 
those circumstances, the patient’s safety was the first priority of the general 
practitioners and they would seek guidance from hospital specialists.   
 
Similarly, medical staff outwith the oncology department often found patient’s 
presentations were not classical of MSCC, for example, as pain may not be as 
significant in some patients, or it could be subtle (Section 5.2.1).  For example, 
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one patient (case study 8) with prostate cancer experienced breathlessness, 
localised pain at his nipple area and his PSA test was normal.  Accounts from 
the patient’s general practitioner and the referring hospital medical staff found 
that pain was not a significant feature at that time but breathlessness was a new 
problem for the patient (Section 5.2.1).  This reflects the variations in the 
presentation of symptoms.  Baley et al. (2001), reported that 41% of patients 
(n=9 of 22) in their prospective study with MSCC were pain free.  Furthermore, 
the authors highlighted that the duration of continuous hormone therapy in 
metastatic prostate carcinoma can be a risk factor for the presence of occult 
spinal cord compression (Baley et al. 2001).  Tensions and conflicting opinions 
in establishing a diagnosis between medical staff and the radiological staff can 
be challenging and delay treatment (Section 5.2.1).    
 
This study identified that patients felt vulnerable and may be preoccupied with 
their pain and trusted the healthcare professionals to make the right decisions 
at the acute onset of MSCC (Section 5.2.2).  However, some patients later 
questioned their treatment decisions once their pain was resolved.  For 
example, one patient questioned why surgery was not offered when there was 
evidence of good outcomes from reading information on the internet.  One carer 
questioned why a plan for surgery was changed to radiotherapy with no 
explanation.   
 
Patients expressed a desire to be involved and have an understanding in the 
treatment decision as they want some control over their lives (Section 5.2.2).  
Another study parallel to these findings was reported by Nakano, Mainz and 
Lomborg (2008), on emergency admissions of patients with acute cardiac 
conditions.  They reported that patients do not necessarily participate in 
decision making - they simply need direction and action.  In the current study, 
some patients did leave the decisions on treatment to their consultants.  This 
posed challenges for the medical staff (Section 5.2.1).  For this reason, 
communication about treatment is an on-going discussion and medical staff 
need to review this with the patients from time to time.   
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Establishing spinal instability is an important basis for making decisions about 
treatment and mobilisation, but accounts from radiologists indicated there is no 
agreed criteria for determining spinal status in malignancy and it was difficult to 
assess the functional status based on MRI static images (Sections 4.4 and 
5.2.2).  This concurs with the literature on the lack of consensus evidence in 
assessing spinal instability (Dirksmeier and Kang 2001; Loblaw et al. 2005; 
Kilbride et al. 2010; Lee et al. 2012).  In the current study, views on having a 
guideline or protocol to help in decision making on commencement of 
mobilisation vary with some wanting a guide and others citing that care should 
be individualised.  Interestingly, the current study indicates healthcare 
professionals found the NICE guidelines on MSCC (2008) on total 
immobilisation unhelpful and at odds with clinical practice (Sections 4.3 and 
5.2.2).   
 
NICE guidelines (2008: 7), recommend: “Patients with severe mechanical pain 
suggestive of spinal instability, or any neurological symptoms or signs 
suggestive of MSCC, should be nursed flat with neutral spine alignment 
(including ‘log rolling’ or turning beds, with use of a slipper pan for toilet) until 
bony and neurological stability are ensured and cautious remobilisation may 
begin”.  Similar findings were also noted during my scoping exercises with 
healthcare professionals in West Scotland; they also doubted the 
recommendations, in their own regional guidelines, of total immobilisation 
(WoSCAN 2007).  This is useful knowledge and there remains a clinical 
problem.  NICE guidelines (2008) need further review and to take healthcare 
professionals’ and patients’ views into consideration for it to be meaningful.    
 
Several audits have reported a lack of a clear plan or guidance for patients on 
positioning and mobilisation (Warnock et al. 2008; Sui, Fleming and Kehoe 
2012, Whigham 2012).  Moreover, there is risk of chest infection and of deep 
vein thrombosis (DVT) if immobilised (Pease, Harris and Finlay 2004).  
However, this study identified that the threatening nature and unpredictability of 
MSCC reflected the anxiety in staffs’ decisions regarding the provision of care 
to patients.  A common notion that threaded through the views here was a 
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feeling of fear and a lack of role and responsibility in who should make the 
decision with respect to the patient mobilising (Sections 4.4, Section 5.2.3).  
These findings have not been reported in the literature.  Although the oncologist 
was the decision maker, the role seemed less defined.  Within the findings, 
medical staff said they advocate early mobilisation but the decision to 
commence mobilisation was sometimes left to the discretion of the 
physiotherapist and nurses.  There was a lack of evidence to suggest a 
patient’s spine is at risk should the patient mobilises, so, extreme pain on 
mobilisation seemed to be the indicator for spinal instability (Mercadante 1997; 
Coleman 2006; Izzo et al. 2012).   
 
The range of opinions and the lack of guidance and protocols caused anxieties 
for the nurses in this study who often decided to ‘play safe’ in caring for their 
patients (Section 4.3 and 5.2.2).  Nurses rationalised that the patients would not 
hurt themselves if they were on bed rest, thus safeguarding the patient safety 
aspect of care.  Similarly, some registrars ‘played safe’ when information about 
spinal instability was not confirmed.  Physiotherapists, on the other hand 
expressed that they needed information from the medical staff about the 
patient’s spinal status before initiating mobilisation, as the unpredictability of 
paralysis was a great concern.  Again, these findings are new knowledge on 
how healthcare professionals make decisions at different levels when there is a 
lack of evidence on the process of care.   
 
In this study, there were inconsistencies in communicating and documenting 
care for patients.  As a result, patients reported conflicting information on 
mobilisation, resulting in distress and uncertainty about when paralysis could 
occur (Section 5.2.2).  Evidence in the current study indicated that patients were 
not included in discussions and decisions about mobilisation.  For example, one 
patient felt that strict bed rest meant his personal needs were met by nursing 
staff and he perceived this as undignified.  This finding adds to the body of 
knowledge in MSCC as previous audits have reported this anecdotally (Pease, 
Harris and Finlay 2004).   
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Documentation was identified as a problem in the current study, as each 
discipline had different documentation which may not be easily accessible to 
other members of the team (Section 5.2.2).  For example, a weekly nursing care 
plan was introduced to the ward, however, some nurses said this was too 
general and depended on whether someone would record and pass on crucial 
information.  The evidence from these data indicates that the patient’s care 
should be viewed as a process with a range of issues and ongoing decision 
making.  However, this information needs to be transparent so that ‘who does 
what and when’ is easily accessible to healthcare professionals.  The problem is 
that as the health system is designed to deliver episodes of care, often patients 
have multiple problems and integrated documentation is an issue management 
need to address. 
 
Analysis of these data revealed that uncertainty about one’s physical body 
changes and existential fear could be influenced by seeing other patients with a 
similar condition but in an advanced stage of their cancer trajectory.  In Section 
5.2.1, I highlighted how witnessing other patients’ distress caused anxiety in 
one patient who went on to have recurrent nightmares after her discharge from 
hospital.  Likewise, one patient compared his condition with another who was 
going for surgery and was not sure why he received radiotherapy.  This 
suggested that a poor understanding of one’s condition could have an ongoing 
psychological impact.  Healthcare professionals seemed to be focused on the 
management of treatment.  However, they may not have recognised the need to 
explore a patient’s concerns or understanding during the course of receiving 
treatment. 
6.4 Finding a balance in MSCC  
Finding a balance between treatment interventions, communication and patient 
preferences in the acute stage of MSCC was threaded through the views of all 
the participants.  The fact that MSCC is an acute condition, sometimes with 
impending cord compression, requiring emergency treatment, meant that quick 
decisions had to be made to maintain the patient’s functional status.  The 
uncertainty of treatment response could be challenging and healthcare 
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professionals made trade-off decisions based on treating the advanced cancer 
versus the patient’s short life expectancy.  Patient and carers tried to establish 
ways of achieving a balance between treatments versus quality of life for the 
family (Sections 5.3.1and 5.3.2). 
 
After the initial acute symptoms were resolved, patients and carers found other 
difficulties emerging around accessing timely information; being aware of what 
was happening and the reasons why; lacking understanding of how cancer was 
affecting them; knowing how the treatment was going to affect them; how long 
they would remain mobile; and issues around prognosis (Sections 5.2.3 and 
5.2.4).  This concurs with other studies of patients with advanced cancer where 
their information needs have been underestimated (Fallowfield, Jenkins and 
Beveridge 2002; Gaston and Mitchell 2005).   
 
Within this study, information was identified as difficult to obtain by patients and 
carers, citing healthcare professionals’ lack of time explaining to them about 
their condition as the main cause.  This made it difficult for them to feel informed 
about their condition and therefore identify their priorities for care as they tried 
to keep some balance in their lives.  They expressed strongly that this was 
about their life and a 15 minute consultation was not sufficient to address their 
concerns.  Nanton et al. (2009), highlight that in prostate cancer patients, men 
viewed information on the process of care as important.  However, the current 
study findings suggest patients want information about care and also to 
understand the process of decision making.  For example, they wanted to know 
why surgery was not an option when studies indicated positive outcomes.  They 
wanted information about them as an ‘individual’.  It is also apparent within this 
study that patients were used to getting lots of information about their treatment 
for their primary cancer, but this was a new event.  Therefore, there was a 
sense of no structure to help make immediate or long term plans (Section 
5.2.3).  This is also evident in acute cardiac conditions, where patients’ attitude 
towards participation in their care changed over time (Nakano, Mainz and 
Lomborg 2008).   
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Wilson (1997), described this information-seeking behaviour as a coping 
strategy.  Patients suggested it was important that a designated healthcare 
professional should go through with them the information their consultant had 
given them as back-up information while some patients wanted both reinforced 
in a leaflet format (Section 5.2.3).  Van der Molen (1999), said this activity gives 
one a sense of cognitive control through active participation.   
 
Literature indicates that patient navigators may improve the care of patients with 
cancer (Wells et al. 2008).  Patient navigators has been widely used in the care 
of patients with head and neck cancers (Rogers, El-Sheikha and Lowe 2009; 
Ghazali et al. 2012).  According to Paskett, Harrop and Wells (2011), patient 
navigators are more effective for interventions for cancer screening outcomes.  
Less is known about their impact on advanced cancer patients’ experience.   
 
In the UK, the clinical nurse specialist’s (CNS) roles in specific cancer groups 
and palliative care are effective in collaborating patient and organisation needs 
(Poole 1996; Tarrant et al. 2008; Ream et al. 2009).  The findings in the current 
study indicate the CNS may not be involved once the patient was diagnosed 
with MSCC.  However, one patient (Case Study 3), expressed he continued to 
received good support from his tumour specific CNS and district nurse (Section 
5.4.1).  Within this study, the patient’s referral to a palliative nurse varies in the 
acute stage.  As well as the need for a CNS, another mechanism to identify 
patient needs is through the use of a patient’s concerns inventory (PCI).   
Delivering for Health (Scottish Executive 2005), has set out that we must 
recognise and develop the services to meet the changing health needs, and 
that the care of patients with MSCC should be a priority.   
 
Most of the patients and carers in this study looked for information on the 
internet including cancer websites, but felt that information might not be relevant 
to them.  Thus most of their trust was in their consultants (Section 5.2.2).  
Ziebland, Evans and McPherson (2006), reported that cancer patients used the 
internet for a wide range of information, often for support needs, many of which 
were not met by conventional health care.   
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In the current study, not all patients are computer literate or know how to source 
information and leave the decisions on treatment to their consultants.  Although 
Mishel et al. (1988; 1990), suggest that it is important healthcare professionals 
provide information to the patient to initiate a positive response and cope with 
uncertainty, the current study indicates that healthcare professionals 
themselves faced uncertainty.   Healthcare professionals were aware that 
treatment is palliative and the difficulty is to determine the patient’s response to 
treatment. However, patients may not be aware of this decision making process 
and may not have an explanation about why there was a change in their 
radiotherapy dosage.  The treatment dose of radiotherapy may compromise the 
patient’s mobility, causing paralysis.  For example, in Section 1.4.3, the 
treatment impact on the spinal column is not known.  This illustrates that the 
treating oncologist had to find a balance in treatment where the outcomes could 
be uncertain.  
 
This study also revealed that healthcare professionals themselves were also 
looking for evidence (Sections 1.3.2, 4.5, 5.2.2 and 5.3.1).  Oncologists talked 
about evidence of a ‘good’ surgical outcome for patients as reported in the 
NICE guidelines (2008).  However, some medical staff expressed less support 
was received from the neurosurgical team when they referred their patients for 
surgical opinion.  They were unsure how decisions were made and whether 
neurosurgeons used any tools to guide their decisions to consider patients for 
surgery (Sections 4.4 and 5.3.1).   
 
As I had identified in Sections 1.4.3 and 2.7, several studies proposed 
prognostic scoring systems to help clinicians make treatment decisions (Tomita 
et al. 2001; Tokahasi et al. revised version 2005; Bilsky and Azeem 2007; 
Tokuhashi, Ajiro and Umezawa 2009).  However, their use is not evident in the 
current study (Section 5.2.2).  Neurosurgeons assert that decisions for surgery 
should be made on a team basis.  They need information from the oncologist 
about the patient’s life expectancy in order to determine the potential benefits of 
surgery.  In addition, one neurosurgeon talked about respecting the patients’ 
preferences.  Decisions about treatment are complex, as current guidelines lack 
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an evidence base so have limited use in clinical decision making (Kilbride et al. 
2010; Lee et al. 2012).  There is a lack of research to provide the evidence and 
despite all this, patients were not offered a choice and might not fully 
understand the intricacies of medical decision making.  This indicates that all 
stakeholders want evidence to make trade-off decisions and it was important to 
know the process of decision making.  For these reasons, there seemed to be a 
lack of clarity in the local referral pathway and guidelines.   
 
An issue in the current study is about who should see the patient first.  Some 
oncologists felt that the first contact should be the neurosurgeons to assess the 
patients, but they are aware that not all patients would be treated neuro-
surgically.   Patients were admitted through different pathways, so referral to 
neurosurgeons often happened at a late stage when there was already cord 
compression and patients were less likely to have a good outcome from surgery 
(Section 5.2.2).   
 
Another problem identified within the current study was that the availability of 
expertise for complex spinal thoracic surgery may be limited.  The same issue 
was also identified in a recent audit where patients were referred to 
orthopaedics for surgical opinion, but the local service does not specialise in 
spinal surgery (Sui, Fleming and Kehoe 2012).  On the other hand, there were 
views amongst the participants in the current study that the NICE guidelines 
(2008) are enormously long and lacked supporting evidence, with a bias 
towards the surgical perspective and lack of representation from the 
radiotherapy perspective (Sections 4.5 and 5.3.1).  Their rationale was that 
many of the patients are elderly and may not be suitable for surgery so the 
guidelines offered limited support in decision making for this group of patients.  
What emerged was the inconsistency or the lack of understanding in the 
decision making process amongst all concerned.   
 
Eleraky, Papanastassiou and Vrionis (2010), and Tancioni et al. (2010), have 
suggested a multidisciplinary team approach in the management of MSCC that 
includes a medical and radiation oncologist and a spine surgeon/neurosurgeon 
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would be helpful.   The current study also suggests this.  However, the 
possibility of patient involvement in this team and in the decision making 
process was not expressed.   
 
Despite the patients need for more information, discussions around prognosis 
varied between patients and their carers’ in the current study.  There was 
vacillation between wanting to know and not wanting to know, which one carer 
described as ‘a mixed bag’ (Section 5.2.4).  This supports the study by Eva et 
al. (2009).  However, within this study, patients and carers want to take control 
of their lives in order to make immediate or long-term plans, decisions about 
continuing their jobs and preparing their children to cope with the bad news 
(Section 5.2.4).  However, the type of information varied.  For example, one 
carer said he wanted to know “whether it’s good or bad or indifferent”.  
Schapira, Nattinger and McHorney (2001), suggest using a qualitative method 
to explore how patients interpret and assign meaning to probabilistic 
information.   
 
Cherlin et al. (2005), used questionnaires and in-depth interviews with family 
caregivers to elicit their need for prognostic information.  The authors found 
family caregivers had difficulty hearing the news, ambivalence about what they 
wanted to know and difficulty in understanding the bad news.  These difficulties 
related to ineffective communication about end of life issues.  In the current 
study, some carers found information on prognosis a burden to know, thus did 
not desire to know.  However, they expressed a need for prognosis information 
as the patient’s condition deteriorated (Section 5.2.4).   
 
Within the current study, some patients may not verbalise a need for information 
immediately for reasons that they needed time to comprehend the information 
before they could ask questions.  Another factor was the fear of dying.  
However, this was sometimes interpreted as not wanting to know by their 
oncologists (Section 5.2.4).  Their approach varied and was linked to whether 
the patient asked questions or opened up a discussion around end of life.  
Some patients may not know what to ask and expressed anxieties and fears 
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when they read information about suffering in pain and dying in an undignified 
way (Section 5.2.3).  This can be a source of misunderstanding (Hardey 1999; 
Prior 2003).   
 
Some carers felt they were given second hand information by their spouse and 
were not necessarily consulted, and when they were included they had difficulty 
discussing their concerns in the presence of their spouse.  However, in Section 
5.2.3, evidence suggests that doctors sometimes face a dilemma whether to 
give information about the patient’s condition to their carer.  Some patients did 
not want their doctor to inform their spouse of their condition.  Communication 
channels, establishing who knows what, and respecting the patient’s 
preferences are complex.  Thomas, Morris and Harman (2002), and Vivar, 
Whyte and McQueen (2010), assert that attention must be given to the carer’s 
role for their contributions in the patient’s care as they are co-carers.  Evidence 
from the current study indicates that communication of information to patients 
and their carers is an ongoing and paced process and its scope varies.     
 
There was also the difficulty in predicting the prognosis in different cancer 
pathways and the treatment response (Section 5.2.4).  Some healthcare 
professionals talked of not wanting to take away the patient’s hope unless there 
was no treatment available.  Therefore, discussions about prognosis are 
inherently fraught with concerns about taking away a patient’s hope.  Daugherty 
& Hlubocky (2008), surveyed 729 oncologists in the United States about their 
approach to disclosing prognosis and found that whilst 98% (714/729) of 
physicians would disclose the terminal nature of the illness, fewer (57%: 
416/729) would give an estimated time frame to death.  Studies suggest that 
medical staff are reluctant to discuss prognosis with their patients due to the 
difficulties in estimating this (Harrington and Smith 2008; Grunfield et al. 2006 
Rose et al, 2004). 
 
Some patients found that their diagnosis of MSCC enabled them to re-prioritise 
their life, while others found it hard to strike a balance.  Some patients had 
continuing worries: difficulties coping with immobility, returning to work, fear of 
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deterioration and coping with relationships and home management.  Older 
patients seemed to adopt a positive attitude to overcoming cancer.  Patients 
who remained mobile talked about their fears and were uncertain if and when 
they would lose their mobility and independence.  Healthcare professionals had 
mixed views about giving information to patients regarding their future 
symptoms (Section 5.2.4).  There existed a preference to help patients to 
remain hopeful whilst balancing this against wanting to give realistic information.  
There was also a notion of ‘wait and see’ in relation to the outcomes of 
treatment.   
 
As the patients and carers became more aware of the consequences of MSCC, 
they recognised they had to take control of their situation in coping with 
uncertainty.  Some patients and carers accepted and knew the progression of 
cancer was beyond their control and discussed spending quality time with 
family.  Some talked about whether to continue working or cutting down the 
hours.  Others talked about being positive and taking ‘one day at a time’, ‘living 
for now’ and ‘I’m still living’.  Some older patients took comfort in their religious 
faith and that gave them a sense of meaning.  Whilst some patients accepted 
their condition, they were still trying to find a balance with alternative treatment 
possibilities versus spending quality time with family.  Similar evidence showed 
patients spoke of having a positive attitude and finding other ways of coping 
after the initial shock at diagnosis (Eva et al. 2009).   
 
The notion of finding a balance was also about patients and carers being in 
control, rather than cancer controlling them, and this is evident in the sub-theme 
“battle plan – what is the next step” (Section 5.3.2).  Patients who had defied 
the odds of a poor prognosis and lived longer than expected with cancer were 
hopeful they would survive as they did before.  Some healthcare professionals 
felt patients might be unrealistic about their prognosis.   
 
Many patients revealed that they were worried about the demands on their 
spouse and felt that support should be available to help them cope (Section 
5.3.3).  This is commonly reflected in end of life issues faced by patients, who 
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want inclusion and recognition of their family (Curtis et al.2001).  Healthcare 
professionals, on the other hand were arranging support that they felt was best 
for the patient without putting these additional demands on the carers.  It 
appears that all parties were unaware of the intentions of each other.  Vivar et 
al. (2010), found that when diagnosed with recurrence of cancer patients and 
their families needed to adapt to the uncertainty caused by the unpredictability 
of the disease.  However, there is a difference in MSCC cases, Eva et al. 
(2009), describe that patients did not survive long enough to adapt to their 
disability, and hence there was ambiguity in their plans.  In the current study, 
the patients and carers struggle between wanting to prolong life and palliative 
intent, while at the same time grieving their impending loss. 
6.5 Support beyond the treatment of MSCC 
In this study, the patients’ and carers’ support needs varied during the transition 
from hospital to home/district hospital/hospice.  The Phase Two findings 
indicated that it was primarily the patient’s mobility that dictated the support they 
required.  Patients and carers have multifaceted needs and these needs 
changed over time and they might not necessarily get the support required.   
 
In the current study, there appear to be variations in the availability of and 
referral to other agencies.  Pursuing rehabilitation services for patients varied 
depending on the patient’s age and their geographical areas.  Healthcare 
professionals in the current study faced challenges in referring patients for 
rehabilitation.  Community rehabilitation and rehabilitation centre staff were 
reluctant to accept patients with MSCC as they perceived patients with cancer 
would not improve (Sections and 4.6 and 5.4.1).  Patients were either not aware 
of access to rehabilitation support or were not offered rehabilitation despite 
several studies reporting that patients with MSCC benefit from a structured 
rehabilitation programme (Guo et al. 2003; Garrard et al 2004; Ruff et al. 2007a; 
2007b; Saarik and Harley 2010; Tan and New 2012).   
 
However, in the current study, those patients who did receive rehabilitation, the 
services provided did not necessarily meet the patient’s needs (Section 4.6).  
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Garrard et al (2004), commented that many rehabilitation staff members have 
little experience of managing dying patients and suggest staff would benefit 
from support by the palliative care teams.  This strengthened the need for joint 
working amongst specialised health providers to have an integrated health 
service to see to the needs of patients with MSCC.   
 
Rehabilitation allows patients and carers to gain mastery over their situation and 
thereby achieve empowerment and have some sense of control and quality of 
life (Zimmerman 1995; Sherwood 2004; Given, Given and Sherwood 2001; 
2012).  More needs to be done to support patients and carers to maximise the 
quality towards the patient’s end of life (Scottish Government 2008).  This study 
highlights the problems with both continuity of care and need attention.  Often 
patients were treated very quickly in an acute setting and then the patient’s 
practical needs were not followed up, or there was a delay in delivering 
equipment aids, or assumptions were made without further assessment 
(Section 5.4.1).  There were also variations in the referral to palliative care.  
Lung cancer patients, when diagnosed with MSCC with a short life expectancy, 
had palliative care access arranged immediately on discharge.  However, if a 
patient was referred from a district hospital for specialist treatment, and if they 
were discharged home afterwards, there was a possibility of the patient not 
receiving the support they required.  Palliative care nurses were not involved 
unless patients were referred to them for pain control.   
 
In a recent report, Goodwin et al. (2012), highlighted that integrated care is 
important to better co-ordinate the care being provided by a number of different 
professionals and health agencies to meet the needs of patients.  However, the 
setback is that its implementation is still being debated.  For example, one 
patient felt that the district nurse did not undertake any follow up and she had 
difficulty obtaining practical, emotional and financial help, meaning that levels of 
support were variable (Section 5.4.1).   
 
In relation to the patient’s place of care once they became paralysed, the 
findings suggest disparity in the patient’s and carer’s experiences in the 
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transition from hospital to home (Section 5.4.1).  Peters and Sellick (2006), 
compared 32 in-patients and 26 home-based patients receiving palliative care 
services in Australia.  The home-based patients reported higher quality of life, 
feeling more in control and had lower depression scores.  However, in the 
current study, choices influenced the patient’s views of the carer’s capacity in 
coping at home and this supports the studies by McCall and Rice (2005), and 
Tang (2003), in advanced cancer cases.   
 
This study highlights that sometimes patients, carers and community staff may 
not have been involved in a discussion about the availability of support in the 
community (Section 5.4.1).  Carers and primary care healthcare professionals 
described hospital’s plans for patients care as ‘prescriptive’.  Some of the 
primary care professionals reported receiving fragmented information which 
delayed the patient going home.  A similar communication problem was 
reported by McIlfatrick (2007), on the palliative care needs of patients with 
cancer, diseases of the respiratory system, circulatory and the nervous system.  
Studies by Field (1998), and McIlfatrick (2007), found that patients with cancer 
were more likely to receive palliative care compared to other conditions.  The 
current study found variations in the initiation of palliative care for patients with 
MSCC (Section 5.4.1).  
 
Studies have shown that the impact of recurrence caused great suffering in 
families with the spouse taking over the running of the family often experiencing 
psychological stress (Northouse et al, 2002; Jiwa et al. 2008; Vivar et al, 2010).  
Similarly, in the current study, patients who remained mobile on discharge 
found that their needs increased as their physical capabilities deteriorated and 
this increased the demands on their spouse or carer (Section 5.4.1).  Studies 
have found strong associations between patient and carer satisfaction with 
accessibility to care in advanced cancers (Lorenz et al. 2008; Morse and Fife 
1998).  Although the carers in the current study appreciated the support they 
received, when support is imposed on patients and carers this can cause 
distress and resentment on the part of the carers (Section 5.4.1).  As I have 
shown in my findings, some healthcare professionals in the acute setting may 
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not have a discussion of future symptoms with patients or carers (Section 
5.2.4).  Therefore, patients and carers may not know or anticipate progression 
of the disease and hence would not understand the decisions made.   
 
Patients and carers described great efforts to regain a sense of normality after 
treatment and experienced constant fears of the end.  For example, a carer did 
not understand why the hospice staff used the hoist or the purpose of the bowel 
regimen, and felt that the patient’s independence was taken away (Section 
5.2.4).  Although Peppercorn et al. (2011), suggested individualised care for 
patients with advanced cancer, I believe social support needs to be an ongoing 
conversation not only with the patient and carer but between health agencies. 
 
The reality of being paralysed and disabled was not fully felt until patient and 
carer were home, and this realisation could be emotional.  One patient talked 
about her loss of confidence and was concerned about being seen in public and 
not having the ability to walk again.  For those patients who were mobile, they 
expressed the fear of losing their mobility and independence.  Patients talked 
about the triviality of being told to ‘think positive’ or ‘living with cancer’ by others.  
The thought of physical and social constraint was debilitating and patients 
expressed difficulty living with cancer. 
 
Studies on other cancers have reported the motivational aspects of support 
groups having a positive impact on group efficacy and individual self-efficacy 
(Docherty 2004; Wilson 2008; Power and Hegarty 2010).  However, patients 
within this current study perceived that such groups might not be helpful.  The 
patients’ and carers’ views about support groups were negative.  They felt 
support groups weighed them down with negative talk about cancer which they 
did not want to be reminded of.  Only one patient talked about the benefits of 
listening to other patients.  Moreover, carers were overseeing their spouse’s 
hospital appointments and children’s needs.  Therefore, trying to get a balance 
was difficult for patients and carers.   
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The need for psychological support was not necessarily recognised by 
healthcare professionals unless they knew their patients well.  This has also 
been reported by other studies: Simpson and Whyte (2006), and Geiser et al. 
(2006).  In the current study, patients said they were happy with the support 
from their spouse and family, while at the same time they had difficulty 
expressing their emotions to them because they too were emotionally involved. 
Some patients stated that it would help them to talk to someone who was not 
emotionally involved, as and when the need arose.  Some patients perceived 
friends and family expected them to move on, having had cancer for a long 
time.  In addition, some patients did not have friends or neighbours who lived 
nearby.  There was a sense of being abandoned as their illness progressed 
(Section 5.4.1).  Patients felt loneliness and distress after treatment, but this can 
be unrevealed and needs exploring.  Some patients talked about ‘journeying 
alone’ and being lonely.  In a gynaecological cancer study, Sevil et al. (2006), 
found that women who expressed a need for psychological help had a higher 
loneliness level (Sevil et al. 2006).   
 
Fawzy (1999), explained that patients with advanced cancer fear abandonment 
by family and medical staff as they are going through a personal mourning and 
thus may experience depression and anxiety.  Healthcare professionals need to 
clearly verbalise their commitment to remain available (Fawzy 1999).  However, 
this current study adds new knowledge that verbalising commitment or giving a 
telephone number is not sufficient as the participants in my study were reluctant 
to bother healthcare professionals, but would welcome a call from them just to 
ask how they were getting on, every now and again (Section 5.4.1).  Some 
consultants referred patients to the Macmillan Centre for emotional support, 
however, as I indicated in Section 5.3.1, not all patients considered these 
centres helpful.  This is an area healthcare policy makers need to address in 
order to ensure quality end of life care. 
 
A study by Kennedy et al (2011), showed that some healthcare professionals 
were more disease-orientated and that emotional aspects could be neglected.  
In this study, some oncologists felt that nurses should be able to provide 
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generic psychological help to patients.  In a review, McIlfatrick (2010), identified 
an increase in end-of-life education in nursing programmes.  However, students 
and newly qualified nurses felt ill prepared to provide end-of-life care.  In the 
current study, the reasons nurses gave was they lacked knowledge of different 
cancers to provide emotional support but did recognise the importance of this 
support.  This suggests that nurses require further education to fully integrate 
palliative care within cancer care and this finding is in line with the findings of 
Mahon & McAuley (2010).   
 
In the current study, one patient compared her experience of seeing a 
counsellor and a psychologist.  She explained the difference a psychologist 
made in her life was that she helped her structure her thoughts and make plans.  
But this service was discontinued as her consultant thought she was coping.  
This suggests patients who had depression previously and patients who had 
immediate completion of treatment, needed to be assessed to determine 
whether they need psychological support.   
 
Another concern raised by patients was the lack of information on monitoring of 
their tumour.  They felt there was a lack of urgency to their follow up 
appointment, giving them a sense of uncertainty of what to expect (Sections 
5.4.1 and 5.4.2).  Patients expressed fears of not knowing whether their 
treatments were effective and were puzzled why there was no surveillance from 
the healthcare professionals, as they normally would have had during their 
primary cancer treatment.  Leydon et al (2000), suggested that monitoring of 
tumours by scans seemed vital for patients to maintain hope.  In the current 
study, patients had no idea that they would not have their scan if there was no 
treatment planned.  This underlines that healthcare professionals need to have 
a discussion with the patient of what future investigation or monitoring entails.   
 
Despite well recognised initiatives to integrate palliative support for those with 
metastatic cancer, data on practice showed facilitating the transition from active 
oncology to palliative care occurred late (Dy et al. 2008; Guo et al. 2010; 
Peppercorn et al. 2011).  This can seem fragmented to patients (Sections 5.2.3 
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and 5.4.1).  It is perhaps not surprising that some patients thought that palliative 
care services were rationed to the final months of life (Section 5.4.1).  While the 
patient continued to receive non-curative treatment, there was the risk of not 
being supported by a palliative care nurse.  The Scottish Government action 
plan ‘Living and dying well (2011)’, advocates a person centred approach based 
on the needs of patients and carers rather than diagnosis.  This indicates a 
need to consider a blended approach of oncology/palliative services for patients 
who develop acute onset of MSCC and are discharged back to the community.  
 
In the current study, carers were finding it hard to balance the demands of care 
and were experiencing anticipatory grief.  The knowledge that the end is near 
allowed the carer to see to the comfort needs of their loved one rather than 
anticipate further treatment.  Moreover, it allowed the patient to have their 
wishes expressed at the end of life.  The findings here suggest patients’ and 
carers’ needs vary at different times in the illness trajectory and support needs 
to be flexible.   
6.6 Summary  
In summary, the three key themes portraying MSCC when presented as an 
acute condition, can be challenging and complex to manage.  Accurate 
diagnosis is further compromised by the fact that MSCC can develop and 
overlap at different points in the trajectory of cancer.  It influences all facets of 
the patients and carer’ lives and they need timely information, and moreover, 
those needs change over time.  It is evident that the lack of information on the 
process of care, decision making process, disease pathway, treatment and 
follow up causes uncertainty, thus enduring the inconsistencies.  More 
importantly it signifies finality of life for patients.  However, patients and carers 
expressed a wish to take control of their lives and this is linked to having 
information to make immediate and future plans.    
 
The findings of this study add new knowledge to the management of MSCC.  All 
stakeholders experienced uncertainty because of the unpredictability and life 
threatening nature of MSCC.  There was a sense of seeking some structure and 
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direction in its management.  Patients and carers want timely information, want 
involved in discussions about their immediate and long term plans, and to 
understand the decision making process and be able to negotiate support.  
Healthcare professionals also need timely information to inform decisions about 
patient treatment and care, as a multidisciplinary team.  However, they need to 
include patients and/or carers as key players and need to embrace the concept 
of collaborative decision making with multi-agencies to optimise the overall care 
of patients with MSCC. 
 
Franks et al. (2000), suggest some form of needs assessment is necessary to 
identify the patients and carers level of palliative support needs.  McIlfatrick 
(2007) and Ferris et al. (2009), suggests an integrated approach to palliative 
care.  In the current study, the findings suggest MSCC is a significant event 
which is unpredictable and the strategy adopted requires a collaborative 
approach which includes transition from acute oncology to palliative care.   
 
The linkage from the data to theory is described as emic-etic or micro-macro 
(Morse and Field 2002).  The process of theorising has revealed “the 
insignificance of the significance and the significance of the insignificant” from 
the data of the key stakeholders (Morse and Field 2002).  These findings are 
recontextualised to form the proposed theory which can be considered as a 
contribution to middle range theory that is applicable to other similar conditions 
or (Morse and Field 2002; Smith and Liehr 2008).   
6.7 Developing a theory of collaborative decision making in 
MSCC  
As seen in the previous section, Figure 16 illustrates the abstraction of concepts 
at both level 1 and level 2 of theory development.  As a result of the discussion, 
the constructs of uncertainty and enduring inconsistencies seemed to be the 
key message that all stakeholders were struggling to find a balance in the 
management of MSCC.  This further culminates with level 3 abstraction, 
resulting in a proposed theory; which is illustrated in Figure 17.  This theory of 
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collaborative decision making in MSCC, recognises that MSCC is widely 
acknowledged to be an oncological emergency.  To place the emphasis on 
involving patients in their own care in MSCC, the structure is seen as a process 
and not a linear journey.  The rationale being that some patients may still be 
receiving their adjuvant treatment and some will have prolonged survival based 
on their response to treatment and the extent of tumour control.  However, 
MSCC also signifies the finality of life which is represented as end of life.  The 
main concepts for the building blocks of this theory are: significant event; 
awareness; collaborative decision making; prioritising and maximising life; and 
end of life care that would help enable the patient’s journey in MSCC.  The 
concepts are explained after Figure 17. 
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Figure 17: Level 3 abstraction - Theory of collaborative decision making in MSCC 
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Assumptions of the theory: 
 A critical window of opportunity exists in recognising signs and symptoms of a threatening condition. 
 Balancing acute interventions with progressive advanced disease. 
 Patient and carer require opportunities to collaborate in decisions at the end of life. 
 Prioritising and maximising patient preferences in the midst of acute intervention. 
 Transition from acute care to palliative care 
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This theory allows patients, carers and healthcare professionals to process 
strategies and guidance to reduce the uncertainty that is inherent in MSCC.  
The concepts of the theory of collaborative decision making include: significant 
event, awareness of MSCC, collaborative decision making, prioritising and 
maximising life and end of life care.  
1. Significant event 
In this study, MSCC is described as a significant event that can result in 
irreversible paralysis with loss of bladder and bowel control.  As a result, it will 
impact on the patient’s survival and quality of life, and normally signifies 
transition towards the end-of-life.  The onset of MSCC may cause confusion, 
distress or creates feelings of fear, uncertainty of the unknown and a sense of 
hopelessness for patients and carers.  People can construct uncertainty as a 
problem or they can be disposed to interpret and manage it as a potentially 
positive force within the social context in which they live.  The healthcare 
professionals’ perspectives were of dealing with a condition with limited 
treatment options which can be complex.      
2. Awareness 
Evidence from this study shows that conversations about awareness of signs 
and symptoms of MSCC, potential benefits and uncertainty of treatment 
outcomes, prognosis, deterioration of condition and the palliative intent of 
treatment often did not occur or occurred late in the patient’s trajectory of 
cancer.  The key issue from this study is that patients had difficulty in 
comprehending the new or vague symptoms they experienced or recognising 
their significance.  Therefore, patients at high risk of MSCC or bony metastases 
should be informed about the signs and symptoms of MSCC.  Awareness is 
about providing patients with the information about their likely cancer pathway 
and exploring their goals for the future.  This would empower patients and/or 
carers to know when, how, and where to get help urgently.  The findings from 
this study suggest that often patients were followed-up by their tumour specific 
consultant.  Therefore, information about MSCC should be embedded during 
the patient’s consultation with their tumour specific consultant and reinforced by 
their general practitioner.   
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The current study also identified that carers and/or family members look for 
information for the patient so they understand when assistance may be 
required.  Supporting carers includes providing them with signs and symptoms 
of MSCC and involving them as a partner in the patient care and this did not 
always happen, but was important to carers in this study.  People are also 
embedded within social networks that influence how they make decisions.  
Carers are part of that network.  A key population-based study in Canada 
estimated that at least 2.5% of all people with cancer experienced one or more 
episodes of spinal cord compression in the five years preceding death (Loblaw, 
Laperriere and Mackillop 2003).  This suggests that information about the 
recurrence of MSCC should also be provided to patients on discharge. 
 
The concept of awareness includes giving timely information and tailored 
education to all stakeholders.  Awareness also encompasses informing general 
practitioners, community staff, and medical staff out with oncology through 
tailored education.  Raising awareness and education on the early signs and 
symptoms of MSCC to healthcare professionals should be from a collaborative 
perspective.  In an ideal situation, patients, carers and healthcare professionals 
will be aware of MSCC, because they will be communicating at the same level. 
3. Collaborative decision making 
It is evident that all stakeholders can make decisions.  The patients and carers 
in this study perceived that healthcare professionals were not working together 
as a multidisciplinary team and the patients and carers were often not included 
in the decision making process.  This study draws attention to the fact that each 
discipline can make decisions in isolation thus contributing to problems of 
communication across and within disciplines.  The resulting decisions could 
therefore sometimes be fragmented and not clearly communicated and 
understood by all the key stakeholders.  
 
As the key stakeholder, the patients, alongside their carers’, were not always 
involved in important discussions and they felt left in the dark about how their 
problems were being managed especially around the time of onset of MSCC, 
and initial treatment.  Patients and carers need to navigate through a complex 
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system, often not knowing what treatment or support is available to them.  The 
healthcare professionals in the study stressed: “treatment is a team decision, 
not a surgical decision”; “what we need is a multidisciplinary team to manage 
MSCC”; and “we need to identify what our goals are” and “it was shared 
decision making”.  Although in Chapter 2, section 2.8, the wider literature on 
oncology suggests that a ‘shared decision making’ approach is not helpful in the 
treatment decision (Menard et al. 2012), Da Silva (2012), argues that there is no 
agreed definition for ‘shared decision making’.  Moreover, it can be used as a 
tool to identify the goals of patients.  Shared decision making requires all 
stakeholders involved in patient care to be informed, engaged and decisions 
reviewed.  For shared decision making to be effective, this has to be 
acknowledged by the healthcare professionals in partnership with the patient 
and carer (Da Silva 2012).  Moreover, Brock (1991) and Jefford and Tattersall 
(2002), found that most patients preferred shared decision making with their 
multi-disciplinary team.  In the current study, shared decision making is not just 
about treatment decisions; it also encompasses support beyond treatment and 
end-of-life care.   
 
Collaborative decision making is about effective communication between and 
amongst healthcare professionals within the acute setting and across health 
agencies (including the patient and/or carer).  Boon et al. (2004:3), defined 
collaborative care as “practitioners who normally practice autonomously from 
each other; however, they share information concerning a particular patient who 
is being treated by each of them”.   
 
However, findings from this study, confirm collaborative decisions should 
include the patient and/or carers.  It is also about respecting opinions and 
making shared decisions among healthcare professionals, the patient, and/or 
carer and working closely together in delivering optimal care to meet the 
preferences of the patients with MSCC.  The evidence from the literature shows 
that collaboration between care providers, coordination of care and patient 
involvement contribute to better quality of life (Canadian Health Services 
Research 2005).  A mechanism suggested by Jiwa et al. (2008) is to harness 
an effective information technology strategy to ensure practitioners in different 
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care sectors have access to the same data on patients to improve continuity of 
care.   
 
It is also about understanding that requirements for support vary at different 
times within the trajectory of cancer.   The level of care needs to be explained 
and reviewed taking into account patients and carers views.  Therefore, support 
is through negotiation and a mutual approach.  It is also about recognising that 
patients and carers need help to make adjustments to deal with the 
consequences of disability and end of life issues.   
4. Prioritising and maximising life 
The process that an individual moves through during the experience of MSCC 
depends on several factors; whether they have functional independence or 
whether there is a threat to it and whether there are further treatment options.   
Whilst patients said they accepted their cancer had progressed and was beyond 
their control, they still had hopes for a prolonged survival.  However, a 
discussion about treatment intent would let patients make a balanced decision.  
This concept is also about dealing with the complexity of MSCC with an 
unpredictable outcome. 
 
There was also a sense of recapturing what was most important to them and to 
take stock of what they could still do and the time they had left.  The experience 
of MSCC often initiates a re-prioritisation of life’s priorities.  The key focus here 
is about the patients and carers coming to terms with the reality of dying.  
5. End of life care 
Evidence from this study shows the acute care setting was challenging in 
managing MSCC and that the transition from active treatment to palliative care 
could be less than optimal.  This is supported by studies which reported 
negative consequences for patients who lacked an insight into their disease 
stage, resulting in late end of life planning and late access to palliative care 
services (Innes and Payne 2009; Guo et al. 2010).  The preparation for the 
transition from curative to palliative care is necessary to reduce suffering and to 
improve the patient’s quality of end of life.  The main issue is the tension 
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between acute intervention and palliative care and this is a key problem with 
MSCC in that its acute onset normally indicates transition towards the end of life 
and goal setting and aims may be contradictory.  Quality end of life care is 
highly individual and this can only be achieved through a process of shared 
decision making taking into consideration patients’ and carers’ preferences and 
needs.  Therefore, in a complex condition like MSCC, treatment and care 
decisions are usually not made in isolation but need to include social context, 
interactions and changes in the disease or situations which are not necessarily 
limited to one setting such as acute care. 
6.8 Strengths and limitations of the study 
In this section I reflect on the research process and consider the strengths and 
limitations of this study.  The body of knowledge on key stakeholders’ 
perceptions and experiences in the acute management of MSCC is limited.  
This thesis makes a unique contribution to the current state of knowledge in 
MSCC as it illuminates the perspectives of the key stakeholders when MSCC 
presents.  This study explores the patient’s journey in MSCC and provides in-
depth information about how patients’ and carers’ experiences and perspectives 
change over time and illuminates the tensions between acute intervention and 
planning end of life care.    
 
By utilising a qualitative paradigm, this study has obtained a level of detail and 
understanding that would not be possible through the use of a quantitative 
paradigm (Silverman 2000:8).  A case study approach using real patients as the 
focus of the case analysis has illuminated how care is provided in the clinical 
setting and has presented the illness trajectory from all perspectives providing a 
more holistic approach (Yin 2009).   The findings of this study contribute to 
greater knowledge and understanding of MSCC and the construction of a theory 
to illuminate the components of collaborative decision making can inform future 
clinical practice.  The use of focus groups and interviews provided strength to 
this study and these were effective in gaining rich data on key stakeholders’ 
experiences of MSCC (Yin 2009).   
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This study took place in four regional health boards in Scotland and as such 
there could potentially be limitations to the generalisation of the findings.  It is 
proposed that as there were considerable variations in socio-economic 
conditions and health services represented in the sample of eight cases, that 
the interpretation presented here is likely to have relevance to a range of 
settings. Furthermore, the emerging theory presented here can be applied, 
tested and refined in different contexts thus providing opportunities to unpack 
and illuminate decision making in MSCC.   
Qualitative descriptive research using a case study approach was an 
appropriate method, as it enabled the collection of in-depth information; 
however, it was time consuming to gather data from different sources, 
especially from healthcare professionals who may work different shifts or have 
gone on their day off or on leave.  In addition, this study dealt with vulnerable 
patients who were at the end of their lives.  Access to longitudinal data in the 
patient’s journey in MSCC took time, as some of the patients were still receiving 
treatment, or became unwell.  One patient died before the second interview was 
possible and another was not well enough to participate.  Despite these 
limitations, the findings from this case study indicate that MSCC is a complex 
condition, fraught with uncertainty and all stakeholders endured inconsistencies 
at all levels.  In addition, these results indicate that the needs of carers and 
patients must be addressed when planning any supportive care.  Future support 
also needs to assist both patients and their carers to manage ongoing stressors 
and to maintain resources which can have a positive effect on each person’s 
quality of life. 
6.9 Chapter summary 
This chapter has incorporated and discussed the experiences of patients, 
carers and healthcare professionals in the management of MSCC in relation to 
relevant literature.  The synthesis presented within the discussion identified that 
patients diagnosed with MSCC and their carers face vague new symptoms, a 
significant event, and they face multifaceted aspects of uncertainty in the 
trajectory of MSCC. The current study has highlighted that an acute onset of 
MSCC warrants emergency treatment.  Moreover, it normally signifies that 
 
 
 
258 
 
patients are facing their end of life.  For patients and carers manoeuvring 
through the acute setting and different health agencies, proved complicated and 
many of their needs were unmet.   
 
At the same time, they wanted information and some sense of structure so they 
were able to think ahead and plan for whatever time they had left to live.  Their 
support needs vary between individuals and may change over time.  However, 
patients may not necessarily have the information to help them understand and 
make decisions and endure uncertainties.   
 
Importantly, healthcare professionals knew they had to make decisions, but the 
lack of guidance resulted in them often trying to ‘play safe’ in the management 
of the patients.  Due to the lack of guidance or protocol, healthcare 
professionals also endured inconsistencies and provided what they thought 
would be best for the patients.  However, these decision making processes may 
not be known to the patients and carers and they continued to endure 
uncertainty. 
 
The findings in this study represent an in-depth exploration of the boundary 
between the acute management of a complication of advanced cancer and 
transition to end of life care in MSCC.  The analysis illustrates the challenges, 
tensions and conflicts from the perspectives of healthcare professionals in their 
decision making process in MSCC.  More importantly, it draws attention to the 
patients and carers difficulties in navigating a complex system.   
 
The discussion presented levels one, two and three abstractions leading to the 
development of a proposed theory in MSCC.  The discussion reveals that all 
key stakeholders make decisions albeit with different goals.  This places 
healthcare professionals in an enabling role: through collaborative decision 
making they can enable patients towards make decisions in their end of life 
care.   
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Chapter 7: Conclusion and Recommendations 
This chapter concludes this research by providing key findings with 
recommendations to inform patients, carers, healthcare professionals and 
suggestions for future research.  This qualitative study has sought to explore 
the perceptions and experiences of patients, carers and healthcare 
professionals in the management of metastatic spinal cord compression 
(MSCC) in a region in Scotland.  Using case study as a research strategy this 
study highlights the management of MSCC is complex due to the threatening 
and unpredictable nature of the condition.  There is a distinct need to recognise 
the complex reality of MSCC and the resulting tensions, conflicts and 
challenges faced by all stakeholders. Optimal service provision is based on 
negotiating support, according to the needs of patient and carer. Patients are 
more likely to benefit from a blended acute oncology and palliative care that 
would allow healthcare professionals to provide optimum care.   
7.1 Original contribution to knowledge on MSCC 
Metastatic spinal cord compression is normally a condition with acute onset.  
The orientation in management remains towards acute care rather than 
palliative care which produce tensions and challenges in meeting the needs and 
support required by patients and carers.  MSCC is a complex condition 
requiring multiple interventions and care co-ordination by a variety of healthcare 
professionals across healthcare agencies.  All stakeholders make decisions and 
the evidence suggests MSCC has a significant impact on a patient’s quality 
end-of-life.  The theory of collaboration decision making can inform key 
stakeholders about strategies to deal with uncertainty and inconsistencies in the 
management of MSCC.  
7.2 Recommendations for patients 
The findings in this study raise a number of implications for patients as outlined 
below: 
 The most urgent implication for patients is to provide information on early 
signs and symptoms of MSCC to patients.  There is a need to update 
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awareness and address new concerns to help patients cope and to 
provide patients with timely information about treatment or change of 
treatment plans, pathway of disease, effectiveness of treatment, side 
effects of treatment, and prognosis.  Patients want information about 
them as an ‘individual’.  In addition to the information the consultant has 
given to the patient, a designated healthcare professional should 
reinforce this.  Education can be further facilitated through visual aids 
and leaflets.  
 A progress chart at the patient’s bedside indicating, for example, ‘patient 
is due for stairs assessment tomorrow’ – healthcare professionals will 
then have an idea of the immediate plans for the patient.  This 
information would also benefit carers when they visit the patient. 
 There is a need to have a discussion with patients about functional 
deterioration.  Giving information and working alongside patients and 
carers would enable them to make decisions rather than assuming the 
needs of their care.    
 Provide psychological support to patients immediately after treatment, to 
enable coping abilities and find meaning and adapt to a diagnosis of 
MSCC.  This may be input from the palliative care team/telephone 
support.  Offer psychological support to patients who have suffered 
depression before.   
 It is important to emphasise the availability of oncology team and a 
telephone number for contact and emergencies should be provided. 
Patients and carers reported being hesitant about contacting NHS 24 as 
they felt they might not get immediate help.  To overcome this, NHS 24 
staff should be made aware of the guidelines.  Similarly, locums should 
be made aware to phone the advice service if MSCC is suspected.  
 Support for children and adolescents who are faced with a dying parent.   
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7.3 Recommendations for carers 
From the findings of the study, the following recommendations are for carers. 
 Carers want information about how to recognise the signs of 
deterioration and how to cope with changes in the patient.  Information 
and education to carers can be facilitated with visual aids and leaflets.  
 Service providers need to address the concerns of carers in order for 
them to support their loved ones to experience a quality end of life.  
 Provision of support should be flexible, discussed and negotiated with 
not only the patients but also in consultation with the carers.   
7.4  Recommendations for healthcare professionals 
 There is a need for clarity in the local referral pathway.  
 A multi-disciplinary team specific to MSCC may be beneficial in 
improving continuity of care.  The team should include patient and/or 
carer and in particular palliative care team or a palliative clinical nurse 
specialist.  The use of ‘shared decision making’ as a tool in patient 
centred care – to identify each patient’s preferences, values and needs.   
 As patients may require and process information incrementally, a 
patient’s concerns inventory (PCI) may be beneficial to allow them to 
express their anxieties and needs.   
 Unitary documentation for all healthcare professionals involved in the 
patients’ care for MSCC to ensure continuity of care.  This would provide 
clarity and guidance for mobilising the patient, follow-up on rehabilitation; 
and the equipment needs of patients.  In addition, a tick-box in the care 
pathway to remind healthcare professionals to document what had been 
discussed, or any updated information given to the patients. 
 Nursing staff need to be sensitive to where patients are placed in the 
ward as seeing other patients in an advanced stage of cancer may evoke 
anxiety and fear.   
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 Perform neurological examination and functional assessments of patient 
shortly before discharge may be useful as a patient’s mobility can 
deteriorate rapidly.   
 An awareness of MSCC should be raised in all staff.  For example, 
through discussion groups that includes primary, secondary and tertiary 
healthcare professionals using a tailored approach - ‘whole clinical 
picture’.   
 The primary care team has a vital role in the support of cancer patients 
and their families.  Keeping the primary care team informed about the 
patients is crucial; however, the support provided must be flexible and 
negotiated.  Healthcare professionals need to understand that patients 
and carers deal with different health providers and getting their concerns 
addressed needs collaboration between the different settings.  Providing 
support in the form of telephone calls would benefit patients and carers.  
It could create a platform for carers to voice their concerns in providing 
support to their loved ones.  
 Rehabilitation services for patients with MSCC should be embedded in 
their care.  
7.5  Recommendations for policymakers 
 Develop a collective strategy for managing MSCC in Scotland. 
 
 Evaluate MSCC provision against the quality care standard. 
 
 Institute an ICD code for MSCC for effective mechanisms to identify 
those patients who are approaching their end of life. 
 
 A single electronic end of life care register to better co-ordinate care 
which is accessible to all health care settings.  
 
 It is recommended that NICE guidelines or pathway be made simple.   
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7.6 Recommendations for future research 
This study has made a contribution to the knowledge base of MSCC through 
the perceptions and experiences of patients, carers and key healthcare 
professionals.  The study has identified concepts such as significant event, 
awareness, collaborative decision making, prioritising and maximising life and 
end of life care.  However, further research is needed:  
 The proposed theory of collaborative decision making in MSCC requires 
further development, testing and refinement. 
 
 To investigate the use of a clinical radiological predictive tool to inform 
decisions about positioning, mobilisation and rehabilitation. 
 
 Investigate the use of orthosis to relieve pain in MSCC. 
 
 To evaluate the views of rehabilitation staff to understand their decision 
making process in determining MSCC patients’ suitability for 
rehabilitation. 
 
 To evaluate patients’ and carers’ experiences in receiving rehabilitation 
input. 
 
 Undertake a review of current information and resources on MSCC 
awareness.  This could aid in the production of MSCC awareness 
materials. 
7.7 Dissemination of findings 
The findings from this research will be made available through various 
approaches including journals, conferences and posters. These will be made 
accessible to patients, carers, healthcare professionals, the MSCC cord 
compression steering group and cancer organisations. 
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7.8 Reflections on the process of this study 
My experience of undertaking this research has been a steep learning curve; 
from despair combing through the vast amount of data to the joy of discovering 
a theory.  I have heard other researchers say ‘your theory would drop out from 
the sky’ – there was anxiety provoking when nothing seemed to happen as I 
wrote my discussion chapter.  However, I felt a sense of elation when the theory 
did develop.  It was not an easy process as my mind kept going into overdrive.   
 
Although qualitative research is a useful means of collecting sensitive data and 
obtaining a deeper understanding of a phenomenon, I found it an emotional 
journey, particularly when hearing participants’ stories on facing end of life.  I 
also found it a privilege that participants trusted me to hear their stories.  The 
process of transcribing can be both emotionally draining and distressing to hear 
peoples’ experiences.  I feel the opportunity to debrief is important for a 
researcher as support in this area is neglected.   Another difficulty in analysis 
was seeking to make sense of the different stakeholders’ perspectives and 
finding common themes – there was a need for constant movement between 
the eight case studies which can be very paralysing for the mind. 
 
Although, I recruited key healthcare professionals who were involved in the 
management of patients with MSCC, there are healthcare professionals’ 
perspectives that have not been captured in this study.  For example, 
radiotherapists who provide radiotherapy treatment to patients - despite them 
having being invited.  It would have been valuable to capture the views from 
other primary cancer groups such as haematology, renal and gynaecology.  
However, some patients were too ill or did not want to participate in the study.  
Overall, this journey has been a valuable training in opening my mind to 
qualitative research and data analysis has challenged me intellectually. 
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Lothian MSCC Referral Pathway (back of card) 
 
 
 
 
304 
 
Appendix 2: Medline search strategy 
Medline search strategy: 1st January 2000 – 9th August 2012 
No. Search terms/keywords Number of 
hits 
1 (MM “Spinal cord compression”) 5688 
2 (MM “Spinal cord neoplasms+”) 7096 
3 (MM “Neoplasm metastasis+”) 30221 
4 “Metastatic spinal cord compression" 160 
5 “Malignant spinal cord compression” 62 
6 1 or 2 or 3 or 4 or 5  42434 
7 (MM “Patient participation”) 8134 
8 (MM “Patient satisfaction”) 18360 
9 (MM “Consumer participation+”) 15191 
10 (MM “ Consumer satisfaction+”) 25758 
11 “Patient attitude” 95 
12 (MM “Patient-Centered Care”) 4903 
13 “Decision making, patient” 67 
14 “Patient experience” 1054 
15 “Patient perspective” 697 
16 “Patient journey” 124 
17 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16  46468 
18 6 and 17 6 
19 (MM “Palliative Care”) 18694 
20 (MM “Terminal Care+”) 28526 
21 19 or 20 44085 
22 6 and 21 165 
23 6 and 21 (Limit: year = January 2000 - August 2012; 
English Language; human; adult) 
29 
24 (MM “ Quality of Life”) 44007 
25 “Coping” 28728 
26 “Psychosocial aspects of illness” 24 
27 24 or 25 or 26 71559 
28 6 and 27 35 
29 6 and 27 (Limit: year = January 2000 – August 
2012; English Language; human; adult) 
21 
30 “Healthcare professionals” 5933 
31 “Multidisciplinary team” 5678 
32 “Decision making, clinical” 43 
33 30 or 31 or 32 11593 
34 6 and 33 8 
35 “Caregiver experience” 33 
36 “Caregiver perspective” 16 
37 “Caregiver support” 237 
38 35 or 36 or 37 285 
39 6 and 38 0 
 
 
 
305 
 
Appendix 3: Level of evidence (SIGN 2012) 
Annex B: Key to evidence statements and grades of recommendations (2012) 
Levels of evidence  
 
1++ High quality meta-analyses, systematic reviews of RCTs, or RCTs with a very 
low risk of bias 
1+ Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk 
of bias 
1- Meta-analyses, systematic reviews, or RCTs with a high risk of bias 
2++ High quality systematic reviews of case control or cohort or studies 
High quality case control or cohort studies with a very low risk of 
confounding or bias and a high probability that the relationship is causal 
2+ Well-conducted case control or cohort studies with a low risk of confounding 
or bias and a moderate probability that the relationship is causal 
2- Case control or cohort studies with a high risk of confounding or bias and a 
significant risk that the relationship is not causal 
3 Non-analytic studies, e.g. case reports, case series 
4 Expert opinion 
 
Grades of recommendations 
 
At least one meta-analysis, systematic review, or RCT rated as 1++, 
and directly applicable to the target population; or 
A body of evidence consisting principally of studies rated as 1+, 
directly applicable to the target population, and demonstrating 
overall consistency of results 
 
 
A body of evidence including studies rated as 2++, directly 
applicable to the target population, and demonstrating overall 
consistency of results; or 
Extrapolated evidence from studies rated as 1++ or 1+ 
 
 
A body of evidence including studies rated as 2+, directly applicable 
to the target population and demonstrating overall consistency of 
results; or 
Extrapolated evidence from studies rated as 2++ 
 
 
Evidence level 3 or 4; or 
Extrapolated evidence from studies rated as 2+ 
 
Good practice points 
 
Recommended best practice based on the clinical experience of the 
guideline development group 
 
 
 
 
306 
 
Appendix 4: Summary of studies - The impact of MSCC on patients’ experience 
Author Year Country Care setting  Aim Type of study 
1. Cowap, J., Hardy, J.R. & A’Hern, R. 2000 UK Hospital To review the presenting features of patients with MSCC 
and to determine the functional outcome of patients at 
diagnosis, treatment and at follow up. 
Quantitative - 
retrospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Medical records of patients diagnosed 
with MSCC from August 1987-
September 1995. 
 
Retrospective analysis of 
patient’s medical records 
(n=166) regarding functional 
outcome and performance 
status using the Eastern 
Cooperative Oncology Group 
(ECOG) performance scale. 
The median survival was 82 days (range, 1-1349 days).  Limb weakness was 
identified as the most common followed by back pain, sensory loss and sphincter 
dysfunction.  Back pain may not have been documented.  The majority of patients 
(92%) received radiotherapy, only 20% showed an improvement in neurological 
function.  The authors suggest poor performance scale and neurological status on 
admission indicate patients require high level of care.  23 patients (14%) had 
recurrence of MSCC (10 at previous site and 11 at a new site). 
Highlight patient’s short life expectancy after diagnosis of MSCC.  There was 
delayed presentation of MSCC.  Functional outcome after radiotherapy is 
uncertain.  MSCC can recur after treatment.  
SIGN level 3 
   
Author Year Country Care setting  Aim Type of study 
2. Conway, R., Graham, J., Kidd, J., Levack, P. 
& other members of the Scottish Cord 
Compression Group. 
2007 UK 3 oncology centres 
in Scotland 
To present further findings from the Scottish Cord 
Compression study. 
Quantitative-
prospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Data of patients collected at 1 month 
after diagnosis of MSCC. 
Assessment include: mobility; 
pain using the Visual Analogue 
Scale (VAS), Karnofsky 
performance Status (KPS); 
semi-structured questions 
Schedule for Evaluation of 
Individualised Quality of Life-
Direct weighting (SEIQoL-Dw); 
Hospital Anxiety and 
Depression Scale (HAD); and 
survival.  Patients (n=128) 
were interviewed 1 month after 
diagnosis of MSCC. 
Survival was short (median 59 days) but varied between different primary cancer 
groups.  Patients reported continued pain after radiotherapy.  The benefit from 
radiotherapy was not immediate.  Planning for future care should involve a 
discussion with what was important for patients, for example, place of care.  Poor 
performance status at 1 month after diagnosis was also associated with a lower 
QOL but individual scores were high and not all patients with low performance 
status had low QOL scores.  Mood was reported as normal in most patients.  
Some patients rated their QOL to be high and at the same time rated high levels of 
emotional distress and patients who had low QOL scores rated low levels of 
emotional distress. 
Life expectancy is short in MSCC and varied in different primary cancer 
groups.  The effectiveness of treatment is uncertain.  Pain issues were not 
addressed.  The study indicates the difficulty in capturing information on 
patients’ emotional well-being.   
SIGN level 2+ 
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Author Year Country Care setting  Aim Type of study 
3. Huang, J.& Jatoi, A. 2009 USA Tertiary medical 
centre 
To assess the needs and outcomes of patients with solid 
tumours who had become non ambulatory as a result of 
cord compression. 
Quantitative-
retrospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Medical records of patients with a 
radiographic confirmation of MSCC.  
Treatment included corticosteroids, 
radiation and surgical decompression.  
Study was carried out between 1999 and 
2006. 
Retrospective analysis of 
patient medical notes (n=39).   
Patients who become non ambulatory after diagnosis of MSCC do poorly with a 
median survival of 76 days (range, 4-1975 days).  The majority of patients required 
bladder and bowel care. 64% patients did not regain mobility. 33% patients went 
home without assistance.  Stress the importance of palliative care in meeting 
patients’ end-of-life needs.  Suggest patients may benefit from an early discussion 
of hospice resources.  Authors acknowledged study cannot capture whether 
patients have severe morbidity.  Unable to capture the emotional status of 
patients. 
Findings indicate poor survival.  Treatment outcome is uncertain.  End of life 
needs may not have been addressed.  Patients may have unmet needs.   
SIGN level 3 
 
 
Author Year Country Care setting  Aim Type of study 
4. Guo, Y., Palmer, J.L., Bianty, J., Konzen, B., 
Shin, K., & Bruera, E. 
2010 USA Cancer Centre To determine presence of advanced directives and do-not-
resuscitate (DNR) orders among patients with MSCC. 
Quantitative-
retrospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Electronic medical records of patients 
with MSCC.    Review was carried out 
form September 2005 to August 2008. 
Retrospectively reviewed 88 
patients’ medical records for 
advance directive and do-not-
resuscitate (DNR) orders.  The 
mean age of patients was 55 
years (range, 24-81). 
The median survival time was 4.3 months for patients with MSCC.  The authors 
suggest patients were not aware of the urgency to have an advanced directive and 
do-not-resuscitate (DNR) order.  Among 59 patients who had died, 26 (46%) had a 
DNR note.  There was a short interval between DNR order and death (16.5 days) 
– this indicates a need for communication about end of life goals of care.  The 
authors suggest the physicians can consider the development of MSCC as a 
baseline in prognostication and to initiate a palliative discussion. 
Strong evidence of short survival times for MSCC patients.  Decision making 
around treatment intent may not have been discussed with patients and 
family members. 
SIGN level 3 
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Author Year Country Care setting  Aim Type of study 
5. Aass, N. & Fossa, S.D. 2005 Norway Regional Cancer 
Hospital 
To identify prognostic factors and prospectively evaluate 
daily life function and pain experience in hormone resistant 
prostate cancer patients with MSCC treated with 
radiotherapy. 
Quantitative -
prospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients with MSCC from hormone 
resistant prostate cancer.  Study period 
May 1996 to October 1999.  All 
patients received 30 Gy given in 10 
fractions except patients treated to 
large fields received 40 Gy in 20 
fractions. 
Used Barthel Activity of Daily 
Living (ADL) Index.  Patients 
(n=49) were given the 
questionnaire at pre and post 
radiotherapy.  
Median survival 3.5 months (range, 0.3-36.0). Improvement in mobility, daily 
function and sphincter control.  Barthel ADL Index was not sensitive to differentiate 
between paralysis and paresis.  Patient’s mobility, daily life activities and sphincter 
control did not improve at the end of radiotherapy.  Radiotherapy treatment was 
started at a median of 4 days (range, 1-66 days).  The authors suggest prostate 
tumours may be slow to response to radiotherapy.  Another possible reason was 
patients and/or their doctors may not have recognised the early symptoms of 
MSCC, therefore, there may have been a longer delay in receiving treatment.  
Difficult to detect functional deterioration with Barthel ADL Index.  Limited 
study to patients with primary prostate cancer.  Treatment outcomes with 
radiotherapy were uncertain. 
SIGN level 2- 
 
Author Year Country Care setting  Aim Type of study 
6. Schoeggl, A., Reddy, M. & Matula, C. 2002 Austria Department of 
Neurosurgery 
To demonstrate the mobility, continence, pain and quality 
of life in patients following palliative de-compressive 
laminectomy. 
Quantitative - 
retrospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
The study included only patients who 
had metastases with infiltration of the 
dorsal epidural parts or those who 
could not be operated on via an 
anterior approach. 
84 patients met the criteria (53 
male and 31 female).  The 
average age was 60 years 
(range, 23-82 years).  20% of 
patients have been mobile pre 
operatively. 
Post operative assessment showed mobility rose to 45% but deteriorated after 2 
months. The set back in the dorsal approach is the inability to remove the tumour 
completely.  Heterogeneous group of patients with varying prognosis made 
treatment choice difficult and subjected to controversy.  The authors suggest a 
randomised prospective study is required. Palliative laminectomy with total or 
subtotal tumour reduction in patients with malignant spinal metastatic disease 
improved patients’ quality of life. However, outcome would be poor if there is pre-
operative paraparesis and in such instance the authors recommend laminectomy 
only.   
Decision making with regards to treatment, incision approach, primary 
cancer types and prognosis is complex.  Regaining and maintaining mobility 
is unpredictable. 
SIGN level 2 - 
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Author Year Country Care setting  Aim Type of study 
7. Wai, E.K., Finkelstein, J.A., Tangente, R.P., 
Holden, L., Chow, E., Ford, M. & Yee, A. 
2003 Canada Division of 
Orthopaedics 
Surgery 
To evaluate the efficacy of surgery in patients with 
metastatic spinal disease with respect to QOL. 
Quantitative - 
prospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Indications for surgery included: 
intractable pain, neurologic 
deterioration, or failure of radiation 
treatment.  Patients were excluded 
from the study if stabilisation was not 
possible, if expected survival was < 3 
months.  The cohort study was 
conducted from November 1999 to 
May 2001.   
Patient-centered questionnaire 
Edmonton Symptom 
Assessment Scale (ESAS) to 
assess quality of life.  
Physician-determined 
assessment with the modified 
Townsend Functional 
Assessment.  Patients (n=25) 
participated. Average age of 
the patients was 59.3 years 
(range, 37-77 years). 
Time to death ranged from 1-21 months.  Great improvement in pain relief after 
surgery. Other domains of improvement: tiredness, nausea, anxiety, appetite and 
overall wellbeing.  No improvement in drowsiness, depression and shortness of 
breath.  Only 44% had functional improvement. No outcome difference with 
regards to age, tumour extension.  There is risk of post-operative morbidity in 
thoracic lesions. 
Neurological recovery is unpredictable.  Pre-operative neurological function 
is a strong predictor of functional outcome.  Psychological issues may not 
have been addressed.  No definition of QOL and justification given for the 
choice of instruments.  The abstract of the article reported positive 
outcomes but not the negative aspects.   
SIGN level 2+ 
 
Author Year Country Care setting  Aim Type of study 
8. Sandalcioglu, I.E., Gasser, T., Asgari, S., 
Lazorisak, A., Engelhorn, T., Egelhof, T., 
Stolke, D. & Wiedemayer, H. 
2005 Germany Department of 
Neurosurgery 
To analyse factors that impact on the functional outcome 
of patients with surgically treated intra-medullary spinal 
cord tumours and to identify characteristics of different 
histology. 
Quantitative – 
case series 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients with intra-medullary spinal 
cord tumours.  The study was 
conducted between 1990 and 2000. 
Functional outcome assessed 
with Frankel grade (Frankel et 
al 1969) and analysed against 
age, tumour type, site and 
extent of tumour.  Frankel 
grade outcome grade as poor 
(A+B), fair (C), and good 
(D+E).  78 patients 
participated in the study.  The 
mean age of patients was 43.3 
years (range, 1-75 years).  
There were 46 males and 32 
females.   
Pre-operative neurological status is a strong predictor of functional outcome.  
Functional outcome is related to histological type and grade of tumour growth.  In 
some cases complete tumour removal may not be possible if there was absence 
of a clear plane for dissection.  No outcome difference with respect to age, 
tumour extension, however, there is increased risk of post-operative morbidity in 
thoracic located tumours. 
 
Pre treatment neurological status is an indicator of functional outcome.  
Functional outcome depends on the primary cancer histology and extend 
of metastases.  High risk of surgical complications if tumour involved the 
thoracic region. 
SIGN level 3 
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Author Year Country Care setting  Aim Type of study 
9. Falicov, A., Fisher, C., Sparkes, J., Boyd, 
M.C., Wing, P.C. & Dvorak, M.F. 
2006 Canada General hospital To assess HRQOL outcomes in patients undergoing 
surgery for spinal metastases. 
Quantitative- 
prospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients with bony spinal metastases 
requiring surgical intervention were 
included in the study.  Excluded 
patients who had previous surgery for 
MSCC and patients who were unable 
to fill out the questionnaires.  Study 
was conducted from April 1999 to 
March 2004. 
85 patients were given 
questionnaires at 5 points – 
before surgery, at 6 weeks, 3 
months, 6 months and at 1 year.  
HRQoL questionnaires include: 
the European Organisation for 
Research and Treatment of 
Cancer Quality of Life 
Questionnaire (EORTC QLQ-
C30), Health Utility Index (HUI-3), 
the European Quality of Live – 5 
Dimensions (EQ-5D), Visual 
Analogue Score (VAS) and 
Eastern Cooperative Oncology 
Group (ECOG).  
Survival was 39.1 weeks.  Surgery significantly relieves pain, improves QOL 
and daily functional status.  Pain was measured using several instrument tools. 
There was a statistically significant correlation between baseline global health 
status and survival time (P=0.041). No significant improvement in ECOG 
functional scale from pre-operative status.  Surgical complications were 
reported as low.   
Survival is poor.  Functional outcome may not improve after surgery.  No 
definition for HRQOL.  No justification for choice of assessment tools 
used.  Limitations of the study – patients whose estimated survival of 
less than 3 months and patients who were unable to fill out the 
questionnaires were disadvantaged.  Authors did not give the 
abbreviations for the assessment tools.  The number of assessments and 
the different time points were time consuming for patients to complete. 
SIGN level 2- 
 
 
Author Year Country Care setting  Aim Type of study 
10. Fujibayashi, S., Neo, M., Miyaki, K., 
Nakayama, T. & Nakamura, T. 
2010 Japan Department of 
Orthopaedic 
Surgery and related 
hospitals 
To evaluate the value of palliative surgery for spinal 
metastases and to identify the factors predicting 
satisfaction of patients and their family members after 
surgery. 
Quantitative – 
prospective, 
survey 
Sample, characteristics, patient 
or staff groups 
Methods Key messages Evidence 
Patients deemed fit with an 
expected survival of at least 3 
months were eligible for the 
surgery.  The objective of the 
surgery was palliative.  Surgical 
approach total en bloc 
spondylectomy were excluded in 
the study.    
Questionnaire-based survey on 
satisfaction of patients and their 
family members 3 months after 
surgery.  37 patients responded to 
the questionnaires. 
80% of patients were satisfied with the outcome of surgery.  However, 16 of the 
responses were made by family members as the patients were dead at the time of 
completion of questionnaire (limitations - the views of patients and their family 
members may differ).  Improvement in pain after surgery.  Patients aged below 65 
years with neurological improvement correlated with increased patient satisfaction.  
Satisfactions of family members were influenced by pain improvement and length 
of the patient survival.  The authors highlight that Japanese patients tend to trust 
their physicians to make decisions, however, in this study, the decisions were 
made by the patients in 23 cases, by patient and family in 12 cases, by family 
SIGN level 3 
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alone and by physician 1 case each.    
Thirty-seven (37 of 71) patients responded.  Patients and carers who did not 
respond may have been unsatisfied or had poor outcomes.  Information 
about patients’ expectations of treatment and physician treatment intent was 
not discussed.    
 
 
Author Year Country Care setting  Aim Type of study 
11. Wu, J., Zheng, W, Xiao, J-R., Sun, X., Liu, W-
Z. & Guo, Q. 
2010 China 2 hospitals To determine whether surgery for patients with spinal 
metastases could improve the quality of remaining life and 
prolong survival. 
Quantitative – 
prospective 
longitudinal 
study  
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients confirmed with a diagnosis of 
MSCC with at least 1 neurological sign 
or symptom (focused on pain), 
restricted to a single area.  Estimated 
survival of > 3 months. Study period 
from July 2007 to June 2009.  
67 patients (patients in the 
surgery group n=33 and the 
non-surgery group n=34) 
completed the Functional 
Assessment of Cancer 
Therapy (FACT-G) 
questionnaire at baseline, 1, 3, 
6 and 9 months.  Recruited 
patients: surgery group n=46; 
non surgery group n=50    
29 patients died within 9 months after diagnosis of MSCC. 67 patients completed 
all 5 follow up assessments.  The surgery group had significantly higher QOL 
scores, physical well being, emotional well being and functional well being than the 
non surgery group over the 9 months assessment.  Patient selection may be bias. 
There was no statistical significant difference between the 2 groups in terms of 
survival (P=.056).  The authors acknowledged it is traditional for patients to be 
attended by family members and this may have contributed favourably in the 
social/family well being domain. 
The authors acknowledged that both groups were eligible for surgery; the 
decision making was left to the patients and their family members.  Patient 
selection may be biased.  There is no information about patients’ 
preferences and choice in treatment decisions.  Moreover, family members 
may have influenced the patients’ decisions.   
SIGN level 2+ 
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Author Year Country Care setting  Aim Type of study 
12. Patchell, R.A., Tibbs, P.A., Regine, W.F., 
Payne, R., Saris, S., Kryscia, R.J., 
Mohiuddin, M. & Young, B. 
2005 USA Multi-institutional (7 
centres) 
To determine the value of surgery (randomised trial) 
comparing the efficacy of direct de-compressive surgery 
plus post-operative radiotherapy with that of 
radiotherapy alone. 
Randomised 
controlled Trial 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Eligibility of patients: at least 18 years 
old with a tissue-proven diagnosis of 
cancer; MRI evidence of MESCC; to 
have at least one neurological sign; 
paraplegic no longer than 48 hours 
before surgery; tumour restricted to a 
single area; in good medical status; 
and expected survival of at least 3 
months. 
Exclusion criteria: multiple discrete 
compressive lesions; radiosensitive 
tumours; previous MESCC; and 
previously received spinal radiation.  
Randomised, multicentre, non-
blinded trial with two treatment 
groups: surgery plus 
radiotherapy (n=50) or 
radiotherapy alone (n=51).  
Both treatment groups were 
treated with ten 3 Gy fractions.  
The primary end point was the 
ability to walk.  Secondary end 
points were urinary 
continence, muscle strength, 
functional status, the need for 
analgesics and survival time. 
 Patients treated with surgery plus radiotherapy retained the ability to walk for 
longer than patients treated with radiotherapy alone.  Of patients who could walk 
prior to surgery, 94% (32/34) retained mobility compared to 74% (26/35) of the 
patients who received radiotherapy alone, group.  32 patients (16 in each group) 
who were unable to walk prior to surgery; 10 patients (62%) regained mobility 
compared to 3(19%) patients in the radiation group.  Similarly, the authors 
reported the 30 day mortality rates were 6% in the surgery group and 14% in the 
radiation group.  There was reduction in the use of corticosteroids and 
analgesics.  The authors highlight that an intention-to-treat analysis was used 
throughout the study.  The authors acknowledged the study limitation had patient 
selection bias. 
Although the authors suggest the best treatment for MSCC is surgery, 
many of the patients may not meet the strict criteria.  However, the survival 
time is reported as prolonged due to the ability to remove the tumour and 
the preservation of neurological function.  In patients who were treated 
with radiotherapy alone; regrowth and secondary compression is more 
likely.    
SIGN level 1+ 
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Author Year Country Care setting  Aim Type of study 
13. Tomita, K., Kawahara, N., Kobayashi, T., 
Yoshida, A., Murakami, H. & Akamaru, T. 
2001 Japan Department of 
Orthopaedics 
Surgery 
To propose a new surgical strategy for the treatment of 
patients with spinal metastases. 
Quantitative - 
prospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients with spinal metastases. 
Phase 1 Study period 1987-1991 - 
Retrospective analysis of 67 patients’ 
predictive value of prognostic factors to 
design a new surgical scoring system. 
1987 -1991  
 
Phase 2 Study period 1993- 1996.  
Prospectively evaluated 61 patients 
prognostic outcomes based on 
decisions using the surgical scoring 
system. 
61 patients included in the 
Phase 2 study.  The mean age 
was 57.7 years (range, 33-72 
years).  There were 34 women 
and 27 men. 
The authors suggest patients with paraplegia may have a long survival period 
with the appropriate treatment.  The authors proposed a new surgical scoring 
system to help clinicians in decision making.  The system consisted of 3 
prognostic factors and the points were added to give a score between 210: 
grade of malignancy; visceral metastases; and bone metastases.  The treatment 
decision for patients will be based on this strategy: 2-3 points suggest a wide or 
marginal surgical excision for long-term control; 4-5 points suggest marginal or 
intra-lesional decision for middle-term local control; 6-7 points, palliative surgery 
for short-term palliation; and 8-10 points indicated supportive care.    
Further research is required to test the practically and accuracy of the 
scoring system. 
SIGN level 2+ 
 
 
Author Year Country Care setting  Aim Type of study 
14. Omeis, I.A., Dhir, M., Sciubba, D.M., 
Gottfried, O.N., McGirt, M.J., Attenello, F.J., 
Wolinsky, J-P. & Gokaslan, Z.L. 
2011 USA Hospital To determine the incidence and identify risk factors for 
surgical site infections (SSIs) in patients undergoing 
surgery for spinal tumours. 
Quantitative – 
retrospective case 
control study 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients who had spinal tumours and 
had undergone surgery.  Database was 
created to record patient information 
from January 1995 to February 2008. 
Retrospective review of 678 
patients’ records.  Patients 
who were included in the study 
(n=65) with surgical site 
infections (SSIs) were 
compared to a control group of 
patients (n=162).  The mean 
age was 52.1 years in the 
SSIs group and 47.4 in the 
control group.      
There is a high risk of surgical site infections (9.5 %) in spinal tumour surgeries.  
The factors that increased the risk of infection were related to the use of complex 
plastic closures, previous surgery and radiotherapy treatment, increasing 
number of co- morbidities and longer duration of hospitalisation during primary 
surgery.  Increase in age was not significantly associated with development of 
infection (P=0.093).  
There is increased risk of surgical complications in patients with an 
increased number of co-morbidities.  The reporting of the results was 
confusing in terms of the number of patients who were included in the 
study. 
SIGN level 3 
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Author Year Country Care setting  Aim Type of study 
15. Murakami, H., Kawahara, N., Demura, S., 
Kato, S., Yoshioka, K., Sasagawa, T., & 
Tomita, K. 
2010  Japan Not stated To evaluate in elderly patients the peri -operative 
complications and prognosis for metastatic spinal 
disease. 
Quantitative - 
retrospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
193 patients with metastatic spinal 
disease underwent surgery based on 
Tomita’s (2001) surgical strategy since 
1999.  Reviewed patients who were 
older than 70 years (32 patients were 
>70 years and 161 patients were 
younger <70 years).   
Retrospective reviewed 32 
elderly patients (>70 years) 
who underwent surgery.  The 
mean age of the 32 elderly 
patients was 73.7 years 
(range, 70-82). 20 men and 12 
women were included in the 
study.  Pre-operative 
assessment on general 
condition based on the 
Eastern Cooperative Oncology 
Group (ECOG) and the 
Karnofsky performance scale. 
Other outcomes: prognostic 
score, survival time and post- 
operative complications. 
Post-operative occurrence of respiratory and delirium were significantly higher in 
the elderly population.  The authors explained that cardiopulmonary reserve in 
the elderly is not enough and often cannot withstand the anaesthesia or surgical 
stress.  There was no significant difference in achieving normal temperature after 
surgery for the elderly and non elderly patients.  However, in radical surgery 
(total en bloc spondylectomy), the average time was 9.5 days in the elderly and 
5.6 days in younger patients.  Despite the risk of complications, the authors 
suggest that total en bloc spondylectomy should not be avoided due to advanced 
patient age.  The authors suggest that post-operative prognosis could be 
predicted by the surgical strategy, however, this may deviate due to patient’s 
pre-operative condition. 
Elderly patients with increased co-morbidities are at higher risk of 
complications post surgery.  Patient selection is based on generally fit 
patients.   
SIGN level 2- 
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Author Year Country Care setting  Aim Type of study 
16. Levack, P., Graham, J., Collie, D., Grant, R., 
Kidd, J., Kunkler, I., Gibson, A., Hurman, D., 
McMillan, N., Rampling, R., Slider, L., 
Statham, P., Summers, D., The Scottish Cord 
Compression Study Group. 
2002 UK 3 oncology centres 
in Scotland 
To report details concerning symptoms (especially pain) 
preceding the development of malignant cord 
compression; delays between onset/reporting of 
symptoms and confirmed diagnosis; and accuracy of 
investigation carried out. 
Quantitative- 
Prospective 
observational  
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Criteria for entry to the study: a 
definitive diagnosis of malignant cord 
or cauda equine compression by MRI 
of the spine. 
Study period: 1 January 1998 to 14 
April 1999. 
319 patients (203 male and 
116 female) participated in the 
study.  The median age was 
65 years with 89% of patients 
over 50 years. 
 82% of patients were either unable to walk or only able to walk with help.  Pain 
was the most common complaint (94%) and had been present for about 3 
months (a median of 90 days).  84% of patients reported severe pain; the site of 
pain did not correspond to the site of compression.  Weakness and/or sensory 
abnormalities were reported late leading to delayed diagnosis (median of 66 
days).  The majority of patients had reported early symptoms to their GP.   The 
authors recommend that a referral guideline based on the index of suspicion of 
MSCC is required.  The authors also proposed a national programme of 
awareness of MSCC, including educating patients.  Patients with cancer with a 
complaint of severe back pain or nerve root pain need urgent assessment and 
treatment. 
MSCC is an oncology emergency.  Early treatment is paramount to 
preserve neurological function.  Patients who are at risk of developing 
MSCC are those who have a history of cancer when they first develop pain, 
age >50, known bone metastases especially in prostate or breast cancer.  
SIGN level 2+ 
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Author Year Country Care setting  Aim Type of study 
17. Levack, P., Graham, J. & Kidd, J. 2004 UK 3 oncology centres 
in Scotland 
To report QOL of patients shortly after diagnosis of 
malignant cord compression, its relation to physical 
disability and to emotional well being.  
Quantitative- 
prospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients diagnosed with malignant cord 
compression. 
Data collection January 1998 to April 
1999. 
QOL measures using 
Schedule for the Evaluation of 
Individual QoL (SEIQoL-Dw); 
Hospital Anxiety and 
Depression scale (HAD) for 
emotional wellbeing, Barthel 
Disability Index (BDI) for 
activities of daily living, 
Karnorsky Performance (KPS) 
to assess functional status.  
261 patients participated in the 
study. 
The majority of patients scored high on family life and marriage (91% and 39% 
respectively).  Health and mobility were nominated by 44% and 35 % 
respectively and 29% on independence. The findings indicate that what the 
health professionals perceived was important to patients may not correspond to 
those of the patients.  However, what contributes to quality of life varies widely 
between patients.  Few patients were severely depressed shortly after diagnosis. 
Younger patients were more distressed than older patients.  The authors 
highlight that the SEIQoL-Dw finding encourages health professionals to listen to 
what matters to patients.  Physical function matters, however, non-physical 
issues may be more important. 
There is a lack of information on whether patients had an understanding of 
their prognosis shortly after diagnosis.  Treatment with corticosteroids, 
radiotherapy and analgesics may have given the patients a sense of 
optimism.   
SIGN level 2+ 
 
Author Year Country Care setting  Aim Type of study 
18. Street, J., Berven, S., Fisher, C & Ryken, T. 2009 Not 
applicable 
Not applicable To examine the available literature on health related 
quality of life (HRQOL) 
Systematic review 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Reviewed clinical studies on HRQoL 
assessment tools from 1966 to 
December 2008. There were 2 studies 
at level 2, 16 at level 3, and 123 at 
level 4. 
141 clinical studies included.  
Reviewed the validity of existing 
outcome instruments used in the 
studies judged on correlation 
with the International 
Classification Functioning 
Disability and Health (ICF). 
The most common patient self assessment tools used were Short Form (SF-
36), SIP 5, and the Activities of Daily Living (ADL).  The common cancer-
specific quality of life assessment tools used were Eastern Cooperative 
Oncology Group (ECOG), the European Organisation for Research and 
Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), and the 
European Quality of Life – 5 Dimensions (EUROQOL 5D).  None of the studies 
defined health related quality of life or justified the choice of the assessment 
tool.  There is no HRQOL measure to assess patients with metastatic spinal 
tumours.   
There is disparity in the choice of instruments to measure the QOL of 
patients with MSCC.  The outcomes measures were process variables 
and were not a true reflection of QOL.  This suggests difficulty in 
capturing the different domains of QOL specific to MSCC.   
SIGN level 2++ 
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Author Year Country Care setting  Aim Type of study 
19. Street, J., Lenehan, B., Berven, S. & Fisher, 
C. 
2010 Not 
applicable 
Not applicable To identify HRQOL questionnaire previously reported for 
spinal metastases and to validate the new Spine 
Oncology Study Group Quality Questionnaire 
(SOSGOQ). 
Systematic review 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Reviewed clinical studies on HRQOL 
assessment tools from 1966 to 
December 2008. 
Based on the previous 
systematic review of 141 clinical 
studies (Street et al. 2009), the 
reviewers developed a new 
measure Spine Oncology Study 
Group Outcomes Questionnaire 
(SOSGOQ) 
The SOSGOQ questionnaire was based on the 4 domains of the International 
Classification of Functioning, Disability and Health (ICF): physical function; 
neurological function; pain; mental health; social function; and post therapy 
questions.  The questionnaires were developed via consultation with patients 
with metastatic disease of the spine.  Face validity assumed from consensus of 
an international expert working group.   
There is no publication validating the feasibility of this assessment tool.    
SIGN level 2++ 
 
 
Author Year Country Care setting  Aim Type of study 
20. Mitera, G., Zeiadin, N., Sahgal, A., 
Finkelstein, J., Chow, E. & Loblaw, A. 
2010 Not 
applicable 
Not applicable To identify the need to develop a tool specific for MSCC 
to generate a meaningful data for future trials 
Systematic review 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Reviewed clinical studies on quality of 
life measures in radiation therapy trials 
for patients with MSCC. 
No levels were assigned to the studies.  
There were 4 prospective and 1 
retrospective studies.  The review was 
conducted from 1950 to October 2008. 
Reviewed 5 studies that 
assessed QOL as primary and 
secondary end points.  2 studies 
employed the Schedule for 
Evaluation of Individualised 
Quality of Life-Direct weighting 
(SEIQoL-Dw). 1 study used the 
Short Form 36 (SF36) Health 
survey questionnaire. 1 study 
used the Paediatrics Quality of 
Life inventory (PedsQL) and the 
other used Functional 
Assessment of Cancer Therapy 
(FACT-G). 
Difficult to give meaning of a score on a measure. No consistent QOL 
measures employed across studies. Only 2 (SEIQoL-Dw and FACT-G) meet 
aspects of QOL, however, were not specific to MSCC and can be time 
consuming to complete.  Concept of QOL to include cognitive, emotional and 
subjective components of patients. 
The concept of quality of life is complex and the subjective component of 
patient experience is important.  The quality of life measures may not be 
relevant to patients with MSCC.  The authors did not include social/family 
domain which can influence the quality of life of patients.  The review 
limits studies related to outcomes after radiotherapy. 
 
SIGN level 2++ 
 
 
 
318 
 
Author Year Country Care setting  Aim Type of study 
21. Hutchison, C., Morrison, A., Rice, A.M., Tait, 
G & Harden, S.  
2012  UK Cancer Centre  To determine patients and staff views on the provision of 
information to patients with a diagnosis of, or considered to 
be at high risk of developing MSCC. 
Prospective - 
survey 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients diagnosed with MSCC. 
Staff include: consultants, registrars, 
radiographer, senior ward/charge 
nurse and clinical nurse specialist.  
Survey - open and closed 
questions.  Patients with 
MSCC (n=56) and staff (n=50) 
participated in the study. (75% 
male and 25% female).   
Staff group: 29 consultants, 7 
registrars, 1 radiographer, 6 
senior ward/charge nurse and 
7 clinical nurse specialists. 
The majority of patients (86%) wanted to be informed about the signs and symptoms 
of MSCC if they were at risk of developing it.  54% of staff gave prophylactic 
information about MSCC to patients.  45% of consultants were not sure whether 
prophylactic information should be given to patients (no reasons given for this 
response).  There was a lack of clarity on whom, when and how information on 
MSCC should be given to patients.  The authors suggest the lack of responsibility 
could be due to MSCC cuts across all site-specific cancers and care settings.  Other 
possible reasons suggested were staff may not be aware of what information was 
available, or it may have been overlooked. 
Patients may not have the full information to understand their condition.  Early 
detection of MSCC is important in decision making about treatment to 
improve outcomes.  Patients’ preferences for information have not been 
explored in depth. 
SIGN level 3 
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22. Ruff, R.L., Adamson, V.W., Ruff, S.S. & 
Wang, X. 
2007a USA Neurology Service To determine whether directed rehabilitation affect 
survival, pain, depression, independence and satisfaction 
with life for patients who were non ambulatory after spinal 
epidural metastases.  
Quantitative – 
prospective 
Sample, characteristics, patient 
or staff groups 
Methods Key messages Evidence 
Patients with paraplegia due to 
epidural metastatic spinal cord 
compression.  Patients with poor 
prognosis were excluded. 
 
 
Compared paraplegic patients 
(n=12) who had 2 weeks of 
rehabilitation to a ‘No Rehab’ 
(n=30) historical control group. 
Depression was assessed with 
the Beck Depression Inventory-
Second Edition (BDI-II), 
Satisfaction with Life Scale 
(SWLS).  Patients were followed 
up by telephone contacts monthly 
and outpatient visits 3 monthly. 
  
Patients who received rehabilitation had longer survivals (26 weeks compared to 
6 weeks for patients who did not receive rehabilitation).  Fewer deaths from 
myelopathic complications, reduced pain level, lower depression scores and 
higher satisfaction with life.   26 patients (86.7%) out of the 30 patients in the ‘No 
Rehab’ group suffered clinical depression and were treated with anti-
depressants.  One patient from the rehabilitation group was diagnosed with 
depression. 
Highlights patients and carers coped better with structured rehabilitation 
programme.  However, patients with a short life expectancy were excluded.  
Psychological issues may not have been addressed or neglected in the ‘No 
Rehab’ group. 
 
SIGN level 2- 
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23. Ruff, R.L., Ruff, S.S. & Wang, X. 2007b USA Neurology Service To determine whether the benefits of directed 
rehabilitation for pain, depression, and satisfaction with 
life, persisted for patients who were non ambulatory after 
spinal epidural metastases treatment. 
Quantitative – 
prospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
See the description of previous study 
(Ruff et al. 2007a). 
This article reports on the patients’ pain 
level for the remainder of their lives. 
Expand on the previous study 
on the patient reported 
outcome for pain levels, 
depression, and satisfaction 
with life. 
Patients in the rehabilitation group had lower depression score two weeks after 
completion of treatment and until death (minimal to mild depression).  The ‘No 
Rehab’ group had severe depression.  Patients who received rehabilitation 
reported less pain, consumed less analgesics, were less depressed and had 
higher satisfaction scores compared to the ‘No Rehab’ group. 
Same comments as above. 
SIGN level 2- 
 
Author Year Country Care setting  Aim Type of study 
24. Tan, M. & New, P.W. 2012 Australia In-patient Spinal 
Rehabilitation Unit 
To examine the rehabilitation outcomes for patients with 
spinal cord injury (SCI) due to tumour, the impact of pain 
on disability and length of stay. 
Quantitative- 
retrospective 
cohort case series 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients with spinal cord injury due to 
tumour. 
Review 108 patients’ medical 
notes.  The median age of 
patients was 61.5 years 
(interquartile range 53.6-74).  
Functional Independence 
Measure (FIM) scores, 
documented presence of pain 
and analgesia and length of 
stay. 
Patients with secondary tumours causing spinal cord injury have problems with 
pain which affected their outcome and progress in rehabilitation.  However, they 
do benefit from a focused specialised rehabilitation programme with careful 
patient selection.  The authors suggest balancing the goals of rehabilitation due 
to the patients’ short life expectancy. 
The authors did not describe the support, length and specific details of 
their rehabilitation program.  Patients who were perceived to have 
prognosis of less than 3 months were excluded from the study.   
SIGN level 3 
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25. Eva, G., Paley, J., Miller, M. & Wee, B.  2009 UK NHS Region To ascertain patients’ constructions of disability as a 
result of MSCC. 
Qualitative, 
longitudinal case 
studies 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Semi-structured interviews with 
patients, carers and health 
professionals. 
 
 
 
 
 
Used semi-structured 
interviews with Adapted 
Pawson and Tilley’s Context-
Mechanism-Outcome (CMO) 
for data collection. George and 
Benett’s (2004) process 
tracing for within-case analysis 
and Glaser and Strauss (1967) 
for between-case analysis.   9 
patients, 6 carers and 29 
health care staff participated in 
the study. 
Patients oscillate between acknowledging and not acknowledging their disability. 
The “failure to acknowledge” seemed to be a positive illusion and have 
psychological benefits for patients.  Understanding the patients’ construction of 
disability can help to inform the rehabilitation needs of patients with MSCC.  
There was no information about each patient’s carer or family members and 
healthcare professionals’ views on how they dealt with this ambiguity. 
Little evidence on whether the patient had an understanding of their poor 
prognosis.  No evidence of end-of-life discussions.  The time points of 
follow up were not stated.  The use of Glaser and Strauss (1967) may not 
capture the broader issues of the patients’ experience. 
SIGN level 3 
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Appendix 5:  Summary of study – Carers’ experience supporting the patient with MSCC 
Author Year Country Care setting  Aim Type of study 
1. Fujibayashi, S., Neo, M., Miyaki, K., 
Nakayama, T. & Nakamura, T. 
2010 Japan Department of 
Orthopaedic 
Surgery and related 
hospitals 
To evaluate the value of palliative surgery for spinal 
metastases and to identify the factors predicting 
satisfaction of patients and their family members after 
surgery. 
Quantitative – 
prospective, 
survey 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients deemed fit with an expected 
survival of at least 3 months were 
eligible for the surgery.  The objective 
of the surgery was palliative.  Surgical 
approach total en bloc spondylectomy 
were excluded in the study.    
Questionnaire-based survey 
on satisfaction of patients and 
their family members 3 months 
after surgery.   37 patients 
responded to the 
questionnaires. 
80% of patients were satisfied with the outcome of surgery.  However, 16 of the 
responses were made by family members as the patients were dead at the time 
of completion of questionnaire (limitations - the views of patients and their family 
members may differ).  Improvement in pain after surgery.  Patients aged below 
65 years with neurological improvement correlated with increased patient 
satisfaction.  Satisfaction of family members was influenced by pain 
improvement and length of the patient survival.  The authors highlight that 
Japanese patients tend to trust their physicians to make decisions, however, in 
this study, the decisions were made by the patients in 23 cases, by patient and 
family in 12 cases, by family alone and by physician 1 case each.    
Thirty-seven (37 of 71) patients responded.  Patients and carers who did 
not respond may have been unsatisfied or had poor outcomes.  
Information about patients’ expectations of treatment and physician 
treatment intent was not discussed.    
SIGN level 3 
 
 
 
 
 
 
 
 
322 
 
Appendix 6:  Summary of studies - Healthcare professionals’ experiences in managing patients with 
MSCC 
 
Author Year Country Care setting  Aim Type of study 
1. Yamashita, T., Aota, Y., Kushida, K., 
Murayama, H., Hiruma, T., Takeyama, M., 
Iwamura, Y. & Saito, T. 
2008 Japan Department of 
Orthopaedic 
Surgery 
To investigate the short-term function recovery and 
duration of improvement after palliative surgery, to 
correlate these outcomes with the revised Tokuhashi’s 
(2005) score, and to examine the relationship between 
function and neurologic deterioration. 
Quantitative - 
retrospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Patients’ medical records were 
analysed.  The criteria for surgery was 
life expectancy of more than 3 months. 
 
Reviewed 86 patients’ clinical 
charts. Used the Eastern 
Cooperative Oncology Group 
Performance Status (ECOG-
PS) to assess patient’s 
physical function prior to 
surgery and at monthly time-
point post surgery. The mean 
follow up was 14 months 
(range, 4.0– 36.0) 
Patients with vital organ metastases have shortened duration of improvement (P 
<0.05).  The patient’s post surgical physical function is strongly dependent on 
neurological status.  The authors found the revised Tokuhashi’s (2005) score 
was helpful in predicting short-term improvement in physical function after 
palliative surgery.  The authors suggest more information on the natural 
progression of MSCC with palliative care only and non-surgically treatment are 
required.  Patients who might benefit from surgery are those who still have 
effective adjuvant therapies, for example, in breast or prostate cancers.  The 
author suggests physicians who are planning optimal treatment for their patients 
should also consider the primary cancer types when helping patients and their 
families make informed decisions. 
The palliative treatment intent is often not discussed with patients and/or 
family members.    
SIGN level 3 
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2. Tancioni, F., Navarria, P., Pessina, F., 
Marcheselli, S., Rognone, E., Mancosu, P., 
Santoro, A. & Baena, R.R.Y. 
2010 Italy Department of 
Neurosurgery 
To assess the impact of a multi-disciplinary approach for 
treatment of patients with MSCC in terms of feasibility, 
local control and survival. 
Quantitative -  
retrospective 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Study period January 2004 and 
December 2007. 
89 consecutive patients were 
included in the study. 
Good pain relief was achieved in the majority of patients (91%).  Local relapse 
occurred in 10%.  Median survival was 11 months (range, 0-46 months).  The 
types of primary tumour significantly affect the survival.  The combination of 
surgery plus radiotherapy is feasible and provides benefits for patients.  The 
authors suggest the importance of discussing each case within a multi-
disciplinary team in implementing the most appropriate treatment approach. 
Decision making often did not involve patient participation.  Therefore, 
patients may not have an understanding of the treatment intent. 
SIGN level 2- 
 
 
Author Year Country Care setting  Aim Type of study 
3. Pease, N.J., Harris, R.J. & Finlay, I.G. 2004 UK Hospital To develop a care pathway for the management of 
patients with MSCC 
Audit 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Audit was carried out pre 
implementation and post 
implementation of care pathway. 
Audit  Lack of supporting evidence to detect spinal instability.  Used clinical features 
such as mechanical pain and neurological changes and radiological findings as 
indicators for assessing spinal stability.  Compared two audits and found that 
mobilisation does not appear to jeopardise patient’s neurological function.  The 
authors suggest the use of collars and braces to provide functional 
independence, increased sense of control and reduce pain.  Early mobilisation 
resulted in decreased complications rate and increase in patient survival.   
Although reported that patients’ quality of life was improved, this was an 
anecdotal finding.  Patients’ perspective of their care was not explored. 
Criteria of spinal stability for the purpose of mobilising the patients are 
unclear.   
Audit 
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Author Year Country Care setting  Aim Type of study 
4. Warnock, C., Cafferty, C., Hodson, S., 
Kirkham, E., Osguthorpe, C., Siddall, J., 
Walsh, R. & Foran, B. 
2008 UK Regional cancer 
centre 
To evaluate the care of patients with MSCC Audit 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Two-linked study: a staff 
questionnaire and retrospective audit 
of medical and nursing 
documentation.  
Questionnaire topic includes: mobility 
during and after treatment; referral 
and treatment pathways; steroid 
prescription patterns; patient 
problems during admission; bowel 
and bladder management; 
psychological support and the impact 
of MSCC on sexuality.   
Review of patients’ medical 
notes and questionnaire to staff. 
50 patients’ notes were 
reviewed (38 male and 12 
female).  The mean age was 68 
(range, 42-91).  The majority of 
patients (43) were aged over 60 
years.  
Fourteen (66%) consultants, 10 
(71%) specialist registrars and 
32 (30%) nurses responded to 
the questionnaire. 
There are delays in diagnosis. The average time from diagnosis of cancer to 
onset of MSCC was 24 months (range, 0 days -11 years).  In the majority of 
patients there was no significant change in functional status after treatment.  The 
majority of patients were nursed flat during their radiotherapy treatment.  There 
was a discrepancy between the medical and nursing staff on issues on mobility 
during the treatment period and documentation practice. 
Documentation revealed patients suffered low mood, anxiety, being tearful and 
this was often related to loss of independence, being incontinent, and in pain.  
The authors suggest a need to develop a clear guideline on mobility, assessing 
spinal stability and early referral pathway to the physiotherapists.   
The evaluation reflected that the majority of patients were elderly.  Review 
of patients’ notes may not capture an in-depth understanding of the 
patient’s concerns and needs.    
Audit 
 
Author Year Country Care setting  Aim Type of study 
5. Kilbride, L., Cox, M., Kennedy, C.M., Lee, 
S.H. & Grant, R. 
2010 Non 
applicable 
Non applicable To explore the main issues which surround the 
management of patients with MSCC. 
Literature review 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Literature review to address issues 
around: (1) how is spinal stability 
assessed; (2) what is the role of 
bracing/should braces be used; (3) 
when is it safe to mobilise the patients 
and (4) what position should the patient 
be nursed in. 
35 studies met criteria and 
were reviewed.   
Most of the articles were retrospective and of a descriptive nature.  The review 
identified a gap in evidence relating to spinal stability, bracing, patient positioning 
and mobilisation.   
The reviewers suggest further studies to investigate whether imaging and clinical 
correlated to spinal instability; patient’s quality of life issues; clarifying positioning 
and mobilisation from the patients and healthcare professionals’ perspectives 
and possibly a randomised controlled trial to determine the efficacy and 
functionality of bracing.   
Current evidence on positioning, mobilisation and the use of bracing is 
limited and inconclusive.  The preferences of patients with a poor 
prognosis and their quality of life are paramount and healthcare 
professionals need to help patients decide on their care and treatment.   
SIGN level 2++ 
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Author Year Country Care setting  Aim Type of study 
6. Lee, S.H., Cox, K.M., Grant, R., Kennedy, C. 
& Kilbride, L. 
2012 Non 
applicable 
Non applicable To investigate the correct positioning (or mobilisation) 
and examine the effects of spinal bracing to relieve pain 
or to prevent further vertebral collapse in patients with 
MSCC 
Cochrane 
systematic review 
Sample, characteristics, patient or 
staff groups 
Methods Key messages Evidence 
Cochrane systematic review of 
randomised controlled trials of 
interventions on positioning or 
mobilisation and bracing. 
No studies met the inclusion 
criteria. 
Guidelines recommend the use of spinal orthosis to relieve pain and increase 
spinal stability.  Spinal bracing may provide comfort and quality of life for some 
patients with MSCC.  The reviewers did not identify any studies that would 
guide healthcare professionals in decision making in this area.   
There is a lack of evidence to inform the effectiveness of bracing for 
patients with MSCC.   
SIGN level 1+ 
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Appendix 7: Topic guide - Healthcare professionals 
The opening  
 Welcome and thank you for coming to this focus group session. 
 This session will take no more than an hour. 
 You are free to withdraw at any point. 
 Ensure you have signed the consent form. 
 Recording discussion – confidentiality will be maintained. 
 Let’s begin by briefly introducing yourself: 
- Name (for the purpose of transcribing) 
- Professional post 
 Purpose of this focus group 
(Refer to flip chart on the research title, background to the study and purpose of 
the focus group session) 
 
Research title:  A case study to explore the management of patients with metastatic 
spinal cord compression (MSCC) 
 
Background to the study: 
The literature I have found so far indicated: 
 There are differences in the treatment of MSCC. 
 There are inconsistencies in patient management. 
 Lack of patients’ and carers’ information on their experience. 
The purpose of interview is: 
1. To gather information about your perspective in delivering care to patients 
with metastatic spinal cord compression. 
And 
2. To determine any particular issues that you would like me to explore further 
with patients and carers. 
 Ground rules 
- Everyone’s opinion are important 
- Everyone has an opportunity to speak 
- There are no right or wrong answers; even negative comments are useful in 
gaining insight about the topic in discussion 
- Please feel free to express your opinion openly 
- Are there any questions before I start? 
The interview questions 
I would like to open to the group by asking:  
1) Do you have any issues or opinions/thoughts from your experience in caring for 
patients with MSCC? 
(If no response, then I will make a start at the point of referral of patients) 
 
2) Referrals of patients with MSCC 
I know there are several ways patients are referred for MSCC.  
 Can you tell me your experience of the referral process? 
 
3) Investigations 
 Do you have any opinions about the various diagnostic investigations used for 
this group of patients? 
            Prompt: MRI, CT scan, X-rays 
 
4) Clinical managements of patients with MSCC 
There are several treatments in the management of patients with MSCC.  
 Can you tell me about the treatment offered to patients? 
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 Prompts: - Corticosteroids 
  - Radiotherapy 
  - Surgery 
  - Spinal stability/instability 
  - Mobility and rehabilitation 
 
Literature suggests that the patient’s and carer’s perspectives of care in MSCC are not 
well represented.  What do you think are the important aspects of care for the patients 
and carers? 
(If participant discuss the above questions and covers physical care, psychological 
and supportive needs, then I would not ask question 4 and 5 below) 
5) Physical care and psychological needs 
 Can you tell me how you tend to discuss the likely physical symptoms that a 
patient may face in the future?  
 Can you tell me how you would address patient’s psychological needs? 
 
6) Information  and supportive needs of patients or those close to them 
Discussing the future where no cure is possible can often be difficult. 
 Can you tell me how you tend to approach questions about the future? 
 Can you tell me how you tend to address patient’s support needs? 
 Can you tell me who do you involve? 
 Can you tell me where does the support come from? 
 
7) Focus group with GPs, District Nurses and Palliative Care Nurses 
I am going to have a focus group session with GPs, District Nurses and Palliative 
Care Nurses.   
 What aspects of care do you think might be valuable for me to discuss with 
them? 
8) Is there anything else you would like to add? 
The wrap-up 
 Thank you for taking your time to attend this focus group session. 
 The information gathered today will help to generate questions for the patients, 
carers and healthcare professionals. 
 You would receive a summary of the discussion. 
 Before we end this session, I would like you to answer 2 questions on a piece of 
paper. 
1. Can you write down one issue that stood out for you that is really important in the 
care of patients with MSCC? 
2. Can you write down one thing that stands out to you about the value of having a 
focus group? 
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Appendix 8: Interview schedule 1 – Patient 
Introduction 
 Patient consent  
 Ensure patient is happy to go ahead with interview. 
 Ensure patient is comfortable. 
 Briefly go through information sheet. 
 Go through consent form and ensure it is signed (emphasise confidentiality). 
 This session will take no more than an hour. 
 You are free to withdraw at any point. 
 Recording interview – confidentiality will be maintained. 
 Please feel free to express your opinion openly. 
 
 Purpose this interview 
 In this interview, I am particularly interested to understand your views about 
your illness and some of the problems you may experience.    
 Aim of this interview 
 I am interested in hearing your thoughts or opinions about your experience of 
your illness in your own words.   
 
 Are there any questions or concerns before I start? 
The interview questions  
General questions  
I would like start by asking:   
1. Do you have any issues or opinions or thoughts about your experience of 
your illness? 
2. Can you describe to me your experience of the symptoms? 
Prompts: 
Can you tell me how much you are able to do at the moment? 
 Are there things that you find difficult to do as a result of your illness? 
 What is your pain score in the last 24 hours? 
 Were you given any information about positioning and mobility? 
 Was there any help that you needed? 
 Were you given any help that you needed? 
3.  Can you tell me any issues/concerns/worries that you had at that time? 
Prompts: 
 What were they? 
 How did you deal with them? 
 Were you offered any help in dealing with these issues? 
4. Can you tell me what kind of support were you offered? 
Prompts 
 Did you receive adequate support at this time? 
 Was the support helpful/unhelpful? 
 What are the things that are important to you? 
 What sort of support would have helped you best during your first week? 
 Were your family involved in this support needs? 
Specific questions 
5. Can you tell me your understanding of your diagnosis, treatment and advice 
given to you on your illness? 
 What is your understanding of your diagnosis? 
 What is your understanding of your prognosis? 
 Do you have enough information about your prognosis? 
 Can you tell me whether knowing the prognosis is important for you? 
 When do you think this should be discussed? 
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 Does your cord compression (paralysis) give you an idea about your 
prognosis? 
 What is your understanding of your treatment you have received? 
 What is going to happen to you next in relation to treatment? 
 Can you tell me how you feel about the amount of information you have 
been given? 
 Have you been given information on the risk of cord compression? 
 Can you tell me about your information expectations? 
 If you need information, what format do you think would be best for you? 
6. Finally, I need to understand whether these questions actually relate to the 
issues that you think are important to you. 
 Am I asking the right questions? 
 Did these questions relate to your own experience? 
 Did these questions allow you to talk about what are really important to you? 
7. Is there anything else you would like to add? 
The wrap-up 
 Thank you for your time. 
Before I end this session, I would like you to answer 2 questions on a piece of paper. 
 
1. Can you list the things that are really important to you with the most important first? 
 
2 Can you write down one thing that stands out to you about the value of having this 
interview? 
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Appendix 9: Interview schedule 2 – Patient 
Introduction 
 Patient consent  
 Ensure patient is happy to go ahead with interview. 
 Ensure patient is comfortable. 
 Briefly go through information sheet. 
 Go through consent form and ensure it is signed (emphasise confidentiality). 
 Inform patient that participating in this interview will not affect their care or 
treatment. 
 This session will take no more than an hour. 
 You are free to withdraw at any point. 
 Recording interview – confidentiality will be maintained. 
 Please feel free to express your opinion openly. 
 
 Purpose this interview 
 In this interview, I am particularly interested to check my understanding of your 
views about your illness and anything you want to add since our last interview.     
 
 Are there any questions or concerns before I start? 
The interview questions  
General questions  
I would like start by asking:   
1. Can you tell me whether there is anything additional you would like to tell me 
about your illness since we last met? 
2. Can you tell me how you feel about things that are happening at the moment? 
3. Can you tell me about any symptoms and how they affect you now? 
Prompts: 
 Can you tell me how much you are able to do at the moment? 
 Can you tell me how has the treatment helped with your symptoms? 
 Are there things that you find difficult to do as a result of your illness? 
 What are the activities that make you feel more/less comfortable? 
 Are you experiencing any difficulties lying down, sitting or walking? 
 If so what has been done to help you? 
 Was there any help that you needed? 
4.  Can you tell me what is most prominent (or focussed) in your mind at the 
moment?  
Prompts: 
 What are they? 
 How are you dealing with them? 
 Were you offered any help/contact in dealing with these issues/concerns? 
 In comparison with the time of your admission, can you tell me how you feel 
now? 
5. Can you tell me what kind of support were you offered? 
Prompts 
 Did you receive adequate support at the moment? 
 Was the support helpful/unhelpful? 
 What are the things that are important to you now? 
 What sort of support would have helped you best at the moment? 
 Were your family involved in this support needs? 
 What do you think of the care you received when you were in the hospital? 
6. What do you know your illness? 
(If patient discuss diagnosis and prognosis) 
 What is your understanding of your diagnosis/prognosis now? 
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 What is your understanding of your care and treatment you have received? 
 What is going to happen to you next in relation to your care and treatment? 
7. Can you tell me how you feel about the amount of information you have been 
given on discharged? 
 Do you feel that you still have links with the hospital? 
 Were you given enough information for next appointment? 
 How do you feel about the information you have been given so far? 
8. Finally, I need to understand whether these questions actually relate to the 
issues that you think are important to you. 
 Am I asking the right questions? 
 Did these questions relate to your own experience? 
 Did these questions allow you to talk about what are really important to you? 
9. Is there anything else you would like to add? 
The wrap-up 
 Thank you for your time. 
 
Before I end this session, I would like you to answer 2 questions on a piece of paper. 
 
1.  Can you list the things that are really important to you with the most important first 
and the least important last? 
2. Can you write down one thing that stands out to you about the value of having this 
2nd interview? 
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Appendix 10:  Interview schedule 1 – Carer 
Introduction 
 Carer consent  
 Ensure carer is happy to go ahead with interview. 
 Briefly go through information sheet. 
 Go through consent form and ensure it is signed (emphasise confidentiality). 
 Inform patient that participating in this interview will not affect their care or 
treatment. 
 This session will take no more than an hour. 
 You are free to withdraw at any point. 
 Recording interview – confidentiality will be maintained. 
 Please feel free to express your opinion openly. 
 
 Purpose this interview 
 In this interview, I am particularly interested to understand your views on 
[patient’s name] illness and some of the problems that you may experience in 
caring for [patient’s name].    
 Aim of this interview 
 I am interested in hearing your thoughts or opinions about your experience in 
caring for [patient’s name] in your own words.   
 
 Are there any questions or concerns before I start? 
The interview questions  
General questions  
I would like start by asking:   
3. Can you tell me whether you have any issues or opinions or thoughts from 
your experience in caring for [patient’s name] illness? 
4. Can you describe to me how you feel about these changes in [patient] at the 
moment? 
Prompts 
 Describe why you feel this way? 
 Was there any help that you needed? 
 Were you given any help that you needed?  
 Can you give me your opinion of what sort of support would have helped you 
cope best? 
 
5. Can you tell me any issues/concerns/worries that you have at this time? 
Prompts: 
 What are they? 
 How are you dealing with them? 
 Are there things that you find easier/difficult in supporting [patient]? 
 What were the main issues you had to deal with? 
 Were you offered any help in dealing with these issues? 
6. Can you tell me what kind of support you were offered? 
Prompts 
 Did you receive adequate support at the moment? 
 Was the support helpful/unhelpful? 
 What are the things that are important to you? 
 What sort of support would have helped you best at the moment? 
 Were you involved in discussion of [patient] support needs? 
7. Can you tell me what you know about [patient] illness? 
Prompts: 
(If carer discuss diagnosis and prognosis) 
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a. What is your understanding of [patient] diagnosis/prognosis? 
b. When do you think this should be discussed? 
c. What is your understanding of [patient] care and treatment? 
d. Can you tell me what is going to happen to [patient] next in relation to care 
and treatment? 
8. Can you tell me how you feel about the amount of information you have been 
given? 
a. Can you tell me about your information expectations? 
b. If you need information, what format do you think would be best for you? 
9. Finally, I need to understand whether these questions actually relate to the 
issues that you think are important to you. 
a. Am I asking the right questions? 
b. Did these questions relate to your own experience? 
c. Did these questions allow you to talk about what are really important to you? 
10. Is there anything else you would like to add? 
 
The wrap-up 
 Thank you for your time. 
 
Before I end this session, I would like you to answer 2 questions on a piece of paper. 
1. Can you list the things that are really important to you in caring for [patient] with the 
most important first and the least important last? 
2. Can you write down one thing that stands out to you about the value of having this 
one-to-one interview? 
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Appendix 11: Interview schedule 2 – Carer 
Introduction 
 Carer consent  
 Ensure carer is happy to go ahead with interview. 
 Briefly go through information sheet. 
 Go through consent form and ensure it is signed (emphasise confidentiality). 
 Inform patient that participating in this interview will not affect their care or 
treatment. 
 This session will take no more than an hour. 
 You are free to withdraw at any point. 
 Recording interview – confidentiality will be maintained. 
 Please feel free to express your opinion openly. 
 
 Purpose this interview 
 In this interview, I am particularly interested to understand your views on 
[patient’s name] illness and some of the problems that you may experience in 
caring for [patient’s name].    
 Aim of this interview 
 I am interested in hearing your thoughts or opinions about your experience in 
caring for [patient’s name] in your own words.   
 
 Are there any questions or concerns before I start? 
The interview questions  
General questions  
I would like start by asking:   
1. Can you tell me whether you have any issues or opinions or thoughts from 
your experience in caring for [patient’s name] illness since the last time I saw 
you? 
2. Can you describe to me how you feel about these changes in [patient] since 
our last interview? 
Prompts 
 Describe why you feel this way? 
 Was there any help that you needed? 
 Were you given any help that you needed?  
 Can you give me your opinion of what sort of support would have helped you 
cope best? 
3. Can you tell me what is the most prominent (or focus) in your mind at the 
moment?  
Prompts: 
 What are they? 
 How are you dealing with them? 
 Are there things that you find easier/difficult in supporting [patient]? 
 What were the main issues you had to deal with? 
 Were you offered any help in dealing with these issues? 
4. Can you tell me what kind of support you were offered since the last time I 
saw you? 
Prompts 
 Did you receive adequate support at the moment? 
 Was the support helpful/unhelpful? 
 What are the things that are important to you? 
 What sort of support would have helped you best at the moment? 
 Were you involved in discussion of [patient] support needs? 
5. Can you tell me what you know about [patient] illness? 
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Prompts: 
(If carer discuss diagnosis and prognosis) 
 What is your understanding of [patient] diagnosis/prognosis? 
 When do you think this should be discussed? 
 What is your understanding of [patient] care and treatment? 
 Can you tell me what is going to happen to [patient] next in relation to care 
and treatment? 
6. Can you tell me how you feel about the amount of information you have been 
given since [patient] discharge from hospital? 
 Do you feel that you still have links with the hospital? 
 Were you given enough information for [patient] next appointment? 
 Can you tell me about your information expectations? 
 If you need information, what format do you think would be best for you? 
7. Finally, I need to understand whether these questions actually relate to the 
issues that you think are important to you. 
 Am I asking the right questions? 
 Did these questions relate to your own experience? 
 Did these questions allow you to talk about what are really important to you? 
8. Is there anything else you would like to add? 
 
The wrap-up 
 Thank you for your time. 
 
Before I end this session, I would like you to answer 2 questions on a piece of paper. 
1. Can you list the things that are really important to you in caring for [patient] with the 
most important first and the least important last? 
2. Can you write down one thing that stands out to you about the value of having this 
one-to-one interview? 
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Appendix 12: Interview schedule – Healthcare professionals 
The opening 
 Introduction 
 This session will take no more 30 minutes. 
 You are free to withdraw at any point. 
 Ensure you have signed the consent form. 
 Recording discussion – confidentiality will be maintained. 
 Let’s begin by briefly introducing yourself: 
 Name (for the purpose of transcribing) 
 Professional post 
Purpose of this interview 
Research title:  A case study to explore the management of patients with metastatic 
spinal cord compression (MSCC) 
 
 The management of MSCC is an area we know little about. 
 
The purpose of interview is: 
 To gather information about your perspective in delivering care to patients with 
metastatic spinal cord compression. 
 To determine any particular issues that you would like me to explore further with 
patients and carers. 
 There are no right or wrong answers; even negative comments are useful in 
gaining insight about the topic in discussion 
 Please feel free to express your opinion openly 
 Are there any questions before I start? 
The interview questions   
I would like start by asking:   
1. Can you tell me about [patient’s name] illness? 
2. Can you outline what you feel is the most effective overall management plan this 
patient can be offered?  
3. Regarding mobilisation, what instruction or advice have you been able to give the 
nursing staff?   
 Is this your usual advice? 
 And what advice can you give the patient and their family regarding 
mobilisation? 
 How do you think mobilisation will affect patient’s situation? 
4. Moving on to other aspects of the patient’s management, has any prophylaxis to 
prevent possible DVT been used? 
5. What role do you feel surgery might have? 
6. What do you feel about the patient having an orthosis or brace? 
7. What do you regard as the more challenging areas in making decisions with this 
patient on both their care and their treatment? 
 Are these the kind of challenges that occur most often with your MSCC patient? 
 
Literature suggests that the patient’s and carer’s perspectives of care in MSCC are not 
well represented.  What do you think are the important aspects of care for the patients 
and carers? 
 
8. Physical care and psychological needs 
 Can you tell me how the likely physical symptoms that a patient may face in the 
future should be discussed?  
 Can you tell me how you would address patient’s psychological needs/end of 
life issues? 
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9. Information  and supportive needs of patients or those close to them 
 
Discussing the future where no cure is possible can often be difficult. 
 Can you tell me how you tend to approach questions about the future? 
 Can you tell me how you tend to address patient’s support needs? 
 Can you tell me who do you involve? 
 Radiological predictors 
 
10. Interviews with GPs, District Nurses and Palliative Care  
      Nurses 
 
11. Is there anything else you would like to add? 
The wrap-up 
 Thank you for your time. 
 
Before we end this session, I would like you to answer 3 questions. 
1. Can you write down one issue that stood out for you that is really important in the 
care of patients with MSCC? 
2. Can you write down one issue that stood out for you that is really important in the 
care of [patient’s name]? 
3. Can you write down one thing that stands out to you about the value of having this 
one-to-one interview? 
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Appendix 13: Lothian Research Ethics Committees Approval 
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Appendix 14: Lothian Research and Development approval 
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Appendix 15: Information sheet – Healthcare professional 
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Appendix 16: Consent form – Healthcare professional 
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Appendix 17: Invitation letter – Patient/Carer 
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Appendix 18: Information sheet – Patient/Carer 
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Appendix 19: Consent form – Patient/Carer 
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Appendix 20: Information letter – General Practitioner 
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Appendix 21:  Ladder of abstraction in theory development  
The ladder of abstraction in middle range theory was used to illuminate the 
theoretical constructs which have emerged from this study.  The ladder of 
abstraction is a structure that maps the levels of discourse or different ways of 
describing ideas as seen below (Figure 18).   
 
The lowest rung of the ladder represents the discourse at the practice level 
(empirical level) through the senses of perceptions gathered through narratives, 
field notes, observations and documentations which bring about a theory to 
explain a phenomenon (Smith and Liehr 2008).  For example, in this study, the 
perceptions of patients, carers and healthcare professionals were gathered 
through interviews, focus groups, documentation, field notes, policies, and 
guidelines to explain about MSCC.   
 
The next level up the ladder is the theoretical level which is represented by 
concepts that characterise, define, provide clarity and facilitate the 
understanding of the phenomena of MSCC.  This move from empirical level to 
theoretical level in understanding the phenomena involved inductive reasoning.  
In the current study, the concepts emerge from both phases of the study, 
literature review, scoping exercise, policies, guidelines and the wider literature.  
Finally, the philosophical level represents the highest level of assumption, 
beliefs, perspectives and points of view.  The interactive – integrative paradigm 
describes persons as shared interacting entities, changes as probabilistic and 
related to multiple factors grounded in the perspective of social sciences (Smith 
and Liehr 2008). 
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Figure 18: Ladder of abstraction (adapted from Smith and Liehr 2008) 
 
Interactive - integrative paradigm 
 
   Assumption of the theory 
 A critical window of opportunity exists in recognising  
signs and symptoms of a threatening condition. 
 Balancing acute interventions with progressive 
advanced disease. 
 Patient and carer require opportunities to  
collaborate in decisions at the end of life. 
 Prioritising and maximising patient preferences 
 in the midst of acute intervention. 
 Transition from acute care to palliative care. 
  
    Concepts of the middle range theory  
(Identified from Figure 17) 
    
Significant event 
       Awareness 
   Collaborative decision making 
   Prioritising and maximising life 
   End-of-life care       
 
   Practice   Research  
(Identified in Figure 16) 
      
      Offer timely information               Findings from this thesis  
      Shared decision making     Evidence is not static 
      Negotiate support 
     
       
 
Starting at the bottom of the ladder there are four key activities evident at the 
initial stages of MSCC.  Recognising the onset by patients, carers and 
healthcare professionals is linked to identifying the symptoms.  Decision making 
at the initial stages is often rapid and complex and opportunities to involve the 
views of all stakeholders difficult.  Analysis of data in this study supports five 
key concepts (Figure 17) which are central to managing MSCC and the 
uncertainty which permeates this condition.  The onset of MSCC is a significant 
event which involves individualised management and decision making.  
Decision making should be linked to the priority outcomes for patients.  The 
underpinning assumptions of this theory illuminate the complexity of managing 
MSCC. 
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There is potential for this theory to be refined and tested in a range of long term 
conditions which have acute manifestation such as acute cardiac condition, 
bleeding in patients with advanced cancer, pancreatic cancer and cystic 
fibrosis.  For example, haemorrhaging may occur as a significant event in up to 
10% of patients with advanced cancer (Pereira and Phan 2004).  It needs 
tested further and refined in MSCC. 
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354 
 
 
 
 
 
 
 
 
355 
 
 
 
 
 
 
 
 
 
356 
 
 
 
 
 
 
 
 
 
357 
 
 
 
 
 
 
 
 
 
358 
 
 
 
 
 
 
 
 
 
359 
 
 
 
 
 
 
 
 
 
360 
 
 
 
 
 
 
 
 
361 
 
 
 
 
 
 
 
 
 
362 
 
 
 
 
 
 
 
 
 
363 
 
 
 
 
 
 
 
 
 
364 
 
 
 
 
 
 
 
 
 
365 
 
 
 
 
 
 
 
 
 
366 
 
 
 
 
 
 
 
 
 
367 
 
 
 
 
 
 
 
 
 
368 
 
 
 
 
 
 
 
 
 
369 
 
 
 
 
 
 
 
 
370 
 
Appendix 23:  Publication 2 
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